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ABSTRACT 
 In neuropsychological assessment, performance validity tests (PVTs) are used to assess 
whether patients’ performances on cognitive testing represent their true ability levels. Higher 
base rates of PVT failure (BRFail) have been consistently found in the context of external 
incentives to appear impaired (e.g., medical-legal settings) as compared to settings without such 
incentives (e.g., clinical referrals). Despite the exponential growth of interest and empirical 
research on PVTs within the past decades, most studies have had relatively limited sample sizes 
and focused on a small number of instruments and clinical populations. To address this void in 
large-scale research, this dissertation aimed to characterize performance on 14 PVTs of interest 
(3 free-standing PVTs and 11 embedded validity indicators) in a large sample of adults assessed 
in a predominantly medical-legal setting (N = 4,721). Specifically, BRFail were reported as a 
function of several patient characteristics (i.e., diagnosis, age, education, gender, and English 
language status) in the overall sample (Study 1) and in a subsample demonstrating valid 
performance on an external criterion PVT (the Word Memory Test [WMT], Study 2). 
Classification accuracies for various cutoffs on each PVT of interest were also investigated 
against the WMT (Study 3). In Studies 1 and 2, free-standing PVTs tended to be more robust to 
the effects of patient characteristics than embedded validity indicators. In Study 3, the majority 
of previously published cutoffs for PVTs of interest achieved acceptable specificity, with three 
isolated exceptions. Free-standing PVTs demonstrated better classification accuracy than 
embedded validity indicators, although no PVT achieved perfect classification accuracy. Taken 
together, the results of this dissertation highlight the importance of using multiple PVTs and 
interpreting individual PVT scores in the context of patient characteristics rather than by rigidly 
adhering to omnibus cutoffs. 
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CHAPTER 1 
Introduction 
 Neuropsychological assessment involves the administration of psychometric tests to 
evaluate cognitive and emotional functioning. The test results, in turn, are integrated with other 
relevant data (e.g., behavioural observations, clinical history) in order to answer one or more 
referral questions (Strauss, Sherman, & Spreen, 2006). Neuropsychologists can make valuable 
contributions in clinical, medical-legal, and forensic settings using these methods. However, the 
major assumption underlying the use of psychometric measures in neuropsychology is that there 
is a relationship between an examinee’s behaviour, as measured by neuropsychological tests, and 
the condition of the brain (Lezak, Howieson, & Loring, 2004). 
 Any non-neurological factor that can affect performance on neuropsychological tests and 
thereby produce a skewed representation of the underlying brain-behaviour relationship can be 
considered a threat to the validity of neuropsychological test data (Greiffenstein, 2008). One 
such threat to validity that has received a great deal of attention in the research literature over the 
past few decades is invalid responding (Larrabee, 2000; Reynolds, 1998; Sweet, 1999). Invalid 
responding can manifest as exaggeration or fabrication of reported symptoms and/or the display 
of reduced abilities on cognitive performance measures (Larrabee, 2003; Heilbronner et al., 
2009). 
It is imperative to detect invalid responding on neuropsychological testing in order to 
maximize the validity of the test results and resulting conclusions. However, several studies have 
shown that neuropsychologists are inaccurate when asked to discriminate valid from invalid 
performance based on clinical judgment or scores on ability tests alone (e.g., Ekman, O’Sullivan, 
& Frank, 1999; Faust, 1995; Faust, Hart, Guilmette, & Arkes, 1988). Psychometric measures, on 
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the other hand, have proven to be quite effective in determining response validity (e.g., Larrabee, 
2003): symptom validity tests (SVTs) assess the extent to which the symptoms endorsed by 
examinees on a self-report measure reflect their true experience, while performance validity tests 
(PVTs) evaluate the degree to which examinees’ performance on cognitive tests reflects their 
true abilities (Larrabee, 2012). PVTs are further classified as free-standing (i.e., tests that were 
developed specifically for the purpose of evaluating performance validity and often do not assess 
any other cognitive functions) or embedded (i.e., indices derived from ability tests, which have 
been found to be useful in discriminating valid from invalid performance). 
 This dissertation consisted of three studies. Study 1 aimed to characterize performance on 
a total of 14 PVTs of interest (three free-standing and 11 embedded) in a large sample of patients 
assessed in a primarily medical-legal setting. Specifically, base rates of failure (BRFail) were 
reported at various cutoffs on each PVT of interest in the overall sample, as a function of 
performance on a well-validated criterion PVT (Green’s Word Memory Test or WMT; Green, 
2003), and as a function of five patient variables (i.e., diagnosis, age, education level, gender, 
English language status). Although Study 1 represented an important first step, considering the 
estimated 30% base rate of invalid performance for psychological assessment settings involving 
a mix of clinical and medical-legal referrals (Mittenberg, Patton, Canyock, & Condit, 2002), 
invalid performance represented a significant confound in Study 1 in terms of determining the 
true relationships between BRFail and patient variables. For example, if higher BRFail were to be 
observed among less educated examinees as compared to more educated examinees on a given 
PVT in Study 1, this finding could reflect (a) higher rates of invalid performance among the 
former group, (b) false positive errors, wherein the patients were performing credibly but failed 
the published cutoffs due to their low education levels, or (c) a combination of these outcomes. 
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Considering this, in Study 2, a subsample was created by retaining only those cases that passed 
the WMT at standard cutoffs, and data on the 14 PVTs of interest were analyzed in a similar 
manner to Study 1. Thus, Study 2 investigated BRFail on the 14 PVTs of interest in large sample 
of patients who had demonstrated clearly valid performance on an external criterion PVT. 
Finally, in Study 3, classification accuracy statistics were computed for various cutoff scores on 
each PVT of interest, again using the WMT as the criterion PVT. 
 The discussion below summarizes the existing literature that is relevant to the present 
dissertation. Topics discussed include: (1) an introduction to neuropsychological assessment and 
performance validity, (2) methods for detecting invalid responding, (3) use of PVTs in clinical 
practice including a brief discussion of malingering and the issue of intent, and (4) the PVT 
research base, its implications for practice, and its limitations. 
Neuropsychological assessment and validity 
 Neuropsychological assessment involves the integration of scores on standardized 
measures of cognitive performance with historical, neurological, psychiatric, medical, 
behavioural, and other relevant information for the purpose of answering one or more referral 
questions. Cognitive abilities that can be assessed in the course of a neuropsychological 
assessment include general intellectual functioning, executive functions, attention, memory, 
language, visual perception, sensory function (including somatosensory, olfactory, and body 
orientation), and motor function (Strauss et al., 2006). Scores on cognitive tests are often 
supplemented with self-report questionnaires or rating scales assessing an examinee’s mood, 
personality, and/or adaptive functioning. The results of psychometric testing are combined and 
interpreted in the context of the examinee’s clinical history to answer questions about diagnosis, 
patient care (management and planning), treatment (identifying treatment needs and/or 
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evaluating treatment efficacy), or medical-legal/forensic issues (Lezak, Howieson, Bigler, & 
Tranel, 2012). 
A major tenet underlying the practice of neuropsychology is that there is a relationship 
between an examinee’s behaviour, as measured by neuropsychological tests, and the condition of 
the brain (Lezak et al., 2004). In order to arrive at accurate diagnoses and make appropriate 
treatment recommendations, therefore, the clinician must first establish that the 
neuropsychological test data are valid—that they accurately represent the underlying brain-
behaviour relationships (Lezak et al., 2012; Suhr & Gunstad, 2002). 
Threats to the validity of neuropsychological test data. Non-neurological factors that 
affect an examinee’s performance on one or more neuropsychological tests, and thereby result in 
a misleading picture of the brain-behaviour relationship, represent threats to the validity of 
neuropsychological test data (Greiffenstein, 2008). While some threats to validity concern the 
assessor (e.g., professional competence, selection and use of assessment measures; Larrabee, 
2012), most threats relate to the examinee. These may include physical problems (e.g., vision or 
hearing deficits, difficulties with motor output), inattentiveness secondary to various causes, 
psychiatric conditions (e.g., depression, anxiety, schizophrenia), limited cooperation, and invalid 
responding (Heaton, Smith, Lehman, & Vogt, 1978; Larrabee, 1992; Reitan, 2001). 
Although numerous factors may jeopardize the validity of neuropsychological test data, 
the discussion here focuses exclusively on invalid responding. 
Detection of invalid responding 
In the context of neuropsychological evaluation, invalid responding may manifest as 
reduced capabilities on cognitive performance measures, exaggeration of symptom complaints 
on self-report measures, or both (Larrabee, 2003; Heilbronner et al., 2009). Not surprisingly, 
BASE RATES OF PVT FAILURE  5
invalid responding can alter substantially the emerging picture of the brain-behaviour 
relationship, resulting in an underestimate of the examinee’s true abilities and, ultimately, 
diagnostic error. Considering the potential consequences, it is imperative that neuropsychologists 
be able to detect invalid responding. 
Clinical judgment. Although clinical judgment was once thought to be sufficient to 
detect invalid responding, several empirical studies have shown that experienced experts are 
inaccurate when asked to identify valid versus invalid performances using behavioural 
observations or scores on cognitive ability tests alone (e.g., Ekman et al., 1999; Faust, 1995; 
Faust et al., 1988). According to Millis and Putnam (1996), clinical judgment is ineffective for 
detecting invalid responding because (1) response distortion is not evident when examining 
ability test data alone, (2) clinicians may under- or over-diagnose noncredible performance as a 
result of confirmatory bias or attribution error, and (3) upon establishing rapport with examinees, 
clinicians tend to overestimate their capacity to identify individuals who are motivated to 
perform poorly. 
As the limitations of clinical judgment have become apparent, researchers and clinicians 
have turned to psychometric measures to accomplish the task of identifying invalid responding in 
neuropsychological assessment. A large number of psychometric measures have shown promise 
in this regard. 
Psychometric measures. For many years, all psychometric measures used for the 
purpose of detecting invalid responding, including those designed to detect reduced capabilities 
on cognitive performance measures and those designed to identify exaggeration of symptom 
complaints on self-report measures, were called symptom validity tests (SVTs). Recently, 
however, Larrabee (2012a) argued for a shift in terminology. He defined symptom validity as the 
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extent to which examinees’ endorsements of symptoms on self-report measures reflect their true 
experience of those symptoms, and proposed that the term SVT be limited to psychometric 
indicators that detect invalid responding on self-report measures. The term performance validity, 
on the other hand, was defined as the extent to which examinees’ performance on cognitive tests 
represents their true abilities; accordingly, it was suggested that psychometric measures used to 
detect invalid performance on cognitive tests should be referred to as performance validity tests 
(PVTs). 
Research using factor analytic techniques has provided support for the SVT/PVT 
distinction proposed by Larrabee (2012a): indeed, PVTs and SVTs have been found to load on 
different statistical factors in multiple studies (Nelson, Sweet, Berry, & Bryant, 2007; Ruocco et 
al., 2008; Van Dyke, Millis, Axelrod, & Hanks, 2008). These results imply that performance 
validity and symptom validity should be evaluated independently, and that failure in one domain 
does not automatically invalidate the other domain (Van Dyke et al., 2008). Not surprisingly, 
modest correlations between performance validity and symptom validity have been reported in 
some studies (Haggerty, Frazier, Busch, & Naugle, 2007; Whiteside, Dunbar-Mayer, & Waters, 
2009). 
While it is recognized that both performance validity and symptom validity must be 
assessed in the course of a neuropsychological assessment, the discussion here is limited to the 
assessment of performance validity. 
Performance validity tests. PVTs are psychometric measures or indices that are designed 
to detect invalid performance on cognitive tasks. Broadly, there are two types of PVTs at the 
disposal of the neuropsychologist: (1) free-standing PVTs, which are developed specifically to 
evaluate performance validity and therefore, in most cases, do not assess any other cognitive 
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function, and (2) embedded validity indicators, which represent scores derived from standard 
tests of cognitive ability that were later calibrated as PVTs. 
Like cognitive ability tests, PVTs use continuous scales, where scores on one end of the 
scale indicate clearly valid performance and scores on the other end provide strong evidence of 
invalid performance. While scores on cognitive ability tests tend to be normally distributed, 
however, distributions of PVT scores are often skewed such that the majority of examinees 
perform well on these tests. Research has shown that potentially relevant nuances in performance 
validity can be identified by examining continuous scores on PVTs (Erdodi, 2017). However, the 
interpretation of PVT scores in practice is often based on dichotomous outcomes. A cutoff score 
is identified on the test, and scores representing better performance relative to the cutoff are 
interpreted as a Pass, while those representing worse performance are interpreted as a Fail.  
In order to be effective, PVTs must assess the credibility of an examinee’s performance 
while remaining unaffected by true cognitive impairment (Hartman, 2002) so that individuals 
with genuine cognitive dysfunction are not incorrectly identified as exhibiting invalid 
performance. Research has shown that PVTs are generally able to accomplish this task. Indeed, 
conditions like brain injury (e.g., Boone, Lu, & Herzberg, 2002a, 2002b; Green, 2003, 2004, 
2008; Macciocchi, Seel, Alderson, & Godsall, 2006; Slick, Hopp, Strauss, Hunter, & Pinch, 
1994; Tombaugh, 1997), learning disability (Boone, Lu, Herzberg, 2002a, 2002b; Hurtubise, 
Scavone, Sagar, & Erdodi, 2017), depression (Goldberg, Back-Madruga, & Boone, 2007), and 
aphasia (Tombaugh, 1997) are not typically associated with failure on PVTs. Failures have, 
however, been reported among more severely impaired populations (e.g., individuals with 
dementia or moderate-to-severe intellectual disability), suggesting that PVT failures provide 
weak evidence of invalid performance in such cases (Milanovich, Axelrod, & Millis, 1996). 
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Free-standing performance validity tests. Most free-standing PVTs employ a forced-
choice recognition paradigm: the presentation of target stimuli is followed by a recognition task 
in which each target is paired with one or more foils (non-targets) and the examinee is instructed 
to identify the target. Most commonly, each target is paired with one foil, resulting in a two-
alternative forced-choice task. The nature of stimuli varies between tasks and can include words 
(e.g., Green, 2003), digits (e.g., Binder & Willis, 1991; Binder, 1993a, 1993b), photographs (e.g., 
Warrington, 1984), and line drawings (e.g., Tombaugh, 1996). 
Forced-choice paradigms, particularly those that involve two-alternative recognition 
tasks, were considered especially effective in the detection of invalid performance in the early 
days of PVT research because (1) chance levels of performance can be computed on such tasks, 
and (2) scores that are worse-than-chance can be argued to represent convincing evidence of 
noncredible performance (e.g., Millis, 1992). However, as research evidence accumulated, it 
became apparent that individuals with significant cognitive dysfunction (e.g., Warrington, 1984), 
those asked to feign cognitive deficits (e.g., Guilmette, Hart, & Giuliano, 1993; Martin, Bolter, 
Todd, Gouvier, & Niccolls, 1993), and those suspected of feigning cognitive deficits (e.g., 
Hiscock, Branham, & Hiscock, 1994) typically perform above chance levels on these tasks. In 
light of these findings, investigators have identified more liberal cutoffs, which are based on the 
lowest scores observed in bona-fide patients (Bianchini et al., 2001). Examples of such measures 
include the Computerized Assessment of Response Bias (CARB; Allen, Conder, Green, & Cox, 
1997), Portland Digit Recognition Test (PDRT; Binder, 1993a), Test of Memory Malingering, 
(TOMM; Tombaugh, 1996), and Word Memory Test (WMT; Green, 2003). 
While the majority of free-standing PVTs employ a forced-choice paradigm, some free-
standing PVTs do not. Non-forced-choice PVTs are designed in accordance with the floor effect 
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principle (Rogers, Harrell, & Liff, 1993) such that even individuals with true cognitive 
impairment are able to pass them. They can vary considerably in the types of stimuli used (e.g., 
digits, letter strings, words, pictures of unfamiliar faces, line drawings) and in the responses 
required of the examinee. For example, they may evaluate random responding, non-credibly poor 
performance, atypical errors, or inconsistencies in patterns of responding as compared to 
individuals with true brain dysfunction (Heilbronner et al., 2009). 
The Rey 15-Item test (FIT; Rey, 1964 as cited in Nitch & Glassmire, 2007) has been 
identified as the most widely used non-forced-choice PVT (Sharland & Gfeller, 2007; Slick et 
al., 2004). In this task, a page with 15 stimuli is presented to examinees for 10 seconds. After 10 
seconds, the page is removed and examinees are asked to draw as many of the 15 items as they 
can remember on a blank sheet of paper. With limited exposure time and 15 items to remember, 
the task appears to be difficult. However, due to the simplicity and redundancy of the stimuli, 
only five conceptual units need to be memorized to correctly reproduce all fifteen items, and 
even individuals with cognitive dysfunction can pass the task (e.g., Millis & Kler, 1995). 
 In another non-forced-choice PVT called the Dot Counting Test (DCT; Boone, Lu, & 
Herzberg, 2002b), examinees are presented with twelve 5”x7” cards with varying numbers of 
dots and instructed to count the dots as quickly as possible and then verbalize an answer. On the 
first six cards, the dots are ungrouped (i.e., in a random arrangement), while on the last six cards 
they are grouped (i.e., arranged in clear visual patterns to facilitate quick counting). Performance 
is evaluated by comparing the time taken to count (a) larger versus smaller numbers of dots, and 
(b) ungrouped versus grouped dots. Examinees are expected to take longer to count larger 
numbers of dots and to count ungrouped dots. There are several non-forced-choice PVTs in 
addition to the FIT and DCT (see Nitch & Glassmire, 2007, for a review). 
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Embedded validity indicators. In addition to administering free-standing PVTs, 
neuropsychologists can glean information about performance validity from indicators embedded 
within standard tests of neuropsychological abilities. These include tests of intellectual 
functioning, memory, attention and executive function, and motor and sensory functioning (for a 
review, see Boone, 2007). 
Embedded validity indicators can include (1) traditional scores from ability tests (i.e., 
scores that are reported as part of the standard scoring procedures for a particular task), (2) 
indicators that use information from an ability test but are not reported as part of the standard 
scoring procedures (i.e., indicators developed specifically to evaluate performance validity), and 
(3) atypical patterns of performance. Patterns of test performance are evaluated for atypicality 
using scores that compare performance on one (often more difficult) task to another (easier) task. 
Based on knowledge about neuropsychological functioning, poorer performance is expected on 
the more difficult task relative to the easier task. Thus, performance is identified as atypical 
when an examinee’s scores on the easier task are either worse than or comparable to their scores 
on the more difficult task. Finally, some researchers have developed discriminant functions and 
logistic regression equations that use multiple scores from one or more standard 
neuropsychological tests to determine performance validity (e.g., Millis & Putnam, 1994; Suhr & 
Boyer, 1999; Wolfe, Millis, Hanks, Fichtenberg, Larrabee, & Sweet, 2010). 
 There are several advantages associated with the use of embedded validity indicators in 
clinical practice (Strauss et al., 2006). First, they can provide information about performance 
validity independent of that obtained from free-standing PVTs. Second, considering that testing 
time is limited in most settings (e.g., due to time constraints, reimbursement issues or examinee 
stamina), embedded indicators do not require any additional testing time: information about 
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performance validity is obtained from standard administration procedures of existing 
neuropsychological tests. Third, they are cost-efficient: the tests serve double-duty by 
simultaneously assessing the purported cognitive functions and performance validity. Fourth, 
embedded validity checks allow a clinician to monitor an examinee’s task engagement 
throughout the course of the evaluation rather than just at a single point in time. Fifth, given the 
availability of the neuropsychology literature to the general public and lawyers, embedded 
validity indicators may be harder to identify and therefore, more resistant to coaching than more 
common PVT formats, such as forced-choice procedures (Strauss et al., 2006). Finally, 
embedded validity indicators are useful for retroactively assessing the validity of past 
neuropsychological evaluations in which free-standing PVTs were not administered (Mittenberg, 
Aguila-Puentes, Patton, Canyock, & Heilbronner, 2002). 
Use of PVTs in Clinical Practice 
Performance validity is best conceptualized as falling on a continuum (Heilbronner et al., 
2009). On one end of the continuum lie individuals who are fully engaged and demonstrating 
their true abilities during testing. The other extreme denotes individuals whose level of 
performance suggests markedly reduced cognitive capabilities but is thought to be non-credible 
(i.e., their scores likely underestimate their true ability level).  
Various factors may underlie the demonstration of markedly reduced cognitive 
capabilities, and examinees may demonstrate this level of performance in the presence or 
absence of external incentives (e.g., receiving compensation for an injury, being released from 
work obligations). Examinees who demonstrate markedly reduced cognitive capabilities in the 
context of external incentives are described as displaying Malingered Neurocognitive 
Dysfunction (MND; Slick, Sherman, & Iverson, 1999) or malingering. 
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Because invalid performance may occur for a variety of reasons, of which malingering is 
only one, the main purpose of assessing performance validity is not to identify malingering but 
rather to rule out invalid performance as an explanation for neuropsychological test data in the 
larger context of differential diagnosis (Millis, 2008). Furthermore, inconsistent scores across 
tasks may be observed when test-taking motivation fluctuates during the course of a 
neuropsychological evaluation. In these instances, assessment of performance validity, which 
includes multiple measures administered throughout the evaluation, can help to make sense of 
seemingly discordant data. 
Although the goal of performance validity assessment has expanded over the years from 
identifying malingering in forensic or medical-legal settings to determining the veracity of 
neuropsychological test data in clinical contexts, a more elaborate discussion of the construct of 
malingering and some of the associated issues is warranted from both clinical and research 
standpoints. From a clinical perspective, it is important to review the definition of malingering; 
the criteria used to identify it; and the implications of such a label. On the other hand, an 
understanding of the construct of malingering is necessary to appreciate the research literature in 
the area of performance validity: when developing and validating new PVTs, researchers 
frequently assign participants to valid and invalid groups using the proposed criteria for MND or 
some variant thereof. In light of these arguments, the following discussion covers (1) the 
definition and diagnostic criteria for malingering, (2) the controversy around neuropsychologists’ 
ability to infer the intent of an examinee and how the issue may be addressed in practice, and (3) 
the estimated prevalence or base rates of malingering and/or invalid performance in various 
assessment contexts. 
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Malingering. Slick, Sherman, and Iverson (1999) coined the term Malingered 
Neurocognitive Dysfunction (MND) to refer to “the volitional exaggeration or fabrication of 
cognitive dysfunction for the purpose of obtaining substantial material gain, or avoiding formal 
duty or responsibility” (pp. 552). They also specified criteria for the identification of MND in 
clinical, medical-legal, or forensic practice, which are based on (A) information about the 
presence of substantial external incentive, (B) evidence from neuropsychological testing, and (C) 
evidence from self-report. Notably, the criteria do not limit the diagnosis of malingering to 
individuals without psychiatric, neurological, or developmental conditions: the only instance 
when MND cannot be diagnosed is when the behavioural or psychometric evidence can be fully 
accounted for by existing psychiatric, neurological, or developmental factors (Criterion D). The 
Slick et al. (1999) MND criteria are summarized in Table 1. 
Slick et al.’s (1999) criteria have three modifiers reflecting various levels of certainty: 
definite MND, probable MND, and possible MND. A classification of definite MND requires 
external incentive to malinger and definite negative response bias as indicated by below-chance 
performance on one or more forced-choice PVTs. Probable MND is concluded when, in addition 
to external incentive to malinger, there is either (a) failure on two or more PVTs, excluding 
below-chance performance on forced-choice tests (i.e., two of Criteria B2-B6), or (b) one non-
below-chance PVT failure and one instance of non-credible self-reported symptoms or self-
report discrepancy (i.e., one of Criteria B2-B6 and one of Criteria C1-C5). Finally, possible 
MND may be indicated (a) in the presence of external incentive and discrepant evidence from 
self-report (one or more of Criteria C1-C5), or (b) when criteria for definite or probable MND 
are met but the behaviours may be accounted for by psychiatric, neurological, or developmental 
factors (i.e., Criterion D not met). 
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Table 1 
Summary of Criteria for Malingered Neurocognitive Dysfunction (MND) as Proposed by Slick, 
Sherman, & Iverson (1999) 
A. Presence of a substantial external incentive 
1. At least one clearly identifiable and substantial external incentive for exaggeration 
or fabrication of symptoms is present at the time of examination (e.g., personal 
injury settlement, disability pension, evasion of criminal prosecution, or release 
from military service). 
B. Evidence from neuropsychological tests 
1. Definite response bias. Below chance performance (p <.05) on one or more 
forced-choice PVTs. 
2. Probable response bias. Performance on one or more well-validated PVTs is 
consistent with feigning. 
3. Discrepancy between test data and known patterns of brain functioning. 
4. Discrepancy between test data and observed behavior. 
5. Discrepancy between test data and reliable collateral reports. 
6. Discrepancy between test data and documented background history. 
C. Evidence from self-report 
1. Self-reported history is discrepant with documented history. 
2. Self-reported symptoms are discrepant with known patterns of brain functioning. 
3. Self-reported symptoms are discrepant with behavioral observations. 
4. Self-reported symptoms are discrepant with information obtained from collateral 
informants. 
5. Evidence of exaggerated or fabricated psychological dysfunction (based on well-
validated validity scales or indices). 
D. Behaviors meeting necessary criteria from groups B or C are not fully accounted for by 
psychiatric, neurological, or developmental factors. 
 
 Slick et al.’s (1999) requirement of below-chance performance on one or more forced-
choice PVTs for the diagnosis of definite MND has been criticized (Boone, 2007; Larrabee, 
Greiffenstein, Greve, & Bianchini, 2007). Among the strongest criticisms of this criterion is the 
idea that it limits the diagnosis of definite MND to “unsophisticated” (i.e., blatant) malingerers. 
Indeed, more sophisticated malingerers would likely not exhibit such extremely poor 
performance and, therefore, would not be identified as displaying definite MND. In light of this, 
Boone (2007) argued that failure on at least three validated PVTs with minimal shared variance 
and behavioural evidence of noncredible symptoms should be sufficient for a diagnosis of 
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definite MND. Similarly, Larrabee (2008, 2012b) has shown that failure on three independent 
PVTs is diagnostically equivalent to below-chance performance on a forced-choice PVT, when it 
occurs in a context with external incentive to malinger and cannot be explained by 
developmental, psychiatric, or neurological factors. 
 The issue of intent. Given Slick and colleagues’ (1999) definition of MND (i.e., “the 
volitional exaggeration or fabrication of cognitive dysfunction”), the diagnosis of MND requires 
a clinician to make an inference about the intent of the examinee. Not surprisingly, there has 
been considerable controversy around the idea of clinicians’ ability to infer an examinee’s intent. 
Some (e.g., Boone, 2007; Pankratz & Erickson, 1990) have argued that, despite the development 
and implementation of PVTs and SVTs, neuropsychologists remain unable to establish the 
degree of conscious intent to appear impaired. Therefore, MND cannot be diagnosed with 
absolute certainty. Others (e.g., Heilbronner et al., 2009; Larrabee et al., 2007), however, have 
stated that malingering can be diagnosed in some examinees. According to Larrabee and 
colleagues (2007), intent is established by the presence of multiple improbable findings that 
occur in the context of external incentive and without any reasonable alternative explanation. 
 Although there is disagreement about whether or not neuropsychologists are able to make 
inferences about intent, the determination of intent is often unnecessary (Boone, 2007; 
Tombaugh, 2002). Indeed, the role of the neuropsychologist is to determine whether an examinee 
exhibits credible cognitive impairment and, used in concert, ability tests and PVTs allow the 
neuropsychologist to fulfill this role quite well. In cases where results indicate invalid 
performance, it has been recommended that the behaviour be described using terms such as 
“noncredible”, “implausible”, and/or “inconsistent with injury”, without any inference(s) about 
the reason for the lack of credibility (Boone, 2007; Heilbronner et al., 2009). 
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 Prevalence of invalid performance by setting. Rates of noncredible performance are 
highest in forensic or medical-legal contexts where there is potential for secondary gain. 
Considering data from eleven different studies conducted in settings with potential for secondary 
gain, Larrabee (2003) found an overall BRFail of 40%. Estimates ranged from 15% (Trueblood & 
Schmidt, 1993) to 64% (Heaton et al., 1978), which were interpreted by Larrabee (2003) as 
under- and over-estimates, respectively. 
In clinical settings where the purpose of neuropsychological assessment is typically to 
assist with diagnosis or treatment, there is less apparent incentive on the part of the examinee to 
appear impaired. Despite this, however, such settings are not immune to invalid performance. In 
fact, a figure of 15% has been suggested as a lower bound for BRFail in general clinical settings 
(Boone et al., 2002b as cited in Strauss et al., 2006). In settings where a mixture of clinical and 
forensic referrals is seen, BRFail is approximately 30% (Mittenberg et al., 2002). 
 These estimates indicate that although there are relative differences in the prevalence of 
invalid performance across assessment contexts, the issue of invalid performance is ubiquitous. 
Thus, it is important to consider invalid performance in the larger context of differential 
diagnosis in all settings, as suggested by Millis (2008), and assess performance validity using the 
appropriate tools. 
The PVT Research Base and Its Implications for Practice 
 In order to fully appreciate the assessment of performance validity, it is necessary to 
understand the research base underlying the use of PVTs. The following sections provide a 
review of (1) the research designs used to validate PVTs, (2) the computational aspects of 
classification accuracy, and (3) methodological limitations of the PVT research base. 
Implications for practice are also discussed where relevant. 
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Research designs. The three major research designs used in the validation of PVTs 
include (1) analogue-simulation designs, (2) criterion groups or “known-groups” designs, and (3) 
differential prevalence designs (Heilbronner et al., 2009; Larrabee, 2012c). 
Analogue-simulation designs. Analogue-simulation designs represent a practical and 
cost-effective method for investigating new PVTs. Research studies falling in this category 
typically involve non-clinical participants, such as college students or community volunteers, 
who are randomly assigned to different experimental conditions. One group may be asked to 
malinger (i.e., simulate cognitive impairment consistent with a brain injury on one or more tests, 
for example), while another group is asked to perform to the best of their ability. Test scores 
from these two groups are then compared to each other and sometimes also to the scores of a 
clinical group of interest (e.g., individuals with moderate to severe brain injury). 
Although they have the advantage of experimental control, analogue-simulation studies 
have been criticized for their low generalizability (Babikian & Boone, 2007; Bianchini, Mathias, 
& Greve, 2001; Rogers, 2008). They tend to overestimate classification accuracy (Babikian & 
Boone, 2007; Sollman & Berry, 2011), and cutoffs that are found to perform optimally in such 
designs often do not generalize to real-world samples (e.g., DiCarlo, Gfeller, & Oliveri, 2000; 
Greve, Bianchini, & Roberson, 2007; Tenhula & Sweet, 1996). 
Other issues that have been raised with analogue-simulation designs include differences 
between simulators and real-world malingerers in demographic variables (e.g., age, education 
level), presence or absence of brain insult, and the smaller monetary incentives to feign cognitive 
impairment in analogue-simulation studies as compared to real-world settings (Babikian & 
Boone, 2007; Bianchini et al., 2001; Demakis, 2004). Furthermore, instructions for malingering 
groups vary between studies. Even within studies, researchers often fail to provide clear 
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descriptions of the instructions that were given to different experimental groups, particularly the 
simulating malingerers. Finally, in many studies, researchers do not assess the degree to which 
simulators comply with instructions. According to Bianchini and colleagues (2001), in studies 
that evaluated simulator compliance (Frederick, Sarfaty, Johnston, & Powel, 1994; Goebel, 
1983), between 6 and 10% of simulators reported making little or no attempt to perform poorly, 
which is likely an underestimate. These criticisms indicate the need for greater caution in both 
executing and reporting findings from studies based on analogue-simulation designs. 
To increase generalizability, Rogers (1997) has suggested using analogue-simulation 
designs that include four groups: (a) simulating nonclinical subjects, (b) honestly responding 
nonclinical subjects, (c) honestly responding clinical subjects, and (d) clinical subjects 
simulating greater impairment than they actually experience. Such designs are more useful 
because they address the more clinically relevant question of whether a pattern of impaired 
performance is due to brain injury or to invalid performance, rather than whether noncredible 
performance can be differentiated from the performance of normal controls (Millis, 2008). 
Criterion groups (known groups) designs. In a criterion-groups design, two groups are 
established: bona fide patients and noncredible patients (Larrabee, 2012b). Individuals are 
assigned to the noncredible group based on a priori criteria, which may include failure on a well-
validated PVT or the Slick et al. (1999) criteria for definite or probable MND. Once established, 
the two groups are examined by way of a systematic analysis of similarities and differences. 
When validating a new PVT, this analysis involves comparing performance of the two groups on 
the test of interest. Conceptually, the selection of the bona fide patient group aids in establishing 
an “empirical floor” on the test of interest: a norm-referenced, clinically-derived cutoff below 
which individuals with true impairment rarely perform. 
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The strength of criterion-groups designs lies in their use of real-world patients with real 
incentives to perform noncredibly, which ultimately results in increased generalizability to 
clinical and forensic settings. Furthermore, criterion-groups designs directly assess the critical 
diagnostic question of whether a pattern of impaired performance is due to brain injury or 
noncredible performance (Bianchini et al., 2001). 
Criterion-groups designs are not without limitations. For example, it may be difficult, if 
not impossible, to ensure that the group of bona-fide patients does not include any individuals 
who performed non-credibly and that the noncredible group does not include any bona-fide 
patients. The purity of the two groups may further be compromised when individuals in the 
clinical bona-fide patients group are in litigation (Larrabee, 2012b). 
According to Heilbronner and colleagues (2009), both analogue-simulation designs and 
criterion-groups designs represent rigorous and clinically relevant research designs that are 
useful in the validation of PVTs. 
Differential prevalence designs. Differential prevalence designs are based on the 
assumption that the prevalence of invalid performance varies as a function of the assessment 
context and the likelihood of incentives to malinger (Larrabee, 2012b). As such, groups are 
comprised on the basis of assumed incentives: individuals who are known to be in litigation (and 
therefore assumed to have a higher rate of invalid responding) are compared, for example, to 
those who are not in litigation (and thus are thought to have a lower rate of invalid responding). 
Differential prevalence designs are problematic because it is difficult, if not impossible, 
to know the accuracy of the assumptions that are inherent to the design (Heilbronner et al., 
2009). In other words, while rates of invalid performance tend to be higher among 
compensation-seeking individuals as compared to those not seeking compensation, this may not 
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be the case in a given sample. In fact, it is highly unlikely that all individuals in a litigating group 
would demonstrate invalid responding and all of those in a non-litigating group would perform 
optimally. Thus, one of the major criticisms of differential prevalence designs has been the 
difficulty in determining which participants in each group, and how many of them, are exhibiting 
invalid performance (Rogers, 1997). 
Differential prevalence designs are considered less rigorous as compared to analogue-
simulation and criterion-groups designs. As a result, although such designs can be used to 
supplement evidence of test validation from other designs, they should not be used as the sole or 
primary research design to validate a PVT (Heilbronner et al., 2009). 
Classification accuracy statistics. In the research designs described above, participants 
are assigned to either the valid group or the invalid group based on a criterion of the researcher’s 
choice, which, in many cases, constitutes performance on a given PVT (criterion PVT). When 
validating a new PVT (PVT of interest), data analysis begins with null hypothesis significance 
testing, which yields information about whether or not mean scores on the PVT of interest differ 
significantly between the valid and invalid groups. While this represents an important first step, 
such analyses may not reflect clinically significant effects and do not provide information that is 
useful to clinicians (Woods, Weinborn, & Lovejoy, 2003; Larrabee, 2012c). Therefore, null 
hypothesis significance testing is usually followed by analyses of classification accuracy, which, 
unlike null hypothesis significance testing, do provide diagnostically meaningful information to 
the clinician (Baldessarini, Finklestein, & Arana, 1983; Glaros & Kline, 1988; Meehl & Rosen, 
1955). 
Given that no PVT has perfect classification accuracy, the criterion PVT is likely to be 
imperfect. However, classification accuracy analyses rest on the working assumption that the 
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researcher’s criterion represents the “truth”: those cases identified as valid by the criterion PVT 
are considered to be valid for the purpose of the given analysis, and those identified as invalid 
are assumed to be invalid. Participants are also designated as valid or invalid based on scores on 
the PVT of interest (independently of the criterion PVT). Then, the classification accuracy of 
PVT of interest, relative to the criterion PVT, is evaluated by computing the concordance rate. 
Results are reported in the form of traditional classification accuracy statistics, which may 
include area under the curve, sensitivity, specificity, hit rates, predictive values, likelihood ratios, 
and odds ratios (Baldessarini et al., 1983; Glaros & Kline, 1988; Ivnik et al., 2001; Woods et al., 
2003). Of these, sensitivity and specificity are most relevant for establishing and evaluating cut-
off scores on PVTs. 
When evaluating the concordance rate between the predictor and criterion PVTs, there 
are four possible outcomes. Of all cases that were originally identified as invalid by the criterion 
PVT, some are correctly classified as invalid by the PVT of interest (true positives), while others 
are incorrectly classified as valid (false negatives). Similarly, of all cases originally identified as 
valid by the criterion PVT, a subset is correctly classified as valid by the PVT of interest (true 
negatives), while the rest are incorrectly classified as invalid (false positives). Sensitivity refers 
to the proportion of invalid participants who are correctly identified as invalid (true 
positives/[sum of true positives and false negatives]), while specificity is the proportion of valid 
participants who are correctly identified as valid (true negatives/[sum of true negatives and false 
positives]). The hit rate represents the total proportion of accurately classified cases ([sum of true 
negatives and true positives]/total number of cases; e.g., Larrabee, 2012c). Table 2 illustrates the 
concepts of true positives, true negatives, false negatives, and false positives using a 2x2 matrix. 
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Table 2 
Summary of Major Classification Accuracy Parameters 
 
PVT of interest 
 Criterion PVT 
 Valid (Pass) Invalid (Fail) 
Valid (Pass)  True negatives False negatives 
    
Invalid (Fail)  False positives True positives  
 
 Implications for practice. Cut-off scores on PVTs, which are used to discriminate valid 
from invalid performance, are established after careful consideration of the relative cost of false-
positive and false-negative errors. There is a consensus in the literature that false positives (i.e., 
incorrectly identifying an examinee’s performance as invalid) carry more significant 
consequences compared to false negatives (i.e., incorrectly classifying an examinee as valid). In 
a forensic or medical-legal context, a false positive could result in substantial financial, social, 
and/or personal ramifications (Greve & Bianchini, 2004). In a clinical context, suspected 
noncredible performance may impact the clinician’s formulation, the diagnosis, and/or the 
development of a care plan (Seusse, Wong, Stamper, Carpenter, & Scott, 2015). Considering 
these potential consequences, specificity is usually set at ≥.90 when selecting cutoffs on PVTs, 
which keeps the false positive rate at ≤10% (Boone, 2007; Larrabee, 2012b; Vickery, Berry, 
Inman, Harris, & Orey, 2001), although specificity values as low as ≥.84 have been suggested 
(Larrabee, 2003). 
 Prioritizing specificity over sensitivity means that fewer instances of invalid performance 
are detected. Fixing specificity at .90 typically results in sensitivity around .50 – in other words, 
approximately half of invalid subjects are correctly identified (Vickery et al., 2001). This 
seemingly inescapable trade-off has been labeled the “Larrabee limit” (Erdodi, Kirsch et al., 
2014). With specificity of .90 and sensitivity of .50, PVTs are able to identify the presence of 
invalid performance more effectively than the absence of invalid performance. In other words, 
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failure on a PVT provides strong evidence for invalid performance, while a passing score does 
not rule out invalid performance (Heilbronner et al., 2009; Seusse et al., 2015). 
 With regard to their relative diagnostic power, PVTs vary considerably in sensitivity and 
specificity. However, when comparing individual PVTs, free-standing PVTs are not only more 
sensitive to invalid performance than embedded PVTs, but they also demonstrate higher overall 
classification accuracy (Iverson & Binder, 2000; Miele, Gunner, Lynch, & McCaffrey, 2012; 
Sweet & Nelson, 2007). 
 While there are differences in the classification accuracies of free-standing and embedded 
PVTs, no single test has perfect sensitivity and specificity. As a result, it has been recommended 
that clinicians employ multiple PVTs in practice, which are interspersed throughout the test 
battery and provide relatively independent information regarding performance validity (Bush et 
al., 2005; Heilbronner et al., 2009; Larrabee, 2012c; Orey, Cragar, & Berry, 2000; Sweet & 
Nelson, 2007; Vickery et al., 2004). Support for this recommendation comes from research 
showing that classification accuracy, and sensitivity to invalid performance in particular, is 
improved when multiple measures are used (Larrabee, 2003; Nelson, Boone, Dueck, Wagener, 
Lu, & Grills, 2003; Vickery et al., 2004; Victor, Boone, Serpa, Buchler, & Ziegler, 2009). In the 
literature, the best overall hit rates have been achieved when invalid performance is defined as 
failure of ≥2 PVTs, and failing ≥3 or ≥4 PVTs has been associated with zero false-positive errors 
(Larrabee, 2003; 2014; Vickery et al., 2004; Victor et al., 2009). The improved specificity 
associated with the use of multiple PVTs is a result of the very low multivariate base rate of 
failure even among significantly impaired individuals: while a credible examinee may, on rare 
occasion, obtain one score in the failing range, two or more scores in this range are highly 
unlikely (Larrabee, 2012b). 
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 Limitations of the PVT research base. The last few decades have seen a rapid 
expansion of the PVT literature. However, several methodological limitations persist. First, 
although the methodology described above is a valuable tool in PVT research, the manner in 
which cutoffs are developed has been criticized for imposing artificial Pass/Fail dichotomies 
(Dwyer, 1996). In addition, given the use of inherently imperfect instruments, some amount of 
error is inevitable (e.g., Bigler, 2014). Furthermore, and perhaps as a result of using an imperfect 
procedure, optimal cutoffs for many PVTs vary across studies, producing ambiguity around the 
most appropriate cutoff.  
The variability in cutoffs is further complicated by the fact that most PVT studies use 
small samples consisting of one or few diagnostic groups. In fact, the majority of the research in 
the area of performance validity has been conducted with mild traumatic brain injury (mTBI) 
samples, largely to the neglect of other syndromes that may be encountered in clinical and 
forensic settings (Bianchini et al., 2001). Although the practice of applying cutoffs to samples 
other than those from which they were derived is not uncommon, the degree to which cutoff 
scores generalize to different clinical populations remains unknown (Millis, 2008). Considering 
this, it is important to empirically determine the appropriateness of PVT cutoff scores for new 
clinical populations. 
The need for better characterization of PVT profiles among specific diagnostic groups is 
also supported by data suggesting that BRFail may differ depending on the patient population. In 
a survey of neuropsychologists belonging to the American Academy of Clinical 
Neuropsychology (AACN), Mittenberg and colleagues (2002) obtained estimates based on a 
total of 33, 531 cases that had been referred for personal injury (n = 6371), disability (n = 3688), 
criminal (n = 1341) or medical (n = 22,131) matters. Results revealed a wide range in estimated 
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BRFail among different patient populations: mild head injury (39%), fibromyalgia or chronic 
fatigue (35%), pain or somatoform disorder (31%), neurotoxic disorders (27%), electrical injury 
(22%), depressive disorders (15%), anxiety (14%), dissociative disorders (11%), seizure 
disorders (9%), moderate or severe head injury (9%), and vascular dementia (2%). Considering 
the clinical relevance of such data, further empirical exploration is warranted in this area. Ideally, 
population-specific cutoffs would be developed for each PVT so that the same measures could be 
used to evaluate performance validity with confidence across a wide range of diagnostic groups 
(Pearson, 2009). 
In addition to diagnosis, other demographic and/or background variables, such as age, 
education, and English language status, have been found to impact performance on some PVTs 
as well. For example, reading level below the 3rd grade was associated with elevated BRFail on 
the Word Memory Test (Green & Flaro, 2003). Additionally, examinees who spoke English as a 
second language demonstrated lower scores on the WAIS Reliable Digit Span as compared to 
native English speakers (Erdodi, Nussbaum, Sagar, Abeare, & Schwartz, 2017; Salazar, Lu, 
Wen, & Boone, 2007). Given the clinical implications of such findings, this area also requires 
further exploration. 
 Another limitation of the PVT research base is the fact that despite recommendations for 
the use of multiple PVTs in practice (Boone, 2007; Larrabee, 2012), there is little by way of 
research evidence to help clinicians determine which and how many PVTs to use, in what order, 
and in what context (Bigler, 2012). This may be due, at least in part, to the fact that many studies 
investigate only a few PVTs at a time. More studies in which large numbers of PVTs are 
evaluated simultaneously would allow clinicians to directly compare PVTs to each other, to 
select individual PVTs that are most appropriate for specific diagnostic categories, and to explore 
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the combinations of PVTs that are optimal for detecting invalid performance among different 
patient groups. 
Finally, most studies do not report information in a format that is useful to practitioners. 
Sensitivity and specificity are the most commonly provided signal detection parameters. 
Although these statistics are relevant for the development and validation of cutoff scores, they 
are not helpful when making decisions about performance validity on a case-by-case basis, 
particularly when an examinee with a known neurological condition fails a PVT with a score that 
is close to the specified cutoff or within the range of multiple specified cutoffs (i.e., “near-Pass”, 
Bigler, 2014 or “soft Fail”, Erdodi & Lichtenstein, 2017). In such cases, a clinician must 
interpret the score either (1) as representing invalid performance, or (2) as reflecting underlying 
neuropathology (i.e., that the score belongs to an individual who performed in the lower end of a 
clinical group demonstrating valid performance). However, sensitivity and specificity offer little 
information to help a clinician make this determination. 
Other classification accuracy statistics, such as positive predictive power (PPP) and 
negative predictive power (NPP), are more useful when interpreting individual PVT scores 
obtained by examinees in clinical or forensic settings. PPP is defined as the ratio of true positive 
scores to total positive scores (Baldessarini et al., 1983) and represents the probability that the 
profile is invalid given a failure on a PVT (Larrabee, 2012b). NPP, on the other hand, is defined 
as the ratio of true negatives to total negative scores (Baldessarini et al., 1983) and reflects the 
probability of valid performance given a passing score on a PVT (Larrabee, 2012b). When 
sensitivity and specificity are held constant, PPP and NPP depend on BRFail such that a passing 
score on a PVT is more likely to be true than a failing score in settings with a low BRFail, while a 
failing score on a PVT is more likely to be true than a passing score in settings with high BRFail 
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(Baldessarini et al., 1983). Considering this, PPP and NPP represent highly useful indices for 
clinical practitioners. Unfortunately, however, these statistics remain underused in biomedical 
and neuropsychological research (Woods et al., 2003) and in clinical practice. 
The underuse of PPP and NPP may be due to various factors. First, PPP and NPP require 
a nuanced understanding of classification accuracy analyses in order to be used accurately and 
effectively. Furthermore, the interpretation of predictive values is quite abstract and may not be 
accessible to most clinical practitioners. Finally, such estimates rely on precise knowledge of the 
setting-specific BRFail, which many clinicians may not have. 
As an alternative to the complex statistical modeling procedures that are prevalent in 
PVT research, the authors of the Advanced Clinical Solutions (ACS) technical manual for the 
Wechsler Adult Intelligence Scale—Fourth Edition (WAIS-IV) and Wechsler Memory Scale—
Fourth Edition (WMS-IV) presented a descriptive model for one free-standing PVT and four 
embedded PVTs, which enables quick and easy interpretation of individual PVT scores in 
clinical practice (Pearson, 2009). Specifically, scores on each PVT were reported at various 
BRFail (i.e., ≤75%, ≤50%, ≤25%, ≤15%, ≤10%, ≤5%, and ≤2%) in an overall mixed clinical 
sample (N = 371), 10 diagnostic groups (i.e., TBI, temporal lobectomy, schizophrenia, major 
depressive disorder, mild intellectual disability, autistic disorder, Asperger’s disorder, reading 
disorder, mathematics disorder, and ADHD), and a group of simulators. Given that PVT failures 
typically represent unusually poor scores, presentation of data in this manner establishes 
magnitude of failure, where scores observed in ≤2% of the sample, for example, represent more 
severe failures than scores observed in ≤15% of the sample. In practice, such a methodology 
helps clinicians to determine the degree to which an examinee’s PVT score is unusually poor 
compared to a general clinical sample and to the specific diagnostic group to which the examinee 
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belongs. Furthermore, it allows an examinee’s score to be compared directly with scores of a 
group asked to simulate cognitive impairment (i.e., simulator group). 
While the clinical utility of the PVT research base can be increased by reporting 
predictive values (PPP and NPP) or by using descriptive methodologies similar to that used in 
the ACS manual (Pearson, 2009), the ACS methodology is likely more attractive to the clinical 
practitioner because it is easily comprehensible and intuitive, yet methodologically sophisticated. 
It is also less prone to errors in interpretation than are predictive values. Given the simplicity and 
concreteness of this method, presentation of PVT data in such a manner has the potential to 
provide a user-friendly, evidence-based template for the clinical interpretation of PVT scores in 
various assessment contexts. 
The Present Dissertation 
 The present dissertation consisted of three studies and aimed to characterize performance 
on three free-standing PVTs and 11 embedded validity indicators (collectively referred to as 
PVTs of interest) in a large, real-world medical-legal sample. Performance on each PVT of 
interest was characterized using descriptive models in Studies 1 and 2 and traditional 
classification accuracy statistics in Study 3. 
Study 1 examined whether BRFail on each PVT of interest varied as a function of five key 
patient variables in the overall sample (N = 4721). Specifically, relative cumulative frequency 
distributions were reported for each PVT of interest, showing the BRFail at various cutoffs for 
individuals in the overall sample; nine diagnostic groups (mTBI, moderate-severe TBI, 
neurological, depression, anxiety, severe mental illness, chronic pain/fibromyalgia, orthopedic, 
and other); five age groups; six education levels; gender (male or female); and as a function of 
English language status (i.e., native versus non-native speakers of English). Finally, as a first 
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step to investigating the relationships between the 14 PVTs of interest and the Word Memory 
Test (WMT; Green, 2003), which was used as a criterion measure in subsequent studies, BRFail 
were also reported on each PVT of interest for examinees who passed versus failed the WMT. 
While Study 1 was inspired by the methodology used in the ACS manual (Pearson, 
2009), it represents a more comprehensive effort than that of Pearson (2009) as it includes more 
PVTs, a much larger sample of patients (who, in the majority of cases, had real incentives to 
appear impaired), and several diagnostic groups that are commonly seen in clinical and forensic 
practice. Furthermore, in addition to clinical diagnosis, Study 1 characterizes PVT BRFail as a 
function of age, education level, gender, and English language status. 
 Study 2 replicated the methodology used in Study 1, while addressing an additional major 
limitation of the ACS model. Although the authors of the ACS manual reported data separately 
for clinical patients and a group of simulators, performance validity was not assessed 
independently of the PVTs on which they reported data. Given estimates indicating a 15% BRFail 
in clinical populations without external incentives (Boone et al., 2002b as cited in Strauss et al., 
2006), it is likely that the ACS clinical sample included numerous cases demonstrating invalid 
performance, none of which were identified or reported as having been excluded from the 
analyses. Although this practice is epistemiologically problematic, it is virtually ubiquitous in 
normative samples, and has only been recently identified as a potential confound (Erdodi & 
Lichtenstein, 2017). To address this limitation, the WMT was used as a criterion measure in 
Study 2, such that only cases passing the WMT at standard cutoffs (Green, 2003) were included 
in the analyses (valid sample; N = 3297). The nature of data reported was similar to that reported 
in Study 1 (i.e., relative cumulative frequency distributions showing PVT performance across 
patient variables). 
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Finally, as an alternative to the descriptive information provided in Studies 1 and 2, Study 
3 used traditional classification accuracy analyses to determine the sensitivity and specificity of 
each of the 14 PVTs of interest against the WMT. In order to enhance the clinical utility of the 
data presented, PPP and NPP were also reported for each cutoff at five hypothetical BRFail: 10%, 
20%, 30%, 40%, and 50%. Finally, the classification accuracies of the PVTs of interest were 
compared to each other in order to determine their relative sensitivities to invalid performance.  
  




For the purpose of this dissertation, two large, independent databases were merged, 
which contained psychological and neuropsychological test data from adults assessed at private 
psychological practices in a mid-western Canadian city. Although various studies have been 
conducted and published with each independent database (by Paul Green and Roger O. Gervais), 
the databases have not previously been combined as they were for the present dissertation. 
The total sample consisted of 4721 independent cases of adults who were referred for 
psychological or neuropsychological testing. The majority of examinees were evaluated in the 
context of seeking compensation claims (i.e., they had an external incentive to appear impaired). 
At the time of assessment, consent was obtained from all examinees for their demographics, 
diagnostic information, and test data to be used for future archival research. Information unique 
to each participant was coded and all identifying information was removed before the data were 
released to the researcher for this dissertation. 
The Word Memory Test (WMT; Green, 2003) was used as an independent criterion to 
classify participants as valid or invalid: those who passed the WMT at standard cutoffs were 
identified as valid, while those who failed the WMT at standard cutoffs were identified as 
invalid. Approximately one third of the overall sample (30.1%) was classified as invalid based 
on WMT performance. Table 3 shows the mean age, education, and Full Scale IQ for the overall 
sample, the valid group, and the invalid group. Results of independent samples t-tests indicated 
that participants in the valid group were slightly younger and more educated than those in the 
invalid group, t(4719) = -8.23, p < .001 and t(4715) = 7.94, p < .001 (small effects). Mean Full 
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Means and Standard Deviations of Age, Years of Education, and Full Scale IQ, for Participants 









Note. Valid Group = Participants who passed the Word Memory Test (WMT; Green, 2003); Invalid Group = 
Participants who failed the WMT; FSIQ = Full Scale IQ. 
an = 4721. bn = 3297. cn = 1424. 
*p < .05. 
 
 
Table 4 summarizes additional characteristics of participants in the overall sample, the 
valid group, and the invalid group, including gender, handedness, primary diagnosis, first 
language, and oral English fluency. Information about gender, handedness, and first language 
was collected during the clinical interview. Examinees who identified themselves as non-native 
English speakers were classified as English as a second language (ESL). Oral English fluency 
was coded subjectively by the licensed clinical psychologist who conducted each evaluation 
based on examinees’ abilities to express themselves and comprehend the examiner while 
conversing in English. Data from ESL examinees was only included in the present dissertation if 
the assessments were completed in English and without an interpreter. All ESL cases tested with 
an interpreter were excluded from the analyses. 
In the database, each participant’s primary diagnosis was identified by assigning one of 
several diagnostic classes to the case. The classes included mTBI, moderate-severe TBI, 
neurological conditions, depression, anxiety, bipolar disorder/psychosis, chronic 
 Overall Samplea  Valid Groupb  Invalid Groupc    
 M SD  M SD  M SD df t d 
            
Age 42.3 11.2  41.4 11.3  44.3 10.8 4719 -8.23* -0.25 
Education 12.0 2.61  12.2 2.54  11.6 2.70 4715 7.94* 0.23 
FSIQ 99.7 14.2  102.1 13.5  93.5 14.0 3646 16.97* 0.63 
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pain/fibromyalgia, orthopedic, and other diagnoses. Notably, participants with diagnoses of 
intellectual disability and probable dementia were excluded from this dissertation. In most cases, 
the diagnostic classes assigned to participants represented the diagnoses under which they were 
referred for the psychological or neuropsychological assessments. There were, however, some 
cases where patients were not formally diagnosed prior to the assessment or where the diagnosis 
rendered at the conclusion of the assessment differed from the diagnosis of referral. In such 
cases, the diagnostic class coded in the database reflected the diagnosis rendered by the 
psychologist after the assessment.  
When assigning diagnostic classes for research purposes, TBI severity was determined 
primarily using post-traumatic amnesia (PTA): patients with PTA of 24 hours or longer were 
identified as having sustained a moderate-severe TBI, while those with PTA of less than 24 
hours were identified as having sustained a mild TBI. Information about length of PTA was 
obtained from medical records where they were available. Patient reports of PTA duration were 
accepted in cases where PTA was undocumented but other data (e.g., GCS, neuroimaging, other 
medical records) provided clear evidence of a severe TBI. Predictably, the mTBI group had a 
mean PTA duration of 1.19 hours (SD = 4.60), and the moderate-severe TBI group had a mean 
PTA duration of approximately 17 days (M = 416.25 hours; SD = 543.8). The mild and 
moderate-severe TBI groups had mean GCS scores of 14.6 (SD = 1.1) and 8.7 (SD = 4.0), 
respectively. Approximately half of mTBI patients (52.4%) did not have any intracranial 
abnormalities on neuroimaging, while abnormalities were documented in 15.2% of mTBI cases. 
Among moderate-severe TBI patients, there was evidence of intracranial abnormalities in 77.3% 
of cases, and no evidence of any abnormalities in 7.7% cases. For the remainder of TBI cases 
(32.3% mTBI patients, 15.0% moderate-severe TBI), results of neuroimaging were not available 
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for review. Although information about time since injury (i.e., how much time had elapsed 
between a patient’s TBI and the neuropsychological assessment) was not available in the 
database, according to the source of the database, TBI cases were invariably assessed more than 
three months post-injury, and often one or more years post-injury (P. Green, personal 
communication, May 3, 2018). 
The diagnostic class labeled other contained a wide range of individuals not captured by 
the other eight classes, including those assessed in the context of general medical conditions 
(e.g., leukemia, AIDS), substance abuse, and work-related accidents. Notably, the diagnostic 
classes identified in the database are not mutually exclusive. Although individuals assessed in 
clinical practice often have multiple diagnoses, only information about the primary diagnostic 
class was coded for each case. Information about comorbid conditions was not available. 
Results of chi-square tests of independence indicated that English language status and 
primary diagnosis were related to being classified as valid versus invalid based on WMT 
performance, χ2 (1, N = 4501) = 108.97, p <.001, and χ2 (8, N = 4721) = 97.66, p <.001; these 
variables explained 2.4% and 2.1% of the variance in WMT results (Pass or Fail) in the overall 
sample (small effect). Effect sizes for analyses involving gender, oral English fluency, and 
handedness were close to zero, suggesting that these variables were not meaningfully related to 
WMT classification. The statistically significant chi-square tests of independence for gender, χ2 
(1, N = 4721) = 23.70, p <.001, and oral English fluency, χ2 (1, N = 4716) = 9.71, p = .002, were 
likely the result of overpowered analyses given the large sample size. The chi-square test 
involving handedness did not reach statistical significance, χ2 (1, N = 4662) = 0.02, p = .89. 
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Table 4 
 
Characteristics of Participants in the Overall Sample and in the Valid and Invalid Groups 
 
 Overall Samplea  Valid Groupb  Invalid Groupc   
 N %  n %  n % χ2 Φ2 
           
Gender           
   Male 2817 59.7  1892 67.2  925 32.8 23.70* .005 
   Female 1904 40.3  1405 73.8  499 26.2   
           
Handedness           
   Right 4198 90.0  2934 69.9  1260 30.0 0.02 .000 
   Left 468 10.0  326 69.7  142 30.3   
           
Primary diagnosis           
   Mild TBI 643 13.6  386 60.0  257 40.0 97.66* .021 
   Moderate-severe TBI 220 4.7  173 78.6  47 21.4   
   Neurological 247 5.2  187 75.7  60 24.3   
   Depression 888 18.8  606 68.2  282 31.8   
   Anxiety 917 19.4  655 71.4  262 28.6   
   Severe mental illness 65 1.4  46 70.7  19 29.2   
   Chronic pain/ 
   Fibromyalgia 
899 19.0  574 63.8  325 36.2   
   Orthopaedic injury 396 8.4  321 81.0  75 18.9   
   Other 446 9.4  349 78.3  97 21.7   
           
First language           
   English 3872 86.0  2801 72.3  1071 27.7 108.97* .024 
   Other 629 14.0  325 51.7  304 48.3   
           
Oral English fluency           
   Fluent 4622 98.0  3245 70.2  1377 29.8 9.71* .002 
   Not fluent 94 2.0  52 55.3  42 44.6   
           
 
Note. Valid Group = Participants who passed the Word Memory Test (WMT; Green, 2003); Invalid Group = 
Participants who failed the WMT; TBI = traumatic brain injury. 
an = 4721. bn = 3297. cn = 1424. 
*p < .05. 
 
 Table 5 summarizes characteristics of the assessment context for the overall sample, valid 
group, and invalid group. Although results of chi-square tests of independence were statistically 
significant for assessment type (χ2 (2, N = 4669) = 43.61, p <.001) and referral source (χ2 (4, N = 
4644) = 28.22, p <.001), effect sizes were very small, indicating the absence of any meaningful 
relationship between these variables and WMT classification. The significant findings are likely 
due to the analyses being overpowered by the large sample size.  
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Table 5 
 
Characteristics of the Assessment Context for the Overall Sample and the Valid and Invalid Groups 
 
 Overall Samplea  Valid Groupb  Invalid Groupc   
 N %  n %  n % χ2 Φ2 
           
Assessment type           
   Psychological 2392 51.2  1620 67.7  772 32.2 43.61* .009 
   Neuropsychological 1743 37.3  1198 68.7  545 31.2   
   Vocational 534 11.4  438 82.0  96 17.9   
           
Referral Source           
   WCB/Legal 3414 72.5  2332 68.3  1082 31.7 28.22* .006 
   Insurance 843 17.9  608 72.1  235 27.9   
   Canada Pension 27 0.6  12 44.4  15 55.6   
   Private 64 1.4  49 76.5  15 23.4   
   Other 296 6.3  235 79.4  61 20.6   
           
 
Note. Valid Group = Participants who passed the Word Memory Test (WMT; Green, 2003); Invalid 
Group = Participants who failed the WMT; TBI = traumatic brain injury. 
aN = 4721. bn = 3297. cn = 1424. 
*p < .05. 
 
Measures 
As part of each assessment, participants were administered a comprehensive test battery 
containing cognitive tests, self-report symptom and personality inventories, as well as various 
PVTs and SVTs. Due to a flexible approach to test selection, however, not all participants were 
administered all tests and some PVTs were administered much more consistently than others.  
Of all the measures in the database, only those relevant to this dissertation are described 
below. Standard cutoffs on free-standing PVTs represent those reported in the respective test 
manuals. All other cutoffs described below reach the minimal threshold for specificity (.84; 
Larrabee, 2003) and most exceed .90. Cutoffs producing an unacceptably high proportion of 
false-positive errors (i.e., unacceptably low specificity) are explicitly noted as such. 
 Free-standing PVTs. The dissertation includes a total of four free-standing PVTs. 
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Word Memory Test (WMT; Green, 2003). The WMT was used as the main criterion 
PVT. The WMT is a verbal memory task in which the examinee is presented twice with a list of 
20 semantically-linked word pairs. The presentation of stimuli is followed by a two-alternative 
forced-choice Immediate Recognition (IR) trial in which each target is paired with a foil and the 
examinee is asked to select the target. Auditory and visual feedback is provided, which assists 
with learning for later trials. After a 30-minute delay, a second two-alternative forced-choice 
recognition trial is administered (Delayed Recognition or DR), which includes new foils. The 
DR subtest is followed by the Multiple Choice (MC), Paired Associates (PA), and Free Recall 
(FR) subtests, respectively. The WMT may be administered orally or on the computer. 
 Performance validity is determined using scores on IR, DR, and the consistency (CNS) of 
responses between IR and DR, where ≤82.5% accuracy on one or more of these indicators is 
considered an overall Fail (Green, 2003). Children with various neurodevelopmental conditions 
have been shown to pass the WMT performance validity indicators (Carone, 2014; Green, Lees-
Haley, & Allen, 2003), suggesting that the WMT performance validity subtests place minimal 
demands on attention, language abilities, and memory. The test does, however, require a 3rd 
grade English reading level (Green, 2003). 
Patients with very severe cognitive impairment (e.g., as seen in dementia) exhibit higher 
BRFail on the WMT. To protect against false-positive errors in such groups, a genuine memory 
impairment profile (GMIP) has been developed for the instrument (Green, 2003), which further 
distinguishes severe cognitive impairment from noncredible performance in cases where 
standard cutoffs are failed. The GMIP criteria rely on scores from the easy (performance 
validity) subtests, scores from the difficult (memory) subtests, and information about the 
patient’s clinical history and presentation. The GMIP has been shown to reduce false positives 
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on the WMT in groups with very severe verbal memory impairment (Green, Montijo, & 
Brockhaus, 2011). 
The WMT is well studied in the literature, with much of the validation research involving 
individuals seeking compensation rather than simulators (Green et al., 2003; Strauss et al., 2006). 
The WMT has been found to have high sensitivity and high specificity (Tan, Slick, Strauss, & 
Hultsch, 2002), and to differentiate valid vs. invalid groups with a large effect size in several 
studies (d = 1.07-3.07; Batt, Shores, & Chekaluk, 2008; Greve, Ord, Curtis, Bianchini, & 
Brennan, 2008; Hubbard, 2008; Lindstrom, Lindstrom, Coleman, Nelson, & Gregg, 2009). 
Failure on the WMT has been associated with lower scores on a large battery of 
neuropsychological tests in a compensation-seeking sample (Green, Rohling, Lees-Haley, & 
Allen, 2001; Green, 2007). Finally, in a survey of neuropsychologists, the WMT was identified 
as one of the top five most accurate tests for the detection of invalid performance (Sharland & 
Gfeller, 2007). 
In the present dissertation, the WMT was used as an independent criterion for 
performance validity at standard cutoffs. The GMIP was not used due to several reasons: patients 
with very severe cognitive and functional impairment are rarely, if ever, assessed at the practices 
from which the data were obtained; the small group of patients who were assigned primary 
diagnoses of probable dementia were excluded from analyses; and information about patients’ 
clinical histories and/or presentations was not available. 
 Medical Symptom Validity Test (MSVT; Green, 2004). Modeled after the WMT, the 
MSVT contains 10 word pairs, with each pair representing a single concept (e.g., ballpoint pen). 
The word pairs are presented twice at the beginning of the test and followed by an IR trial. The 
remaining subtests (DR, PA, and FR) are administered 10 minutes after the completion of IR. 
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The test may be administered orally or on a computer, although there is evidence to suggest that 
the computerized version is more sensitive to invalid performance than the oral version (Green, 
2004). The IR, DR, and CNS scores represent the primary indicators of performance validity on 
the MSVT (Green, 2004), with scores ≤85% on one or more of these subtests producing a failure 
on the test. Standard cutoffs were used for the purposes of the present dissertation. 
A GMIP has been developed for this instrument as well (Green, 2004) and has been 
found to reduce false positives in patients referred to a memory disorders clinic (Howe et al., 
2007; Howe & Loring, 2009), patients with very severe verbal memory impairment (Green et al., 
2011), and patients with dementia (Singhal et al., 2009). However, recent research suggests that 
the GMIP is observed in a substantial proportion of individuals asked to simulate dementia 
(Armistead-Jehle & Denney, 2014) and in veterans between the ages of 18 and 64 years, who are 
highly unlikely to have dementia (Reslan & Axelrod, 2017). These findings highlight the 
importance of interpreting MSVT scores in the context of clinical history and presentation. 
Given that such information was unavailable in the data set used for this dissertation, the GMIP 
was not used. 
 Non-verbal Medical Symptom Validity Test (NV-MSVT; Green, 2008). The NV-MSVT 
is a computerized visual-memory based PVT that consists of a total of six subtests, two of which 
assess memory. The stimuli consist of 10 artist-drawn coloured images, each of which contains 
two items that tend to be associated with each other (e.g., horse and cart). The set of 10 images is 
presented twice on a computer screen and then the examinee is asked to select the targets as part 
of a two-alternative forced-choice IR trial. A 10-minute delay follows the IR subtest. At the 
beginning of the delay, the examinee is presented with a sheet of paper containing several 
images, which are used as foils in the DR subtest to be administered after the delay. The images 
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on this sheet are “degraded” by white lines that are drawn through them. Following the delay, the 
examinee is presented with a two-alternative forced-choice recognition task containing three 
types of test items and is instructed to choose the images that were seen earlier on the computer. 
The three types of test items are used to compute three different subtest scores. They include: (1) 
the original target stimuli paired with the images on the degraded foil sheet (called Delayed 
Recognition or DR for scoring purposes), (2) the foils from the IR trial paired with archetypal 
images such as a snake or a bat (Delayed Recognition-Archetypes or DRA), and (3) the original 
target stimuli paired with similar images containing slight variations such as a horse and cart 
versus a horse and cart with a wheel missing (Delayed Recognition-Variations or DRV). The 
delayed recognition trial is followed by the PA and FR subtests, respectively. 
 The NV-MSVT yields six subtest scores (IR, DR, DRA, DRV, PA, and FR) and a CNS 
score. Invalid performance is defined by the following algorithm: (1) mean of IR, DR, CNS, 
DRA, DRV, and PA ≤90% (Criterion A1), and/or (2) mean of DR, CNS, DRA, and DRV is 
<88% (Criterion A2; Green, 2008). For the purpose of this dissertation, the standard cutoffs 
(Criteria A1 and A2) were used on the NV-MSVT in all analyses. Although a GMIP has been 
identified on this test (Green, 2008) and has been shown to reduce false positives in patients with 
dementia (Henry et al., 2009; Singhal et al., 2009), it was not used. 
 Test of Memory Malingering (TOMM; Tombaugh, 1996). The TOMM is a 50-item 
picture recognition test, which includes two learning trials and a retention trial. Stimuli consist of 
line drawings of common objects. In each learning trial (Trial 1 and Trial 2), the examinee is 
presented with 50 stimuli, one after the other, at a rate of 3 seconds per picture. Following the 
first presentation of the list (Trial 1), a two-alternative forced-choice recognition task is 
administered where each target is paired with a foil and the examinee is asked to select the target. 
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Feedback is provided after each item. Immediately after this task, the set of 50 drawings is 
presented again, in a different order than the first presentation (Trial 2), and followed with a 
second two-alternative forced-choice recognition task with new foils. Again, feedback is 
provided to the examinee. The Retention Trial consists of only the forced-choice recognition task 
and is administered after approximately a 20-minute delay. According to the test manual 
(Tombaugh, 1996), the Retention Trial of the TOMM is optional except when the performance 
validity criterion involving Trial 2 is failed. Tombaugh (1996) suggests that a score <45 on Trial 
2 indicates possible invalid performance and should be followed with administration of the 
Retention Trial. A score of <45 on the Retention Trial provides further evidence of invalid 
performance. 
Although standard cutoffs on the TOMM demonstrate adequate specificity in most 
individuals with cognitive impairment (Duncan, 2005; Teichner & Wagner, 2004), they have 
been found to be less sensitive to invalid performance as compared to other free-standing PVTs. 
For example, in one study, a cutoff of Trial 2 <45 correctly identified less than half (44%) of 
those who failed the WMT (Greiffenstein, Greve, Bianchini, & Baker, 2008). In another study 
(Armistead-Jehle & Gervais, 2011), this cutoff detected only 21% of claimants failing the WMT, 
32% of those failing the NV-MSVT, and 35% of those failing the MSVT. The standard cutoff on 
the TOMM also demonstrated low sensitivity (.42) against a criterion measure derived from 
multiple PVTs (Kulas, Axelrod, & Rinaldi, 2014).  
Over the years, researchers have proposed more liberal cutoffs on TOMM Trial 2 to 
improve its sensitivity to invalid performance, while retaining acceptable specificity. For 
example, Trial 2 ≤46 and ≤47 detected 55% of individuals with moderate-to-severe TBI who 
were identified as demonstrating probable/definite MND (Greve, Bianchini, & Doane, 2006). 
BASE RATES OF PVT FAILURE  42
Trial 2 ≤48 correctly identified 73% of individuals feigning low IQ (Smith et al., 2014) and 70% 
of mTBI litigants exhibiting probably/definite MND (Greve, Bianchini, & Doane, 2006a). Trial 2 
≤49 correctly detected 55% of TBI patients and 39% of psychiatric patients failing the WMT, 
with good specificity (.91 and .96, respectively; Erdodi & Rai, 2017). The same cutoff also 
achieved .55 sensitivity in a sample of patients with malingered pain-related disability (Greve, 
Etherton et al., 2009), and sensitivities of .61, .77, and .77, respectively, in individuals with toxic 
exposure (Greve et al., 2006b), mTBI litigants (Greve et al., 2006a), and forensic examinees 
(Schroeder et al., 2013) exhibiting probable/definite MND, while retaining acceptable 
specificity. In another study (Jones, 2013), Trial 2 ≤49 detected 96% of those obtaining below-
chance performance on the Victoria Symptom Validity Test (Slick et al., 1997), 86% of those 
failing a total of three PVTs and/or SVTs (with no scores below chance), and 56% of those 
failing a total of two PVTs and/or SVTs (with no scores below chance) at .96 specificity. 
 In addition to exploring more liberal cutoffs on Trial 2, researchers have investigated the 
utility of Trial 1 as an indicator of performance validity against a variety of criterion measures 
including the standard administration of the TOMM (Bauer et al., 2007; Fazio et al., 2016; 
Hilsabeck et al., 2011; Horner et al., 2006; Wisdom et al., 2012), other free-standing PVTs used 
alone (Denning, 2012) and in combination (Jones, 2013; Kulas, Axelrod, & Rinaldi, 2014), and 
criteria for probable or definite MND (Greve et al., 2006a; Greve et al., 2006b; O’Bryant et al., 
2007; Smith et al., 2014) and MPRD (Greve, Etherton et al., 2009). Interestingly, there is 
considerable variability in the cutoffs identified as optimal across studies, with Trial 1 ≤35 
representing the most conservative cutoff (Horner et al., 2006) and ≤45 the most liberal cutoff 
(Greve et al., 2006b). This variability appears to be due, in large part, to the criterion measures 
used in different studies. In general, studies evaluating Trial 1 cutoffs against the standard 
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administration of the TOMM appear to suggest more conservative cutoffs (e.g., Trial 1 ≤34 
through ≤39; Bauer et al., 2007; Fazio, 2016; Horner et al., 2006; Wisdom et al., 2012), while 
those evaluating Trial 1 cutoffs against MND or MPRD criteria suggest more liberal cutoffs 
(e.g., ≤43 and ≤44; Greve et al., 2006a; Greve et al., 2006b; O’Bryant et al., 2007; Schroeder et 
al., 2013). These findings are not surprising given the more recent research on the TOMM, in 
which standard cutoffs have been shown to be overly conservative and less sensitive to 
noncredible performance compared to other free-standing PVTs (Armistead-Jehle & Gervais, 
2011; Greiffenstein et al., 2008; Kulas et al., 2014). Nevertheless, in an attempt to review and 
combine TOMM Trial 1 findings, Denning (2012) reported that a high level of classification 
accuracy (mean weighted sensitivity of .77 and specificity of .92) can be achieved using a Trial 1 
cutoff of ≤40 in most populations, although lower cutoffs are needed for individuals with 
dementia or severe amnestic disorders (Greve et al., 2006; Hilsabeck, Gordon, Hietpas-Wilson, 
& Zartman, 2011). 
Scores on TOMM Trials 1 and 2 were used for the purpose of this dissertation. Scores 
from the Retention Trial were excluded as the Retention Trial is administered very infrequently 
in the practices from which the data were obtained. 
 Embedded validity indicators. A total of eleven embedded validity indicators, derived 
from five different neuropsychological tests, were used in this dissertation. Each of these 
indicators has been examined previously in the literature. 
 Six of the embedded validity indicators included in this dissertation represent scores that 
are traditionally reported as part of standard scoring procedures for the respective tasks (TMT-A, 
TMT-B, FTT-DH, FTT-NDH, CT-TE, WCST FMS); three represent scores that are derived from 
performance on clinical tests of neuropsychological ability but not routinely reported as part of 
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standard scoring procedures (RDS, TMT A+B, FTT-C); and two represent comparison scores 
used to identify atypical patterns of performance (TMT-B/A, FTT-DIFF). 
 Wechsler Adult Intelligence Scale—Third and Fourth Editions (WAIS-III, Wechsler, 
1997; WAIS-IV, Wechsler, 2008). The Digit Span subtest of the WAIS is a measure of auditory 
attention and working memory in which the examinee is asked to repeat strings of digits (of 
increasing length) after the examiner in forward and backward order. Based on this test, 
Greiffenstein, Baker, and Gola (1994) developed an embedded validity indicator called the 
Reliable Digit Span (RDS), which is calculated by summing the highest number of digits that is 
repeated reliably (across both of two trials) in the forward and backward conditions. 
In Greiffenstein and colleagues’ (1994) original study, an RDS cutoff of ≤7 correctly 
identified 70% of probable malingerers, 89% of those with persistent post-concussive syndrome, 
and 73% of closed head injury patients. In subsequent studies, a cutoff of ≤7 detected 48.9% of 
litigating patients with mild closed head injury (Meyers & Volbrecht, 1998); 67% mixed-severity 
TBI referrals identified as MND (Mathias, Greve, Bianchini, Houston, & Crouch, 2002); 50-52% 
of moderate-severe closed head injury MND patients (Larrabee, 2003; Heinly, Greve, Bianchini, 
Love, & Brennan, 2005); and 60% of chronic pain MND patients (Etherton, Bianchini, Greve, & 
Heinly, 2005). However, the original cutoff of ≤7 was found to produce unacceptably high false-
positive error rates in a number of clinical groups including those with psychiatric difficulties 
(28%; Heinly et al., 2005), cerebrovascular accidents (44%; Heinly et al., 2005), memory 
disorders (52%; Heinly et al., 2005), and a mixed clinical group referred for neuropsychological 
testing (23%; Babikian, Boone, Lu, & Arnold, 2006). 
A more conservative cutoff of RDS ≤6 has been found to correctly classify 56.6% of 
malingering pretrial and pre-sentence detainees (Duncan & Ausborn, 2002); 46% of mTBI cases 
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identified as MND (Heinly et al., 2005); and 66% of patients in a mixed clinical sample 
displaying noncredible test performance in the context of external incentives (Babikian et al., 
2006). Sensitivity was modest in two samples of veterans: .18 in one study (Spencer, Axelrod, 
Drag, Waldron-Perrine, Pangilinan, & Bieliauskas, 2013) and .24 in another (Young, Sawyer, 
Roper, & Baughman, 2012). Notably, RDS ≤6 was found to produce unacceptably high false 
positive error rates in patients with moderate (24%) and severe (83%) dementia (Kiewel, 
Wisdom, Bradshaw, Pastorek, & Strutt, 2012) and patients with schizophrenia spectrum 
disorders (Glassmire, Ross, Kinney, & Nitch, 2016). 
Consistent with these findings, in a systematic review and cross-validation study 
(Schroeder, Twumasi-Ankrah, Baade, & Marshall, 2012), RDS ≤7 achieved good sensitivity (.48 
when using weighted averages) but was found to have specificity rates below 90% for the pooled 
data and for all clinical subgroups. A cutoff of ≤6 produced lower sensitivity rates (.30 when 
using weighted averages) but increased specificity to adequate levels (i.e., above 90%) for most 
clinical subgroups. Notably, a few diagnostic groups consistently produced specificity rates 
below 90% for both cutoff scores (≤7 and ≤6). These included individuals with cerebrovascular 
accident, severe memory disorders (e.g., dementia), intellectual disability, borderline IQ and 
below, and English as a second language. 
An RDS cutoff of ≤5 has been found to be associated with perfect and near-perfect (.98) 
specificity in TBI referrals identified as non-malingering (Mathias et al., 2002) and veterans with 
various diagnoses who passed the WMT (Young et al., 2012), respectively. This cutoff also 
demonstrated adequate specificity (.84; Larrabee, 2003) in individuals with schizophrenia 
spectrum disorders who had Full Scale IQs of 70 and higher (Glassmire et al., 2016). 
Furthermore, in another study (Zenisek, Millis, Banks, & Miller, 2016), while RDS cutoffs of ≤7 
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and ≤6 were associated with high BRFail among individuals suspected for dementia, scores of ≤5 
were found to be infrequent (BRFail = 4.3%). These findings suggest that a score of ≤5 is highly 
specific to noncredible performance.  
Wisconsin Card Sorting Test (WCST; Heaton, Chelune, Talley, Kay, & Curtiss, 1993). 
The WCST is a measure of concept formation and abstract problem solving, which requires 
examinees to match cards based on changing rules. Standard scoring procedures yield scores on 
several different indicators of performance, one of which is Failure to Maintain Set (FMS). An 
FMS error is recorded when an examinee matches a card incorrectly after making five or more 
consecutive correct responses, but before successfully completing the operating category. The 
present dissertation investigates the FMS raw score as an indicator of performance validity. 
Larrabee (2003) proposed an FMS cutoff of ≥2, which correctly identified 48% of 
definite MND cases in his study. In another study, a cutoff of ≥3 correctly identified 29% of 
mTBI cases classified as MND (Greve, Heinly, Bianchini, & Love, 2009). Although specificity 
rates were adequate in patients with mTBI, moderate-severe TBI, psychiatric disorders, and 
cerebrovascular accidents, an unacceptably high proportion of false positives were observed in 
individuals with memory disorders (.17) and severe TBI (.18; Greve, Heinly et al., 2009). 
 Category Test (CT; DeFlippis & McCampbell, 1979, 1991, 1997). The CT is measure of 
concept formation, novel problem solving, and the ability to learn from experience (Strauss et al., 
2006), which can be administered in booklet or computer form (Choca & Morris, 1992). The test 
consists of 208 items. Although several CT scores have been examined for their utility as PVTs, 
the present dissertation only examines the raw number of Total Errors (CT-TE). 
In an analogue-simulation design, CT-TE ≥87 correctly detected 51.1% of simulating 
malingerers (Tenhula & Sweet, 1996). Similarly, in a subsequent study, CT-TE ≥87 correctly 
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classified 76.7% of uncoached simulators, 34.4% of coached simulators, 100% of optimal 
controls, and 83.3% of TBI patients (DiCarlo, Gfeller, & Oliveri, 2000). 
Greve, Bianchini, and Roberson (2007) also reported classification accuracy data for 
several CT-TE cutoffs. CT-TE ≥90 achieved .41 sensitivity in individuals with mixed-severity 
TBI identified as MND, although false-positive error rates in non-TBI general clinical patients 
were unacceptably high (18%). CT-TE ≥100 produced .25 and .18 sensitivity in TBI and general 
clinical patients, respectively, with adequate specificity. Finally, a cutoff of ≥120 was associated 
with zero false positives in TBI and a cutoff of ≥140 was associated with zero false positives in a 
group of general clinical patients. 
Trail Making Test (TMT; Reitan & Wolfson, 1985). The TMT includes two tasks: Part 
A, which assesses processing speed and attention, and Part B, which assesses cognitive 
flexibility. The present dissertation utilized four embedded PVTs derived from the standard 
administration of the TMT including Part A completion time (TMT-A; raw score in seconds), 
Part B completion time (TMT-B; raw score in seconds), sum of completion times on Parts A and 
B (TMT A+B; in seconds), and the ratio of Part B completion time (in seconds) to Part A 
completion time (in seconds; TMT-B/A). The logic of TMT-B/A is based on the notion that 
examinees should take approximately twice as long to complete TMT-B than TMT-A due to the 
added cognitive load (Lamberty, Putnam, Chatel, Bieliauskas, & Adams, 1994). Therefore, as a 
validity indicator, TMT-B/A is designed to detect a violation of the normative difficulty gradient 
(i.e., performing better on a more difficult task compared to an easier task). 
TMT-A ≥63” correctly identified 16.7% of individuals with mTBI and 11.1% of those 
with well-defined TBI who failed at least one free-standing PVT, with perfect and near-perfect 
(.98) specificity, respectively (Iverson, Lange, Green, & Franzen, 2002). 
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A TMT-B cutoff of ≥200” produced good specificity in mild and well-defined TBI with 
sensitivity rates of 7.1% and 18.5%, respectively (Iverson et al., 2002). In consecutive patients 
assessed in a multi-specialty private practice and identified as biased or unbiased responders 
based on the TOMM, Busse and Whiteside (2012) found .61 sensitivity using TMT-B ≥120” 
with acceptable specificity. 
TMT A+B ≥170” correctly identified 48% of invalid response sets on the TOMM (Busse 
& Whiteside, 2012) while maintaining acceptable specificity, but was found to be overly 
conservative (SENS = .11, SPEC = .99) in a sample of post-deployment veterans (Shura Miskey, 
Rowland, Yoash-Gantz, & Denning, 2016). In the Shura et al. (2016) study, TMT A+B ≥137” 
achieved .90 specificity and .21 sensitivity. 
Finally, a cutoff of ≤1.49 on TMT-B/A correctly identified 2.4% (mTBI) and 7.4% (well-
defined TBI) of those failing one or more free-standing PVTs (Iverson et al., 2002). 
Finger Tapping Test (FTT; Reitan, 1969). Originally called the Finger Oscillation Test, 
the FTT assesses self-directed manual motor speed using a specially adapted tapper and counter 
(Strauss et al., 2006). Examinees are instructed to tap the index fingers of each hand on a key as 
quickly as possible over multiple 10-second trials. Although a few different administration and 
scoring procedures have been identified (Straus et al., 2006), the procedure of Reitan and 
Wolfson (1985) was used in the data collected for this dissertation. This procedure requires five 
consecutive 10-second trials within a range of five taps for each hand; scoring involves 
calculation of the mean over five trials. If the five-trials-within-five-taps criterion is not met, ten 
trials are administered for each hand and the score for each hand is the mean number of taps 
achieved over the 10 trials (Reitan & Wolfson, 1985). 
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Four indices based on the FTT have been investigated as embedded PVTs including the 
average number of taps achieved with the dominant hand (FTT-DH), the average number of taps 
achieved with the non-dominant hand (FTT-NDH), the sum of the average number of taps 
achieved with the dominant and non-dominant hands (FTT-Combined or FTT-C), and the 
difference between the average number of taps achieved with the dominant and non-dominant 
hands (FTT-DIFF). Like TMT-B/A, FTT-DIFF is designed to detect a violation of the normative 
difficulty gradient (i.e., performing better on a more difficult task compared to an easier task). 
FTT-DH ≤43.6 produced .48 sensitivity in an mTBI group identified as invalid, while a 
more conservative cutoff of ≤37.7 was associated with zero false positives (Backhaus, 
Fichtenberg, & Hanks, 2004). Based on evidence for gender differences in finger tapping speed, 
Arnold, Boone, Lu, Dean, Wen, Nitch, and McPherson (2005) proposed cutoffs of ≤35 for men 
and ≤28 for women, which produced .50 and .61 sensitivity, respectively, in mixed clinical 
examinees identified as noncredible based on psychometric and behavioural criteria. Arnold and 
colleagues’ (2005) FTT-DH cutoffs correctly identified 50% of forensic examinees and 36% of 
veterans failing two or more PVTs (Axelrod, Meyers, & Davis, 2014). However, FTT-DH ≤35 
only achieved .12 sensitivity in another, mostly male sample of postdeployment veterans (Shura 
et al., 2016). Increasing the FTT-DH cutoff from ≤35 to ≤37 produced modest gains in 
sensitivity (.19) in the latter study, while maintaining adequate specificity. Finally, Arnold and 
colleagues’ (2005) FTT-DH cutoff of ≤28 for females produced unacceptably high false-positive 
rates in credible female patients with low IQ; a cutoff of ≤23, however, achieved acceptable 
specificity (.91) and correctly detected 37% of women feigning low IQ (Smith et al., 2014). In 
this dissertation, FTT-DH was examined separately in males (FTT-DHM) and females (FTT-
DHF). 
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FTT-NDH ≤38.9 was associated with .56 sensitivity in mTBI patients identified as 
invalid, while a cutoff of ≤32.9 was associated with .28 sensitivity and no false-positive errors 
(Backhaus et al., 2004). In Arnold and colleagues’ (2005) study, cutoffs of ≤30 and ≤25 
produced .36 sensitivity in males and females, respectively, in the noncredible sample. The 
cutoff of ≤25 for females, however, resulted in unacceptably low specificity rates (.81) in 
credible female patients with low IQ in another study (Smith et al., 2014); lowering the cutoff to 
≤19 resulted in correct detection of 31% of women feigning low IQ with adequate specificity. In 
this dissertation, FTT-NDH was examined separately in males (FTT-NDHM) and females (FTT-
NDHF). 
FTT-C ≤62 correctly identified 40% of malingerers (Larrabee, 2003) and 55% of 
individuals who failed two or more PVTs in a forensic context (Axelrod et al., 2014). Cutoffs of 
≤66 for men and ≤58 for women achieved .43 to .55 sensitivity in the noncredible sample 
(Arnold et al., 2005). In this dissertation, FTT-C was examined separately in males (FTT-CM) 
and females (FTT-CF). 
Finally, FTT-DIFF cutoffs of ≤-2 in men and ≤-5 in women achieved .21 sensitivity in 
the noncredible sample with acceptable specificity rates (Arnold et al., 2005). In this dissertation, 
FTT-DIFF was examined separately in males (FTT-DIFFM) and females (FTT-DIFFF). 
Data Analysis 
 Studies 1 and 2. In Studies 1 and 2, performance was examined on a total of 14 PVTs of 
interest, which included three free-standing PVTs and 11 embedded validity indicators. Among 
the free-standing PVTs were the MSVT, NV-MSVT, and TOMM (Trials 1 and 2). Embedded 
PVTs included the RDS, WCST FMS, CT-TE, TMT-A, TMT-B, TMT A+B, TMT-B/A, FTT-
DH, FTT-NDH, FTT-C, and FTT-DIFF. 
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In Study 1, performance on each PVT of interest was characterized in the overall sample 
(N = 4721) and across a number of key patient variables using relative cumulative frequency 
distributions. Specifically, BRFail were reported at various cutoffs on each PVT of interest in the 
overall sample and across nine diagnostic groups, five age groups, six levels of education, gender 
(i.e., males versus females), and English language status (i.e., native speakers of English [NSE] 
versus non-native English speakers [ESL]). Diagnostic groups included mTBI, moderate-severe 
TBI, neurological conditions, depression, anxiety, bipolar disorder/psychosis, chronic 
pain/fibromyalgia, orthopedic, and other diagnosis. Age groups included participants aged 16-29 
years, 30-39 years, 40-49 years, 50-59 years, and 60-69 years. Education groups included those 
with ≤8 years, 9-11 years, 12 years, 13-15 years, 16 years, and ≥17 years of formal education. 
 In addition to the aforementioned variables, in Study 1, BRFail on each PVT of interest 
were reported as a function of outcome on a well-validated free-standing PVT: the WMT (Green, 
2003). In previous research, the prevalence of PVT failure/invalid responding in settings with 
potential for secondary gain has been estimated to fall between 30% and 40% (e.g., Larrabee, 
2003; Mittenberg et al., 2002). Given that the majority of examinees in this data set had external 
incentives to appear impaired, it was expected that neuropsychological test data from a 
significant proportion of cases in the overall sample would be invalid. Thus, to examine the 
impact of invalid performance on PVTs of interest, in Study 1, BRFail on each PVT of interest 
were also reported separately for those who passed versus failed the WMT. 
 Because a substantial proportion of the overall sample was expected to demonstrate 
invalid performance, invalid performance represented a significant confound with respect to 
determining the true relationships between BRFail on PVTs of interest and the patient variables 
examined in Study 1. As a result of this, in Study 2, a valid subsample was created, which 
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consisted of only those participants in the overall sample who passed the WMT at standard 
cutoffs (n = 3297; referred to as the valid sample). Data were analyzed in a similar manner to 
Study 1. Specifically, BRFail were reported at various cutoffs on each PVT across the total valid 
sample, nine diagnostic groups, five age groups, six levels of education, as well as gender (i.e., 
male or female) and English language status (i.e., NSE and ESL). 
Throughout Studies 1 and 2, chi-square tests of independence and Fisher’s exact tests 
were used to determine whether scores on each PVT of interest were related to the 
demographic/background variables examined (diagnosis, age, education, gender, English 
language status) and to performance on the WMT (in Study 1 only) at various cutoffs. Chi-
square tests were conducted if (1) the value of expected cell counts was 5 or more in at least 80% 
of cells, and (2) no cells had an expected cell count of less than 1 (McHugh, 2013), whereas 
Fisher’s exact tests were conducted in cases where cell sizes were small and the aforementioned 
assumptions were not met. Neither test was performed if one or more groups had a BRFail of 
zero. 
For the chi-square and Fisher’s exact test analyses, Phi squared (Φ2) was used as an 
estimate of effect size for analyses that involved variables with multiple levels (i.e., diagnosis, 
age, education). Likelihood ratios were used as an estimate of effect size for analyses that 
involved variables with only two levels (i.e., gender [male or female], English language status 
[NSE or ESL], and WMT [pass or fail]). Likelihood ratios were calculated by dividing the 
cumulative percentage of one group (e.g., males) failing a given cutoff by the cumulative 
percentage of the corresponding group (e.g., females) failing the same cutoff. The calculations 
were performed from left to right in the relevant tables, such that cumulative percentages for 
males, NSEs, and those who passed the WMT served as numerators in each computation, and 
BASE RATES OF PVT FAILURE  53
cumulative percentages for females, ESL patients, and those who failed the WMT served as 
denominators. As a result of this, the reported ratios reflect the likelihood of males, NSEs, and 
individuals who passed the WMT failing a given PVT of interest cutoff relative to their 
counterparts. With regard to interpretation, likelihood ratios at or around 1.00 reflect comparable 
BRFail among the two groups being compared. As likelihood ratios become smaller (i.e., closer to 
zero), they indicate large differences in BRFail among the two groups, with lower rates in the left-
column group (i.e., males, NSEs, those who passed the WMT). As likelihood ratios become 
larger (further away from 1.00 in the increasing direction; e.g., 2.00), they represent large 
differences in BRFail among the two groups, with higher rates in the left-column group. 
Studies 1 and 2 contained a very large number of null-hypothesis significance tests, 
which inflated the Type I error rate. This problem was further compounded by the large sample 
size, as a result of which many of the analyses were likely overpowered. In light of these facts, 
effect sizes were emphasized in the interpretation of Studies 1 and 2 results rather than the 
statistical significance of chi-square tests or Fisher’s exact tests. 
Given evidence for gender differences on the FTT (e.g., Arnold et al., 2005), it was 
decided that data on FTT-based PVTs would be reported separately for males and females in 
Studies 1 and 2. This precluded chi-square analyses involving gender for these PVTs. Further 
examination of the dataset revealed that the FTT was administered only about half as often to 
females as it was administered to males. As a result of the small sample size, data were not 
reported for FTT-based indicators in females as part of Studies 1 and 2. 
Selection of cutoffs for Studies 1 and 2. In order to adequately characterize performance 
on the PVTs of interest, multiple scores on each PVT of interest were selected at which 
cumulative percentages (i.e., BRFail) would be reported across various groups. To select these 
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scores, the PVTs of interest were conceptually separated into those on which scores fell into a 
restricted or relatively-restricted range and those on which scores varied widely. Three PVTs of 
interest were considered to fall in the former category (TOMM Trials 1 and 2, RDS, WCST 
FMS), while nine PVTs of interest were thought to fall in the latter category (CT-TE, TMT-A, 
TMT-B, TMT A+B, TMT-B/A, FTT-DH, FTT-NDH, FTT-C, FTT-DIFF). For PVTs of interest 
with a restricted range of possible scores, cumulative percentages were reported at multiple 
scores, including values below, above, and corresponding to previously-identified cutoffs. For 
PVTs of interest on which scores could vary widely, a methodology similar to that of Pearson 
(2009) was used: scores at or near the 2nd, 5th, 10th, 15th, 25th percentiles in the overall sample 
were identified, and cumulative percentages were reported at these scores in both Studies 1 and 
2.  
 While BRFail were reported at multiple cutoffs on most PVTs of interest, on the MSVT 
and NV-MSVT, BRFail were only reported at standard cutoffs specified in the test manuals 
(Green, 2004, 2008). This is because these tests use fixed, published algorithms based on 
multiple subtests, rather than single scores, to make determinations about performance validity. 
 It is important to note that the sample sizes for data reported in Studies 1 and 2 varied 
depending on a number of factors. First, sample sizes were affected by how widely a given PVT 
was administered. Second, because the valid sample represents a subset of the overall sample, for 
each PVT of interest, analyses involving the overall sample contained more cases than analyses 
involving the valid sample. Finally, considering the skewed distributions of most PVT scores, it 
is not only rare for examinees to demonstrate poor performance on these tests, but also, the 
worse the performance, the less likely it is to be observed. Thus, for each PVT of interest, sample 
sizes were larger at more liberal cutoffs as compared to conservative cutoffs. In light of these 
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issues, readers are encouraged to note the sample size associated with each PVT and each cutoff 
when examining data for Studies 1 and 2. 
 Study 3. In Study 3, the classification accuracy of each PVT of interest was evaluated 
against the WMT (Green, 2003), which served as the criterion PVT. Invalid performance was 
defined as failure on the WMT at standard cutoffs specified in the test manual (Green, 2003). 
Scores on the all PVTs of interest were dichotomized such that a score of zero represented a Pass 
on that PVT and a score of one represented a Fail. For the MSVT and NV-MSVT, scores were 
dichotomized according to standard cutoffs (Green 2004, 2008). For each of the other PVTs of 
interest, multiple potential cutoffs were examined for their sensitivity and specificity against the 
WMT, including scores identified as cutoffs in previous literature as well as alternative scores 
that produced acceptable levels of specificity (.84-1.0; Larrabee, 2003). Positive and negative 
predictive values (PPP and NPP) were reported at five hypothetical base rates of invalid 
performance (10%, 20%, 30%, 40%, and 50%) for each cutoff. 
 Although the total sample used for Study 3 was very large (N = 4721), the number of 
cases included in specific analyses depended on how widely the relevant PVT of interest was 
administered. All cases containing data on a PVT of interest were included in the analyses for 
that PVT. 
Once the classification accuracies of each PVT were computed, PVTs of interest were 
compared in terms of their relative sensitivities to invalid performance. The most liberal cutoff to 
achieve at least 90% specificity was identified on each PVT of interest, and sensitivity values at 
these cutoffs were compared across PVTs. Because multiple cutoffs were not examined on the 
MSVT and NV-MSVT, sensitivity values associated with standard cutoffs were used for these 
instruments. 
BASE RATES OF PVT FAILURE  56
CHAPTER 3 
Results 
Studies 1 and 2 
 Results from Studies 1 and 2 are presented together in this dissertation to facilitate 
comparison between the performances of the overall and valid samples on each PVT of interest. 
Data on the WMT (criterion PVT) is presented first and followed by the PVTs of interest, 
beginning with free-standing PVTs. For each PVT of interest, performance is initially 
characterized as a function of WMT result (Pass/Fail). Then, corresponding tables from Studies 
1 and 2 (i.e., those examining BRFail on a particular PVT of interest across the same 
demographic/background variable) are presented one after the other for diagnosis, age, 
education, gender and English language status, in that order. 
As mentioned above, given (1) the large sizes of the overall and valid samples, and (2) 
the inflated Type I error rate resulting from multiple comparisons, chi-square tests of 
independence and Fisher’s exact tests were likely to reach statistical significance in the absence 
of meaningful effects. In light of this, when interpreting results from Studies 1 and 2, effect sizes 
are emphasized rather than the results of null-hypothesis significance tests. 
WMT. Approximately one-third of the overall sample (30.2%) failed the WMT at 
standard cutoffs. Table 6 characterizes WMT BRFail as a function of diagnosis. The chi-square 
test of independence was statistically significant χ2 (8, N = 4721) = 97.66, p <.001. However, 
diagnosis accounted for only 2.1% of the variance in BRFail (small effect). Patients with mild TBI 
and those with chronic pain/fibromyalgia demonstrated the highest BRFail (40.0% and 36.2%, 
respectively), while patients with other diagnoses (21.7%), moderate-to-severe TBI (21.4%) and 
orthopedic injuries (18.9%) had the lowest BRFail.  
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Table 6 
 
Percentages of Participants Failing the Standard Cutoff on the Word Memory Test in the Valid Sample and in 
Specific Clinical Groups 
 
 Overall Samplea  TBI  Diagnostic Groups   
WMT f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
STN 1424 30.2  40.0 21.4  24.3 31.8 28.6 29.2 36.2 18.9 21.7 97.66* .021 
 
Note. Word Memory Test (Green, 2003); STN = standard cutoffs specified in the test manual; TBI = traumatic brain 
injury, Mild = mild TBI; M-S = moderate/severe TBI; NEU = neurological; DEP = depression; ANX = anxiety; SMI 
= severe mental illness (psychosis/Bipolar Disorder); CP/F = chronic pain and fibromyalgia; ORT = orthopedic; 
OTH = other. 
an = 4721. bn = 643. cn = 220. dn = 247. en = 888. fn = 917. gn = 65. hn = 899. in = 396. jn = 446. 
*p < .05. 
 
Table 7 characterizes WMT BRFail as a function of age. The chi-square test of 
independence was statistically significant, χ2 (4, N = 4127) = 60.67, p <.001, although age only 
accounted for 1.3% of the variance in BRFail (small effect). The youngest group (16-29 years) had 




Percentages of Participants Failing the Standard Cutoff on the Word Memory Test in the Valid Sample and across 
Several Age Groups 
 
 Overall Samplea  Age (years)  
WMT f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
STN 1424 30.2  19.8 28.7 31.2 34.5 40.8 60.67* .013 
 
Note. Word Memory Test (Green, 2003); STN = standard cutoffs specified in the test manual. 
an = 4721. bn = 718. cn = 1159. dn = 1480. en = 1133. fn = 218. 
*p < .05. 
 
 Table 8 characterizes WMT BRFail as a function of education level. The chi-square test of 
independence was statistically significant, χ2 (5, N = 4127) = 82.46, p <.001. Education level 
accounted for only 1.9% of the variance in BRFail (small effect). Patients with ≤8 years of formal 
education demonstrated the highest BRFail (46.9%), followed by those with 9-11 years of 
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education (34.7%), and BRFail were generally comparable (at about 25.0%) among those with 12 




Percentages of Participants Failing the Standard Cutoff on the Word Memory Test in the Valid Sample and across 
Several Education Levels 
 
 Overall Samplea  Education (years)  
WMT f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
STN 1424 30.2  46.9 34.7 27.9 23.8 25.6 26.0 82.46* .017 
 
Note. Word Memory Test (Green, 2003); STN = standard cutoffs specified in the test manual. 
an = 4721. bn = 343. cn = 1265. dn = 1769. en = 773. fn = 363. gn = 204. 
*p < .05. 
 
 Table 9 characterizes WMT BRFail as a function of gender and English language status. 
Males demonstrated a somewhat higher BRFail than females, χ2 (1, N = 4127) = 23.70, p <.001 
(LR = 1.25), and the BRFail among native English speakers (NSEs) was approximately half that 
of patients who spoke English as a second language (ESL), χ2 (1, N = 4127) = 108.97, p <.001 




Percentages of Participants Failing the Standard Cutoff on the Word Memory Test in the Valid Sample and as a 
Function of Gender and English Language Status 
 
 Overall Samplea  Gender    English   
WMT f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
STN 1424 30.2  32.8 26.2 23.70* 1.25  26.2 48.3 108.97* 0.54 
 
Note. Word Memory Test (Green, 2003); STN = standard cutoffs specified in the test manual; LR = likelihood ratio; 
NSE = Native speakers of English; ESL = English as a second language. 
an = 4721. bn = 2817. cn = 1904. dn = 3872. en = 629. 
*p < .05. 
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MSVT. In the overall sample, 21.3% of cases failed the MSVT at standard cutoffs. Table 
10 shows that there was considerable overlap between performance on the MSVT and 
performance on the WMT, χ2 (1, N = 2165) = 580.66, p <.001. Participants who passed the 
WMT (i.e., the valid sample) demonstrated a lower MSVT BRFail (6.8%) than those who failed 
the WMT (52.4%). Compared to participants who failed the WMT, those who passed the WMT 




Percentages of Participants Failing the Standard Cutoff on the Medical Symptom Validity Test in the Overall 
Sample and as a Function of Word Memory Test Performance 
 
 Overall Samplea  WMT   
MSVT f %  Passb Failc χ2 LR 
        
STN 462 21.3  6.8 52.4 580.66* 0.13 
 
Note. MSVT = Medical Symptom Validity Test (Green, 2004); STN = standard cutoffs specified in the test manual; 
WMT = Word Memory Test (Green, 2003); Pass = participants passing the WMT at standard cutoffs; Fail = 
participants failing the Word Memory Test at standard cutoffs; LR = likelihood ratio. 
an = 2165. bn = 1476. cn = 689. 
*p < .05. 
 
 
 Tables 11 and 12 characterize MSVT BRFail as a function of clinical diagnosis in the 
overall and valid samples, respectively. Effect sizes indicated that diagnosis accounted for only 
0.3% of the variance in MSVT BRFail in the overall sample and only 0.5% of the variance in 
MSVT BRFail in the valid sample (very small effects). Although the contrast was statistically 
significant in the overall sample, this was likely an artifact of the large sample size. 
Visual inspection of BRFail indicates that patients with mTBI (38.6%) and orthopedic 
injury (32.7%) demonstrated the highest BRFail in the overall sample, while those with anxiety 
(15.7%) and moderate-severe TBI (14.1%) had the lowest BRFail. In the valid sample, BRFail 
were comparable across most groups at about 9%, with lower rates among participants with 
anxiety (5.0%), depression (5.6%), and other diagnoses (6.9%). 




Percentages of Participants Failing the Standard Cutoff on the Medical Symptom Validity Test in the Overall 
Sample and Specific Clinical Groups 
 
 Overall Samplea  TBI  Diagnostic Groups   
MSVT f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
STN 462 21.3  38.6 14.1  21.0 20.4 15.7 22.5 24.9 32.7 17.2 55.05* .003 
 
Note. MSVT = Medical Symptom Validity Test (Green, 2004); STN = standard cutoffs specified in the test manual; 
TBI = traumatic brain injury, Mild = mTBI; M-S = moderate/severe TBI; NEU = neurological; DEP = depression; 
ANX = anxiety; SMI = severe mental illness (psychosis/Bipolar Disorder); CP/F = chronic pain and fibromyalgia; 
ORT = orthopedic; OTH = other. 
an = 2165. bn = 184. cn = 85. dn = 124. en = 592. fn = 562. gn = 40. hn = 349. in = 341. jn = 174. 





Percentages of Participants Failing the Standard Cutoff on the Medical Symptom Validity Test in the Valid Sample 
and in Specific Clinical Groups 
 
 Valid Samplea  TBI  Diagnostic Groups   
MSVT f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
STN 101 6.8  9.7 8.7  9.5 5.6 5.0 8.3 9.0 9.4 6.9 7.89 .005 
 
Note. MSVT = Medical Symptom Validity Test (Green, 2004); STN = standard cutoffs specified in the test manual; 
TBI = traumatic brain injury, Mild = mTBI; M-S = moderate/severe TBI; NEU = neurological; DEP = depression; 
ANX = anxiety; SMI = severe mental illness (psychosis/Bipolar Disorder); CP/F = chronic pain and fibromyalgia; 
ORT = orthopedic; OTH = other. 
an = 1476. bn = 103. cn = 69. dn = 95. en = 396. fn = 403. gn = 24. hn = 223. in = 32. jn = 131. 
*p < .05. 
  
Tables 13 and 14 characterize MSVT BRFail by age in the overall and valid samples, 
respectively. Although MSVT BRFail varied significantly across age groups in both samples, χ2 
(4, N = 2163) = 34.47, p <.001 (overall sample) and χ2 (4, N = 1475) = 15.67, p = .003 (valid 
sample), age accounted for only 1.1 to 1.6% of the variance in MSVT BRFail (small effects). 
In the overall sample, BRFail increased steadily with age and ranged from 9.6% (in 
individuals aged 16-29 years) to 27.9% (in those aged 60-69 years). In the valid sample, BRFail 
were comparable among individuals aged 16-49 years, and almost twice as high in older groups 
(≥50 years). 
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Table 13 
 
Percentages of Participants Failing the Standard Cutoff on the Medical Symptom Validity Test in the Overall 
Sample and across Several Age Groups 
 
 Overall Samplea  Age (years)   
MSVT f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
            
STN 462 21.3  9.6 20.8 21.0 25.9 27.9 34.47* .016 
 
Note. MSVT = Medical Symptom Validity Test (Green, 2004); STN = standard cutoffs specified in the test manual. 
an = 2165. bn = 281. cn = 433. dn = 696. en = 613. fn = 140. 




Percentages of Participants Failing the Standard Cutoff on the Medical Symptom Validity Test in the Valid Sample 
and across Several Age Groups 
 
 Valid Samplea  Age (years)  
MSVT f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
STN 101 6.8  4.8 4.1 5.9 10.7 9.1 15.67* .011 
 
Note. MSVT = Medical Symptom Validity Test (Green, 2004); STN = standard cutoffs specified in the test manual. 
an = 1476. bn = 231. cn = 293. dn = 460. en = 403. fn = 88. 
*p < .05. 
 
 
 Tables 15 and 16 characterize MSVT BRFail as a function of education in the overall and 
valid samples, respectively. Effect sizes indicate that education accounted for only 1.5% of the 
variance in MSVT BRFail in the overall sample (small effect) and 0.4% of the variance in MSVT 
BRFail in the valid sample (very small effect). Although the chi-square test of independence 
reached statistical significance in the overall sample, χ2 (5, N = 2165) = 32.57, p <.001, given the 
effect size, this finding was likely driven by the large sample size. 
The highest BRFail were observed in individuals with the fewest years of formal 
education, and BRFail generally decreased with higher levels of education. Notably, in both 
samples, individuals with ≥17 years of formal education demonstrated higher BRFail than would 
be expected based on the trends. 
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Table 15 
 
Percentages of Participants Failing the Standard Cutoff on the Medical Symptom Validity Test in the Overall 
Sample and across Several Education Levels 
 
 Overall Samplea  Education (years)   
MSVT f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
              
STN 462 21.3  36.7 24.8 18.8 18.6 15.3 24.7 32.57* .015 
 
Note. MSVT = Medical Symptom Validity Test (Green, 2004); STN = standard cutoffs specified in the test manual. 
an = 2165. bn = 139. cn = 536. dn = 921. en = 322. fn = 170. gn = 77. 






Percentages of Participants Failing the Standard Cutoff on the Medical Symptom Validity Test in the Valid Sample 
and across Several Education Levels 
 
 Valid Samplea  Education (years)  
MSVT f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
STN 101 6.8  11.3 7.0 7.4 5.8 3.1 7.1 5.71 .004 
 
Note. MSVT = Medical Symptom Validity Test (Green, 2004); STN = standard cutoffs specified in the test manual. 
an = 1476. bn = 71. cn = 496. dn = 649. en = 242. fn = 128. gn = 56. 
*p < .05. 
 
 
 Tables 17 and 18 characterize MSVT performance as a function of gender and English 
language status in the overall and valid samples, respectively. Results of analyses involving 
gender showed that males were slightly more likely to fail the MSVT than females in both 
samples (LR = 1.22 in the overall sample; LR = 1.06 in the valid sample), although differences 
only reached statistical significance in the overall sample, χ2 (1, N = 2165) = 5.19, p = .023. 
With regard to English language status, in the overall sample, MSVT BRFail were 
significantly lower among NSEs than ESL patients, χ2 (1, N = 2157) = 52.36, p <.001. 
Likelihood ratios indicated that NSEs were only 0.49 times as likely to fail the MSVT as ESL 
patients. In the valid sample, BRFail were roughly comparable between the two groups (6.8% for 
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NSEs and 8.0% in ESL patients), and the chi-square test failed to reach statistical significance, χ2 




Percentages of Participants Failing the Standard Cutoff on the Medical Symptom Validity Test in the Overall 
Sample and as a Function of Gender and English Language Status 
 
 Overall Samplea  Gender    English   
MSVT f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
STN 462 21.3  23.0 18.9 5.19* 1.22  19.0 38.5 52.36* 0.49 
 
Note. MSVT = Medical Symptom Validity Test (Green, 2004); STN = standard cutoffs specified in the test manual; 
LR = likelihood ratio; NSE = Native speakers of English; ESL = English as a second language. 
an = 2165. bn = 1292. cn = 873. dn = 1895. en = 262. 





Percentages of Participants Failing the Standard Cutoff on the Medical Symptom Validity Test in the Valid Sample 
and as a Function of Gender and English Language Status 
 
 Valid Samplea  Gender    English   
MSVT f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
STN 101 6.8  7.0 6.6 0.09 1.06  6.8 8.0 0.29 0.85 
 
Note. MSVT = Medical Symptom Validity Test (Green, 2004); STN = standard cutoffs specified in the test manual; 
LR = likelihood ratio; NSE = Native speakers of English; ESL = English as a second language. 
an = 1476. bn = 841. cn = 635. dn = 1332. en = 138. 
*p < .05. 
 
 
NV-MSVT. In the overall sample, 18.7% of participants failed the NV-MSVT at 
standard cutoffs. As shown in Table 19, there was considerable overlap between NV-MSVT 
performance and WMT performance, χ2 (1, N = 1645) = 320.78, p <.001. There was a 7.3% NV-
MSVT BRFail among those who passed the WMT, and a 44.6% NV-MSVT BRFail among those 
who failed the WMT. Compared to examinees who failed the WMT, examinees who passed the 
WMT were only 0.16 times as likely to fail the NV-MSVT. 
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Table 19 
 
Percentages of Participants Failing the Standard Cutoff on the Non-Verbal Medical Symptom Validity Test in the 
Overall Sample and as a Function of Word Memory Test Performance 
 
 Overall Samplea  WMT   
NV-MSVT f %  Pass Fail χ2 LR 
        
STN 308 18.7  7.3 44.6 320.78* 0.16 
 
Note. NV-MSVT = Non-Verbal Medical Symptom Validity Test (Green, 2008); STN = standard cutoffs specified in 
the test manual; WMT = Word Memory Test (Green, 2003); Pass = participants passing the WMT at standard 
cutoffs; Fail = participants failing the WMT at standard cutoffs; LR = likelihood ratio. 
an = 1645. bn = 1141. cn = 504. 
*p < .05. 
 
 Tables 20 and 21 characterize NV-MSVT BRFail across clinical groups in the overall and 
valid samples, respectively. Although NV-MSVT BRFail varied significantly across clinical 
groups in the overall sample, χ2 (8, N = 1645) = 23.91, p = .002, the effect size was small (Φ2 = 
.015). The highest BRFail was observed in the mTBI group (28.0%) and was closely followed by 
orthopedic injury patients (26.5%) and those with chronic pain/fibromyalgia (23.9%). 
Individuals with moderate-severe TBI had the lowest BRFail (4.9%). 
In the valid sample, neither a chi-square test nor a Fisher’s exact test was conducted. 
Patients with other diagnoses (9.7%), those with mTBI (9.5%), and those with chronic 
pain/fibromyalgia (9.4%) failed the NV-MSVT most frequently. No failures were observed 
among those with severe mental illness, although the group size was small (n = 18). 
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Table 20 
 
Percentages of Participants Failing the Standard Cutoff on the Non-Verbal Medical Symptom Validity Test in the 
Overall Sample and in Specific Clinical Groups 
 
 Overall Samplea  TBI  Diagnostic Groups   
NV-MSVT f %  Milda M-Sb  NEUc DEPd ANXe SMIf CP/Fg ORTh OTHi χ2 Φ2 
                
STN 308 18.7  28.0 4.9  19.8 18.9 14.3 21.9 23.9 26.5 17.4 23.91* .015 
 
Note. NV-MSVT = Non-Verbal Medical Symptom Validity Test (Green, 2008); STN = standard cutoffs specified in 
the test manual; TBI = traumatic brain injury, Mild = mTBI; M-S = moderate/severe TBI; NEU = neurological; DEP 
= depression; ANX = anxiety; SMI = severe mental illness (psychosis/Bipolar Disorder); CP/F = chronic pain and 
fibromyalgia; ORT = orthopedic; OTH = other. 
an = 1645. bn = 107. cn = 41. dn = 86. en = 482. fn = 483. gn = 32. hn = 259. in = 34. jn = 121. 






Percentages of Participants Failing the Standard Cutoff on the Non-Verbal Medical Symptom Validity Test in the 
Valid Sample and in Specific Clinical Groups 
 
 Valid Samplea  TBI  Diagnostic Groups   
NV-MSVT f %  Milda M-Sb  NEUc DEPd ANXe SMIf CP/Fg ORTh OTHi χ2 Φ2 
                
STN 83 7.3  9.5 3.0  8.7 7.1 6.0 0.0 9.4 5.3 9.7 - - 
 
Note. NV-MSVT = Non-Verbal Medical Symptom Validity Test (Green, 2008); STN = standard cutoffs specified in 
the test manual; TBI = traumatic brain injury, Mild = mTBI; M-S = moderate/severe TBI; NEU = neurological; DEP 
= depression; ANX = anxiety; SMI = severe mental illness (psychosis/Bipolar Disorder); CP/F = chronic pain and 
fibromyalgia; ORT = orthopedic; OTH = other. 
an = 1141. bn = 63. cn = 33. dn = 69. en = 325. fn = 350. gn = 18. hn = 171. in = 19. jn = 93. 
*p < .05. 
  
Tables 22 and 23 characterize NV-MSVT BRFail as a function of age in the overall and 
valid samples, respectively. In both samples, NV-MSVT BRFail varied significantly across age 
groups, χ2 (4, N = 1642) = 20.79, p <.001 (overall sample) and χ2 (4, N = 1141) = 23.63, p <.001 
(valid sample). However, effect sizes indicated that age accounted for only 1.3% (overall 
sample) to 2.1% (valid sample) of the variance in NV-MSVT BRFail (small effects). 
In the overall sample, the youngest group demonstrated the lowest BRFail (9.7%), and 
BRFail increased with age. Almost one-third (29.6%) of individuals aged 60-69 years failed the 
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NV-MSVT. In the valid sample, BRFail remained stable at about 5% for participants between the 




Percentages of Participants Failing the Standard Cutoff on the Non-Verbal Medical Symptom Validity Test in the 
Overall Sample and across Several Age Groups 
 
 Overall Samplea  Age (years)   
NV-MSVT f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
STN 308 18.7  9.7 18.5 18.7 20.3 29.6 20.79* .013 
 
Note. NV-MSVT = Non-Verbal Medical Symptom Validity Test (Green, 2008); STN = standard cutoffs specified in 
the test manual. 
an = 1645. bn = 216. cn = 313. dn = 523. en = 482. fn = 108. 





Percentages of Participants Failing the Standard Cutoff on the Non-Verbal Medical Symptom Validity Test in the 
Valid Sample and across Several Age Groups 
 
 Valid Samplea  Age (years)  
NV-MSVT f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
STN 83 7.3  5.0 5.3 5.3 9.2 20.3 23.63* .021 
 
Note. NV-MSVT = Non-Verbal Medical Symptom Validity Test (Green, 2008); STN = standard cutoffs specified in 
the test manual. 
an = 1141. bn = 179. cn = 207 dn = 358. en = 327. fn = 69. 
*p < .05. 
 
 Tables 24 and 25 show NV-MSVT BRFail as a function of education level in the overall 
and valid samples, respectively. Although BRFail varied significantly across education groups in 
the overall sample, χ2 (5, N = 1645) = 28.17, p <.001, this was a small effect (Φ2 = .017). The 
least educated groups failed the NV-MSVT most frequently (33.3% in those with ≤8 years of 
education and 23.4% in those with 9-11 years of education), while BRFail were lower and 
relatively similar (i.e., around 15%) across the remaining groups. There was no significant 
association between NV-MSVT failure and education level in the valid sample, χ2 (5, N = 1140) 
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= 3.85, p = .571, and education level accounted for only 0.3% of the variance in NV-MSVT 




Percentages of Participants Failing the Standard Cutoff on the Non-Verbal Medical Symptom Validity Test in the 
Overall Sample and across Several Education Levels 
 
 Overall Samplea  Education (years)   
NV-MSVT f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
              
STN 308 18.7  33.3 23.4 15.8 14.4 18.3 14.8 28.17* .017 
 
Note. NV-MSVT = Non-Verbal Medical Symptom Validity Test (Green, 2008); STN = standard cutoffs specified in 
the test manual. 
an = 1645. bn = 108. cn = 389. dn = 751. en = 216. fn = 120. gn = 61. 






Percentages of Participants Failing the Standard Cutoff on the Non-Verbal Medical Symptom Validity Test in the 
Valid Sample and across Several Education Levels 
 
 Valid Samplea  Education (years)  
NV-MSVT f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
STN 83 7.3  6.7 8.7 6.8 5.8 11.0 4.4 3.85 .003 
 
Note. NV-MSVT = Non-Verbal Medical Symptom Validity Test (Green, 2008); STN = standard cutoffs specified in 
the test manual. 
an = 1141. bn = 60. cn = 242. dn = 532. en = 171. fn = 91. gn = 45. 
*p < .05. 
 
 Tables 26 and 27 characterize NV-MSVT BRFail as a function of gender and English 
language status in the overall and valid samples, respectively. Gender was significantly related to 
NV-MSVT BRFail in the overall sample, χ2 (1, N = 1645) = 5.14, p = .023, such that males were 
1.27 as likely to fail the NV-MSVT as females. No significant relationship was found between 
gender and NV-MSVT failure in the valid sample, χ2 (1, N = 1141) = 0.03, p = .869 (LR = 1.04). 
With regard to English language status, NSEs demonstrated significantly lower NV-
MSVT BRFail than ESL patients in both samples, χ2 (1, N = 1644) = 41.30, p <.001 (overall 
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sample) and χ2 (1, N = 1140) = 5.89, p = .015 (valid sample). More specifically, NSEs were half 




Percentages of Participants Failing the Standard Cutoffs on the Non-Verbal Medical Symptom Validity Test in the 
Overall Sample and as a Function of Gender and English Language Status 
 
 Overall Samplea  Gender    English   
NV-MSVT f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
STN 308 18.7  20.5 16.1 5.14* 1.27  16.6 36.3 41.30* 0.46 
 
Note. NV-MSVT = Non-Verbal Medical Symptom Validity Test (Green, 2008); STN = standard cutoffs specified in 
the test manual; LR = likelihood ratio; NSE = native speakers of English; ESL = English as a second language. 
an = 1645. bn = 985. cn = 660. dn = 1462. en = 182. 





Percentages of Participants Failing the Standard Cutoffs on the Non-Verbal Medical Symptom Validity Test in the 
Valid Sample and as a Function of Gender and English Language Status 
 
 Valid Samplea  Gender    English   
NV-MSVT f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
STN 83 7.3  7.4 7.1 0.03 1.04  6.7 13.4 5.89* 0.50 
 
Note. NV-MSVT = Non-Verbal Medical Symptom Validity Test (Green, 2008); STN = standard cutoffs specified in 
the test manual; LR = likelihood ratio; NSE = native speakers of English; ESL = English as a second language. 
an = 1141. bn = 650. cn = 491. dn = 1043. en = 228. 
*p < .05.  
 
 
TOMM Trial 1. Table 28 shows TOMM Trial 1 BRFail, across various cutoffs, as a 
function of WMT performance. Examinees who passed the WMT demonstrated significantly 
lower BRFail across TOMM Trial 1 cutoffs than those who failed the WMT. Not surprisingly, 
differences in cumulative percentages of failure were more pronounced at lower TOMM Trial 1 
scores and less pronounced at higher TOMM Trial 1 scores. Individuals who passed the WMT 
were only 0.03 to 0.27 times as likely to score below previously published TOMM Trial 1 
cutoffs (Trial 1 ≤35 to ≤45) as those who failed the WMT. 














































Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); WMT = Word Memory Test (Green, 2003); Pass 
= participants passing the WMT at standard cutoffs; Fail = participants failing the WMT at standard cutoffs; LR = 
likelihood ratio; Min = minimum TOMM Trial 1 score in the respective group; Max = maximum TOMM Trial 1 
score in the respective group. Boldface font denotes previously published cutoffs. 
an = 1759. bn = 1168. cn = 591. 




Overall Samplea  WMT   
f %  Passb Failc χ2 LR 
        
≤18 2 0.1  0.0 0.3 - - 
≤19 4 0.2  0.0 0.7 - - 
≤20 12 0.7  0.0 2.0 - - 
≤21 16 0.9  0.0 2.7 - - 
≤22 19 1.1  0.0 3.2 - - 
≤23 24 1.4  0.0 4.1 - - 
≤24 28 1.6  0.0 4.7 - - 
≤25 33 1.9  0.0 5.6 - - 
≤26 39 2.2  0.1 6.4 72.85* 0.02 
≤27 47 2.7  0.1 7.8 89.42* 0.01 
≤28 58 3.3  0.1 9.6 112.46* 0.01 
≤29 71 4.0  0.3 11.5 128.20* 0.03 
≤30 86 4.9  0.3 14.0 160.42* 0.02 
≤31 100 5.7  0.3 16.4 191.04* 0.02 
≤32 115 6.5  0.3 18.8 218.37* 0.02 
≤33 125 7.1  0.4 20.3 234.86* 0.02 
≤34 151 8.6  0.8 24.0 270.47* 0.03 
≤35 168 9.6  0.9 26.7 304.22* 0.03 
≤36 188 10.7  1.4 29.1 316.20* 0.05 
≤37 207 11.8  1.6 31.8 344.34* 0.05 
≤38 232 13.2  2.2 34.9 364.93* 0.06 
≤39 258 14.7  3.1 37.6 372.79* 0.08 
≤40 292 16.6  3.8 42.0 413.53* 0.09 
≤41 333 18.9  5.3 45.9 420.37* 0.12 
≤42 380 21.6  6.9 50.6 441.63* 0.14 
≤43 449 25.5  9.8 56.5 449.60* 0.17 
≤44 511 29.1  13.0 60.7 433.77* 0.21 
≤45 605 34.4  18.0 66.8 415.12* 0.27 
≤46 744 42.3  26.2 74.1 369.12* 0.35 
≤47 893 50.8  36.3 79.4 291.06* 0.46 
≤48 1088 61.9  49.9 85.4 210.01* 0.58 
≤49 1372 78.0  69.9 93.9 131.28* 0.74 
≤50 1759 100  100 100 - - 
       
Min 17   26 17  
Max 50   50 50  
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 Tables 29 and 30 characterize TOMM Trial 1 BRFail across clinical groups in the overall 
and valid samples, respectively. In the overall sample, BRFail varied significantly as a function of 
diagnosis across TOMM Trial 1 cutoffs. At previously published cutoffs (i.e., Trial 1 ≤35 
through ≤45), diagnosis accounted for 2.6% to 3.8% of the variance in TOMM Trial 1 BRFail 
(small to medium effects): patients with mTBI and those with chronic pain/fibromyalgia tended 
to demonstrate the highest BRFail, while those with moderate-severe TBI, severe mental illness, 
orthopedic injury, and other diagnoses demonstrated lower BRFail. 
 In the valid sample, Fisher’s exact tests and chi-square tests of independence failed to 
reach statistical significance where conducted (i.e., at cutoffs of ≤43 and higher). Effect sizes 
corresponding to previously identified cutoffs (Trial 1 ≤43 through ≤45) were very small (Φ2 = 
.005-.006). Visual inspection of BRFail at lower cutoffs (e.g., Trial 1 ≤35 through ≤42) also did 
not reveal any consistent trends. 
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Table 29 
 
Cumulative Percentages of Participants Failing Various Cutoffs on TOMM Trial 1 in the Overall Sample and 




Overall Samplea  TBI  Diagnostic Groups   
f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≤18 2 0.1  0.0 0.0  0.0 0.0 0.0 0.0 0.4 0.4 0.0 - - 
≤19 4 0.2  0.0 0.0  0.0 0.0 0.0 0.0 0.9 0.4 0.0 - - 
≤20 12 0.7  0.0 0.0  0.0 0.6 0.2 0.0 1.8 0.6 0.0 - - 
≤21 16 0.9  0.0 0.0  0.0 0.9 0.4 0.0 2.2 0.6 0.0 - - 
≤22 19 1.1  0.0 0.0  0.0 0.9 0.9 0.0 2.4 0.6 0.0 - - 
≤23 24 1.4  0.0 0.0  0.0 1.2 0.9 0.0 2.9 1.1 0.6 - - 
≤24 28 1.6  0.0 0.0  0.0 1.5 1.3 0.0 3.1 1.1 0.6 - - 
≤25 33 1.9  0.0 0.0  0.0 1.5 1.3 0.0 4.0 1.1 1.2 - - 
≤26 39 2.2  0.0 0.0  0.0 2.1 1.7 0.0 4.4 1.1 1.2 - - 
≤27 47 2.7  1.6 0.0  0.0 2.9 1.9 0.0 5.1 1.1 1.2 - - 
≤28 58 3.3  3.2 0.0  0.0 3.8 2.4 7.7 5.8 1.1 1.8 - - 
≤29 71 4.0  4.8 0.0  0.0 4.7 2.8 7.7 6.9 1.7 2.4 - - 
≤30 86 4.9  4.8 0.0  2.0 5.9 3.2 7.7 8.4 1.7 3.0 FET* .013 
≤31 100 5.7  7.9 0.0  6.0 6.5 4.1 7.7 9.3 1.7 3.0 FET* .014 
≤32 115 6.5  9.5 0.0  6.0 7.1 4.7 7.7 11.3 1.7 3.0 FET* .019 
≤33 125 7.1  14.3 0.0  6.0 7.1 5.6 7.7 12.0 1.7 3.0 FET* .021 
≤34 151 8.6  19.0 3.6  8.0 8.8 6.6 7.7 13.6 2.2 4.2 39.68* .023 
≤35 168 9.6  20.6 3.6  8.0 9.1 7.5 7.7 15.8 2.8 4.2 48.10* .027 
≤36 188 10.7  22.2 3.6  8.0 10.3 8.5 7.7 17.1 4.4 4.8 46.04* .026 
≤37 207 11.8  25.4 3.6  8.0 10.9 10.0 7.7 18.2 5.6 5.4 46.95* .027 
≤38 232 13.2  25.4 3.6  10.0 13.3 10.9 7.7 20.0 6.1 7.1 44.87* .026 
≤39 258 14.7  28.6 7.1  12.0 14.5 12.6 7.7 22.2 6.1 7.1 52.04* .030 
≤40 292 16.6  30.2 10.7  14.0 16.2 14.7 7.7 25.1 6.7 7.7 57.16* .032 
≤41 333 18.9  33.3 10.7  16.0 18.9 17.1 7.7 28.4 7.8 8.3 65.55* .037 
≤42 380 21.6  36.5 14.3  18.0 21.8 19.4 15.4 31.8 11.1 8.3 67.80* .038 
≤43 449 25.5  39.7 17.9  24.0 26.3 23.1 30.8 35.6 13.3 13.1 60.87* .035 
≤44 511 29.1  41.3 17.9  26.0 31.3 26.7 30.8 39.1 14.4 17.9 59.51* .034 
≤45 605 34.4  47.6 21.4  28.0 35.7 32.7 30.8 44.9 19.4 23.8 56.94* .032 
≤46 744 42.3  57.1 21.4  32.0 44.2 40.2 53.8 52.2 29.4 31.5 53.26* .030 
≤47 893 50.8  65.1 28.6  44.0 49.6 48.9 69.2 60.4 40.6 42.3 43.43* .025 
≤48 1088 61.9  74.6 32.1  54.0 57.2 61.3 76.9 70.7 51.1 61.9 44.12* .025 
≤49 1372 78.0  83.1 64.3  74.0 72.3 79.7 84.6 82.0 74.4 78.6 18.07* .010 
≤50 1759 100  100 100  100 100 100 100 100 100 100 - - 
               
Min 17  27 34  30 20 20 28 17 20 23   
Max 50  50 50  50 50 50 50 50 50 50   
 
Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); TBI = traumatic brain injury; Mild = mTBI; M-S 
= moderate/severe TBI; NEU = neurological; DEP = depression; ANX = anxiety; SMI = severe mental illness 
(psychosis/Bipolar Disorder); CP/F = chronic pain and fibromyalgia; ORT = orthopedic; OTH = other; FET = 
Fisher’s exact test; Min = minimum TOMM Trial 1 score in the respective group; Max = maximum TOMM Trial 1 
score in the respective group. Boldface font denotes previously published cutoffs. 
an = 1759. bn = 63. cn = 28. dn = 50. en = 339. fn = 468. gn = 13. hn = 450. in = 180. jn = 168. 
*p < .05. 
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Table 30 
 





Valid Samplea  TBI  Diagnostic Groups   
f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≤25 0 0.0  0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 0.0 - - 
≤26 1 0.1  0.0 0.0  0.0 0.5 0.0 0.0 0.0 0.0 0.0 - - 
≤27 - -  0.0 0.0  0.0 0.5 0.0 0.0 0.0 0.0 0.0 - - 
≤28 - -  0.0 0.0  0.0 0.5 0.0 0.0 0.0 0.0 0.0 - - 
≤29 3 0.3  0.0 0.0  0.0 0.5 0.3 0.0 0.0 0.0 0.8 - - 
≤30 - -  0.0 0.0  0.0 0.5 0.3 0.0 0.0 0.0 0.8 - - 
≤31 - -  0.0 0.0  0.0 0.5 0.3 0.0 0.0 0.0 0.8 - - 
≤32 4 0.3  0.0 0.0  0.0 0.5 0.3 0.0 0.4 0.0 0.8 - - 
≤33 5 0.4  0.0 0.0  0.0 0.5 0.6 0.0 0.4 0.0 0.8 - - 
≤34 9 0.8  0.0 0.0  0.0 0.9 1.0 0.0 1.1 0.0 0.8 - - 
≤35 10 0.9  0.0 0.0  0.0 0.9 1.3 0.0 1.1 0.0 0.8 - - 
≤36 16 1.4  0.0 0.0  0.0 1.4 1.6 0.0 1.1 1.9 1.6 - - 
≤37 19 1.6  0.0 0.0  0.0 1.4 1.9 0.0 1.5 1.9 2.4 - - 
≤38 26 2.2  0.0 0.0  0.0 2.3 2.3 0.0 2.7 1.9 3.2 - - 
≤39 36 3.1  0.0 4.5  2.5 2.8 3.2 0.0 4.2 1.9 3.2 - - 
≤40 44 3.8  0.0 4.5  5.0 3.2 4.2 0.0 5.4 1.9 3.2 - - 
≤41 62 5.3  3.2 4.5  5.0 5.1 6.1 0.0 8.0 1.9 3.2 - - 
≤42 81 6.9  3.2 9.1  5.0 6.9 7.4 0.0 10.3 4.5 3.2 - - 
≤43 115 9.8  6.5 13.6  12.5 9.7 9.7 12.5 12.6 7.1 7.1 FET .005 
≤44 152 13.0  6.5 13.6  15.0 14.8 12.3 12.5 16.1 8.4 11.9 7.27 .006 
≤45 210 18.0  16.1 18.2  17.5 18.1 17.7 12.5 22.6 14.3 14.3 6.63 .006 
≤46 306 26.2  35.5 18.2  20.0 30.1 24.5 25.0 30.7 24.0 18.3 12.23 .010 
≤47 424 36.3  48.4 22.7  35.0 35.6 36.1 50.0 40.6 36.4 27.8 10.49 .009 
≤48 583 49.9  61.3 27.3  47.5 44.4 49.7 62.5 55.9 46.8 52.4 14.02 .012 
≤49 817 69.9  74.2 59.1  67.5 62.5 71.9 75.0 71.6 72.7 72.2 9.23 .008 
≤50 1169 100  100 100  100 100 100 100 100 100 100 - - 
               
Min 26  41 39  39 26 29 43 32 36 29   
Max 50  50 50  50 50 50 50 50 50 50   
 
Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); TBI = traumatic brain injury; Mild = mTBI; M-S 
= moderate/severe TBI; NEU = neurological; DEP = depression; ANX = anxiety; SMI = severe mental illness 
(psychosis/Bipolar Disorder); CP/F = chronic pain and fibromyalgia; ORT = orthopedic; OTH = other; FET = 
Fisher’s exact test; Min = minimum TOMM Trial 1 score in the respective group; Max = maximum TOMM Trial 1 
score in the respective group. Boldface font denotes previously published cutoffs. 
an = 1168. bn = 31. cn = 22. dn = 40. en = 216. fn = 310. gn = 8. hn = 261. in = 154. jn = 126. 
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 Tables 31 and 32 characterize TOMM Trial 1 BRFail as a function of age in the overall 
and valid samples, respectively. In the overall sample, Fisher’s exact tests and chi-square tests of 
independence were statistically significant at some values and non-significant at others. 
However, effect sizes were consistently very small and ranged from Φ2 = .004 to .008 at 
previously published cutoffs (Trial 1 ≤35 through ≤45). The youngest group (aged 16-29 years) 
tended to demonstrate the lowest BRFail, and BRFail generally increased with older age. Notably, 
individuals aged 60-69 years demonstrated somewhat lower BRFail than would be expected based 
on the trend at several cutoffs. 
 In the valid sample, Fisher’s exact tests and chi-square tests of independence were largely 
non-significant across TOMM Trial 1 cutoffs, and effect sizes remained very small. Age 
accounted for 0.2% to 0.9% of the variance in TOMM Trial 1 BRFail at previously published 
cutoffs. 
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Table 31 
 
Cumulative Percentages of Participants Failing Various TOMM Trial 1 cutoffs in the Overall Sample and across 




Overall Samplea  Age (years)  
f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≤18 2 0.1  0.4 0.0 0.0 0.3 0.0 - - 
≤19 4 0.2  0.4 0.0 0.2 0.5 0.0 - - 
≤20 12 0.7  0.7 0.2 0.7 1.0 1.4 FET .001 
≤21 16 0.9  0.7 0.2 1.1 1.5 1.4 FET .003 
≤22 19 1.1  0.7 0.2 1.2 2.0 1.4 FET .004 
≤23 24 1.4  0.7 0.7 1.6 2.3 1.4 FET .003 
≤24 28 1.6  0.7 0.9 1.6 3.0 1.4 FET .004 
≤25 33 1.9  0.7 1.6 1.8 3.3 1.4 6.48 .004 
≤26 39 2.2  0.7 1.8 2.3 3.8 1.4 7.82 .004 
≤27 47 2.7  0.7 2.2 2.5 4.8 2.7 11.10* .006 
≤28 58 3.3  1.5 2.7 3.4 5.3 2.7 8.35 .005 
≤29 71 4.0  1.5 3.8 3.9 6.3 4.1 9.92* .006 
≤30 86 4.9  1.8 4.7 4.6 7.5 4.1 11.83* .007 
≤31 100 5.7  2.9 5.6 5.1 8.3 5.5 9.31 .005 
≤32 115 6.5  2.9 6.0 5.8 10.6 5.5 17.18* .010 
≤33 125 7.1  4.0 6.5 6.2 11.1 5.5 14.75* .008 
≤34 151 8.6  5.9 7.6 7.8 12.6 6.8 11.99* .007 
≤35 168 9.6  6.2 8.3 9.2 13.3 9.6 11.02* .006 
≤36 188 10.7  7.7 9.2 10.8 14.1 9.6 8.56 .005 
≤37 207 11.8  8.1 11.2 11.7 15.1 9.6 8.34 .005 
≤38 232 13.2  8.4 12.3 13.6 17.1 9.6 11.97* .007 
≤39 258 14.7  9.9 14.1 14.9 18.8 9.6 12.22* .007 
≤40 292 16.6  10.3 16.3 17.5 20.6 11.0 14.64* .008 
≤41 333 18.9  12.1 18.8 20.4 22.4 13.7 13.47* .008 
≤42 380 21.6  14.3 22.4 23.2 24.1 16.4 12.29* .007 
≤43 449 25.5  18.3 25.1 28.7 27.4 19.2 12.75* .007 
≤44 511 29.1  20.9 28.9 32.2 30.9 24.7 12.95* .007 
≤45 605 34.4  27.8 34.0 36.8 35.9 32.9 7.19 .004 
≤46 744 42.3  37.7 42.1 43.9 42.7 43.8 3.03 .002 
≤47 893 50.8  46.5 51.0 52.7 49.7 53.4 3.23 .002 
≤48 1088 61.9  54.9 62.6 62.8 63.8 63.0 6.55 .004 
≤49 1372 78.0  75.1 80.8 77.9 76.9 78.1 3.62 .002 
≤50 1759 100  100 100 100 100 100   
          
Min 17  18 20 19 17 20   
Max 50  50 50 50 50 50   
 
Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); FET = Fisher’s exact test; Min = minimum 
TOMM Trial 1 score in the respective group; Max = maximum TOMM Trial 1 score in the respective group. 
Boldface font denotes previously published cutoffs. 
an = 1759. bn = 273. cn = 447. dn = 565. en = 398. fn = 73. 
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Table 32 
 
Cumulative Percentages of Participants Failing Various TOMM Trial 1 cutoffs in the Valid Sample and across 




Valid Samplea  Age (years)  
f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≤25 0 0.0  0.0 0.0 0.0 0.0 0.0 - - 
≤26 1 0.1  0.0 0.0 0.0 0.4 0.0 - - 
≤27 - -  0.0 0.0 0.0 0.4 0.0 - - 
≤28 - -  0.0 0.0 0.0 0.4 0.0 - - 
≤29 3 0.3  0.0 0.3 0.3 0.4 0.0 - - 
≤30 - -  0.0 0.3 0.3 0.4 0.0 - - 
≤31 - -  0.0 0.3 0.3 0.4 0.0 - - 
≤32 4 0.3  0.0 0.3 0.3 0.9 0.0 - - 
≤33 5 0.4  0.0 0.3 0.3 1.3 0.0 - - 
≤34 9 0.8  0.0 0.7 0.8 1.7 0.0 - - 
≤35 10 0.9  0.0 0.7 0.8 1.7 2.4 - - 
≤36 16 1.4  0.5 0.7 2.1 1.7 2.4 FET .004 
≤37 19 1.6  0.5 1.3 2.3 1.7 2.4 FET .003 
≤38 26 2.2  1.0 1.7 3.1 2.6 2.4 FET .003 
≤39 36 3.1  1.9 2.6 4.1 3.0 2.4 2.62 .002 
≤40 44 3.8  1.9 4.0 4.9 3.0 4.8 3.82 .003 
≤41 62 5.3  2.9 4.6 7.8 4.3 4.8 7.77 .007 
≤42 81 6.9  3.9 7.0 9.6 5.6 4.8 8.12 .007 
≤43 115 9.8  6.3 9.9 13.5 7.3 7.1 10.62* .009 
≤44 152 13.0  9.7 13.6 16.6 9.9 9.5 8.83 .008 
≤45 210 18.0  17.5 18.2 21.0 13.4 16.7 5.81 .005 
≤46 306 26.2  26.7 26.2 28.0 22.8 26.2 2.01 .002 
≤47 424 36.3  37.4 36.1 38.6 31.0 40.5 4.09 .003 
≤48 583 49.9  47.1 51.0 50.8 49.1 52.4 1.07 .001 
≤49 817 69.9  70.4 73.5 69.9 65.5 66.7 4.22 .004 
≤50 1169 100  100 100 100 100 100 - - 
          
Min 26  36 29 29 26 35   
Max 50  50 50 50 50 50   
 
Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); FET = Fisher’s exact test; Min = minimum 
TOMM Trial 1 score in the respective group; Max = maximum TOMM Trial 1 score in the respective group. 
Boldface font denotes previously published cutoffs. 
an = 1168. bn = 206. cn = 302. dn = 386. en = 232. fn = 42. 
*p < .05. 
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 Tables 33 and 34 characterize TOMM Trial 1 BRFail across education levels in the overall 
and valid samples, respectively. Although chi-square tests reached statistical significance at 
higher TOMM Trial 1 cutoffs in the overall sample, this pattern of findings was likely driven by 
the large sample size. Effect sizes indicate that education accounted for only 0.1% to 1.3% of the 
variance in TOMM Trial 1 BRFail across all cutoffs examined, and for 0.5% to 1.3% of the 
variance in BRFail at previously published cutoffs (Trial 1 ≤35 through ≤45; very small to small 
effect). Nonetheless, BRFail were highest among the group with ≤8 years of education and 
generally decreased with higher levels of education. Examinees with 16 and ≥17 years of 
education did, however, demonstrate higher BRFail than would be expected based on the trend at 
higher TOMM Trial 1 cutoffs. 
 In the valid sample, Fisher’s exact tests and chi-square tests of independence failed to 
reach statistical significance where conducted (i.e., at cutoffs of Trial 1 ≤36 and above), and 
effect sizes remained small. Education level accounted for 0.4% to 1.0% of the variance in Trial 
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Table 33 
 
Cumulative Percentages of Participants Failing Various TOMM Trial 1 Cutoffs in the Overall Sample and across 




Overall Samplea  Education (years) 
f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≤18 2 0.1  0.0 0.2 0.0 0.0 0.0 1.4 - - 
≤19 4 0.2  0.0 0.2 0.2 0.4 0.0 1.4 - - 
≤20 12 0.7  1.4 0.6 0.6 0.7 0.0 1.4 - - 
≤21 16 0.9  3.4 0.8 0.6 0.7 0.0 1.4 - - 
≤22 19 1.1  3.4 1.2 0.8 0.7 0.0 1.4 - - 
≤23 24 1.4  3.4 1.2 1.2 1.1 0.9 1.4 FET .003 
≤24 28 1.6  3.4 1.8 1.2 1.5 0.9 1.4 FET .002 
≤25 33 1.9  4.1 2.4 1.4 1.5 0.9 1.4 FET .004 
≤26 39 2.2  4.1 2.6 1.8 2.2 0.9 1.4 FET .002 
≤27 47 2.7  4.1 2.9 2.4 2.2 1.8 2.8 FET .001 
≤28 58 3.3  4.8 3.7 2.9 2.6 3.7 2.8 FET .001 
≤29 71 4.0  6.1 5.3 3.4 2.6 3.7 2.8 6.25 .004 
≤30 86 4.9  7.5 5.9 4.3 3.7 3.7 4.2 4.94 .003 
≤31 100 5.7  8.8 6.7 5.3 3.7 3.7 5.6 6.52 .004 
≤32 115 6.5  8.8 8.1 6.3 3.7 4.6 6.9 7.39 .004 
≤33 125 7.1  10.2 8.3 7.0 4.1 5.5 6.9 7.19 .004 
≤34 151 8.6  12.9 9.8 8.2 6.0 6.4 6.9 7.80 .004 
≤35 168 9.6  14.3 11.0 9.0 6.7 8.3 6.9 8.50 .005 
≤36 188 10.7  16.3 11.8 10.5 7.1 10.1 6.9 10.22 .006 
≤37 207 11.8  18.4 13.0 11.5 7.9 11.0 8.3 11.73* .007 
≤38 232 13.2  20.4 14.5 12.8 8.6 11.9 11.1 12.88* .007 
≤39 258 14.7  21.1 17.1 13.9 9.0 14.7 12.5 14.70* .008 
≤40 292 16.6  23.1 19.8 15.0 11.2 15.6 16.7 15.29* .009 
≤41 333 18.9  25.9 23.6 16.3 12.0 18.3 22.2 23.54* .013 
≤42 380 21.6  28.6 25.1 19.1 15.7 23.9 23.6 16.38* .009 
≤43 449 25.5  33.3 30.5 22.1 18.4 28.4 27.8 23.07* .013 
≤44 511 29.1  35.4 34.4 26.4 20.6 31.2 30.6 21.66* .012 
≤45 605 34.4  40.1 39.9 32.4 25.8 33.9 34.7 18.80* .011 
≤46 744 42.3  49.0 48.5 40.2 33.7 39.4 40.3 20.57* .012 
≤47 893 50.8  59.2 55.4 49.3 42.7 47.7 48.6 16.60* .009 
≤48 1088 61.9  66.7 66.2 61.7 53.6 55.0 63.9 15.60* .009 
≤49 1372 78.0  80.3 80.9 78.5 71.9 71.6 80.6 11.78* .007 
≤50 1759 100  100 100 100 100 100 100 - - 
           
Min 17  20 17 19 19 23 18   
Max 50  50 50 50 50 50 50   
 
Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); FET = Fisher’s exact test; Min = minimum 
TOMM Trial 1 score in the respective group; Max = maximum TOMM Trial 1 score in the respective group. 
Boldface font denotes previously published cutoffs. 
an = 1759. bn = 147. cn = 509. dn = 655. en = 267. fn = 109. gn = 72. 
*p < .05. 
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Table 34 
 
Cumulative Percentages of Participants Failing Various TOMM Trial 1 Cutoffs in the Valid Sample and across 




Valid Samplea  Education (years)  
f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≤25 0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 - - 
≤26 1 0.1  0.0 0.0 0.2 0.0 0.0 0.0 - - 
≤27 - -  0.0 0.0 0.2 0.0 0.0 0.0 - - 
≤28 - -  0.0 0.0 0.2 0.0 0.0 0.0 - - 
≤29 3 0.3  1.2 0.3 0.2 0.0 0.0 0.0 - - 
≤30 - -  1.2 0.3 0.2 0.0 0.0 0.0 - - 
≤31 - -  1.2 0.3 0.2 0.0 0.0 0.0 - - 
≤32 4 0.3  1.2 0.3 0.2 0.0 0.0 1.9 - - 
≤33 5 0.4  2.4 0.3 0.2 0.0 0.0 1.9 - - 
≤34 9 0.8  2.4 0.9 0.5 0.5 0.0 1.9 - - 
≤35 10 0.9  2.4 1.2 0.5 0.5 0.0 1.9 - - 
≤36 16 1.4  4.9 1.2 1.1 0.5 1.4 1.9 FET .008 
≤37 19 1.6  6.1 1.2 1.6 0.5 1.4 1.9 FET .010 
≤38 26 2.2  6.1 2.5 2.1 1.0 1.4 1.9 FET .006 
≤39 36 3.1  7.3 4.0 2.5 1.5 2.7 1.9 FET .007 
≤40 44 3.8  7.3 5.0 3.0 2.0 2.7 5.7 FET .006 
≤41 62 5.3  8.5 7.1 4.3 2.5 5.4 7.5 FET .007 
≤42 81 6.9  8.5 8.0 6.4 4.0 9.5 9.4 5.00 .004 
≤43 115 9.8  12.2 12.4 8.9 5.0 12.2 13.2 9.60 .008 
≤44 152 13.0  13.4 15.8 13.0 7.0 13.5 17.0 9.25 .008 
≤45 210 18.0  17.1 20.4 18.5 13.1 16.2 20.8 5.15 .004 
≤46 306 26.2  26.8 29.1 26.5 21.1 24.3 26.4 4.26 .004 
≤47 424 36.3  41.5 39.0 36.6 31.2 29.7 37.7 5.70 .005 
≤48 583 49.9  51.2 53.9 51.3 42.7 40.5 52.8 9.30 .008 
≤49 817 69.9  68.3 74.0 71.2 64.3 59.5 73.6 10.13 .009 
≤50 1169 100  100 100 100 100 100 100   
           
Min 26  29 29 26 34 36 32   
Max 50  50 50 50 50 50 50   
 
Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); FET = Fisher’s exact test; Min = minimum 
TOMM Trial 1 score in the respective group; Max = maximum TOMM Trial 1 score in the respective group. 
Boldface font denotes previously published cutoffs. 
an = 1168. bn = 82. cn = 323. dn = 437. en = 199. fn = 74. gn = 53. 
*p < .05.  
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 Tables 35 and 36 characterize TOMM Trial 1 BRFail as a function of gender and English 
language status in the overall and valid samples, respectively. BRFail were not related to gender at 
most TOMM Trial 1 cutoffs in either sample. Although some chi-square tests were statistically 
significant at higher cutoffs in both samples, these findings were likely related to the large 
sample size. 
 With regard to English language status, NSEs demonstrated lower BRFail than ESL 
patients across TOMM Trial 1 cutoffs in both samples. At previously published cutoffs, 
likelihood ratios ranged from 0.29 (Trial 1 ≤35) to 0.58 (Trial 1 ≤44) in the overall sample, and 
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Table 35 
 
Cumulative Percentages of Participants Failing Various TOMM Trial 1 Cutoffs in the Overall Sample and as a 










































Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); LR = likelihood ratio; NSE = native speakers of 
English; ESL = English as a second language; FET = Fisher’s exact test; Min = minimum TOMM Trial 1 score in 
the respective group; Max = maximum TOMM Trial 1 score in the respective group. Boldface font denotes 
previously published cutoffs. 
an = 1759. bn = 1038. cn = 721. dn = 1508. en = 245. 




Overall Samplea  Gender    English   
f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
≤18 2 0.1  0.1 0.1 FET 1.00  0.0 0.8 - - 
≤19 4 0.2  0.1 0.4 FET 0.25  0.0 1.6 - - 
≤20 12 0.7  0.4 1.1 FET 0.36  0.3 3.3 FET* 0.09 
≤21 16 0.9  0.8 1.1 0.54 0.73  0.5 3.3 FET* 0.15 
≤22 19 1.1  1.0 1.2 0.32 0.83  0.7 3.7 FET* 0.19 
≤23 24 1.4  1.3 1.5 0.24 0.87  0.8 4.9 FET* 0.16 
≤24 28 1.6  1.4 1.8 0.35 0.78  0.9 5.3 FET* 0.17 
≤25 33 1.9  1.8 1.9 0.29 0.95  1.1 6.5 FET* 0.17 
≤26 39 2.2  2.3 2.1 0.11 1.10  1.3 7.3 36.02* 0.18 
≤27 47 2.7  2.5 2.9 0.27 0.86  1.6 9.0 45.02* 0.18 
≤28 58 3.3  3.1 3.6 0.37 0.86  1.9 11.4 60.53* 0.17 
≤29 71 4.0  3.9 4.2 0.05 0.93  2.5 13.5 66.71* 0.19 
≤30 86 4.9  5.0 4.7 0.08 1.06  3.1 15.5 70.17* 0.20 
≤31 100 5.7  6.1 5.1 0.70 1.20  3.5 18.8 92.12* 0.19 
≤32 115 6.5  7.0 5.8 1.02 1.21  4.4 19.6 80.25* 0.22 
≤33 125 7.1  7.7 6.2 1.39 1.24  4.8 20.8 81.83* 0.23 
≤34 151 8.6  9.3 7.5 1.87 1.24  6.2 22.9 74.44* 0.27 
≤35 168 9.6  10.4 8.3 2.14 1.25  7.1 24.5 73.99* 0.29 
≤36 188 10.7  11.7 9.3 2.49 1.26  8.2 25.7 67.67* 0.32 
≤37 207 11.8  12.9 10.1 3.18 1.28  9.2 28.2 73.97* 0.33 
≤38 232 13.2  14.6 11.1 4.68 1.32  10.4 30.2 72.17* 0.34 
≤39 258 14.7  15.8 13.0 2.59 1.22  11.9 31.8 67.16* 0.37 
≤40 292 16.6  17.9 14.7 3.18 1.22  13.5 35.5 73.56* 0.38 
≤41 333 18.9  20.1 17.2 2.39 1.17  15.9 37.6 64.26* 0.42 
≤42 380 21.6  22.8 19.8 2.26 1.15  18.6 40.0 56.78* 0.47 
≤43 449 25.5  27.2 23.2 3.59 1.17  22.5 44.1 51.77* 0.51 
≤44 511 29.1  30.6 26.8 3.09 1.14  25.5 50.2 62.34* 0.58 
≤45 605 34.4  36.4 31.5 4.59* 1.16  30.6 57.1 65.67* 0.54 
≤46 744 42.3  44.9 38.6 7.00* 1.16  38.5 64.9 60.08* 0.59 
≤47 893 50.8  53.8 46.5 9.06* 1.16  47.3 71.4 48.90* 0.66 
≤48 1088 61.9  64.5 58.0 7.79* 1.11  58.8 80.0 40.04* 0.74 
≤49 1372 78.0  80.9 73.8 12.63* 1.10  75.9 90.2 24.97* 0.84 
≤50 1759 100  100 100 - -  100 100 - - 
            
Min 17  18 17    20 17   
Max 50  50 50    50 50   
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Table 36 
 
Cumulative Percentages of Participants Failing Various TOMM Trial 1 Cutoffs in the Valid Sample and as a 
Function of Gender and English Language Status 
 
Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); LR = likelihood ratio; NSE = native speakers of 
English; ESL = English as a second language; FET = Fisher’s exact test; Min = minimum TOMM Trial 1 score in 
the respective group; Max = maximum TOMM Trial 1 score in the respective group. Boldface font denotes 
previously published cutoffs. 
an = 1168. bn = 662. cn = 506. dn = 1050. en = 115. 







Valid Samplea  Gender    English   
f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
≤25 0 0.0  0.0 0.0 - -  0.0 0.0 - - 
≤26 1 0.1  0.0 0.2 - -  0.0 0.9 - - 
≤27 - -  0.0 0.2 - -  0.0 0.9 - - 
≤28 - -  0.0 0.2 - -  0.0 0.9 - - 
≤29 3 0.3  0.3 0.2 FET 1.50  0.1 1.7 FET* 0.06 
≤30 - -  0.3 0.2 FET 1.50  0.1 1.7 FET* 0.06 
≤31 - -  0.3 0.2 FET 1.50  0.1 1.7 FET* 0.06 
≤32 4 0.3  0.3 0.4 FET 0.75  0.2 1.7 FET 0.12 
≤33 5 0.4  0.5 0.4 FET 1.25  0.3 1.7 FET 0.18 
≤34 9 0.8  0.6 1.0 FET 0.60  0.6 2.6 FET 0.23 
≤35 10 0.9  0.8 1.0 FET 0.80  0.7 2.6 FET 0.27 
≤36 16 1.4  1.1 1.8 1.10 0.61  1.0 4.3 FET* 0.23 
≤37 19 1.6  1.4 2.0 0.68 0.70  1.1 6.1 FET* 0.18 
≤38 26 2.2  2.1 2.4 0.09 0.88  1.7 7.0 FET* 0.24 
≤39 36 3.1  2.6 3.8 1.35 0.68  2.5 8.7 FET* 0.29 
≤40 44 3.8  3.6 4.0 0.09 0.90  3.0 10.4 FET* 0.29 
≤41 62 5.3  4.7 6.1 1.19 0.77  4.6 12.2 11.89* 0.38 
≤42 81 6.9  6.3 7.7 0.83 0.82  6.2 13.9 9.56* 0.45 
≤43 115 9.8  9.8 9.9 0.00 0.99  9.0 16.5 6.56* 0.55 
≤44 152 13.0  13.3 12.6 0.12 1.06  11.8 23.5 12.51* 0.50 
≤45 210 18.0  18.6 17.2 0.37 1.08  16.3 33.0 19.77* 0.49 
≤46 306 26.2  28.1 23.7 2.85 1.19  24.5 40.9 14.44* 0.60 
≤47 424 36.3  39.1 32.6 5.27* 1.20  34.8 49.6 9.83* 0.70 
≤48 583 49.9  52.3 46.8 3.38 1.12  48.3 64.3 10.70* 0.75 
≤49 817 69.9  73.3 65.6 7.99* 1.12  68.7 80.9 7.33* 0.85 
≤50 1169 100  100 100 - -  100 100 - - 
            
Min 26  29 26    29 26   
Max 50  50 50    50 50   
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 TOMM Trial 2. Table 37 shows TOMM Trial 2 BRFail, across various cutoffs, as a 
function of WMT performance. Participants who passed the WMT demonstrated significantly 
lower BRFail across TOMM Trial 2 cutoffs than did those who failed the WMT. Those who 
passed the WMT were only 0.04 to 0.21 times as likely as those who failed the WMT to fail 
previously published Trial 2 cutoffs (Trial 2 ≤44 through ≤49). 
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Table 37 
 
Cumulative Percentages of Participants Failing Various TOMM Trial 2 Cutoffs in the Overall Sample and as a 









































Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); WMT = Word Memory Test (Green, 2003); Pass 
= participants passing the WMT at standard cutoffs; Fail = participants failing the WMT at standard cutoffs; FET = 
Fisher’s exact test; LR = likelihood ratio; Min = minimum TOMM Trial 2 score in the respective group; Max = 
maximum TOMM Trial 2 score in the respective group. Boldface font denotes previously published cutoffs. 
an = 1756. bn = 1166. cn = 590. 





Overall Samplea  WMT   
f %  Passb Failc χ2 LR 
        
≤18 7 0.4  0.1 1.0 FET* 0.10 
≤19 - -  0.1 1.0 FET* 0.10 
≤20 8 0.5  0.1 1.2 FET* 0.08 
≤21 10 0.6  0.1 1.5 FET* 0.07 
≤22 14 0.8  0.1 2.2 FET* 0.05 
≤23 17 1.0  0.1 2.7 28.18* 0.04 
≤24 22 1.3  0.1 3.6 38.21* 0.03 
≤25 28 1.6  0.1 4.6 50.35* 0.02 
≤26 30 1.7  0.1 4.9 54.42* 0.02 
≤27 34 1.9  0.1 5.6 62.58* 0.02 
≤28 36 2.1  0.1 5.9 66.69* 0.02 
≤29 43 2.4  0.1 7.1 81.12* 0.01 
≤30 46 2.6  0.1 7.6 87.34* 0.01 
≤31 54 3.1  0.1 9.0 104.05* 0.01 
≤32 58 3.3  0.1 9.7 112.46* 0.01 
≤33 60 3.4  0.1 10.0 116.69* 0.01 
≤34 67 3.8  0.2 11.0 125.56* 0.02 
≤35 73 4.2  0.2 12.0 138.36* 0.02 
≤36 81 4.6  0.3 13.2 149.62* 0.02 
≤37 90 5.1  0.3 14.6 163.22* 0.02 
≤38 100 5.7  0.4 16.1 179.19* 0.02 
≤39 118 6.7  0.5 19.0 213.18* 0.03 
≤40 128 7.3  0.7 20.3 223.91* 0.03 
≤41 144 8.2  0.9 22.7 248.55* 0.04 
≤42 152 8.7  0.9 24.1 266.92* 0.04 
≤43 167 9.5  0.9 26.4 295.95* 0.03 
≤44 185 10.5  1.2 29.0 320.82* 0.04 
≤45 199 11.3  1.5 30.8 336.76* 0.05 
≤46 218 12.4  1.6 33.7 371.24* 0.05 
≤47 250 14.2  2.4 37.6 398.14* 0.06 
≤48 301 17.1  3.8 43.6 436.62* 0.09 
≤49 448 25.5  11.3 53.6 367.80* 0.21 
≤50 1756 100  100 100 - - 
       
Min 10  14 10   
Max 50  50 50   
BASE RATES OF PVT FAILURE  84
Tables 38 and 39 characterize TOMM Trial 2 BRFail across clinical groups in the overall 
and valid samples, respectively. In the overall sample, chi-square tests of independence were 
statistically significant where conducted (i.e., at Trial 2 cutoffs of ≤44 and higher). Effect sizes 
indicated that diagnosis accounted for 1.6 to 3.5% of the variance in BRFail at these cutoffs (small 
to medium effects). Patients with chronic pain/fibromyalgia and mTBI had the highest BRFail, 
and those with orthopedic injuries and other diagnoses had the lowest BRFail. Although BRFail 
were also quite low among those with moderate-severe TBI, severe mental illness, and 
neurological conditions, these groups were smaller in size. 
 In the valid sample, neither Fisher’s exact tests nor chi-square tests of independence were 
conducted. However, as shown in Table 39, most participants achieved scores of 49 or 50 on 
TOMM Trial 2, across clinical groups. At Trial 2 ≤49, BRFail were highest among those with 
other diagnoses (15.9%) and lowest in those with orthopedic injury (9.7%), mTBI (9.7%), and 
anxiety (9.0%). No failures were observed in those with severe mental illness, although the 
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Table 38 
 
Cumulative Percentages of Participants Failing Various TOMM Trial 2 Cutoffs in the Overall Sample and in 




Overall Samplea  TBI  Diagnostic Groups   
f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≤18 7 0.4  0.0 0.0  0.0 0.3 0.0 0.0 1.1 0.0 0.6 - - 
≤19 - -  0.0 0.0  0.0 0.3 0.0 0.0 1.1 0.0 0.6 - - 
≤20 8 0.5  0.0 0.0  0.0 0.3 0.0 0.0 1.3 0.0 0.6 - - 
≤21 10 0.6  0.0 0.0  0.0 0.9 0.0 0.0 1.3 0.0 0.6 - - 
≤22 14 0.8  0.0 0.0  0.0 0.9 0.0 0.0 2.2 0.0 0.6 - - 
≤23 17 1.0  0.0 0.0  0.0 1.2 0.0 0.0 2.4 0.6 0.6 - - 
≤24 22 1.3  0.0 0.0  0.0 1.2 0.4 0.0 2.9 1.1 0.6 - - 
≤25 28 1.6  0.0 0.0  0.0 1.5 0.6 0.0 3.8 1.1 0.6 - - 
≤26 30 1.7  0.0 0.0  0.0 1.8 0.9 0.0 3.8 1.1 0.6 - - 
≤27 34 1.9  0.0 0.0  0.0 1.8 1.1 0.0 4.4 1.1 1.2 - - 
≤28 36 2.1  0.0 0.0  0.0 1.8 1.1 0.0 4.7 1.1 1.2 - - 
≤29 43 2.4  1.6 0.0  0.0 2.1 1.5 0.0 5.3 1.1 1.2 - - 
≤30 46 2.6  1.6 0.0  0.0 2.4 1.9 0.0 5.8 1.1 1.2 - - 
≤31 54 3.1  3.2 0.0  0.0 3.6 1.9 0.0 6.2 1.7 1.2 - - 
≤32 58 3.3  3.2 0.0  0.0 3.9 1.9 0.0 6.2 1.7 1.8 - - 
≤33 60 3.4  3.2 0.0  0.0 3.9 2.1 0.0 6.4 1.7 1.8 - - 
≤34 67 3.8  4.8 0.0  0.0 4.2 2.4 0.0 7.3 1.7 1.8 - - 
≤35 73 4.2  4.8 0.0  0.0 4.5 2.8 0.0 8.0 1.7 1.8 - - 
≤36 81 4.6  4.8 0.0  0.0 4.7 3.9 0.0 8.4 1.7 1.8 - - 
≤37 90 5.1  6.3 0.0  0.0 5.0 4.1 0.0 9.3 1.7 3.0 - - 
≤38 100 5.7  6.3 0.0  2.0 5.9 4.7 0.0 10.0 1.7 3.0 - - 
≤39 118 6.7  12.7 0.0  2.0 7.1 5.1 0.0 11.8 1.7 3.0 - - 
≤40 128 7.3  12.7 0.0  2.0 7.4 5.8 0.0 12.9 2.2 3.0 - - 
≤41 144 8.2  14.3 0.0  4.0 8.0 6.9 0.0 14.0 2.2 4.2 - - 
≤42 152 8.7  14.3 0.0  4.0 8.3 7.3 0.0 15.1 2.2 4.2 - - 
≤43 167 9.5  15.9 3.6  6.0 9.2 8.4 0.0 15.8 2.8 4.2 - - 
≤44 185 10.5  17.5 3.6  6.0 9.5 9.9 7.7 17.1 3.3 4.8 42.96* .024 
≤45 199 11.3  17.5 3.6  6.0 11.0 10.3 7.7 18.2 3.9 5.4 43.33* .025 
≤46 218 12.4  20.6 7.1  6.0 11.9 11.8 7.7 19.1 4.4 6.0 42.58* .024 
≤47 250 14.2  27.0 7.1  10.0 13.6 12.6 7.7 21.8 5.0 7.7 51.15* .029 
≤48 301 17.1  28.6 7.1  10.0 19.0 14.6 7.7 26.0 6.1 8.9 61.64* .035 
≤49 448 25.5  33.3 21.7  20.0 27.6 23.1 7.7 33.8 13.3 19.6 40.69* .016 
≤50 1756 100  100 100  100 100 100 100 100 100 100 - - 
               
Min 10  29 43  38 16 24 44 10 23 14   
Max 50  50 50  50 50 50 50 50 50 50   
 
Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); TBI = traumatic brain injury; Mild = mTBI; M-S 
= moderate/severe TBI; NEU = neurological; DEP = depression; ANX = anxiety; SMI = severe mental illness 
(psychosis/Bipolar Disorder); CP/F = chronic pain and fibromyalgia; ORT = orthopedic; OTH = other; Min = 
minimum TOMM Trial 2 score in the respective group; Max = maximum TOMM Trial 2 score in the respective 
group. Boldface font denotes previously published cutoffs. 
an = 1756. bn = 63. cn = 28. dn = 50. en = 337. fn = 467. gn = 13. hn = 450. in = 180. jn = 168. 
*p < .05. 
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Table 39 
 




Valid Samplea  TBI  Diagnostic Groups   
f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≤18 1 0.1  0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 0.8 - - 
≤19 - -  0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 0.8 - - 
≤20 - -  0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 0.8 - - 
≤21 - -  0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 0.8 - - 
≤22 - -  0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 0.8 - - 
≤23 - -  0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 0.8 - - 
≤24 - -  0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 0.8 - - 
≤25 - -  0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 0.8 - - 
≤26 - -  0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 0.8 - - 
≤27 - -  0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 0.8 - - 
≤28 - -  0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 0.8 - - 
≤29 - -  0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 0.8 - - 
≤30 - -  0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 0.8 - - 
≤31 - -  0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 0.8 - - 
≤32 - -  0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 0.8 - - 
≤33 - -  0.0 0.0  0.0 0.0 0.0 0.0 0.0 0.0 0.8 - - 
≤34 2 0.2  0.0 0.0  0.0 0.5 0.0 0.0 0.0 0.0 0.8 - - 
≤35 - -  0.0 0.0  0.0 0.5 0.0 0.0 0.0 0.0 0.8 - - 
≤36 3 0.3  0.0 0.0  0.0 0.5 0.0 0.0 0.0 0.0 0.8 - - 
≤37 4 0.3  0.0 0.0  0.0 0.5 0.3 0.0 0.0 0.0 1.6 - - 
≤38 5 0.4  0.0 0.0  0.0 0.9 0.3 0.0 0.0 0.0 1.6 - - 
≤39 6 0.5  0.0 0.0  0.0 1.4 0.3 0.0 0.0 0.0 1.6 - - 
≤40 8 0.7  0.0 0.0  0.0 1.4 0.3 0.0 0.8 0.0 1.6 - - 
≤41 10 0.9  0.0 0.0  0.0 1.4 0.6 0.0 1.1 0.0 1.6 - - 
≤42 - -  0.0 0.0  0.0 1.4 0.6 0.0 1.1 0.0 1.6 - - 
≤43 11 0.9  0.0 0.0  0.0 1.4 1.0 0.0 1.1 0.0 1.6 - - 
≤44 14 1.2  0.0 0.0  0.0 1.4 1.9 0.0 1.1 0.0 1.6 - - 
≤45 17 1.5  0.0 0.0  0.0 1.9 2.3 0.0 1.5 0.0 1.6 - - 
≤46 19 1.6  0.0 0.0  0.0 1.9 2.3 0.0 1.9 0.6 1.6 - - 
≤47 28 2.4  6.5 0.0  0.0 2.3 2.3 0.0 2.7 1.3 4.0 - - 
≤48 44 3.8  6.5 0.0  0.0 5.1 3.2 0.0 4.2 1.9 5.6 - - 
≤49 132 11.3  9.7 13.6  10.0 12.6 9.0 0.0 12.3 9.7 15.9 - - 
≤50 1166 100  100 100  100 100 100 100 100 100 100 - - 
               
Min 14  47 49  49 34 36 50 40 46 14   
Max 40  50 50  50 50 50 50 50 50 50   
 
Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); TBI = traumatic brain injury; Mild = mTBI; M-S 
= moderate/severe TBI; NEU = neurological; DEP = depression; ANX = anxiety; SMI = severe mental illness 
(psychosis/Bipolar Disorder); CP/F = chronic pain and fibromyalgia; ORT = orthopedic; OTH = other; Min = 
minimum TOMM Trial 2 score in the respective group; Max = maximum TOMM Trial 2 score in the respective 
group. Boldface font denotes previously published cutoffs. 
an = 1166. bn = 31. cn = 22. dn = 40. en = 214. fn = 310. gn = 8. hn = 261. in = 154. jn = 126. 
*p < .05. 
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 Tables 40 and 41 characterize TOMM Trial 2 BRFail as a function of age in the overall 
and valid samples, respectively. Although chi-square tests of independence were significant at 
higher cutoffs in the overall sample, this pattern of results was likely driven by the large sample 
size. Effect sizes were consistently small (Φ2 = .003 - .010) across cutoffs examined, and age 
accounted for only 0.8 to 1.0% of the variance in TOMM Trial 2 BRFail at previously published 
cutoffs (≤44 through ≤49). BRFail tended to be lowest in the youngest group and increase with 
older age across TOMM Trial 2 cutoffs. A spike in BRFail was, however, observed in individuals 
50-59 years of age.  
 In the valid sample, most participants achieved scores of 49 or 50 on TOMM Trial 2 
across age groups. Chi-square tests of independence and Fisher’s exact tests were conducted at 
previously published cutoffs (i.e., ≤44 and higher). Age accounted for only 0.1 to 1.6% of the 
variance in Trial 2 BRFail at these levels of performance (very small to small effects). No 
consistent trends in BRFail were observed across age groups at cutoffs of Trial 2 ≤48 and lower. 
At Trial 2 ≤49, BRFail were stable at about 10% for examinees between aged 16-59 years, and an 
elevated BRFail (31.0%) was observed in the oldest group (60-69 years).  
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Table 40 
 
Cumulative Percentages of Participants Failing Various TOMM Trial 2 Cutoffs in the Overall Sample and across 




Overall Samplea  Age (years)  
f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≤18 7 0.4  0.4 0.2 0.2 1.0 0.0 - - 
≤19 - -  0.4 0.2 0.2 1.0 0.0 - - 
≤20 8 0.5  0.7 0.2 0.2 1.0 0.0 - - 
≤21 10 0.6  0.7 0.4 0.4 1.0 0.0 - - 
≤22 14 0.8  0.7 0.9 0.5 1.3 0.0 - - 
≤23 17 1.0  0.7 0.9 1.1 1.3 0.0 - - 
≤24 22 1.3  0.7 1.1 1.4 1.8 0.0 - - 
≤25 28 1.6  0.7 1.6 1.6 2.5 0.0 - - 
≤26 30 1.7  0.7 1.6 1.6 3.0 0.0 - - 
≤27 34 1.9  0.7 1.8 1.9 3.3 0.0 - - 
≤28 36 2.1  0.7 1.8 2.1 3.5 0.0 - - 
≤29 43 2.4  1.1 2.5 2.3 3.8 1.4 5.42 .003 
≤30 46 2.6  1.1 2.7 2.5 4.0 1.4 6.06 .003 
≤31 54 3.1  1.5 3.4 2.7 4.8 1.4 7.44 .004 
≤32 58 3.3  1.8 3.6 2.8 5.0 1.4 6.95 .004 
≤33 60 3.4  1.8 3.6 3.2 5.5 1.4 9.05 .005 
≤34 67 3.8  2.2 3.8 3.4 6.0 2.7 8.15 .005 
≤35 73 4.2  2.2 4.3 3.4 6.8 2.7 10.85* .006 
≤36 81 4.6  2.6 4.9 3.5 7.1 5.5 9.67* .005 
≤37 90 5.1  2.9 4.9 4.8 7.3 5.5 6.76 .004 
≤38 100 5.7  3.3 5.4 5.3 8.3 5.5 8.21 .005 
≤39 118 6.7  4.0 6.3 6.2 9.8 6.8 9.62* .005 
≤40 128 7.3  4.4 7.4 6.5 10.3 6.8 9.28 .005 
≤41 144 8.2  4.8 7.9 7.8 11.3 8.2 9.71* .005 
≤42 152 8.7  4.8 8.3 8.1 12.3 8.2 12.38* .007 
≤43 167 9.5  5.1 9.4 8.8 13.6 8.2 14.30* .008 
≤44 185 10.5  5.9 10.8 9.6 14.9 9.6 14.93* .008 
≤45 199 11.3  6.2 11.7 10.6 15.6 9.6 14.94* .008 
≤46 218 12.4  7.0 13.3 11.7 16.6 9.6 15.08* .009 
≤47 250 14.2  8.8 13.7 14.9 18.4 9.6 13.84* .008 
≤48 301 17.1  10.6 16.2 18.2 21.2 15.1 13.71* .008 
≤49 448 25.5  18.3 25.6 25.5 27.2 41.1 17.40* .010 
≤50 1756 100  100 100 100 100 100 - - 
          
Min 10  16 14 12 10 29   
Max 50  50 50 50 50 50   
 
Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); Min = minimum TOMM Trial 2 score in the 
respective group; Max = maximum TOMM Trial 2 score in the respective group. Boldface font denotes previously 
published cutoffs. 
an = 1756. bn = 273. cn = 445. dn = 565. en = 397. fn = 73. 
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Table 41 
 
Cumulative Percentages of Participants Failing Various TOMM Trial 2 cutoffs in the Valid Sample and across 




Valid Samplea  Age (years)  
f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≤18 1 0.1  0.0 0.3 0.0 0.0 0.0 - - 
≤19 - -  0.0 0.3 0.0 0.0 0.0 - - 
≤20 - -  0.0 0.3 0.0 0.0 0.0 - - 
≤21 - -  0.0 0.3 0.0 0.0 0.0 - - 
≤22 - -  0.0 0.3 0.0 0.0 0.0 - - 
≤23 - -  0.0 0.3 0.0 0.0 0.0 - - 
≤24 - -  0.0 0.3 0.0 0.0 0.0 - - 
≤25 - -  0.0 0.3 0.0 0.0 0.0 - - 
≤26 - -  0.0 0.3 0.0 0.0 0.0 - - 
≤27 - -  0.0 0.3 0.0 0.0 0.0 - - 
≤28 - -  0.0 0.3 0.0 0.0 0.0 - - 
≤29 - -  0.0 0.3 0.0 0.0 0.0 - - 
≤30 - -  0.0 0.3 0.0 0.0 0.0 - - 
≤31 - -  0.0 0.3 0.0 0.0 0.0 - - 
≤32 - -  0.0 0.3 0.0 0.0 0.0 - - 
≤33 - -  0.0 0.3 0.0 0.0 0.0 - - 
≤34 2 0.2  0.0 0.3 0.0 0.4 0.0 - - 
≤35 - -  0.0 0.3 0.0 0.4 0.0 - - 
≤36 3 0.3  0.5 0.3 0.0 0.4 0.0 - - 
≤37 4 0.3  0.5 0.3 0.3 0.4 0.0 - - 
≤38 5 0.4  0.5 0.3 0.5 0.4 0.0 - - 
≤39 6 0.5  0.5 0.3 0.8 0.4 0.0 - - 
≤40 8 0.7  0.5 0.3 1.3 0.4 0.0 - - 
≤41 10 0.9  0.5 0.3 1.3 1.3 0.0 - - 
≤42 - -  0.5 0.3 1.3 1.3 0.0 - - 
≤43 11 0.9  0.5 0.7 1.3 1.3 0.0 - - 
≤44 14 1.2  0.5 1.0 1.3 1.7 2.4 FET .002 
≤45 17 1.5  1.0 1.3 1.6 1.7 2.4 FET .001 
≤46 19 1.6  1.0 1.3 1.8 2.2 2.4 FET .001 
≤47 28 2.4  1.9 1.3 3.4 2.6 2.4 FET .003 
≤48 44 3.8  2.9 3.0 5.2 3.5 2.4 3.32 .003 
≤49 132 11.3  8.7 11.0 11.9 9.5 31.0 18.41* .016 
≤50 1166 100  100 100 100 100 100 - - 
          
Min 14  36 14 37 34 44   
Max 40  50 50 50 50 50   
 
Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); FET = Fisher’s exact test; Min = minimum 
TOMM Trial 2 score in the respective group; Max = maximum TOMM Trial 2 score in the respective group. 
Boldface font denotes previously published cutoffs. 
an = 1166. bn = 206. cn = 301. dn = 386. en = 231. fn = 42. 
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 Tables 42 and 43 characterize TOMM Trial 2 BRFail as a function of education level in 
the overall and valid samples, respectively. In the overall sample, Fisher’s exact tests and chi-
square tests of independence were not statistically significant where conducted, and education 
level accounted for only 0.3% to 0.5% of the variance in BRFail at previously published Trial 2 
cutoffs (≤44 through ≤49). Nonetheless, visual inspection of BRFail revealed a trend involving 
higher BRFail among those with lower levels of education. Individuals with 16 and ≥17 years of 
education demonstrated somewhat higher BRFail at some cutoffs than would be expected based 
on the trend. 
In the valid sample, Fisher’s exact tests and chi-square tests of independence were 
conducted at Trial 2 ≤48 and ≤49. These tests failed to reach statistical significance, and the 
associated effect sizes indicated that education accounted for only 0.5 to 0.9% of the variance at 
these levels of performance (small effects).   
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Table 42 
 
Cumulative Percentages of Participants Failing Various TOMM Trial 2 Cutoffs in the Overall Sample and across 




Overall Samplea  Education (years)  
f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≤18 7 0.4  1.4 0.4 0.5 0.0 0.0 0.0 - - 
≤19 - -  1.4 0.4 0.5 0.0 0.0 0.0 - - 
≤20 8 0.5  1.4 0.4 0.5 0.0 0.0 1.4 - - 
≤21 10 0.6  2.0 0.4 0.6 0.0 0.0 1.4 - - 
≤22 14 0.8  2.7 0.4 0.8 0.8 0.0 1.4 - - 
≤23 17 1.0  2.7 0.4 1.1 1.1 0.0 1.4 - - 
≤24 22 1.3  2.7 1.0 1.2 1.5 0.0 1.4 - - 
≤25 28 1.6  3.4 1.8 1.4 1.5 0.0 1.4 - - 
≤26 30 1.7  3.4 2.2 1.5 1.5 0.0 1.4 - - 
≤27 34 1.9  3.4 2.6 1.5 1.9 0.0 1.4 - - 
≤28 36 2.1  4.1 2.6 1.7 1.9 0.0 1.4 - - 
≤29 43 2.4  4.8 3.1 2.0 1.9 0.9 1.4 FET .004 
≤30 46 2.6  4.8 3.1 2.3 1.9 1.8 1.4 FET .003 
≤31 54 3.1  5.4 3.7 2.8 2.2 1.8 1.4 FET .003 
≤32 58 3.3  5.4 4.3 2.9 2.2 1.8 1.4 FET .004 
≤33 60 3.4  5.4 4.5 2.9 2.6 1.8 1.4 FET .004 
≤34 67 3.8  6.1 4.7 3.5 3.0 1.8 1.4 6.43 .004 
≤35 73 4.2  6.1 5.3 3.7 3.0 3.7 1.4 6.21 .003 
≤36 81 4.6  7.5 5.5 4.1 3.4 4.6 1.4 5.83 .003 
≤37 90 5.1  8.2 5.7 4.9 3.7 5.5 1.4 6.63 .004 
≤38 100 5.7  8.8 7.1 5.2 3.7 5.5 1.4 6.34 .004 
≤39 118 6.7  10.2 8.1 6.4 4.1 7.3 1.4 9.18 .005 
≤40 128 7.3  10.2 8.8 7.1 4.9 7.3 1.4 10.59 .006 
≤41 144 8.2  10.9 9.0 8.3 5.6 7.3 6.9 9.74 .005 
≤42 152 8.7  11.6 9.4 8.7 6.0 7.3 8.3 4.51 .003 
≤43 167 9.5  12.9 10.2 9.8 6.7 7.3 8.3 4.61 .003 
≤44 185 10.5  14.3 11.6 10.6 7.5 8.3 9.7 5.45 .003 
≤45 199 11.3  15.6 12.0 11.2 8.6 10.1 11.1 6.07 .003 
≤46 218 12.4  16.3 13.0 12.7 9.0 10.1 13.9 5.08 .003 
≤47 250 14.2  19.0 13.9 14.4 11.2 13.8 16.7 5.84 .003 
≤48 301 17.1  23.8 18.3 16.3 13.5 16.5 18.1 5.18 .003 
≤49 448 25.5  34.7 28.7 22.9 21.7 23.9 25.0 8.01 .005 
≤50 1756 100  100 100 100 100 100 100 - - 
           
Min 10  16 16 10 22 29 20   
Max 50  50 50 50 50 50 50   
 
Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); FET = Fisher’s exact test; Min = minimum 
TOMM Trial 2 score in the respective group; Max = maximum TOMM Trial 2 score in the respective group. 
Boldface font denotes previously published cutoffs. 
an = 1756. bn = 147. cn = 509. dn = 652. en = 267. fn = 109. gn = 72. 
*p < .05. 
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Table 43 
Cumulative Percentages of Participants Failing Various TOMM Trial 2 Cutoffs in the Valid Sample and across 




Valid Samplea  Education (years)  
f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≤18 1 0.1  0.0 0.0 0.2 0.0 0.0 0.0 - - 
≤19 - -  0.0 0.0 0.2 0.0 0.0 0.0 - - 
≤20 - -  0.0 0.0 0.2 0.0 0.0 0.0 - - 
≤21 - -  0.0 0.0 0.2 0.0 0.0 0.0 - - 
≤22 - -  0.0 0.0 0.2 0.0 0.0 0.0 - - 
≤23 - -  0.0 0.0 0.2 0.0 0.0 0.0 - - 
≤24 - -  0.0 0.0 0.2 0.0 0.0 0.0 - - 
≤25 - -  0.0 0.0 0.2 0.0 0.0 0.0 - - 
≤26 - -  0.0 0.0 0.2 0.0 0.0 0.0 - - 
≤27 - -  0.0 0.0 0.2 0.0 0.0 0.0 - - 
≤28 - -  0.0 0.0 0.2 0.0 0.0 0.0 - - 
≤29 - -  0.0 0.0 0.2 0.0 0.0 0.0 - - 
≤30 - -  0.0 0.0 0.2 0.0 0.0 0.0 - - 
≤31 - -  0.0 0.0 0.2 0.0 0.0 0.0 - - 
≤32 - -  0.0 0.0 0.2 0.0 0.0 0.0 - - 
≤33 - -  0.0 0.0 0.2 0.0 0.0 0.0 - - 
≤34 2 0.2  0.0 0.0 0.5 0.0 0.0 0.0 - - 
≤35 - -  0.0 0.0 0.5 0.0 0.0 0.0 - - 
≤36 3 0.3  0.0 0.3 0.5 0.0 0.0 0.0 - - 
≤37 4 0.3  1.2 0.3 0.5 0.0 0.0 0.0 - - 
≤38 5 0.4  1.2 0.6 0.5 0.0 0.0 0.0 - - 
≤39 6 0.5  1.2 0.6 0.7 0.0 0.0 0.0 - - 
≤40 8 0.7  1.2 1.2 0.7 0.0 0.0 0.0 - - 
≤41 10 0.9  1.2 1.2 0.7 0.5 0.0 1.9 - - 
≤42 - -  1.2 1.2 0.7 0.5 0.0 1.9 - - 
≤43 11 0.9  1.2 1.5 0.7 0.5 0.0 1.9 - - 
≤44 14 1.2  2.4 2.2 0.7 0.5 0.0 1.9 - - 
≤45 17 1.5  2.4 2.2 0.9 1.5 0.0 1.9 - - 
≤46 19 1.6  2.4 2.5 1.1 1.5 0.0 1.9 - - 
≤47 28 2.4  4.9 3.1 1.8 2.0 0.0 3.8 - - 
≤48 44 3.8  6.1 5.3 2.5 3.5 2.7 3.8 FET .005 
≤49 132 11.3  18.3 14.2 8.7 10.1 9.5 11.3 10.19 .009 
≤50 1166 100  100 100 100 100 100 100 - - 
           
Min 14  37 36 14 41 48 41   
Max 40  50 50 50 50 50 50   
 
Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); FET = Fisher’s exact test; Min = minimum 
TOMM Trial 2 score in the respective group; Max = maximum TOMM Trial 2 score in the respective group. 
Boldface font denotes previously published cutoffs. 
an = 1166. bn = 82. cn = 323. dn = 435. en = 199. fn = 74. gn = 53. 
*p < .05.  
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 Tables 44 and 45 report TOMM Trial 2 BRFail as a function of gender and English 
language status in the overall and valid samples, respectively. In the overall sample, Fisher’s 
exact tests and chi-square tests of independence largely failed to reach statistical significance 
across TOMM Trial 2 cutoffs, suggesting no meaningful relationship between TOMM Trial 2 
performance and gender. The isolated exception to this finding was observed at Trial 2 ≤45, χ2 
(1, N = 1756) = 4.33, p = .037. Given that the LR (1.34) was comparable to those observed at 
lower Trial 2 cutoffs, this significant finding was likely the result of the large sample size. In the 
valid sample, there was no significant relationship between TOMM Trial 2 failure and gender 
across cutoffs, and likelihood ratios ranged from 0.88 to 1.07, indicating largely comparable 
BRFail between males and females. 
 With regard to English language status, in the overall sample, NSEs consistently 
demonstrated lower BRFail than ESL patients, resulting in statistically significant Fisher’s exact 
tests and chi-square tests across TOMM Trial 2 cutoffs. NSEs were 0.28 to 0.46 times as likely 
as ESL patients to fail previously published Trial 2 cutoffs (≤44 through ≤49). A similar pattern 
was observed across most TOMM Trial 2 scores in the valid sample, although contrasts only 
reached statistical significance at ≤45 and above (likely due to the larger sample size at these 
levels of performance). NSEs were approximately one-quarter to one-half as likely as ESL 
patients to fail previously published Trial 2 cutoffs in the valid sample. 
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Table 44 
 
Cumulative Percentages of Participants Failing Various TOMM Trial 2 Cutoffs in the Overall Sample and as a 
Function of Gender and English Language Status 
 
 
Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); LR = likelihood ratio; NSE = native speakers of 
English; ESL = English as a second language; FET = Fisher’s exact test; Min = minimum TOMM Trial 2 score in 
the respective group; Max = maximum TOMM Trial 2 score in the respective group. Boldface font denotes 
previously published cutoffs. 
an = 1756. bn = 1036. cn = 720. dn = 1506. en = 244. 




Overall Samplea  Gender   English   
f %  Maleb Femalec χ2 LR NSEd ESLe χ2 LR 
            
≤18 7 0.4  0.3 0.6 FET 0.50 0.1 2.5 FET* 0.04 
≤19 - -  0.3 0.6 FET 0.50 0.1 2.5 FET* 0.04 
≤20 8 0.5  0.4 0.6 FET 0.67 0.1 2.9 FET* 0.03 
≤21 10 0.6  0.5 0.7 FET 0.71 0.2 2.9 FET* 0.07 
≤22 14 0.8  0.7 1.0 0.47 0.70 0.2 4.5 FET* 0.04 
≤23 17 1.0  0.8 1.3 1.01 0.62 0.4 4.5 FET* 0.09 
≤24 22 1.3  1.2 1.4 0.18 0.86 0.7 4.9 FET* 0.14 
≤25 28 1.6  1.6 1.5 0.04 1.07 1.1 4.9 FET* 0.22 
≤26 30 1.7  1.7 1.7 0.01 1.00 1.1 4.9 FET* 0.22 
≤27 34 1.9  1.9 1.9 0.00 1.00 1.4 4.9 FET* 0.29 
≤28 36 2.1  2.0 2.1 0.01 0.95 1.5 5.3 FET* 0.28 
≤29 43 2.4  2.6 2.2 0.26 1.18 1.7 6.6 20.92* 0.26 
≤30 46 2.6  2.8 2.4 0.32 1.17 1.8 7.4 26.14* 0.24 
≤31 54 3.1  3.3 2.8 0.36 1.18 2.0 9.4 39.52* 0.21 
≤32 58 3.3  3.7 2.8 1.05 1.32 2.3 9.4 34.24* 0.24 
≤33 60 3.4  3.8 2.9 0.93 1.31 2.3 9.8 36.37* 0.23 
≤34 67 3.8  4.3 3.1 1.92 1.39 2.6 11.1 41.57* 0.23 
≤35 73 4.2  4.6 3.5 1.44 1.31 2.8 11.1 48.10* 0.25 
≤36 81 4.6  5. 3.9 1.45 1.28 3.1 12.3 52.10* 0.25 
≤37 90 5.1  5.7 4.3 1.69 1.33 3.5 13.5 59.66* 0.26 
≤38 100 5.7  6.3 4.9 1.58 1.29 4.1 15.2 48.01* 0.27 
≤39 118 6.7  7.3 5.8 1.53 1.26 4.8 18.0 58.52* 0.27 
≤40 128 7.3  8.1 6.1 2.51 1.33 5.3 19.3 60.71* 0.27 
≤41 144 8.2  9.0 7.1 2.02 1.27 5.8 22.5 78.02* 0.26 
≤42 152 8.7  9.4 7.6 1.60 1.24 6.1 24.2 86.98* 0.25 
≤43 167 9.5  10.4 8.2 2.46 1.27 6.8 25.8 88.11* 0.26 
≤44 185 10.5  11.7 8.9 3.51 1.31 7.8 27.5 86.52* 0.28 
≤45 199 11.3  12.6 9.4 4.33* 1.34 8.4 29.1 82.37* 0.29 
≤46 218 12.4  13.6 10.7 3.32 1.27 9.4 30.7 87.77* 0.31 
≤47 250 14.2  15.1 13.1 1.40 1.15 11.1 33.6 87.24* 0.33 
≤48 301 17.1  18.2 15.6 2.16 1.17 13.6 38.9 94.79* 0.35 
≤49 448 25.5  26.9 23.5 2.67 1.14 21.9 47.5 72.63* 0.46 
≤50 1756 100  100 100 - - 100 100 - - 
           
Min 10  12 10   14 10   
Max 50  50 50   50 50   
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Table 45 
 
Cumulative Percentages of Participants Failing Various TOMM Trial 2 Cutoffs in the Valid Sample and as a 
Function of Gender and English Language Status 
 
 
Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); LR = likelihood ratio; NSE = native speakers of 
English; ESL = English as a second language; FET = Fisher’s exact test; Min = minimum TOMM Trial 2 score in 
the respective group; Max = maximum TOMM Trial 2 score in the respective group. Boldface font denotes 
previously published cutoffs. 
an = 1166. bn = 661. cn = 505. dn = 1049. en = 114. 





Valid Samplea  Gender   English   
f %  Maleb Femalec χ2 LR NSEd ESLe χ2 LR 
            
≤18 1 0.1  0.2 0.0 - - 0.1 0.0 - - 
≤19 - -  0.2 0.0 - - 0.1 0.0 - - 
≤20 - -  0.2 0.0 - - 0.1 0.0 - - 
≤21 - -  0.2 0.0 - - 0.1 0.0 - - 
≤22 - -  0.2 0.0 - - 0.1 0.0 - - 
≤23 - -  0.2 0.0 - - 0.1 0.0 - - 
≤24 - -  0.2 0.0 - - 0.1 0.0 - - 
≤25 - -  0.2 0.0 - - 0.1 0.0 - - 
≤26 - -  0.2 0.0 - - 0.1 0.0 - - 
≤27 - -  0.2 0.0 - - 0.1 0.0 - - 
≤28 - -  0.2 0.0 - - 0.1 0.0 - - 
≤29 - -  0.2 0.0 - - 0.1 0.0 - - 
≤30 - -  0.2 0.0 - - 0.1 0.0 - - 
≤31 - -  0.2 0.0 - - 0.1 0.0 - - 
≤32 - -  0.2 0.0 - - 0.1 0.0 - - 
≤33 - -  0.2 0.0 - - 0.1 0.0 - - 
≤34 2 0.2  0.2 0.2 FET 1.00 0.1 0.9 FET 0.11 
≤35 - -  0.2 0.2 FET 1.00 0.1 0.9 FET 0.11 
≤36 3 0.3  0.2 0.4 FET 0.50 0.2 0.9 FET 0.22 
≤37 4 0.3  0.3 0.4 FET 0.75 0.3 0.9 FET 0.33 
≤38 5 0.4  0.3 0.6 FET 0.50 0.4 0.9 FET 0.44 
≤39 6 0.5  0.5 0.6 FET 0.83 0.5 0.9 FET 0.56 
≤40 8 0.7  0.6 0.8 FET 0.75 0.7 0.9 FET 0.78 
≤41 10 0.9  0.6 1.2 FET 0.50 0.8 1.8 FET 0.44 
≤42 - -  0.6 1.2 FET 0.50 0.8 1.8 FET 0.44 
≤43 11 0.9  0.8 1.2 FET 0.67 0.9 1.8 FET 0.50 
≤44 14 1.2  1.2 1.2 0.00 1.00 1.0 2.6 FET 0.38 
≤45 17 1.5  1.5 1.4 0.03 1.07 1.1 4.4 FET* 0.25 
≤46 19 1.6  1.7 1.6 0.01 1.06 1.3 4.4 FET* 0.30 
≤47 28 2.4  2.3 2.6 0.11 0.88 2.0 6.1 FET* 0.33 
≤48 44 3.8  3.8 3.8 0.00 1.00 3.2 8.8 FET* 0.36 
≤49 132 11.3  11.6 10.9 0.16 1.06 10.6 18.4 6.28* 0.58 
≤50 1166 100  100 100 - - 100 100 - - 
           
Min 14  14 34   14 34   
Max 40  50 50   50 50   
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RDS. Table 46 shows RDS BRFail at various cutoffs as a function of WMT performance. 
Fisher’s exact tests and chi-square tests of independence were statistically significant at all RDS 
cutoffs. Participants who passed the WMT consistently demonstrated lower BRFail than those 
who failed the WMT. Those who passed the WMT were 0.22 to 0.39 times as likely as those 




Cumulative Percentages of Participants Failing Various Reliable Digit Span cutoffs in the Overall Sample and as a 
Function of Word Memory Test Performance 
 
 Overall Samplea  WMT   
RDS f %  Passb Failc χ2 LR 
        
≤4 12 0.6  0.1 1.8 FET* 0.06 
≤5 53 2.6  0.7 7.0 65.07* 0.10 
≤6 155 7.7  3.7 16.9 104.58* 0.22 
≤7 425 21.2  14.3 36.9 130.74* 0.39 
≤8 800 39.9  32.1 57.6 114.88* 0.56 
       
Min 0  4 0   
Max 17  17 17   
 
Note. RDS = Reliable Digit Span (Greiffenstein, Baker, & Gola, 1994); WMT = Word Memory Test (Green, 2003); 
Pass = participants passing the WMT at standard cutoffs; Fail = participants failing the WMT at standard cutoffs; 
LR = likelihood ratio; FET = Fisher’s exact test; Min = minimum RDS score in the respective group; Max = 
maximum RDS score in the respective group. Boldface font denotes previously published cutoffs. 
an = 2003. bn = 1388. cn = 615. 
*p < .05. 
 
 
 Tables 47 and 48 characterize RDS BRFail across clinical groups in the overall and valid 
samples, respectively. In the overall sample, chi-square tests reached statistical significance 
where conducted (i.e., at cutoffs between RDS ≤6 and ≤8). However, diagnosis only accounted 
for 1.3% to 1.4% of the variance in RDS BRFail at previously published cutoffs (RDS ≤6 and ≤7; 
small effects). At RDS ≤6, BRFail were highest among those with orthopedic injuries (17.0%), 
mTBI (12.4%), and chronic pain/fibromyalgia (11.5%), and lowest among those with severe 
mental illness (2.6%) and other diagnoses (3.2%). At RDS ≤7, the largest BRFail were observed 
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for patients with orthopedic injuries (32.1%), chronic pain/fibromyalgia (28.0%), mTBI (27.5%), 
and neurological conditions (26.1%), while patients with anxiety (16.5%) and moderate-severe 
TBI (16.7%) had the lowest BRFail. 
 In the valid sample, chi-square tests of independence or Fisher’s exact tests were not 
conducted at RDS ≤6. However, visual inspection of BRFail at this cutoff revealed that patients 
with orthopedic injuries had the highest BRFail (9.1%), and those with severe mental illness 
(0.0%), moderate-severe TBI (1.9%), anxiety (2.0%), and other diagnoses (2.5%) had the lowest 
BRFail. Although a chi-square test of independence did reach statistical significance at RDS ≤7, χ2 
(8, N = 1388) = 16.10, p = .041, diagnosis only accounted for 1.2% of the variance in BRFail at 
this cutoff (small effect). Nevertheless, patients with neurological conditions (21.3%) and 
chronic pain/fibromyalgia (20.2%) had the highest BRFail; moderate-severe TBI patients had the 




Cumulative Percentages of Participants Failing Various Reliable Digit Span Cutoffs in the Overall Sample and in 
Specific Clinical Groups 
 
 Overall Samplea  TBI  Diagnostic Groups   
RDS f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≤4 12 0.6  1.3 1.5  0.0 0.0 1.1 0.0 0.6 0.0 0.6 - - 
≤5 53 2.6  4.6 4.5  1.8 1.1 3.3 0.0 3.1 9.4 1.3 - - 
≤6 155 7.7  12.4 9.1  6.3 7.0 5.9 2.6 11.5 17.0 3.2 26.95* .013 
≤7 425 21.2  27.5 16.7  26.1 19.6 16.5 21.1 28.0 32.1 18.1 27.72* .014 
≤8 800 39.9  43.1 36.4  42.3 36.8 37.5 34.2 47.4 50.9 38.7 15.54* .008 
               
Min 0  0 4  5 5 2 6 2 5 2   
Max 17  15 15  15 16 17 14 15 14 14   
 
Note. RDS = Reliable Digit Span (Greiffenstein, Baker, & Gola, 1994); TBI = traumatic brain injury; Mild = mTBI; 
M-S = moderate/severe TBI; NEU = neurological; DEP = depression; ANX = anxiety; SMI = severe mental illness 
(psychosis/Bipolar Disorder); CP/F = chronic pain and fibromyalgia; ORT = orthopedic; OTH = other; Min = 
minimum RDS score in the respective group; Max = maximum RDS score in the respective group. Boldface font 
denotes previously published cutoffs. 
an = 2003. bn = 153. cn = 66. dn = 111. en = 560. fn = 546. gn = 38. hn = 321. in = 53. jn = 155. 
*p < .05. 
 




Cumulative Percentages of Participants Failing Various Reliable Digit Span Cutoffs in the Valid Sample and in 
Specific Clinical Groups 
 
 Valid Samplea  TBI  Diagnostic Groups   
RDS f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≤4 1 0.1  0.0 0.0  0.0 0.0 0.3 0.0 0.0 0.0 0.0 - - 
≤5 10 0.7  1.1 0.0  1.1 0.5 0.8 0.0 0.0 9.1 0.0 - - 
≤6 51 3.7  6.9 1.9  5.6 3.7 2.0 0.0 5.3 9.1 2.5 - - 
≤7 198 14.3  16.1 9.3  21.3 12.6 10.9 13.0 20.2 12.1 16.7 16.10* .012 
≤8 446 32.1  29.9 29.6  38.2 28.3 31.3 26.1 38.0 39.4 34.2 9.16 .007 
               
Min 4  5 6  5 5 4 7 6 5 6   
Max 17  15 15  15 16 17 14 15 14 14   
 
Note. RDS = Reliable Digit Span (Greiffenstein, Baker, & Gola, 1994); TBI = traumatic brain injury; Mild = mTBI; 
M-S = moderate/severe TBI; NEU = neurological; DEP = depression; ANX = anxiety; SMI = severe mental illness 
(psychosis/Bipolar Disorder); CP/F = chronic pain and fibromyalgia; ORT = orthopedic; OTH = other; Min = 
minimum RDS score in the respective group; Max = maximum RDS score in the respective group. Boldface font 
denotes previously published cutoffs. 
an = 1388. bn = 87. cn = 54. dn = 89. en = 381. fn = 393. gn = 23. hn = 208. in = 33. jn = 120. 
*p < .05. 
 
 
 Tables 49 and 50 characterize RDS BRFail as a function of age in the overall and valid 
samples, respectively. In both samples, the youngest group demonstrated the lowest BRFail, and 
BRFail tended to increase with age. In the overall sample, RDS BRFail were significantly 
associated with age between RDS ≤5 and ≤8, and age accounted for 1.3 to 2.7% of the variance 
in BRFail at previously published cutoffs (i.e., RDS ≤6 and ≤7; small effects). In the valid sample, 
although chi-square tests reached statistical significance at higher cutoffs (likely due to the 
increase in sample size), age accounted for only 0.3% of the variance in BRFail at RDS ≤6 (very 
small effect), and for 1.9% of the variance in BRFail at RDS ≤7 (small effect). 
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Table 49 
 
Cumulative Percentages of Participants Failing Various Reliable Digit Span Cutoffs in the Overall Sample and 
across Several Age Groups 
 
 Overall Samplea  Age (years)  
RDS f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≤4 12 0.6  0.0 0.0 0.2 1.4 2.4 - - 
≤5 53 2.6  1.9 2.0 1.3 3.8 7.9 22.67* .011 
≤6 155 7.7  3.8 5.0 6.7 11.4 12.7 25.82* .013 
≤7 425 21.2  10.7 17.4 18.6 28.8 33.3 54.66* .027 
≤8 800 39.9  29.4 34.3 39.1 45.8 57.1 41.43* .021 
          
Min 0  5 5 2 0 2   
Max 17  17 16 15 17 14   
 
Note. RDS = Reliable Digit Span (Greiffenstein, Baker, & Gola, 1994); Min = minimum RDS score in the 
respective group; Max = maximum RDS score in the respective group. Boldface font denotes previously published 
cutoffs. 
an = 2003. bn = 262. cn = 397. dn = 639. en = 579. fn = 126. 






Cumulative Percentages of Participants Failing Various Reliable Digit Span Cutoffs in the Valid Sample and across 
Several Age Groups 
 
 Valid Samplea  Age (years)  
RDS f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≤4 1 0.1  0.0 0.0 0.0 0.3 0.0 - - 
≤5 10 0.7  0.5 0.7 0.2 1.0 2.5 FET .004 
≤6 51 3.7  2.8 2.9 3.0 4.9 6.2 4.54 .003 
≤7 198 14.3  8.8 12.1 11.3 19.9 24.7 26.55* .019 
≤8 446 32.1  26.9 27.9 30.6 37.0 45.7 16.38* .012 
          
Min 4  5 5 5 4 5   
Max 17  17 16 15 15 14   
 
Note. RDS = Reliable Digit Span (Greiffenstein, Baker, & Gola, 1994); FET = Fisher’s exact test; Min = minimum 
RDS score in the respective group; Max = maximum RDS score in the respective group. Boldface font denotes 
previously published cutoffs. 
an = 1388. bn = 216. cn = 272. dn = 432. en = 387. fn = 81. 
*p < .05. 
 
 Tables 51 and 52 characterize RDS BRFail as a function of education level in the overall 
and valid samples, respectively. In both samples, BRFail varied significantly across education 
groups at all RDS cutoffs where Fisher’s exact tests or chi-square tests were conducted. The 
highest BRFail were observed in participants with ≤8 years of education, and BRFail tended to 
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decrease with higher levels of education. Participants with 16 years of education did, however, 
exhibit somewhat elevated BRFail than would be expected based on the trend at some cutoffs. At 
previously published cutoffs (RDS ≤6 and ≤7), education accounted for 1.3% to 2.5% of the 
variance in BRFail in the overall sample (small effects), and 1.0% to 2.3% of the variance in BRFail 
in the valid sample (small effects). 
Table 51 
 
Cumulative Percentages of Participants Failing Various Reliable Digit Span Cutoffs in the Overall Sample and 
across Several Education Levels 
 
 Overall Samplea  Education (years)  
RDS f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≤4 12 0.6  3.2 0.8 0.1 0.7 0.7 0.0 - - 
≤5 53 2.6  8.7 3.7 1.4 1.6 2.6 4.1 FET* .014 
≤6 155 7.7  18.3 9.5 6.2 5.9 7.2 5.4 26.57* .013 
≤7 425 21.2  42.1 25.7 17.8 16.4 20.9 16.2 49.97* .025 
≤8 800 39.9  64.3 48.4 35.4 34.1 34.0 32.4 61.23* .031 
           
Min 0  2 2 4 0 4 5   
Max 17  14 17 17 15 16 15   
 
Note. RDS = Reliable Digit Span (Greiffenstein, Baker, & Gola, 1994); FET = Fisher’s exact test; Min = minimum 
RDS score in the respective group; Max = maximum RDS score in the respective group. Boldface font denotes 
previously published cutoffs. 
an = 2003. bn = 126. cn = 486. dn = 859. en = 305. fn = 153. gn = 74. 





Cumulative Percentages of Participants Failing Various Reliable Digit Span Cutoffs in the Valid Sample and across 
Several Education Levels 
 
 Valid Samplea  Education (years)  
RDS f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≤4 1 0.1  1.5 0.0 0.0 0.0 0.0 0.0 - - 
≤5 10 0.7  4.5 1.0 0.3 0.4 0.0 1.9 - - 
≤6 51 3.7  11.9 4.2 3.1 2.6 3.4 1.9 FET* .010 
≤7 198 14.3  34.3 17.9 12.3 11.1 13.8 5.6 32.49* .023 
≤8 446 32.1  56.7 40.6 28.5 30.2 25.0 18.5 40.12* .029 
           
Min 4  4 5 5 5 6 5   
Max 17  14 14 17 15 16 15   
 
Note. RDS = Reliable Digit Span (Greiffenstein, Baker, & Gola, 1994); FET = Fisher’s exact test; Min = minimum 
RDS score in the respective group; Max = maximum RDS score in the respective group. Boldface font denotes 
previously published cutoffs. 
an = 1388. bn = 67. cn = 308. dn = 608. en = 235. fn = 116. gn = 54. 
*p < .05. 
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Tables 53 and 54 characterize RDS BRFail as a function of gender and English language 
status in the overall and valid samples, respectively. With regard to gender, Fisher’s exact tests 
and chi-square tests of independence largely failed to reach statistical significance in either 
sample, suggesting no meaningful relationship between gender and RDS performance. 
Likelihood ratios at previously published cutoffs (i.e., RDS ≤6 and ≤7) also suggest comparable 
BRFail between males and females in both the overall sample (LR = 1.17-1.20) and the valid 
sample (LR = 1.10-1.18).  
With regard to English language status, NSEs demonstrated lower BRFail than did ESL 
patients across RDS cutoffs in both samples, and Fisher’s exact tests and chi-square tests of 
independence reached statistical significance in nearly all cases. NSEs were roughly one third to 





Cumulative Percentages of Participants Failing Various Reliable Digit Span Cutoffs in the Overall Sample and as a 
Function of Gender and English Language Status 
 
 Overall Samplea  Gender    English   
RDS f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
≤4 12 0.6  0.8 0.2 FET 4.00  0.3 2.6 FET* 0.12 
≤5 53 2.6  2.8 2.5 0.18 1.12  2.1 6.9 18.24* 0.30 
≤6 155 7.7  8.3 6.9 1.39 1.20  6.1 20.2 57.09* 0.30 
≤7 425 21.2  22.5 19.3 2.98 1.17  18.5 42.1 68.52* 0.44 
≤8 800 39.9  41.8 37.1 4.45* 1.13  36.9 62.7 56.74* 0.59 
            
Min 0  0 2    2 0   
Max 17  17 16    17 14   
 
Note. RDS = Reliable Digit Span (Greiffenstein, Baker, & Gola, 1994); LR = likelihood ratio; NSE = native 
speakers of English; ESL = English as a second language. FET = Fisher’s exact test; Min = minimum RDS score in 
the respective group; Max = maximum RDS score in the respective group. Boldface font denotes previously 
published cutoffs. 
an = 2003. bn = 1190. cn = 813. dn = 1770. en = 233. 
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Table 54 
 
Cumulative Percentages of Participants Failing Various Reliable Digit Span Cutoffs in the Valid Sample and as a 
Function of Gender and English Language Status 
 
 Valid Samplea  Gender    English   
RDS f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
≤4 1 0.1  0.1 0.0 - -  0.1 0.0 - - 
≤5 10 0.7  0.9 0.5 FET 1.80  0.6 1.6 FET 0.38 
≤6 51 3.7  3.9 3.3 0.36 1.18  3.2 8.8 FET* 0.36 
≤7 198 14.3  14.9 13.5 0.54 1.10  12.9 28.0 21.19* 0.46 
≤8 446 32.1  33.8 30.0 2.32 1.13  30.1 52.8 26.91* 0.57 
            
Min 4  4 5    4 5   
Max 17  17 16    17 13   
 
Note. RDS = Reliable Digit Span (Greiffenstein, Baker, & Gola, 1994); LR = likelihood ratio; NSE = native 
speakers of English; ESL = English as a second language; FET = Fisher’s exact test; Min = minimum RDS score in 
the respective group; Max = maximum RDS score in the respective group. Boldface font denotes previously 
published cutoffs. 
an = 1388. bn = 787. cn = 601. dn = 1263. en = 125. 
*p < .05. 
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 WCST FMS. Table 55 shows WCST FMS BRFail, at various cutoffs, as a function of 
WMT performance. Participants who passed the WMT demonstrated lower BRFail than those 
who failed the WMT across cutoffs. At the previously published cutoffs of FMS ≥2 and ≥3, 




Cumulative Percentages of Participants Failing Various WCST FMS Cutoffs in the Overall Sample and as a 




Overall Samplea  WMT   
f %  Pass Fail χ2 LR 
        
≥7 4 0.7  0.4 1.2 FET 0.33 
≥6 11 1.8  1.5 2.3 FET 0.65 
≥5 26 4.2  2.4 8.4 11.61* 0.29 
≥4 57 9.1  5.9 16.8 18.40* 0.35 
≥3 117 18.6  14.3 29.1 18.61* 0.49 
≥2 199 31.5  27.5 41.4 11.47* 0.66 
≥1 366 57.8  56.1 62.1 1.87 0.90 
       
Min 0  0 0   
Max 8  7 8   
 
Note. WCST = Wisconsin Card Sorting Test (Heaton, Chelune, Talley, Kay, & Curtiss, 1993); FMS = Failure to 
Maintain Set; WMT = Word Memory Test (Green, 2003); Pass = participants passing the WMT at standard cutoffs; 
Fail = participants failing the WMT at standard cutoffs; FET = Fisher’s exact test; LR = likelihood ratio; Min = 
minimum FMS score in the respective group; Max = maximum FMS score in the respective group. Boldface font 
denotes previously published cutoffs. 
an = 634. bn = 455. cn = 179. 
*p < .05. 
 
 
Tables 56 and 57 characterize WCST FMS BRFail as a function of diagnosis in the overall 
and valid samples, respectively. In both samples, chi-square tests of independence conducted at 
FMS cutoffs of ≥1 and ≥2 failed to reach statistical significance. Diagnosis accounted for only 
1.6 to 1.9% of the variance in BRFail at these cutoffs in the overall sample (small effects), and 1.4 
to 3.3% of the variance in BRFail at these cutoffs in the valid sample (small to medium effects). 
Chi-square tests were not conducted at the previously published cutoff of FMS ≥3. However, 
visual inspection revealed that patients with mild TBI and orthopedic injury tended to 
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demonstrate high BRFail relative to other groups. Patients with anxiety demonstrated the lowest 
BRFail, although the group was somewhat small in size (n = 24 in the overall sample, n = 18 in 









Overall Samplea  TBI  Diagnostic Groups   
f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≥7 4 0.7  0.0 3.3  1.0 0.0 0.0 0.0 0.0 0.0 0.8 - - 
≥6 11 1.8  0.7 5.0  1.0 1.0 0.0 4.0 2.8 0.0 2.4 - - 
≥5 26 4.2  5.7 6.7  1.0 4.1 0.0 4.0 5.6 4.3 4.0 - - 
≥4 57 9.1  10.7 11.7  8.6 7.2 0.0 8.0 11.2 13.0 8.0 - - 
≥3 117 18.6  28.0 21.7  17.2 10.3 0.0 20.0 19.5 26.0 15.1 - - 
≥2 199 31.5  38.8 36.7  32.4 22.8 12.5 36.0 30.6 30.3 29.4 12.10 .019 
≥1 366 57.8  64.7 66.7  54.3 50.9 50.0 64.0 50.0 65.1 54.8 9.90 .016 
               
Min 0  0 0  0 0 0 0 0 0 0   
Max 8  6 7  8 6 2 6 6 5 7   
 
Note. WCST = Wisconsin Card Sorting Test (Heaton, Chelune, Talley, Kay, & Curtiss, 1993); FMS = Failure to 
Maintain Set; TBI = traumatic brain injury; Mild = mTBI; M-S = moderate/severe TBI; NEU = neurological; DEP = 
depression; ANX = anxiety; SMI = severe mental illness (psychosis/Bipolar Disorder); CP/F = chronic pain and 
fibromyalgia; ORT = orthopedic; OTH = other; Min = minimum FMS score in the respective group; Max = 
maximum FMS score in the respective group. Boldface font denotes previously published cutoffs. 
an = 634. bn = 139. cn = 60. dn = 105. en = 96. fn = 24. gn = 25. hn = 36. in = 23. jn = 126. 
*p < .05. 
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Table 57 
 





Valid Samplea  TBI  Diagnostic Groups   
f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≥7 2 0.4  0.0 2.0  0.0 0.0 0.0 0.0 0.0 0.0 1.1 - - 
≥6 7 1.5  0.0 4.0  0.0 1.3 0.0 6.7 0.0 0.0 3.2 - - 
≥5 11 2.4  1.3 4.0  0.0 2.6 0.0 6.7 4.3 0.0 4.3 - - 
≥4 27 5.9  5.1 6.0  7.1 2.6 0.0 13.4 4.3 13.3 7.5 - - 
≥3 65 14.3  21.8 16.2  15.4 6.4 0.0 20.1 13.0 20.0 13.8 - - 
≥2 125 27.4  32.1 30.5  29.7 20.5 11.1 33.4 21.7 26.7 29.8 6.43 .014 
≥1 255 56.1  68.0 67.5  51.1 47.4 44.4 66.7 39.1 46.7 58.0 15.19 .033 
               
Min 0  0 0  0 0 0 0 0 0 0   
Max 7  5 7  4 6 2 6 5 4 7   
 
Note. WCST = Wisconsin Card Sorting Test (Heaton, Chelune, Talley, Kay, & Curtiss, 1993); FMS = Failure to 
Maintain Set; TBI = traumatic brain injury; Mild = mTBI; M-S = moderate/severe TBI; NEU = neurological; DEP = 
depression; ANX = anxiety; SMI = severe mental illness (psychosis/Bipolar Disorder); CP/F = chronic pain and 
fibromyalgia; ORT = orthopedic; OTH = other; Min = minimum FMS score in the respective group; Max = 
maximum FMS score in the respective group. Boldface font denotes previously published cutoffs. 
an = 455. bn = 78. cn = 49. dn = 84. en = 78. fn = 18. gn = 15. hn = 23. in = 15. jn = 95. 
*p < .05. 
 
Tables 58 and 59 characterize WCST FMS BRFail as a function of age in the overall and 
valid samples, respectively. In both samples, Fisher’s exact tests and chi-square tests of 
independence failed to reach statistical significance where conducted. At previously published 
cutoffs (WCST ≥2 and ≥3), age accounted for only 0.1 to 0.3% of the variance in BRFail in the 
overall sample (very small effects), and only 0.2% to 0.5% of the variance in BRFail in the valid 
sample (very small effects). 
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Table 58 
 
Cumulative Percentages of Participants Failing Various WCST FMS Cutoffs in the Overall Sample and across 




Overall Samplea  Age (years)  
f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≥7 4 0.7  1.6 1.7 0.0 0.4 0.0 - - 
≥6 11 1.8  3.2 2.6 1.1 1.3 1.8 FET .003 
≥5 26 4.2  4.8 6.1 4.0 3.5 1.8 FET .003 
≥4 57 9.1  7.9 10.4 9.1 8.0 10.6 0.78 .001 
≥3 117 18.6  23.8 19.1 18.2 16.5 19.4 1.78 .003 
≥2 199 31.5  28.6 31.3 33.6 30.4 31.7 0.76 .001 
≥1 366 57.8  58.7 60.0 58.7 57.8 49.2 2.09 .003 
          
Min 0  0 0 0 0 0   
Max 8  7 7 6 8 6   
 
Note. WCST = Wisconsin Card Sorting Test (Heaton, Chelune, Talley, Kay, & Curtiss, 1993); FMS = Failure to 
Maintain Set; FET = Fisher’s exact test; Min = minimum FMS score in the respective group; Max = maximum FMS 
score in the respective group. Boldface font denotes previously published cutoffs. 
an = 634. bn = 63. cn = 115. dn = 175. en = 223. gn = 57. 









Valid Samplea  Age (years)  
f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≥7 2 0.4  1.9 1.3 0.0 0.0 0.0 - - 
≥6 7 1.5  3.8 2.6 1.7 0.6 0.0 - - 
≥5 11 2.4  5.8 3.9 2.5 1.2 0.0 - - 
≥4 27 5.9  7.7 5.2 6.7 5.4 5.3 FET .001 
≥3 65 14.3  21.2 13.0 14.2 13.1 13.2 2.35 .005 
≥2 125 27.4  25.0 24.7 30.0 28.0 26.4 0.89 .002 
≥1 255 56.1  57.7 58.5 57.5 56.0 44.8 2.31 .005 
          
Min 0  0 0 0 0 0   
Max 7  7 7 6 6 4   
 
Note. WCST = Wisconsin Card Sorting Test (Heaton, Chelune, Talley, Kay, & Curtiss, 1993); FMS = Failure to 
Maintain Set; FET = Fisher’s exact test; Min = minimum FMS score in the respective group; Max = maximum FMS 
score in the respective group. Boldface font denotes previously published cutoffs. 
an = 455. bn = 52. cn = 77. dn = 120. en = 168. fn = 38. 
*p < .05. 
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Tables 60 and 61 characterize WCST FMS BRFail as a function of education level in the 
overall and valid samples, respectively. Chi-square tests of independence conducted at 
previously published cutoffs (WCST FMS ≥2 and ≥3) were statistically significant in the overall 
sample but failed to reach statistical significance in the valid sample. Education accounted for 
1.9 to 2.6% of the variance in BRFail at these cutoffs in the overall sample (small effects), and 2.2 
to 2.4% of the variance in BRFail at these cutoffs in the valid sample (small effects).  
Estimates of BRFail for patients with ≤8 years of formal education were likely unreliable 
due to the small group size. Patients with 9-11 years of education demonstrated the highest BRFail 
at previously published cutoffs in both samples, however, no consistent trends in BRFail were 




Cumulative Percentages of Participants Failing Various WCST FMS Cutoffs in the Overall Sample and across 




Overall Samplea  Education (years)  
f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≥7 4 0.7  0.0 1.6 0.4 0.0 0.0 2.5 - - 
≥6 11 1.8  0.0 2.4 2.1 1.6 0.0 2.5 - - 
≥5 26 4.2  0.0 4.0 5.9 3.9 1.3 2.5 - - 
≥4 57 9.1  4.8 12.8 9.7 8.6 6.3 2.5 5.62 .009 
≥3 117 18.6  14.3 28.8 17.6 14.0 15.1 15.0 11.94* .019 
≥2 199 31.5  23.8 44.8 31.8 24.1 27.6 22.5 16.29* .026 
≥1 366 57.8  66.7 70.4 55.6 52.0 53.9 52.5 12.08* .019 
           
Min 0  0 0 0 0 0 0   
Max 8  4 7 7 6 5 8   
 
Note. WCST = Wisconsin Card Sorting Test (Heaton, Chelune, Talley, Kay, & Curtiss, 1993); FMS = Failure to 
Maintain Set; Min = minimum FMS score in the respective group; Max = maximum FMS score in the respective 
group. Boldface font denotes previously published cutoffs. 
an = 634. bn = 21. cn = 125. dn = 239. en = 129. fn = 80. gn = 40. 
*p < .05. 
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Table 61 
 





Valid Samplea  Education (years)  
f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≥7 2 0.4  0.0 1.3 0.6 0.0 0.0 0.0 - - 
≥6 7 1.5  0.0 2.6 1.7 2.1 0.0 0.0 - - 
≥5 11 2.4  0.0 10.1 3.4 3.2 0.0 0.0 - - 
≥4 27 5.9  0.0 17.6 5.7 8.5 1.6 0.0 - - 
≥3 65 14.3  11.1 32.6 13.6 11.7 9.4 9.7 9.96 .022 
≥2 125 27.4  22.2 46.4 30.0 20.2 23.5 16.1 10.79 .024 
≥1 255 56.1  77.8 76.4 57.7 48.9 46.9 48.4 12.00* .026 
           
Min 0  0 0 0 0 0 0   
Max 7  3 7 7 6 4 3   
 
Note. WCST = Wisconsin Card Sorting Test (Heaton, Chelune, Talley, Kay, & Curtiss, 1993); FMS = Failure to 
Maintain Set; Min = minimum FMS score in the respective group; Max = maximum FMS score in the respective 
group. Boldface font denotes previously published cutoffs. 
an = 455. bn = 9. cn = 80. dn = 177. en = 94. fn = 64. gn = 31. 
*p < .05. 
 
 Tables 62 and 63 characterize WCST FMS performance as a function of gender and 
English language status in the overall and valid samples, respectively. BRFail on WCST FMS 
were not significantly related to gender at the previously published cutoff of WCST FMS ≥2 in 
either sample (LR = 1.09 in the overall sample, LR = 0.98 in the valid sample). However, males 
were 1.44 times as likely as females to fail WCST FMS ≥3 in the overall sample and 1.36 times 
as likely as females to fail WCST FMS ≥3 in the valid sample. 
BRFail on WCST FMS were unrelated to English language status in either sample. 
Likelihood ratios at previously published cutoffs ranged from 0.91 to 1.04 in the overall sample, 
and from 0.90 to 1.18 in the valid sample. 
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Table 62 
 
Cumulative Percentages of Participants Failing Various WCST FMS Cutoffs in the Overall Sample and as a 




Overall Samplea  Gender    English   
f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
≥7 4 0.7  0.9 0.3 FET 3.00  0.5 1.4 FET 0.36 
≥6 11 1.8  1.5 2.0 FET 0.75  1.4 4.3 FET 0.33 
≥5 26 4.2  2.5 4.8 0.81 0.52  3.9 5.7 0.57 0.68 
≥4 57 9.1  9.6 8.3 0.25 1.16  8.5 12.9 1.55 0.66 
≥3 117 18.6  21.4 14.9 4.20* 1.44  18.2 20.1 0.17 0.91 
≥2 199 31.5  32.6 29.9 0.49 1.09  31.5 30.2 0.03 1.04 
≥1 366 57.8  60.3 54.6 1.97 1.10  57.7 57.7 0.00 1.00 
            
Min 0  0 0    0 0   
Max 8  8 7    7 8   
 
Note. WCST = Wisconsin Card Sorting Test (Heaton, Chelune, Talley, Kay, & Curtiss, 1993); FMS = Failure to 
Maintain Set; LR = likelihood ratio; NSE = native speakers of English; ESL = English as a second language; FET = 
Fisher’s exact test; Min = minimum FMS score in the respective group; Max = maximum FMS score in the 
respective group. Boldface font denotes previously published cutoffs. 
an = 634. bn = 347. cn = 287. dn = 565. en = 69. 




Cumulative Percentages of Participants Failing Various WCST FMS Cutoffs in the Valid Sample and as a Function 




Valid Samplea  Gender    English   
f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
≥7 2 0.4  0.8 0.0 - -  0.5 0.0 - - 
≥6 7 1.5  1.2 1.9 FET 0.63  1.5 2.6 FET 0.58 
≥5 11 2.4  2.4 2.4 0.00 1.00  2.2 5.2 FET 0.42 
≥4 27 5.9  6.5 5.3 0.31 1.23  5.6 10.5 FET 0.53 
≥3 65 14.3  16.3 12.0 1.71 1.36  14.2 15.8 0.08 0.90 
≥2 125 27.4  27.3 27.8 0.02 0.98  27.9 23.7 0.30 1.18 
≥1 255 56.1  58.8 54.1 0.61 1.09  56.7 50.0 0.62 1.13 
            
Min 0  0 0    0 0   
Max 7  7 6    7 6   
 
Note. WCST = Wisconsin Card Sorting Test (Heaton, Chelune, Talley, Kay, & Curtiss, 1993); FMS = Failure to 
Maintain Set; LR = likelihood ratio; NSE = native speakers of English; ESL = English as a second language; FET = 
Fisher’s exact test; Min = minimum FMS score in the respective group; Max = maximum FMS score in the 
respective group. Boldface font denotes previously published cutoffs. 
an = 455. bn = 246. cn = 209. dn = 417. en = 38. 
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CT-TE. Table 64 shows CT-TE BRFail, at various cutoffs, as a function of WMT 
performance. Participants who passed the WMT demonstrated lower BRFail than those who 
failed the WMT at various CT-TE scores, and chi-square tests reached statistical significance at 




Cumulative Percentages of Participants Failing Various Category Test Total Errors Cutoffs in the Overall Sample 
and as a Function of Word Memory Test Performance 
 
 Overall Samplea  WMT   
CT-TE f %  Passb Failc χ2 LR 
        
≥123 51 2.0  1.5 3.3 7.29* 0.45 
≥113 123 4.8  3.4 8.3 22.48* 0.41 
≥105 229 9.9  7.1 17.1 48.33* 0.42 
≥98 338 14.7  10.8 24.8 68.41* 0.44 
≥85 551 25.0  19.1 40.6 108.41* 0.47 
       
Min 3  3 10   
Max 150  150 146   
 
Note. CT-TE = Total Errors on the Category Test (DeFlippis & McCampbell, 1979, 1991, 1997); WMT = Word 
Memory Test (Green, 2003); Pass = participants passing the WMT at standard cutoffs; Fail = participants failing the 
WMT at standard cutoffs; LR = likelihood ratio. Min = minimum CT-TE score in the respective group. Max = 
maximum CT-TE score in the respective group. 
an = 2199. bn = 1595. cn = 604. 
*p < .05. 
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 Tables 65 and 66 characterize CT-TE BRFail across various clinical groups in the overall 
and valid samples, respectively. In the overall sample, chi-square tests were statistically 
significant at CT-TE ≥105 and ≥85. However, diagnosis accounted for only 0.3 to 0.8% of the 
variance in CT-TE BRFail across cutoffs examined (very small effects). The highest BRFail tended 
to be observed in patients with severe mental illness and neurological conditions, while patients 
with depression and mTBI demonstrated the lowest BRFail. A similar pattern was observed in the 
valid sample. Chi-square tests were statistically significant at lower (i.e., more liberal) cutoffs. 
However, diagnosis accounted for only 0.4 to 1.6% of the variance in CT-TE BRFail (very small 




Cumulative Percentages of Participants Failing Various Category Test Total Errors Cutoffs in the Overall Sample 
and in Specific Clinical Groups 
 
 Overall Samplea  TBI Diagnostic Groups   
CT-TE f %  Mildb M-Sc NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
               
≥123 51 2.0  1.3 1.6 1.9 1.5 2.7 3.7 3.5 2.2 2.3 FET .003 
≥113 123 4.8  3.6 6.5 6.0 3.5 4.4 5.6 6.4 7.8 4.7 7.48 .003 
≥105 229 9.9  7.7 12.4 14.8 7.5 9.2 16.7 11.7 14.4 8.5 18.75* .008 
≥98 338 14.7  13.6 15.6 20.8 11.0 14.0 20.4 17.5 16.7 14.0 14.52 .007 
≥85 551 25.0  22.8 25.8 34.3 23.5 22.9 37.0 24.0 28.9 22.5 18.40* .008 
              
Min 3  9 9  3 8 4 5 12 5   
Max 150  133 138 146 150 128 126 136 129 130   
 
Note. CT-TE = Total Errors on the Category Test (DeFlippis & McCampbell, 1979, 1991, 1997); TBI = traumatic 
brain injury, Mild = mTBI; M-S = moderate/severe TBI; NEU = neurological; DEP = depression; ANX = anxiety; 
SMI = severe mental illness (psychosis/Bipolar Disorder); CP/F = chronic pain and fibromyalgia; ORT = 
orthopedic; OTH = other; FET = Fisher’s exact test; Min = minimum CT-TE score in the respective group; Max = 
maximum CT-TE score in the respective group. 
an = 2199. bn = 531. cn = 186. dn = 216. en = 400. fn = 293. gn = 54. hn = 171. in = 90. jn = 258. 
*p < .05. 
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Table 66 
 
Cumulative Percentages of Participants Failing Various Category Test Total Errors Cutoffs in the Valid Sample 
and in Specific Clinical Groups 
 
 Valid Samplea  TBI  Diagnostic Groups   
CT-TE f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≥123 24 1.5  0.6 2.0  0.0 1.0 2.4 5.0 1.7 1.5 2.9 - - 
≥113 54 3.4  2.0 6.1  4.7 2.8 2.8 5.0 3.3 4.4 3.9 7.25 .004 
≥105 113 7.1  4.6 10.1  11.8 4.5 5.2 17.5 8.3 8.8 7.8 22.18* .014 
≥98 172 10.8  8.4 13.5  17.2 7.3 8.1 20.0 11.7 10.3 13.6 20.78* .013 
≥85 305 19.1  14.7 23.0  29.0 17.1 14.7 32.5 15.8 22.1 20.9 26.19* .016 
               
Min 3  9 9  11 3 8 4 5 12 5   
Max 150  126 138  121 150 128 126 136 129 130   
 
Note. CT-TE = Total Errors on the Category Test (DeFlippis & McCampbell, 1979, 1991, 1997); TBI = traumatic 
brain injury, Mild = mTBI; M-S = moderate/severe TBI; NEU = neurological; DEP = depression; ANX = anxiety; 
SMI = severe mental illness (psychosis/Bipolar Disorder); CP/F = chronic pain and fibromyalgia; ORT = 
orthopedic; OTH = other; Min = minimum CT-TE score in the respective group; Max = maximum CT-TE score in 
the respective group. 
an = 1595. bn = 347. cn = 148. dn = 169. en = 286. fn = 211. gn = 40. hn = 120. in = 68. jn = 206. 
*p < .05. 
 
 
Tables 67 and 68 characterize CT-TE BRFail as a function of age in the overall and valid 
samples, respectively. Chi-square tests were statistically significant at nearly all cutoffs 
examined in both samples. Effect sizes indicated that age accounted for 0.6% to 6.1% of the 
variance in CT-TE BRFail across cutoffs in the overall sample (very small to medium effects), and 
0.3% to 5.5% of the variance in CT-TE BRFail in the valid sample (very small to medium effects). 
BRFail were lowest in the youngest age group (16-29 years) and increased with age.  
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Table 67 
 
Cumulative Percentages of Participants Failing Various Category Test Total Errors Cutoffs in the Overall Sample 
and across Various Age Groups 
 
 Overall Samplea  Age (years)  
CT-TE f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≥123 51 2.0  0.3 1.2 1.9 2.9 4.4 12.45* .006 
≥113 123 4.8  1.6 2.7 4.9 6.4 12.3 29.77* .013 
≥105 229 9.9  2.5 5.1 8.8 15.2 28.1 94.34* .043 
≥98 338 14.7  4.1 7.4 14.1 22.6 36.8 123.66* .056 
≥85 551 25.0  9.2 16.2 25.4 34.9 50.9 133.81* .061 
          
Min 3  5 5 3 10 15   
Max 150  124 133 136 150 136   
 
Note. CT-TE = Total Errors on the Category Test (DeFlippis & McCampbell, 1979, 1991, 1997); Min = minimum 
CT-TE score in the respective group; Max = maximum CT-TE score in the respective group. 
an = 2199. bn = 315. cn = 489. dn = 697. en =579. fn = 114. 





Cumulative Percentages of Participants Failing Various Category Test Total Errors Cutoffs in the Valid Sample 
and across Various Age Groups 
 
 Valid Samplea  Age (years)  
CT-TE f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≥123 24 1.5  0.4 1.1 1.6 2.4 1.4 4.67 .003 
≥113 54 3.4  1.2 1.7 3.2 6.0 7.0 18.07* .011 
≥105 113 7.1  1.6 2.8 6.0 13.0 21.1 65.23* .041 
≥98 172 10.8  2.4 4.5 9.9 19.0 29.6 88.05* .055 
≥85 305 19.1  6.8 12.1 18.5 28.6 42.3 84.89* .053 
          
Min 3  5 5 3 10 15   
Max 150  124 133 136 150 127   
 
Note. CT-TE = Total Errors on the Category Test (DeFlippis & McCampbell, 1979, 1991, 1997); Min = minimum 
CT-TE score in the respective group; Max = maximum CT-TE score in the respective group. 
an = 1595. bn = 249. cn = 354. dn = 503. en = 416. fn = 71. 
*p < .05. 
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Tables 69 and 70 characterize CT-TE BRFail across education levels in the overall and 
valid samples, respectively. Chi-square and Fisher’s exact tests were statistically significant at all 
CT-TE scores in both samples. Education accounted for 0.6% (small effect) to 4.5% (small to 
medium effect) of the variance in CT-TE BRFail across cutoffs in the overall sample, and 1.0% 
(small effect) to 3.2% (small to medium effect) of the variance in CT-TE BRFail across cutoffs in 
the valid sample. BRFail were highest in the least educated group (≤8 years) and decreased with 




Cumulative Percentages of Participants Failing Various Category Test Total Errors Cutoffs in the Overall Sample 
and across Several Education Levels 
 
 Overall Samplea  Education (years)  
CT-TE f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≥123 51 2.0  5.7 2.6 2.2 0.8 0.9 0.8 FET* .006 
≥113 123 4.8  7.6 6.8 5.1 3.1 1.9 1.7 15.53* .007 
≥105 229 9.9  29.5 14.1 7.7 6.2 6.1 6.7 71.28* .032 
≥98 338 14.7  36.2 20.5 12.9 9.3 8.5 10.1 72.87* .033 
≥85 551 25.0  56.2 33.1 21.6 18.9 15.1 21.0 98.61* .045 
           
Min 3  9 5 5 3 4 11   
Max 150  130 150 138 136 141 130   
 
Note. CT-TE = Total Errors on the Category Test (DeFlippis & McCampbell, 1979, 1991, 1997); FET = Fisher’s 
exact test; Min = Minimum CT-TE score in the respective group; Max = Maximum CT-TE score in the respective 
group. 
an = 2199. bn = 105. cn = 547. dn = 830. en = 386. fn = 212. gn = 119. 




BASE RATES OF PVT FAILURE  115
Table 70 
 
Cumulative Percentages of Participants Failing Various Category Test Total Errors Cutoffs in the Valid Sample 
and across Several Education Levels 
 
 Valid Samplea  Education (years)  
CT-TE f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≥123 24 1.5  5.1 2.8 1.1 1.0 0.0 1.0 - - 
≥113 54 3.4  6.8 5.8 3.6 2.0 0.6 1.0 15.70* .010 
≥105 113 7.1  23.7 10.9 5.5 5.0 4.3 5.2 39.06* .024 
≥98 172 10.8  32.2 15.9 9.2 7.7 6.1 7.3 47.04* .030 
≥85 305 19.1  44.1 26.7 17.0 14.7 11.0 15.6 50.64* .032 
           
Min 3  9 5 5 3 4 11   
Max 150  129 150 138 136 117 130   
 
Note. CT-TE = Total Errors on the Category Test (DeFlippis & McCampbell, 1979, 1991, 1997); Min = Minimum 
CT-TE score in the respective group; Max = Maximum CT-TE score in the respective group. 
an = 1595. bn = 59. cn = 359. dn = 618. en = 300. fn = 163. gn = 96. 
*p < .05. 
 
 Tables 71 and 72 characterize CT-TE BRFail as a function of gender and English language 
status in the overall and valid samples, respectively. In the overall sample, BRFail were generally 
comparable between males and females, and chi-square and Fisher’s exact tests failed to reach 
statistical significance at the CT-TE cutoffs examined. Likelihood ratios ranged from 0.62 to 
0.89. BRFail between males and females were also generally comparable in the valid sample (LR 
= 0.73 – 1.06). Although chi-square tests were statistically significant at more liberal cutoffs in 
the valid sample (i.e., CT-TE ≥98 and ≥85), this was likely due to the large sample size at these 
cutoffs. 
 With regard to English language status, NSEs demonstrated lower BRFail than ESL 
patients across nearly all CT-TE cutoffs in both samples, and chi-square tests were significant in 
a number of cases. NSEs were only about one-half as likely as ESL patients to fail CT-TE ≥85 
through ≥113 in the overall sample, and two-thirds to three-quarters as likely as ESL patients to 
fail CT-TE ≥85 through ≥113 in the valid sample. 
 
BASE RATES OF PVT FAILURE  116
Table 71 
 
Cumulative Percentages of Participants Failing Various Category Test Total Errors Cutoffs in the Overall Sample 
and as a Function of Gender and English Language Status 
 
 Overall Samplea  Gender    English   
CT-TE f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
≥123 51 2.0  1.6 2.6 2.26 0.62  2.0 2.2 FET 0.91 
≥113 123 4.8  4.5 5.2 0.67 0.87  4.3 7.8 5.51* 0.55 
≥105 229 9.9  9.4 10.6 0.83 0.89  9.0 15.5 10.10* 0.58 
≥98 338 14.7  13.5 16.5 3.82 0.82  13.2 25.9 26.74* 0.51 
≥85 551 25.0  23.7 26.9 2.79 0.88  23.0 41.4 37.60* 0.56 
            
Min 3  4 3    3 9   
Max 150  146 150    150 136   
 
Note. CT-TE = Total Errors on the Category Test (DeFlippis & McCampbell, 1979, 1991, 1997); LR = likelihood 
ratio; NSE = native speakers of English; ESL = English as a second language; FET = Fisher’s exact test; Min = 
minimum CT-TE score in the respective group. Max = maximum CT-TE score in the respective group. 
an = 2199. bn = 1340. cn = 859. dn = 1947. en = 232. 





Cumulative Percentages of Participants Failing Various Category Test Total Errors Cutoffs in the Valid Sample 
and as a Function of Gender and English Language Status 
 
 Valid Samplea  Gender    English   
CT-TE f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
≥123 24 1.5  1.3 1.8 0.71 0.72  1.6 0.7 FET 2.29 
≥113 54 3.4  3.5 3.3 0.06 1.06  3.4 4.3 FET 0.79 
≥105 113 7.1  6.3 8.3 2.25 0.76  6.9 9.3 1.14 0.74 
≥98 172 10.8  9.4 12.8 4.57* 0.73  10.3 16.4 5.05* 0.63 
≥85 305 19.1  17.1 21.9 5.81* 0.78  18.2 28.6 8.97* 0.64 
            
Min 3  4 3    3 9   
Max 150  133 150    150 124   
 
Note. CT-TE = Total Errors on the Category Test (DeFlippis & McCampbell, 1979, 1991, 1997); LR = likelihood 
ratio; NSE = native speakers of English; ESL = English as a second language; FET = Fisher’s exact test; Min = 
minimum CT-TE score in the respective group; Max = maximum CT-TE score in the respective group. 
an = 1595. bn = 932. cn = 663. dn = 1443. en = 140. 
*p < .05.  
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TMT-A. Table 73 shows TMT-A BRFail, across various cutoffs, as a function of WMT 
performance. Chi-square tests were statistically significant at all TMT-A cutoffs, suggesting an 
association between TMT-A performance and WMT classification. Those who passed the WMT 
demonstrated lower TMT-A BRFail than those who failed the WMT across cutoffs. Likelihood 




Cumulative Percentages of Participants Failing Various Trail Making Test Part A Completion Time Cutoffs in the 
Overall Sample and as a Function of Word Memory Test Performance 
 
 Overall Samplea  WMT   
TMT-A f %  Passb Failc χ2 LR 
        
≥92 47 1.9  0.2 6.0 88.63* 0.03 
≥73 120 4.9  1.9 11.9 112.77* 0.16 
≥57 251 10.2  5.7 20.8 129.34* 0.27 
≥50 372 15.1  8.8 29.9 179.01* 0.29 
≥43 599 24.3  17.1 41.0 160.58* 0.42 
       
Min 9  9 12   
Max 302  188 302   
 
Note. TMT-A = Trail Making Test (Reitan & Wolfson, 1985) Part A completion time in seconds; WMT = Word 
Memory Test (Green, 2003); Pass = participants passing the WMT at standard cutoffs; Fail = participants failing the 
WMT at standard cutoffs; LR = likelihood ratio; Min = minimum TMT-A score in the respective group; Max = 
maximum TMT-A score in the respective group. 
an = 2463. bn = 1724. cn = 739. 
*p < .05. 
 
 Tables 74 and 75 characterize TMT-A BRFail across clinical groups in the overall and 
valid samples, respectively. Fisher’s exact tests and chi-square tests were statistically significant 
where conducted in both samples, suggesting that TMT-A BRFail varied as a function of 
diagnosis. However, diagnosis only accounted for 0.8% to 2.1% of the variance across TMT-A 
cutoffs in the overall sample (small effects), and for 2.2% to 3.0% of the variance between 
cutoffs of TMT-A ≥43 and ≥57 in the valid sample (small to medium effects). 
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In the overall sample, the highest BRFail were most consistently observed in patients with 
neurological conditions and those with chronic pain/fibromyalgia, although those with moderate-
severe TBI also had higher BRFail at more liberal TMT-A cutoff scores. The lowest BRFail were 
observed in patients with anxiety. In the valid sample, patients with neurological conditions had 
the highest BRFail, and at more liberal TMT-A cutoffs, elevated BRFail were observed in patients 
with moderate-severe TBI, chronic pain/fibromyalgia, and severe mental illness. Patients with 




Cumulative Percentages of Participants Failing Various Trail Making Test Part A Completion Time Cutoffs in the 
Overall Sample and in Specific Clinical Groups 
 
 Overall Samplea  TBI  Diagnostic Groups   
TMT-A f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≥92 47 1.9  2.3 2.6  2.2 0.6 0.6 1.7 6.6 1.3 1.5 FET* .014 
≥73 120 4.9  5.9 4.6  6.6 3.8 2.4 3.4 9.4 4.0 3.8 19.22* .008 
≥57 251 10.2  12.0 9.2  17.5 8.1 5.6 5.2 15.5 10.7 8.0 35.37* .014 
≥50 372 15.1  16.0 16.8  23.1 11.8 9.4 17.2 20.7 16.0 14.0 30.78* .013 
≥43 599 24.3  23.7 32.1  35.8 21.2 14.2 25.9 31.5 25.3 23.5 51.27* .021 
               
Min 9  12 11  14 12 13 16 14 9 11   
Max 302  302 188  152 213 252 119 238 92 144   
 
Note. TMT-A = Trail Making Test (Reitan & Wolfson, 1985) Part A completion time in seconds; TBI = traumatic 
brain injury, Mild = mTBI; M-S = moderate/severe TBI; NEU = neurological; DEP = depression; ANX = anxiety; 
SMI = severe mental illness (psychosis/Bipolar Disorder); CP/F = chronic pain and fibromyalgia; ORT = 
orthopedic; OTH = other; FET = Fisher’s exact test; Min = minimum TMT-A score in the respective group; Max = 
maximum TMT-A score in the respective group. 
an = 2463. bn = 557. cn = 196. dn = 229. en = 532. fn = 339. gn = 58. hn = 213. in = 75. jn = 264. 
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Table 75 
 
Cumulative Percentages of Participants Failing Various Trail Making Test Part A Completion Time Cutoffs in the 
Valid Sample and in Specific Clinical Groups 
 
 Valid Samplea  TBI  Diagnostic Groups   
TMT-A f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≥92 4 0.2  0.0 1.3  0.0 0.0 0.0 0.0 0.7 0.0 0.5 - - 
≥73 33 1.9  0.9 3.2  4.6 1.4 1.2 0.0 2.9 0.0 2.0 - - 
≥57 98 5.7  3.9 7.8  13.7 4.6 2.7 2.5 10.2 2.0 4.4 37.39* .022 
≥50 152 8.8  5.4 11.7  19.4 6.5 6.2 10.0 12.4 3.9 9.4 39.64* .023 
≥43 295 17.1  11.0 25.3  30.9 14.9 10.4 20.0 22.6 15.7 17.7 52.11* .030 
               
Min 9  12 11  14 14 13 16 14 9 11   
Max 188  86 188  90 90 75 65 109 57 111   
 
Note. TMT-A = Trail Making Test (Reitan & Wolfson, 1985) Part A completion time in seconds; TBI = traumatic 
brain injury, Mild = mTBI; M-S = moderate/severe TBI; NEU = neurological; DEP = depression; ANX = anxiety; 
SMI = severe mental illness (psychosis/Bipolar Disorder); CP/F = chronic pain and fibromyalgia; ORT = 
orthopedic; OTH = other; Min = minimum TMT-A score in the respective group; Max = maximum TMT-A score in 
the respective group. 
an = 1724. bn = 335. cn = 154. dn = 175. en = 370. fn = 259. gn = 40. hn = 137. in = 51. jn = 203. 
*p < .05.  
 
  
Tables 76 and 77 characterize TMT-A BRFail as a function of age in the overall and valid 
samples, respectively. In both samples, chi-square and Fisher’s exact tests were statistically 
significant across TMT-A cutoffs. Age accounted for 1.5% (small effect) to 5.2% (small to 
medium effect) of the variance in TMT-A BRFail in the overall sample, and 0.8% (very small 
effect) to 4.2% (small to medium effect) of the variance in TMT-A BRFail in the valid sample. In 
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Table 76 
 
Cumulative Percentages of Participants Failing Various Trail Making Test Part A Completion Time Cutoffs in the 
Overall Sample and across Several Age Groups 
 
 Overall Samplea  Age (years)  
TMT-A f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≥92 47 1.9  0.0 1.5 2.4 2.4 2.7 - - 
≥73 120 4.9  1.2 3.5 4.2 6.7 12.8 37.22* .015 
≥57 251 10.2  3.7 5.6 9.4 14.1 25.5 77.57* .032 
≥50 372 15.1  6.2 9.3 13.9 20.0 37.6 106.91* .044 
≥43 599 24.3  13.2 14.3 23.8 31.6 51.0 127.75* .052 
          
Min 9  9 12 12 14 17   
Max 302  81 238 258 219 252   
 
Note. TMT-A = Trail Making Test (Reitan & Wolfson, 1985) Part A completion time in seconds; Min = minimum 
TMT-A score in the respective group; Max = maximum TMT-A score in the respective group. 
an = 2463. bn = 325. cn = 518. dn = 791. en = 674. fn = 149. 




Cumulative Percentages of Participants Failing Various Trail Making Test Part A Completion Time Cutoffs in the 
Valid Sample and across Several Age Groups 
 
 Valid Samplea  Age (years)  
TMT-A f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≥92 4 0.2  0.0 0.0 0.2 0.6 0.0 - - 
≥73 33 1.9  0.8 1.1 1.1 3.6 3.3 FET* .008 
≥57 98 5.7  2.7 2.2 4.9 9.0 14.4 35.41* .020 
≥50 152 8.8  5.0 4.5 7.1 12.4 27.8 62.94* .036 
≥43 295 17.1  10.5 9.7 15.4 23.9 40.0 71.59* .042 
          
Min 9  9 12 14 14 17   
Max 188  81 90 109 188 90   
 
Note. TMT-A = Trail Making Test (Reitan & Wolfson, 1985) Part A completion time in seconds; FET = Fisher’s 
exact test; Min = minimum TMT-A score in the respective group; Max = maximum TMT-A score in the respective 
group. 
an = 1724. bn = 258. cn = 359. dn = 546. en = 468. fn = 90. 
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Tables 78 and 79 characterize TMT-A BRFail as a function of education level in the 
overall and valid samples, respectively. In the overall sample, all of the chi-square and Fisher’s 
exact tests were statistically significant, and education level accounted for 1.6% to 2.9% of the 
variance in TMT-A BRFail across cutoffs (small effects). The highest BRFail were observed in the 
group with the least education (≤8 years), and BRFail tended to decrease with higher levels of 
education. Individuals with ≥17 years of education demonstrated somewhat higher BRFail than 
would be expected based on the trend. 
In the valid sample, chi-square and Fisher’s exact tests largely failed to reach statistical 
significance, and education level accounted for only 0.2% to 1.2% of the variance in TMT-A 
BRFail across cutoffs (very small to small effects). Although the chi-square test at TMT-A ≥43 
was statistically significant, given the effect size, this was likely due to the increase in sample 
size at this cutoff. Visual inspection of BRFail revealed higher BRFail among the two least 




Cumulative Percentages of Participants Failing Various Trail Making Test Part A Completion Time Cutoffs in the 
Overall Sample and across Several Education Levels 
 
 Overall Samplea  Education (years)  
TMT-A f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≥92 47 1.9  8.7 1.8 0.9 2.2 2.2 1.7 FET* .016 
≥73 120 4.9  15.9 4.9 3.4 3.7 5.6 6.6 43.25* .018 
≥57 251 10.2  26.8 11.2 8.0 8.4 10.3 10.7 49.01* .020 
≥50 372 15.1  36.2 17.1 11.4 15.0 13.4 15.7 60.88* .025 
≥43 599 24.3  49.3 28.6 19.0 22.9 21.1 27.3 70.01* .029 
           
Min 9  12 11 11 12 9 14   
Max 302  302 121 258 144 219 104   
 
Note. TMT-A = Trail Making Test (Reitan & Wolfson, 1985) Part A completion time in seconds; FET = Fisher’s 
exact test; Min = minimum TMT-A score in the respective group; Max = maximum TMT-A score in the respective 
group. 
an = 2463. bn = 138. cn = 597. dn = 968. en = 407. fn = 232. gn = 121. 
*p < .05. 
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Table 79 
 
Cumulative Percentages of Participants Failing Various Trail Making Test Part A Completion Time Cutoffs in the 
Valid Sample and across Several Education Levels 
 
 Valid Samplea  Education (years)   
TMT-A f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≥92 4 0.2  0.0 0.3 0.1 0.3 0.6 0.0 - - 
≥73 33 1.9  2.9 1.6 1.8 1.3 1.7 4.6 FET .002 
≥57 98 5.7  13.0 6.8 5.2 4.4 5.0 4.6 9.53 .005 
≥50 152 8.8  18.8 10.0 8.0 7.7 7.3 9.2 10.85 .006 
≥43 295 17.1  33.3 20.5 14.9 15.4 14.0 19.5 20.56* .012 
           
Min 9  15 11 11 12 9 14   
Max 188  79 111 109 109 188 90   
 
Note. TMT-A = Trail Making Test (Reitan & Wolfson, 1985) Part A completion time in seconds; FET = Fisher’s 
exact test; Min = minimum TMT-A score in the respective group; Max = maximum TMT-A score in the respective 
group. 
an = 1724. bn = 69. cn = 380. dn = 711. en = 298. fn = 179. gn = 66. hn = 87. 
*p < .05. 
 
 Tables 80 and 81 characterize TMT-A BRFail as a function of gender and English 
language status in the overall and valid samples, respectively. Chi-square and Fisher’s exact tests 
involving gender did not reach statistical significance in either sample, and likelihood ratios 
suggested largely comparable BRFail between males and females in both samples. 
 With regard to English language status, NSEs consistently demonstrated lower BRFail 
across TMT-A cutoffs than did ESL patients, and chi-square and Fisher’s exact tests were 
statistically significant in all but one cutoff (TMT-A ≥92 in the valid sample, p = .050). NSEs 
were 0.09 to 0.43 times as likely as ESL patients to fail various TMT-A cutoffs in the overall 
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Table 80 
 
Cumulative Percentages of Participants Failing Various Trail Making Test Part A Completion Time Cutoffs in the 
Overall Sample and as a Function of Gender and English Language Status 
 
 Overall Samplea  Gender    English   
TMT-A f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
≥92 47 1.9  2.1 1.7 0.63 1.24  0.9 9.5 102.61* 0.09 
≥73 120 4.9  5.0 4.7 0.10 1.06  3.1 17.3 117.15* 0.18 
≥57 251 10.2  10.1 10.4 0.08 0.97  7.8 27.8 116.44* 0.28 
≥50 372 15.1  15.5 14.5 0.47 1.07  12.1 36.6 125.52* 0.33 
≥43 599 24.3  24.6 23.8 0.18 1.03  20.9 48.4 110.20* 0.43 
            
Min 9  11 9    9 12   
Max 302  302 258    302 258   
 
Note. TMT-A = Trail Making Test (Reitan & Wolfson, 1985) Part A completion time in seconds; LR = likelihood 
ratio; NSE = native speakers of English; ESL = English as a second language. Min = minimum TMT-A score in the 
respective group. Max = maximum TMT-A score in the respective group. 
an = 2463. bn = 1506. cn = 957. dn = 2139. en = 306. 




Cumulative Percentages of Participants Failing Various Trail Making Test Part A Completion Time Cutoffs in the 
Valid Sample and as a Function of Gender and English Language Status 
 
 Valid Samplea  Gender    English   
TMT-A f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
≥92 4 0.2  0.3 0.1 FET 3.00  0.1 1.2 FET 0.08 
≥73 33 1.9  2.1 1.6 0.59 1.31  1.4 6.0 FET* 0.23 
≥57 98 5.7  5.3 6.2 0.65 0.85  4.7 15.6 33.27* 0.30 
≥50 152 8.8  9.2 8.2 0.56 1.12  7.6 20.4 30.19* 0.37 
≥43 295 17.1  17.5 16.5 0.27 1.06  15.5 32.9 32.37* 0.47 
            
Min 9  11 9    9 12   
Max 188  188 111    111 188   
 
Note. TMT-A = Trail Making Test (Reitan & Wolfson, 1985) Part A completion time in seconds; LR = likelihood 
ratio; NSE = native speakers of English; ESL = English as a second language; FET = Fisher’s exact test; Min = 
minimum TMT-A score in the respective group. Max = maximum TMT-A score in the respective group. 
an = 1724. bn = 1017. cn = 707. dn = 1546. en = 167. 
*p < .05. 
  
BASE RATES OF PVT FAILURE  124
TMT-B. Table 82 shows TMT-B BRFail, across various cutoffs, as a function of WMT 
performance. Chi-square tests of independence were statistically significant at each TMT-B 
cutoff, suggesting that performance on TMT-B was related to WMT classification. Participants 
who passed the WMT demonstrated lower TMT-B BRFail than those who failed the WMT across 




Cumulative Percentages of Participants Failing Various Trail Making Test Part B Completion Time Cutoffs in the 
Overall Sample and as a Function of Word Memory Test Performance 
 
 Overall Samplea  WMT   
TMT-B f %  Passb Failc χ2 LR 
        
≥304 49 2.0  0.6 5.2 57.14* 0.12 
≥208 122 5.0  2.0 12.0 108.08* 0.17 
≥150 244 10.0  5.1 21.6 154.99* 0.24 
≥127 364 14.9  8.6 29.8 180.83* 0.29 
≥101 620 25.4  17.4 44.3 194.21* 0.39 
       
Min 26  26 27   
Max 863  863 601   
 
Note. TMT-B = Trail Making Test (Reitan & Wolfson, 1985) Part B completion time; LR = likelihood ratio; WMT 
= Word Memory Test (Green, 2003); Pass = participants passing the WMT at standard cutoffs; Fail = participants 
failing the WMT at standard cutoffs; Min = minimum TMT-B score in the respective group; Max = maximum 
TMT-B score in the respective group. 
an = 2442. bn = 1715. cn = 727. 
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Tables 83 and 84 characterize TMT-B BRFail as a function of diagnosis in the overall and 
valid samples, respectively. Fisher’s exact tests and chi-square tests of independence were 
statistically significant at nearly all TMT-B cutoffs in both samples, suggesting an association 
between TMT-B performance and diagnosis. Diagnosis accounted for 0.6% to 1.6% of the 
variance in TMT-B BRFail across cutoffs (very small to small effects) in the overall sample, and 
for 1.2% to 2.1% of the variance in TMT-B BRFail across cutoffs (small effects) in the valid 
sample.  
In the overall sample, patients with moderate-severe TBI had the highest BRFail across 
TMT-B cutoffs, and patients with anxiety had the lowest BRFail. In the valid sample, the highest 
BRFail were most consistently observed in patients with moderate-severe TBI, neurological 





Cumulative Percentages of Participants Failing Various Trail Making Test Part B Completion Time Cutoffs in the 
Overall Sample and in Specific Clinical Groups 
 
 Overall Samplea  TBI  Diagnostic Groups   
TMT-B f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≥304 49 2.0  2.7 5.7  2.2 0.8 0.3 3.4 2.8 4.1 2.7 FET* .006 
≥208 122 5.0  6.3 10.4  6.6 2.7 1.5 5.2 7.1 9.5 4.9 25.36* .010 
≥150 244 10.0  12.1 26.4  15.8 6.7 3.9 8.6 13.7 12.2 10.3 36.45* .015 
≥127 364 14.9  17.8 40.4  20.2 11.2 7.1 20.7 18.5 18.9 14.4 36.19* .015 
≥101 620 25.4  27.0 62.2  34.2 21.5 15.2 29.3 30.3 31.1 25.5 39.84* .016 
               
Min 26  26 26  33 27 26 31 35 29 28   
Max 863  601 500  863 600 315 370 540 448 600   
 
Note. TMT-B = Trail Making Test (Reitan & Wolfson, 1985) Part B completion time; TBI = traumatic brain injury, 
Mild = mTBI; M-S = moderate/severe TBI; NEU = neurological; DEP = depression; ANX = anxiety; SMI = severe 
mental illness (psychosis/Bipolar Disorder); CP/F = chronic pain and fibromyalgia; ORT = orthopedic; OTH = 
other; FET = Fisher’s exact test; Min = minimum TMT-B score in the respective group; Max = maximum TMT-B 
score in the respective group. 
an = 2442. bn = 552. cn = 194. dn = 228. en = 526. fn = 336. gn = 58. hn = 211. in = 74. jn = 263. 
*p < .05. 
 




Cumulative Percentages of Participants Failing Various Trail Making Test Part B Completion Time Cutoffs in the 
Valid Sample and in Specific Clinical Groups 
 
 Valid Samplea  TBI  Diagnostic Groups   
TMT-B f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≥304 10 0.6  0.3 1.3  1.1 0.0 0.0 2.5 0.0 2.0 1.5 - - 
≥208 34 2.0  0.9 4.6  4.0 1.4 0.4 5.0 0.7 4.0 3.0 FET* .012 
≥150 87 5.1  3.6 8.5  9.8 3.5 1.2 7.5 6.6 6.0 6.9 25.82* .015 
≥127 147 8.6  6.6 15.0  13.8 6.8 3.5 17.5 9.6 8.0 10.3 30.67* .018 
≥101 298 17.4  13.8 27.5  25.9 15.2 9.7 22.5 19.9 16.0 20.2 36.64* .021 
               
Min 26  26 26  33 27 26 31 35 29 28   
Max 863  380 500  863 294 208 370 223 448 600   
 
Note. TMT-B = Trail Making Test (Reitan & Wolfson, 1985) Part B completion time; TBI = traumatic brain injury, 
Mild = mTBI; M-S = moderate/severe TBI; NEU = neurological; DEP = depression; ANX = anxiety; SMI = severe 
mental illness (psychosis/Bipolar Disorder); CP/F = chronic pain and fibromyalgia; ORT = orthopedic; OTH = 
other; FET = Fisher’s exact test; Min = minimum TMT-B score in the respective group; Max = maximum TMT-B 
score in the respective group. 
an = 1715. bn = 334. cn = 153. dn = 174. en = 368. fn = 257. gn = 40. hn = 136. in = 50. jn = 203. 
*p < .05. 
 
 
 Tables 85 and 86 characterize TMT-B BRFail as a function of age in the overall and valid 
samples, respectively. In both samples, BRFail varied significantly across age groups at all TMT-
B cutoffs. Age accounted for 0.7% to 6.3% of the variance in TMT-B BRFail across cutoffs in the 
overall sample (small to medium effects), and for 1.0% to 7.0% of the variance in TMT-B BRFail 
in the valid sample (small to medium effects). In both samples, TMT-B BRFail increased with 
older age. 
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Table 85 
 
Cumulative Percentages of Participants Failing Various Trail Making Test Part B Completion Time Cutoffs in the 
Overall Sample and across Several Age Groups 
 
 Overall Samplea  Age (years)  
TMT-B f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≥304 49 2.0  0.6 1.2 1.5 2.5 5.6 17.24* .007 
≥208 122 5.0  2.2 2.1 4.0 6.7 16.8 59.28* .024 
≥150 244 10.0  3.4 5.8 8.3 14.2 27.3 89.46* .037 
≥127 364 14.9  6.6 10.4 12.4 20.0 38.5 106.35* .044 
≥101 620 25.4  11.6 18.7 22.4 33.1 58.7 153.36* .063 
          
Min 26  26 26 27 31 30   
Max 863  462 480 601 863 540   
 
Note. TMT-B = Trail Makimg Test (Reitan & Wolfson, 1985) Part B completion time in seconds; Min = minimum 
TMT-B score in the respective group; Max = maximum TMT-B score in the respective group. 
an = 2442. bn = 320. cn = 518. dn = 784. en = 671. fn = 143. 




Cumulative Percentages of Participants Failing Various Trail Making Test Part B Completion Time Cutoffs in the 
Valid Sample and across Several Age Groups 
 
 Valid Samplea  Age (years)  
TMT-B f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≥304 10 0.6  0.4 0.0 0.0 1.3 2.3 - - 
≥208 34 2.0  1.2 0.8 1.1 3.4 5.7 FET* .010 
≥150 87 5.1  2.0 2.8 2.9 8.6 17.0 52.77* .031 
≥127 147 8.6  4.3 5.6 5.7 12.9 28.4 70.86* .041 
≥101 298 17.4  7.4 11.7 13.8 24.9 51.1 118.88* .070 
          
Min 26  26 26 29 31 30   
Max 863  462 298 296 863 500   
 
Note. TMT-B = Trail Making Test (Reitan & Wolfson, 1985) Part B completion time in seconds; FET = Fisher’s 
exact test; Min = minimum TMT-B score in the respective group; Max = maximum TMT-B score in the respective 
group. 
an = 1715. bn = 256. cn = 359. dn = 543. en = 466. fn = 88. 
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Tables 87 and 88 characterize TMT-B BRFail across education levels in the overall and 
valid samples, respectively. Fisher’s exact tests and chi-square tests of independence were 
statistically significant at nearly all TMT-B cutoffs in both samples. Education level accounted 
for 0.7% (small effect) to 5.1% (small to medium effect) of the variance in TMT-B BRFail across 
cutoffs in the overall sample, and for 0.8% (very small effect) to 3.8% (small to medium effect) 
of the variance in TMT-B BRFail across cutoffs in the valid sample. In both samples, the least 
educated group demonstrated the highest BRFail across TMT-B cutoffs, and BRFail decreased with 
higher levels of education. Patients with 12 and more years of education demonstrated generally 
comparable BRFail, although individuals with ≥17 years of education had larger BRFail at some 




Cumulative Percentages of Participants Failing Various Trail Making Test Part B Completion Time Cutoffs in the 
Overall Sample and across Several Education Levels 
 
 Overall Samplea  Education (years)  
TMT-B f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≥304 49 2.0  10.0 2.4 0.5 2.2 2.6 0.8 FET* .023 
≥208 122 5.0  18.5 6.8 2.7 4.4 3.9 3.3 66.38* .007 
≥150 244 10.0  35.4 13.4 5.9 7.9 6.5 12.4 124.41* .051 
≥127 364 14.9  43.1 19.1 9.2 13.1 13.8 18.2 116.01* .048 
≥101 620 25.4  59.2 30.5 19.8 21.7 22.0 28.1 106.94* .044 
           
Min 26  27 27 27 26 26 26   
Max 863  600 863 601 600 600 396   
Note. TMT-B = Trail Making Test (Reitan & Wolfson, 1985) Part B completion time in seconds; FET = Fisher’s 
exact test; Min = minimum TMT-B score in the respective group; Max = maximum TMT-B score in the respective 
group. 
an = 2442. bn = 130. cn = 591. dn = 963. en = 405. fn = 232. gn = 121. 
*p < .05. 
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Table 88 
 
Cumulative Percentages of Participants Failing Various Trail Making Test Part B Completion Time Cutoffs in the 
Valid Sample and across Several Education Levels 
 
 Valid Samplea  Education (years)  
TMT-B f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≥304 10 0.6  3.0 1.3 0.1 0.3 0.6 0.0 - - 
≥208 34 2.0  7.5 2.7 1.7 1.0 1.7 1.1 FET .008 
≥150 87 5.1  22.4 6.9 3.9 2.4 3.4 5.7 51.87* .030 
≥127 147 8.6  28.4 11.7 6.5 6.1 8.4 6.9 44.40* .026 
≥101 298 17.4  50.7 22.0 14.7 12.8 15.6 13.8 66.46* .038 
           
Min 26  45 27 27 26 26 26   
Max 863  500 863 462 308 370 281   
 
Note. TMT-B = Trail Making Test (Reitan & Wolfson, 1985) Part B completion time in seconds; FET = Fisher’s 
exact test; Min = minimum TMT-B score in the respective group; Max = maximum TMT-B score in the respective 
group. 
an = 1715. bn = 67. cn = 377. dn = 709. en = 296. fn = 179. gn = 87. 
*p < .05. 
 
 Tables 89 and 90 characterize TMT-B performance as a function of gender and English 
language status in the overall and valid samples, respectively. Chi-square tests of independence 
largely failed to reach statistical significance, suggesting no meaningful association between 
TMT-B BRFail and gender. Although a chi-square test was statistically significant at TMT-B 
≥101 in the overall sample, this was likely driven by large sample at this cutoff. Likelihood ratios 
ranged from 0.95 to 1.29 in the overall sample and from 0.44 to 1.18 in the valid sample.  
 With regard to English language status, NSEs demonstrated lower BRFail than ESL 
patients at nearly all TMT-B cutoffs in both samples, resulting in statistically significant Fisher’s 
exact tests and chi-square tests of independence. Likelihood ratios ranged from 0.26 to 0.45 in 
the overall sample and from 0.32 to 1.00 in the valid sample. 
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Table 89 
 
Cumulative Percentages of Participants Failing Various Trail Making Test Part B Completion Time Cutoffs in the 
Overall Sample and as a Function of Gender and English Language Status 
 
 Overall Samplea  Gender    English   
TMT-B f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
≥304 49 2.0  1.9 2.0 0.01 0.95  1.5 5.4 20.52* 0.28 
≥208 122 5.0  5.4 4.2 1.88 1.29  3.7 14.2 61.56* 0.26 
≥150 244 10.0  10.5 9.2 0.97 1.14  7.7 26.4 101.22* 0.29 
≥127 364 14.9  15.5 14.1 0.93 1.10  12.2 34.9 104.88* 0.35 
≥101 620 25.4  26.9 23.1 4.43* 1.16  22.2 49.2 99.42* 0.45 
            
Min 26  26 26    26 32   
Max 863  863 600    863 600   
 
Note. TMT-B = Trail Making Test (Reitan & Wolfson, 1985) Part B completion time; LR = likelihood ratio; NSE = 
native speakers of English; ESL = English as a second language. Min = minimum TMT-B score in the respective 
group. Max = maximum TMT-B score in the respective group. 
an = 2442. bn = 1490. cn = 952. dn = 2129. en = 295. 






Cumulative Percentages of Participants Failing Various Trail Making Test Part B Completion Time Cutoffs in the 
Valid Sample and as a Function of Gender and English Language Status 
 
 Valid Samplea  Gender    English   
TMT-B f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
≥304 10 0.6  0.4 0.9 FET 0.44  0.6 0.6 FET 1.00 
≥208 34 2.0  2.1 1.8 0.11 1.17  1.7 4.8 FET* 0.35 
≥150 87 5.1  5.0 5.1 0.00 0.98  4.2 13.3 25.53* 0.32 
≥127 147 8.6  8.5 8.8 0.05 0.97  7.5 19.4 26.41* 0.39 
≥101 298 17.4  18.6 15.8 2.31 1.18  15.6 35.2 39.50* 0.44 
            
Min 26  26 26    26 32   
Max 863  863 600    863 380   
 
Note. TMT-B = Trail Making Test (Reitan & Wolfson, 1985) Part B completion time; LR = likelihood ratio; NSE = 
native speakers of English; ESL = English as a second language; FET = Fisher’s exact test; Min = minimum TMT-B 
score in the respective group. Max = maximum TMT-B score in the respective group. 
an = 1715. bn = 1011. cn = 704. dn = 1539. en = 165. 
*p < .05. 
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TMT A+B. Table 91 shows TMT A+B BRFail, at various cutoffs, as a function of WMT 
performance. Chi-square tests of independence were statistically significant across TMT A+B 
cutoffs. Participants who passed the WMT demonstrated lower BRFail than those who failed the 




Cumulative Percentages of Participants Failing Various Trail Making Test A+B Cutoffs in the Overall Sample and 




Overall Samplea  WMT   
f %  Passb Failc χ2 LR 
        
≥391 49 2.0  0.6 5.2 57.24* 0.12 
≥271 122 5.0  1.9 12.3 116.95* 0.15 
≥202 247 10.1  4.8 22.6 178.50* 0.21 
≥175 366 15.0  8.2 31.3 213.14* 0.26 
≥143 610 25.0  16.7 44.8 214.47* 0.37 
       
Min 38  38 49   
Max 928  928 902   
 
Note. TMT A+B = Sum of completion times (in seconds) on Trail Making Test Part A and Part B (Reitan & 
Wolfson, 1985); WMT = Word Memory Test (Green, 2003); Pass = participants passing the WMT at standard 
cutoffs; Fail = participants failing the WMT at standard cutoffs; LR = likelihood ratio; Min = minimum TMT A+B 
score in the respective group; Max = maximum TMT A+B score in the respective group. 
an = 2441. bn = 1715. cn = 726. 
*p < .05. 
 
Tables 92 and 93 characterize TMT A+B BRFail as a function of diagnosis in the overall 
and valid samples, respectively. Fisher’s exact tests and chi-square tests of independence were 
statistically significant across TMT A+B cutoffs in both samples. Diagnosis accounted for 0.5% 
to 1.7% of the variance in TMT A+B BRFail in the overall sample (small effects), and for 2.0% to 
2.1% of the variance in TMT A+B BRFail in the valid sample (small effects). The highest BRFail 
were most consistently observed in patients with neurological conditions, although those with 
moderate-to-severe TBI also had elevated BRFail at more liberal cutoffs in the valid sample. 
Patients with anxiety demonstrated the lowest BRFail. 




Cumulative Percentages of Participants Failing Various Trail Making Test A+B Cutoffs in the Overall Sample and 




Overall Samplea  TBI  Diagnostic Groups   
f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≥391 49 2.0  2.5 2.6  2.6 1.0 0.3 3.4 2.8 2.7 2.7 FET* .005 
≥271 122 5.0  6.3 6.7  6.6 2.9 0.9 5.2 8.5 8.1 4.9 28.83* .012 
≥202 247 10.1  12.9 10.4  17.1 7.0 3.9 10.3 12.8 12.2 9.1 39.18* .016 
≥175 366 15.0  17.4 18.1  22.4 11.6 8.0 17.2 17.5 18.9 13.7 33.70* .014 
≥143 610 25.0  25.7 30.6  32.9 21.3 14.6 29.3 31.8 29.7 25.9 40.89* .017 
               
Min 38  42 38  47 43 45 49 54 42 47   
Max 928  902 544  928 813 534 426 646 503 711   
 
Note. TMT A+B = Sum of completion times (in seconds) on Trail Making Test Part A and Part B (Reitan & 
Wolfson, 1985); TBI = traumatic brain injury, Mild = mTBI; M-S = moderate/severe TBI; NEU = neurological; 
DEP = depression; ANX = anxiety; SMI = severe mental illness (psychosis/Bipolar Disorder); CP/F = chronic pain 
and fibromyalgia; ORT = orthopedic; OTH = other; FET = Fisher’s exact test; Min = minimum TMT A+B score in 
the respective group; Max = maximum TMT A+B score in the respective group. 
an = 2441. bn = 552. cn = 193. dn = 228. en = 526. fn = 336. gn = 58. hn = 211. in = 74. jn = 263. 





Cumulative Percentages of Participants Failing Various Trail Making Test A+B Cutoffs in the Valid Sample and in 




Valid Samplea  TBI  Diagnostic Groups   
f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≥391 10 0.6  0.3 2.0  1.1 0.0 0.0 2.5 0.0 2.0 1.0 - - 
≥271 33 1.9  0.3 3.9  4.6 1.4 0.0 5.0 1.5 4.0 3.0 - - 
≥202 82 4.8  3.3 7.2  12.1 3.0 1.6 7.5 4.4 6.0 5.9 33.76* .020 
≥175 141 8.2  5.7 15.0  16.1 6.2 3.9 12.5 8.8 6.0 7.9 36.11* .021 
≥143 286 16.7  13.2 26.8  24.1 13.9 9.7 22.5 19.9 12.0 20.2 36.79* .021 
               
Min 38  42 38  47 43 45 48 54 42 47   
Max 928  448 544  928 360 256 425 332 503 711   
 
Note. TMT A+B = Sum of completion times (in seconds) on Trail Making Test Part A and Part B (Reitan & 
Wolfson, 1985); TBI = traumatic brain injury, Mild = mTBI; M-S = moderate/severe TBI; NEU = neurological; 
DEP = depression; ANX = anxiety; SMI = severe mental illness (psychosis/Bipolar Disorder); CP/F = chronic pain 
and fibromyalgia; ORT = orthopedic; OTH = other; Min = minimum TMT A+B score in the respective group; Max 
= maximum TMT A+B score in the respective group. 
an = 1715. bn = 334. cn = 153. dn = 174. en = 368. fn = 257. gn = 40. hn = 136. in = 50. jn = 203. 
*p < .05. 
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 Tables 94 and 95 characterize TMT A+B BRFail as a function of age in the overall and 
valid samples, respectively. In both samples, chi-square and Fisher’s exact tests were statistically 
significant across TMT A+B cutoffs. Age accounted for 0.5% (very small effect) to 6.7% 
(medium effect) of the variance in TMT A+B BRFail across cutoffs in the overall sample, and 
1.4% (small effect) to 6.8% (medium effect) of the variance in TMT A+B BRFail in the valid 
sample. At nearly all TMT A+B cutoffs, the lowest BRFail were observed in the youngest age 
group (16-19 years). BRFail increased with age, and the oldest age group (60-69 years) 




Cumulative Percentages of Participants Failing Various Trail Making Test A+B Cutoffs in the Overall Sample and 




Overall Samplea  Age (years)  
f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≥391 49 2.0  0.6 1.2 1.7 2.5 4.9 13.20* .005 
≥271 122 5.0  1.6 2.3 4.1 6.4 17.5 69.24* .029 
≥202 247 10.1  3.1 6.0 8.5 13.7 29.4 98.27* .040 
≥175 366 15.0  6.2 10.4 12.8 20.1 37.8 103.14* .042 
≥143 610 25.0  11.2 16.6 22.1 34.3 56.6 162.80* .067 
          
Min 38  38 42 43 49 47   
Max 928  514 646 813 928 619   
 
Note. TMT A+B = Sum of completion times (in seconds) on Trail Making Test Part A and Part B (Reitan & 
Wolfson, 1985); Min = minimum TMT A+B score in the respective group; Max = maximum TMT A+B score in the 
respective group. 
an = 2441. bn = 320. cn = 517. dn = 784. en = 671. fn = 143. 
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Table 95 
 
Cumulative Percentages of Participants Failing Various Trail Making Test A+B Cutoffs in the Valid Sample and 




Valid Samplea  Age (years)  
f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≥391 10 0.6  0.4 0.0 0.0 1.3 2.3 - - 
≥271 33 1.9  0.8 0.8 0.9 3.2 6.8 FET* .014 
≥202 82 4.8  2.0 2.2 2.4 8.2 18.2 62.34* .036 
≥175 141 8.2  3.9 5.3 5.5 12.0 27.3 67.60* .040 
≥143 286 16.7  7.0 10.6 12.5 25.5 46.6 116.95* .068 
          
Min 38  38 42 43 50 47   
Max 928  514 371 350 928 544   
 
Note. TMT A+B = Sum of completion times (in seconds) on Trail Making Test Part A and Part B (Reitan & 
Wolfson, 1985); FET = Fisher’s exact test; Min = minimum TMT A+B score in the respective group; Max = 
maximum TMT A+B score in the respective group. 
an = 1715. bn = 256. cn = 359. dn = 543. en = 466. fn = 88. 
*p < .05. 
 
 
Tables 96 and 97 characterize TMT A+B BRFail as a function of education level in the 
overall and valid samples, respectively. Chi-square and Fisher’s exact tests were statistically 
significant at all TMT A+B cutoffs in the overall sample and nearly all cutoffs in the valid 
sample. Education level accounted for 1.9% (small effect) to 4.5% (small to medium effect) of 
the variance in TMT A+B BRFail across cutoffs in the overall sample, and for 0.8% (very small 
effect) to 3.0% (small to medium effect) of the variance in TMT A+B BRFail across cutoffs in the 
valid sample.  
 In both samples, the highest BRFail were consistently observed in the group with the 
lowest level of education (≤8 years), and BRFail decreased with higher levels of education. 
Patients with ≥12 years of education demonstrated relatively comparable BRFail across TMT 
A+B cutoffs, although BRFail in individuals with ≥17 years of education were higher at some 
cutoffs than would be expected based on the trend. 
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Table 96 
 
Cumulative Percentages of Participants Failing Various Trail Making Test A+B Cutoffs in the Overall Sample and 




Overall Samplea  Education (years)  
f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≥391 49 2.0  9.2 2.2 0.5 2.2 3.0 0.8 FET* .019 
≥271 122 5.0  19.2 6.1 2.7 4.9 3.9 4.1 68.96* .028 
≥202 247 10.1  32.3 12.4 6.5 8.1 9.5 10.7 89.30* .036 
≥175 366 15.0  41.5 18.8 9.8 12.8 13.4 20.7 103.88* .042 
≥143 610 25.0  56.9 31.5 18.7 22.0 20.7 28.1 108.96* .045 
           
Min 38  66 47 43 38 42 45   
Max 928  902 928 798 652 813 500   
 
Note. TMT A+B = Sum of completion times (in seconds) on Trail Making Test Part A and Part B (Reitan & 
Wolfson, 1985); FET = Fisher’s exact test; Min = minimum TMT A+B score in the respective group; Max = 
maximum TMT A+B score in the respective group. 
an = 2441. bn = 130. cn = 591. dn = 962. en = 405. fn = 232. gn = 121. 





Cumulative Percentages of Participants Failing Various Trail Making Test A+B Cutoffs in the Valid Sample and 




Valid Samplea  Education (years)  
f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≥391 10 0.6  3.0 1.3 0.1 0.0 1.1 0.0 - - 
≥271 33 1.9  7.5 2.1 1.6 1.0 1.7 2.3 FET .008 
≥202 82 4.8  19.4 5.0 4.5 2.0 4.5 4.6 36.61* .021 
≥175 141 8.2  25.4 10.6 6.8 5.1 7.3 8.0 35.30* .020 
≥143 286 16.7  44.8 21.5 13.7 13.5 14.5 13.8 52.17* .030 
           
Min 38  66 47 43 38 42 45   
Max 928  544 928 514 367 448 371   
 
Note. TMT A+B = Sum of completion times (in seconds) on Trail Making Test Part A and Part B (Reitan & 
Wolfson, 1985); FET = Fisher’s exact test; Min = minimum TMT A+B score in the respective group; Max = 
maximum TMT A+B score in the respective group. 
an = 1715. bn = 67. cn = 377. dn = 709. en = 296. fn = 179. gn = 87. 
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Tables 98 and 99 characterize TMT A+B BRFail as a function of gender and English 
language status in the overall and valid samples, respectively. In both samples, chi-square tests 
and Fisher’s exact tests generally failed to reach statistical significance, suggesting no 
relationship between gender and TMT A+B BRFail. Although a chi-square test was significant at 
TMT A+B ≥143 in the valid sample, χ2 (1, N = 2441) = 4.98, p = .026, this finding is likely due 
to the increase in sample size at that cutoff. Likelihood ratios ranged from 1.05 to 1.20 in the 
overall sample and from 0.71 to 1.31 in the valid sample. 
 With regard to English language status, chi-square tests were statistically significant at all 
TMT A+B cutoffs in the overall sample and nearly all TMT A+B cutoffs in the valid sample. 
NSEs demonstrated lower BRFail than ESL patients across all TMT A+B cutoffs in both samples. 





Cumulative Percentages of Participants Failing Various Trail Making Test A+B Cutoffs in the Overall Sample and 




Overall Samplea  Gender    English   
f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
≥391 49 2.0  2.0 1.9 0.05 1.05  1.5 5.8 24.74* 0.26 
≥271 122 5.0  5.3 4.4 0.99 1.20  3.6 14.6 66.09* 0.25 
≥202 247 10.1  10.3 9.7 0.30 1.06  7.8 24.4 99.40* 0.32 
≥175 366 15.0  15.9 13.7 2.32 1.16  11.9 37.6 133.65* 0.32 
≥143 610 25.0  26.6 22.6 4.98* 1.18  21.7 49.5 106.38* 0.44 
            
Min 38  38 42    38 50   
Max 928  928 798    928 813   
 
Note. TMT A+B = Sum of completion times (in seconds) on Trail Making Test Part A and Part B (Reitan & 
Wolfson, 1985); LR = likelihood ratio; NSE = native speakers of English; ESL = English as a second language; Min 
= minimum TMT A+B score in the respective group; Max = maximum TMT A+B score in the respective group. 
an = 2441. bn = 1489. cn = 952. dn = 2128. en = 295. 
*p < .05. 
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Table 99 
 
Cumulative Percentages of Participants Failing Various Trail Making Test A+B Cutoffs in the Valid Sample and as 




Valid Samplea  Gender    English   
f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
≥391 10 0.6  0.5 0.7 FET 0.71  0.5 1.2 FET 0.42 
≥271 33 1.9  2.1 1.6 0.60 1.31  1.6 4.2 FET* 0.38 
≥202 82 4.8  4.6 5.0 0.10 0.92  4.1 11.5 17.92* 0.36 
≥175 141 8.2  8.4 7.8 0.20 1.08  6.8 21.8 44.82* 0.31 
≥143 286 16.7  18.0 14.8 3.12 1.22  15.0 33.3 35.82* 0.45 
            
Min 38  38 42    38 50   
Max 928  928 711    928 448   
 
Note. TMT A+B = Sum of completion times (in seconds) on Trail Making Test Part A and Part B (Reitan & 
Wolfson, 1985); LR = likelihood ratio; NSE = native speakers of English; ESL = English as a second language; FET 
= Fisher’s exact test; Min = minimum TMT A+B score in the respective group; Max = maximum TMT A+B score 
in the respective group. 
an = 1715. bn = 1011. cn = 704. dn = 1539. en = 165. 
*p < .05.  
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TMT-B/A. Table 100 shows TMT-B/A BRFail, at various cutoffs, as a function of WMT 
performance. BRFail were generally comparable between those who passed the WMT and those 
who failed the WMT across TMT-B/A cutoffs, and chi-square tests failed to reach statistical 




Cumulative Percentages of Participants Failing Various Trail Making Test B/A Cutoffs in the Overall Sample and 




Overall Samplea  WMT   
f %  Passb Failc χ2 LR 
        
≤1.26 51 2.1  2.3 1.7 0.96 1.35 
≤1.40 122 5.0  5.2 4.5 0.30 1.16 
≤1.57 244 10.0  10.3 9.2 0.68 1.12 
≤1.71 373 15.3  15.5 14.9 0.13 1.04 
≤1.91 608 24.9  25.4 23.8 0.64 1.07 
       
Min 0.24  0.47 0.24   
Max 15.41  13.28 15.41   
 
Note. TMT-B/A = Trail Making Test ratio (Part B completion time in seconds/Part A completion time in seconds; 
Reitan & Wolfson, 1985); WMT = Word Memory Test (Green, 2003); Pass = participants passing the WMT at 
standard cutoffs; Fail = participants failing the WMT at standard cutoffs; LR = likelihood ratio. Min = minimum 
TMT-B/A score in the respective group. Max = maximum TMT-B/A score in the respective group. 
an = 2441. bn = 1715. cn = 726. 
*p < .05. 
 
 
 Tables 101 and 102 characterize TMT-B/A BRFail as a function of diagnosis in the overall 
and valid samples, respectively. In both samples, chi-square and Fisher’s exact tests failed to 
reach statistical significance. Effect sizes indicated that diagnosis accounted for only 0.2% to 
0.4% of the variance in TMT-B/A BRFail in the overall sample (very small effects) and for 0.3% 
to 0.5% of the variance in TMT-B/A BRFail in the valid sample (very small effects). 
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Table 101 
 
Cumulative Percentages of Participants Failing Various Trail Making Test B/A Cutoffs in the Overall Sample and in 




Overall Samplea  TBI  Diagnostic Groups   
f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≤1.26 51 2.1  1.8 2.1  2.6 2.3 1.6 5.2 2.4 5.4 1.1 FET .004 
≤1.40 122 5.0  5.1 7.3  4.8 4.4 4.5 10.3 4.7 5.4 4.2 5.86 .002 
≤1.57 244 10.0  7.8 11.9  10.1 10.3 9.8 17.2 10.0 12.2 10.6 7.73 .003 
≤1.71 373 15.3  12.9 16.1  18.9 16.0 14.3 19.0 13.7 14.9 17.1 6.97 .003 
≤1.91 608 24.9  23.9 25.4  28.9 25.1 24.4 32.8 23.7 21.6 23.6 5.12 .002 
               
Min 0.24  .93 1.19  1.05 0.24 .87 1.06 0.47 1.02 1.14   
Max 15.41  15.41 11.36  13.28 6.77 7.44 6.73 7.87 9.23 11.92   
 
Note. TMT-B/A = Trail Making Test ratio (Part B completion time in seconds/Part A completion time in seconds; 
Reitan & Wolfson, 1985); TBI = traumatic brain injury, Mild = mTBI; M-S = moderate/severe TBI; NEU = 
neurological; DEP = depression; ANX = anxiety; SMI = severe mental illness (psychosis/Bipolar Disorder); CP/F = 
chronic pain and fibromyalgia; ORT = orthopedic; OTH = other; FET = Fisher’s exact test; Min = minimum TMT-
B/A score in the respective group; Max = maximum TMT-B/A score in the respective group. 
an = 2441. bn = 552. cn = 193. dn = 228. en = 526. fn = 336. gn = 58. hn = 211. in = 74. jn = 263. 





Cumulative Percentages of Participants Failing Various Trail Making Test B/A Cutoffs in the Valid Sample and in 




Valid Samplea  TBI  Diagnostic Groups   
f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≤1.26 39 2.3  2.1 2.6  2.9 2.2 1.6 5.0 2.2 6.0 1.5 FET .003 
≤1.40 86 5.0  6.0 8.5  4.6 4.3 3.9 12.5 4.4 6.0 3.9 9.27 .005 
≤1.57 177 10.3  8.7 11.8  10.9 10.3 8.2 17.5 11.8 10.0 11.8 5.70 .003 
≤1.71 266 15.5  12.9 15.0  19.5 16.3 13.2 20.0 14.7 14.0 17.7 6.70 .004 
≤1.91 436 25.4  24.0 24.2  31.6 24.7 24.1 32.5 26.5 22.0 24.6 5.86 .003 
               
Min 0.47  0.93 1.19  1.05 1.00 0.87 1.06 0.47 1.02 1.14   
Max 13.28  6.79 11.36  13.28 5.33 5.64 6.73 7.87 8.15 8.88   
 
Note. TMT-B/A = Trail Making Test ratio (Part B completion time in seconds/Part A completion time in seconds; 
Reitan & Wolfson, 1985); TBI = traumatic brain injury, Mild = mTBI; M-S = moderate/severe TBI; NEU = 
neurological; DEP = depression; ANX = anxiety; SMI = severe mental illness (psychosis/Bipolar Disorder); CP/F = 
chronic pain and fibromyalgia; ORT = orthopedic; OTH = other; FET = Fisher’s exact test; Min = minimum TMT-
B/A score in the respective group; Max = maximum TMT-B/A score in the respective group. 
an = 1715. bn = 334. cn = 153. dn = 174. en = 418. fn = 257. gn = 40. hn = 136. in = 50. jn = 203. 
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Tables 103 and 104 characterize TMT-B/A BRFail as a function of age in the overall and 
valid samples, respectively. In both samples, chi-square and Fisher’s exact tests failed to reach 
statistical significance. Across cutoffs, age accounted for only 0.1% to 0.3% of the variance in 




Cumulative Percentages of Participants Failing Various Trail Making Test B/A Cutoffs in the Overall Sample and 




Overall Samplea  Age (years)  
f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≤1.26 51 2.1  1.3 3.1 1.9 2.2 0.7 5.18 .002 
≤1.40 122 5.0  4.4 5.8 5.5 4.8 2.1 3.94 .002 
≤1.57 244 10.0  9.7 10.8 10.5 9.8 6.3 2.81 .001 
≤1.71 373 15.3  15.3 16.2 16.6 14.5 9.1 5.97 .003 
≤1.91 608 24.9  25.6 26.1 26.0 23.8 18.9 4.18 .002 
          
Min 0.24  1.11 0.87 0.24 0.47 1.20   
Max 15.41  8.88 8.24 15.41 13.28 11.36   
 
Note. TMT-B/A = Trail Making Test ratio (Part B completion time in seconds/Part A completion time in seconds; 
Reitan & Wolfson, 1985); Min = minimum TMT-B/A score in the respective group. Max = maximum TMT-B/A 
score in the respective group. 
an = 2441. bn = 320. cn = 571. dn = 784. en = 671. fn = 143. 





Cumulative Percentages of Participants Failing Various Trail Making Test B/A Cutoffs in the Valid Sample and 




Valid Samplea  Age (years)  
f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≤1.26 39 2.3  1.2 3.6 2.2 2.1 1.1 4.88 .003 
≤1.40 86 5.0  3.9 6.4 6.3 4.3 2.3 5.57 .003 
≤1.57 177 10.3  9.4 11.7 10.9 9.7 8.0 1.91 .001 
≤1.71 266 15.5  14.5 16.4 16.8 14.8 10.2 3.15 .002 
≤1.91 436 25.4  25.8 26.2 26.5 24.2 20.5 1.96 .001 
          
Min 0.47  1.11 0.87 1.02 0.47 1.20   
Max 13.28  8.88 7.10 7.87 13.28 11.36   
 
Note. TMT-B/A = Trail Making Test ratio (Part B completion time in seconds/Part A completion time in seconds; 
Reitan & Wolfson, 1985); Min = minimum TMT-B/A score in the respective group. Max = maximum TMT-B/A 
score in the respective group. 
an = 1715. bn = 256. cn = 359. dn = 543. en = 466. fn = 88. 
*p < .05. 
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Tables 105 and 106 characterize TMT-B/A BRFail as a function of education level in the 
overall and valid samples, respectively. Chi-square and Fisher’s exact tests reached significance 
at more liberal cutoffs in both samples, likely due to the increase in sample size at those cutoffs. 
However, education level accounted for only 0.1% to 1.0% of the variance in TMT-B/A BRFail in 
the overall sample (small effects), and for 0.2% to 1.1% of the variance in TMT-B/A BRFail in 
the valid sample (very small to small effects). Nevertheless, in both samples, the lowest BRFail 
were observed in the least educated group (≤8 years of formal education), and BRFail tended to 




Cumulative Percentages of Participants Failing Various Trail Making Test B/A Cutoffs in the Overall Sample and 




Overall Samplea  Education (years)  
f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≤1.26 51 2.1  1.5 1.9 1.9 2.2 3.4 2.5 FET .001 
≤1.40 122 5.0  2.3 4.4 4.5 5.7 7.8 7.4 9.39 .004 
≤1.57 244 10.0  3.8 8.3 10.5 9.4 15.5 12.4 16.45* .007 
≤1.71 373 15.3  9.2 13.2 15.7 14.6 23.3 15.7 17.42* .007 
≤1.91 608 24.9  16.2 20.6 25.6 26.2 34.9 26.4 24.22* .010 
           
Min 0.24  0.24 0.87 0.47 1.05 1.10 1.16   
Max 15.41  11.36 13.28 15.41 11.92 8.06 8.24   
 
Note. TMT-B/A = Trail Making Test ratio (Part B completion time in seconds/Part A completion time in seconds; 
Reitan & Wolfson, 1985); FET = Fisher’s exact test; Min = minimum B/A score in the respective group; Max = 
maximum B/A score in the respective group. 
an = 2441. bn = 130. cn = 591. dn = 962. en = 405. fn = 232. gn = 121. 
*p < .05. 
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Table 106 
 
Cumulative Percentages of Participants Failing Various Trail Making Test B/A Cutoffs in the Valid Sample and 




Valid Samplea  Education (years)  
f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≤1.26 39 2.3  1.5 2.4 1.8 2.0 3.9 3.4 FET .002 
≤1.40 86 5.0  1.5 4.8 4.5 5.7 8.4 6.9 7.72 .004 
≤1.57 177 10.3  4.5 8.2 10.6 10.1 15.6 11.5 9.93 .006 
≤1.71 266 15.5  10.4 12.7 15.2 14.9 24.6 16.1 14.97* .009 
≤1.91 436 25.4  14.9 19.9 25.4 28.4 34.6 27.6 19.59* .011 
           
Min 0.47  1.15 0.87 0.47 1.19 1.10 1.16   
Max 13.28  11.36 13.28 8.88 6.52 6.73 5.39   
 
Note. TMT-B/A = Trail Making Test ratio (Part B completion time in seconds/Part A completion time in seconds; 
Reitan & Wolfson, 1985); FET = Fisher’s exact test; Min = minimum B/A score in the respective group; Max = 
maximum B/A score in the respective group. 
an = 1715. bn = 67. cn = 377. dn = 709. en = 296. fn = 179. gn = 87. 
*p < .05. 
 
 Tables 107 and 108 characterize TMT-B/A BRFail across gender and English language 
status in the overall and valid samples, respectively. Chi-square tests largely failed to reach 
statistical significance across TMT-B/A cutoffs in either sample, suggesting no meaningful 
relationship between TMT-B/A BRFail and gender. Although chi-square tests were statistically 
significant at TMT-B/A ≤1.91 in both samples, these findings were likely due to the increased 
sample size. Likelihood ratios ranged from 0.84 to 0.91 in the overall sample, and from 0.82 to 
1.25 in the valid sample. 
 TMT-B/A BRFail were unrelated to English language status across cutoffs in either 
sample. Likelihood ratios ranged from 0.65 to 1.00 in the overall sample, and from 0.93 to 0.99 
in the valid sample. 
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Table 107 
 
Cumulative Percentages of Participants Failing Various Trail Making Test B/A Cutoffs in the Overall Sample and 




Overall Samplea  Gender    English   
f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
≤1.26 51 2.1  2.0 2.2 0.10 0.91  2.0 3.1 1.46 0.65 
≤1.40 122 5.0  4.7 5.5 1.00 0.85  4.7 6.8 2.51 0.69 
≤1.57 244 10.0  9.5 10.8 1.18 0.88  9.8 11.5 0.83 0.85 
≤1.71 373 15.3  14.4 16.7 2.44 0.86  15.2 16.6 0.41 0.92 
≤1.91 608 24.9  23.2 27.5 5.70* 0.84  25.0 25.1 0.00 1.00 
            
Min 0.24  0.24 0.47    0.24 0.47   
Max 15.41  15.41 11.92    15.41 9.69   
 
Note. TMT-B/A = Trail Making Test ratio (Part B completion time in seconds/Part A completion time in seconds; 
Reitan & Wolfson, 1985); LR = likelihood ratio; NSE = native speakers of English; ESL = English as a second 
language; Min = minimum TMT-B/A score in the respective group; Max = maximum TMT-B/A score in the 
respective group. 
an = 2441. bn = 1489. cn = 952. dn = 2128. en = 295. 





Cumulative Percentages of Participants Failing Various Trail Making Test B/A Cutoffs in the Valid Sample and as a 




Valid Samplea  Gender    English   
f %  Maleb Femalec χ2 LR  NSEd ESLe χ2 LR 
             
≤1.26 39 2.3  2.5 2.0 0.44 1.25  2.3 2.4 FET 0.96 
≤1.40 86 5.0  5.3 5.0 0.03 1.06  5.1 5.5 0.06 0.93 
≤1.57 177 10.3  10.0 10.8 0.29 0.93  10.3 10.9 0.07 0.94 
≤1.71 266 15.5  14.5 16.8 1.57 0.86  15.4 16.4 0.11 0.94 
≤1.91 436 25.4  23.3 28.3 5.32* 0.82  25.3 25.5 0.00 0.99 
            
Min 0.47  0.87 0.47    0.87 0.47   
Max 13.28  13.28 11.36    13.28 6.00   
 
Note. TMT-B/A = Trail Making Test ratio (Part B completion time in seconds/Part A completion time in seconds; 
Reitan & Wolfson, 1985); LR = likelihood ratio; NSE = native speakers of English; ESL = English as a second 
language; FET = Fisher’s exact test; Min = minimum TMT-B/A score in the respective group; Max = maximum 
TMT-B/A score in the respective group. 
an = 1715. bn = 1101. cn = 704. dn = 1539. en = 165. 
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FTT-DHM. Table 109 shows FTT-DHM BRFail, at various cutoffs, as a function of WMT 
performance. Participants who passed the WMT demonstrated significantly lower BRFail than 




Cumulative Percentages of Male Participants Failing Various Finger Tapping Test Dominant Hand Cutoffs in the 
Overall Sample and as a Function of Word Memory Test Performance 
 
 Overall Samplea  WMT   
FTT-DHM f %  Passd Faile χ2 LR 
        
≤18.0 11 2.0  0.5 5.6 FET* 0.09 
≤27.6 27 4.9  2.6 10.5 15.54* 0.25 
≤36.5 56 10.1  6.1 19.1 23.33* 0.32 
≤42.0 82 14.8  9.0 29.0 36.50* 0.31 
≤45.0 139 25.1  16.6 45.7 51.39* 0.36 
       
Min 4.4  17.4 4.4   
Max 71.2  71.2 65.0   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DHM = average number of taps achieved with the dominant hand 
(males only); WMT = Word Memory Test (Green, 2003); Pass = participants passing the WMT at standard cutoffs; 
Fail = participants failing the WMT at standard cutoffs; FET = Fisher’s exact test; LR = likelihood ratio; Min = 
minimum FTT-DHM score in the respective group; Max = maximum FTT-DHM score in the respective group. 
an = 553. bn = 391. cn = 162. 
*p < .05. 
 
 Tables 110 and 111 characterize FTT-DHM BRFail as a function of diagnosis in the overall 
and valid samples, respectively. The only Fisher’s exact test conducted in the overall sample 
(i.e., at FTT-DHM ≤45) failed to reach statistical significance, and the corresponding effect size 
indicated that diagnosis accounted for only 1.9% of the variance in BRFail at that cutoff (small 
effect). Chi-square or Fisher’s exact tests were not conducted in the valid sample. No comments 
are made about trends in BRFail due to the small sizes of several clinical groups. 
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Table 110 
 
Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Dominant Hand Cutoffs in the 




Overall Samplea  TBI  Diagnostic Groups   
f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≤18.0 11 2.0  2.4 3.0  1.6 4.2 0.0 0.0 0.0 0.0 0.0 - - 
≤27.6 27 4.9  4.4 6.9  8.2 8.3 0.0 0.0 0.0 0.0 2.8 - - 
≤36.5 56 10.1  8.0 14.9  13.1 12.5 0.0 0.0 20.0 20.0 7.0 - - 
≤42.0 82 14.8  12.0 17.8  19.7 25.0 0.0 8.3 40.0 26.7 9.9 - - 
≤45.0 139 25.1  22.7 27.7  24.6 33.3 12.5 16.7 50.0 46.7 22.5 FET .019 
               
Min 4.4  4.4 9.0  14.6 17.4 45.0 38.8 30.2 29.2 18.2   
Max 71.2  71.0 65.0  63.2 71.2 67.2 59.2 56.2 65.2 68.2   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DHM = average number of taps achieved with the dominant hand 
(males only); TBI = traumatic brain injury, Mild = mTBI; M-S = moderate/severe TBI; NEU = neurological; DEP = 
depression; ANX = anxiety; SMI = severe mental illness (psychosis/Bipolar Disorder); CP/F = chronic pain and 
fibromyalgia; ORT = orthopedic; OTH = other; FET = Fisher’s exact test; Min = minimum FTT-DHM score in the 
respective group; Max = maximum FTT-DHM score in the respective group. 
an = 553. bn = 251. cn = 101. dn = 61. en = 24. fn = 8. gn = 12. hn = 10. in = 15. jn = 71. 





Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Dominant Hand Cutoffs in the 




Valid Samplea  TBI  Diagnostic Groups   
f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≤18.0 2 0.5  0.0 1.3  0.0 6.3 0.0 0.0 0.0 0.0 0.0 - - 
≤27.6 10 2.6  1.2 2.7  6.5 12.5 0.0 0.0 0.0 0.0 1.8 - - 
≤36.5 24 6.1  1.9 10.7  8.7 18.8 0.0 0.0 16.7 23.1 3.6 - - 
≤42.0 35 9.0  3.7 12.0  13.0 25.0 0.0 0.0 50.0 30.8 3.6 - - 
≤45.0 65 16.6  10.5 20.0  19.6 25.0 0.0 10.0 50.0 46.2 17.9 - - 
               
Min 17.4  24.8 18.0  18.8 17.4 49.4 42.8 32.2 29.2 24.2   
Max 71.2  71.0 65.0  63.2 71.2 67.2 59.2 56.2 65.2 68.2   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DHM = average number of taps achieved with the dominant hand 
(males only); TBI = traumatic brain injury, Mild = mTBI; M-S = moderate/severe TBI; NEU = neurological; DEP = 
depression; ANX = anxiety; SMI = severe mental illness (psychosis/Bipolar Disorder); CP/F = chronic pain and 
fibromyalgia; ORT = orthopedic; OTH = other; FET = Fisher’s exact test; Min = minimum FTT-DHM score in the 
respective group; Max = maximum FTT-DHM score in the respective group. 
an = 391. bn = 162. cn = 75. dn = 46. en = 16. fn = 7. gn = 10. hn = 6. in = 13. jn = 56. 
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Tables 112 and 113 characterize FTT-DHM BRFail as a function of age in the overall and 
valid samples, respectively. In the overall sample, chi-square and Fisher’s exact tests were 
statistically significant at nearly all cutoffs examined, and age accounted for 1.4% to 7.1% of the 
variance in FTT-DHM BRFail across cutoffs (small to medium effects). BRFail tended to increase 
with age, and the oldest group (60-69 years) consistently demonstrated the highest BRFail. In the 
valid sample, chi-square tests reached statistical significance at more liberal cutoffs (likely due to 
the small sample sizes at more conservative cutoffs), and age accounted for 2.3% (small effect) 
to 3.9% (small to medium effect) of the variance in BRFail. Again, BRFail tended to increase with 




Cumulative Percentages of Male Participants Failing Various Finger Tapping Test Dominant Hand Cutoffs in the 




Overall Samplea  Age (years)  
f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≤18.0 11 2.0  0.9 0.8 1.2 4.1 6.5 FET .014 
≤27.6 27 4.9  1.9 3.1 3.7 9.0 12.9 12.14* .022 
≤36.5 56 10.1  7.5 5.5 9.2 13.1 29.0 17.51* .032 
≤42.0 82 14.8  9.3 9.4 11.0 21.3 48.4 39.23* .071 
≤45.0 139 25.1  17.8 17.3 25.2 32.8 51.6 22.59* .041 
          
Min 4.4  18.0 13.4 14.5 4.4 9.0   
Max 71.2  71.0 67.8 69.2 71.2 58.4   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DHM = average number of taps achieved with the dominant hand 
(males only); FET = Fisher’s exact test; Min = minimum FTT-DHM score in the respective group. Max = maximum 
FTT-DHM score in the respective group. 
an = 553. bn = 107. cn = 127. dn = 163. en = 122. fn = 31. 
*p < .05.  
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Table 113 
 
Cumulative Percentages of Male Participants Failing Various Finger Tapping Test Dominant Hand cutoffs in the 




Valid Samplea  Age (years)  
f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≤18.0 2 0.5  1.2 0.0 0.0 1.2 0.0 - - 
≤27.6 10 2.6  1.2 2.2 2.7 4.8 0.0 - - 
≤36.5 24 6.1  3.7 2.2 7.1 9.6 16.7 8.80 .023 
≤42.0 35 9.0  3.7 5.4 8.8 14.5 27.8 15.12* .039 
≤45.0 65 16.6  8.5 9.7 20.4 24.1 33.3 15.15* .039 
          
Min 17.4  18.0 18.8 20.4 17.4 28.0   
Max 71.2  71.0 67.8 69.2 71.2 58.4   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DHM = average number of taps achieved with the dominant hand 
(males only); Min = minimum FTT-DHM score in the respective group. Max = maximum FTT-DHM score in the 
respective group. 
an = 391. bn = 82. cn = 93. dn = 113. en = 83. fn = 18. 
*p < .05. 
 
Tables 114 and 115 characterize FTT-DHM BRFail as a function of education level in the 
overall and valid samples, respectively. In the overall sample, Fisher’s exact tests failed to reach 
statistical significance where conducted, and education level accounted for only 1.3% to 1.7% of 
the variance in FTT-DHM BRFail across cutoffs (small effects). BRFail tended to be highest in the 
least educated groups and decrease with higher levels of education. However, the most educated 
group (≥17 years of education) demonstrated higher BRFail than would be expected based on the 
trend. At several cutoffs, BRFail among those with ≥17 years of education exceeded those of the 
least educated groups as well. 
In the valid sample, cell sizes at more conservative cutoffs (e.g., ≤18.0, ≤27.6, and ≤36.5) 
were quite small, resulting in potentially unreliable estimates of BRFail across education groups at 
these cutoffs. A chi-square test conducted at FTT-DHM ≤45.0 was statistically significant, χ2 (5, 
N = 391) = 12.97, p = .024, and education accounted for 3.3% of the variance at this cutoff 
(small to medium effect). A trend similar to the overall sample was observed: BRFail tended to 
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Cumulative Percentages of Male Participants Failing Various Finger Tapping Test Dominant Hand cutoffs in the 




Overall Samplea  Education (years)  
f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≤18.0 11 2.0  5.4 0.6 2.2 0.0 4.4 6.9 - - 
≤27.6 27 4.9  10.8 2.9 5.6 2.2 6.7 10.3 FET .015 
≤36.5 56 10.1  10.8 8.8 12.3 5.4 8.9 20.7 FET .013 
≤42.0 82 14.8  16.2 16.5 14.0 9.7 8.9 31.0 FET .016 
≤45.0 139 25.1  32.4 28.8 23.5 20.4 13.3 37.9 FET .017 
           
Min 4.4  4.4 9.0 13.4 18.8 14.6 14.5   
Max 71.2  62.8 65.0 71.2 65.2 68.2 69.2   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DHM = average number of taps achieved with the dominant hand 
(males only); FET = Fisher’s exact test; Min = minimum FTT-DHM score in the respective group; Max = maximum 
FTT-DHM score in the respective group. 
an = 553. bn = 37. cn = 170. dn = 179. en = 93. fn = 45. gn = 29. 






Cumulative Percentages of Male Participants Failing Various Finger Tapping Test Dominant Hand Cutoffs in the 
Valid Sample and across Several Education Levels 
 
 Valid Samplea  Education (years)  
FTT-DHM f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≤18.0 2 0.5  0.0 0.0 0.7 0.0 0.0 4.5 - - 
≤27.6 10 2.6  5.9 0.9 3.6 1.4 0.0 9.1 - - 
≤36.5 24 6.1  5.9 4.7 8.6 1.4 0.0 22.7 - - 
≤42.0 35 9.0  11.8 9.4 10.7 2.8 0.0 27.3 - - 
≤45.0 65 16.6  17.6 17.9 18.6 11.3 2.9 36.4 12.97* .033 
           
Min 17.4  20.4 22.2 18.0 18.8 43.1 17.4   
Max 71.2  56.8 65.0 71.2 65.2 68.2 69.2   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DHM = average number of taps achieved with the dominant hand 
(males only); Min = minimum FTT-DHM score in the respective group; Max = maximum FTT-DHM score in the 
respective group. 
an = 391. bn = 17. cn = 106. dn = 140. en = 71. fn = 35. gn = 22. 
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Tables 116 and 117 characterize FTT-DHM BRFail as a function of English language status 
in the overall and valid samples, respectively. In the overall sample, NSEs demonstrated lower 
BRFail than ESL patients across FTT-DHM cutoffs, although Fisher’s exact tests and chi-square 
tests of independence only reached statistical significance at FTT-DHM ≤18.0 and ≤45.0. 
Likelihood ratios ranged from 0.14 to 0.64 across cutoffs. In the valid sample, sample sizes were 
quite small at many cutoffs, and Fisher’s exact tests and chi-square tests consistently failed to 




Cumulative Percentages of Male Participants Failing Various Finger Tapping Test Dominant Hand Cutoffs in the 
Overall Sample and as a Function of English Language Status 
 
 Overall Samplea  English   
FTT-DHM f %  NSEb ESLc χ2 LR 
        
≤18.0 11 2.0  1.1 8.1 FET* 0.14 
≤27.6 27 4.9  4.0 9.5 FET 0.42 
≤36.5 56 10.1  9.1 16.2 3.51 0.56 
≤42.0 82 14.8  13.8 21.6 3.06 0.64 
≤45.0 139 25.1  23.0 39.2 8.92* 0.59 
       
Min 4.4  9.0 4.4   
Max 71.2  71.2 71.0   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DHM = average number of taps achieved with the dominant hand 
(males only); NSE = native speakers of English; ESL = English as a second language; LR = likelihood ratio; FET = 
Fisher’s exact test; Min = minimum FTT-DHM score in the respective group; Max = maximum FTT-DHM score in 
the respective group. 
an = 553. bn = 470. cn = 74. 
*p < .05. 
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Table 117 
 
Cumulative Percentages of Male Participants Failing Various Finger Tapping Test Dominant Hand Cutoffs in the 
Valid Sample and as a Function of English Language Status 
 
 Valid Samplea  English   
FTT-DHM f %  NSEb ESLc χ2 LR 
        
≤18.0 2 0.5  0.3 2.2 FET 0.14 
≤27.6 10 2.6  2.3 2.2 FET 1.05 
≤36.5 24 6.1  5.6 8.9 FET 0.63 
≤42.0 35 9.0  8.5 11.1 FET 0.77 
≤45.0 65 16.6  15.5 24.4 2.28 0.64 
       
Min 17.4  17.4 18.0   
Max 71.2  71.2 71.0   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DHM = average number of taps achieved with the dominant hand 
(males only); NSE = native speakers of English; ESL = English as a second language; LR = likelihood ratio; FET = 
Fisher’s exact test; Min = minimum FTT-DHM score in the respective group; Max = maximum FTT-DHM score in 
the respective group. 
an = 391. bn = 341. cn = 45. 
*p < .05. 
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FTT-NDHM. Table 118 shows FTT-NDHM BRFail as a function of WMT performance. 
Chi-square and Fisher’s exact tests were statistically significant across FTT-NDHM cutoffs, 
suggesting that FTT-NDHM BRFail were related to WMT classification. Those who passed the 
WMT consistently demonstrated lower BRFail than those who failed the WMT across FTT-




Cumulative Percentages of Male Participants Failing Various Finger Tapping Test Non-dominant Hand Cutoffs in 




Overall Samplea  WMT   
f %  Passb Failc χ2 LR 
        
≤18.4 11 2.0  0.5 5.7 FET* 0.09 
≤27.0 28 5.0  3.1 9.4 9.57* 0.33 
≤35.2 54 9.9  6.2 18.9 20.19* 0.33 
≤38.4 82 15.0  10.9 25.2 17.96* 0.43 
≤41.6 140 25.7  18.9 42.1 31.83* 0.45 
       
Min 5.0  15.0 5.0   
Max 68.0  68.0 61.0   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); NDHM = average number of taps achieved with the non-dominant 
hand (males only); WMT = Word Memory Test (Green, 2003); Pass = participants passing the WMT at standard 
cutoffs; Fail = participants failing the WMT at standard cutoffs; LR = likelihood ratio; FET = Fisher’s exact test; 
Min = minimum FTT-NDHM score in the respective group; Max = maximum FTT-NDHM score in the respective 
group. 
an = 545. bn = 386. cn = 159. 
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Tables 119 and 120 characterize FTT-NDHM BRFail as a function of diagnosis in the 
overall and valid samples, respectively. Chi-square and Fisher’s exact tests were not conducted 





Cumulative Percentages of Male Participants Failing Various Finger Tapping Test Non-dominant Hand Cutoffs in 




Overall Samplea  TBI  Diagnostic Groups   
f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≤18.4 11 2.0  2.4 2.0  3.4 4.2 0.0 0.0 0.0 0.0 0.0 - - 
≤27.0 28 5.0  3.6 8.1  6.8 8.3 0.0 0.0 0.0 20.0 1.4 - - 
≤35.2 54 9.9  8.0 15.2  11.9 12.5 12.5 0.0 0.0 26.7 5.7 - - 
≤38.4 82 15.0  12.0 22.2  16.9 25.0 12.5 0.0 22.2 33.3 8.6 - - 
≤41.6 140 25.7  22.5 29.3  32.2 33.0 25.0 0.0 44.4 46.7 21.4 - - 
               
Min 5.0  5.0 17.8  13 16.2 34.4 41.8 36.0 19.2 18.8   
Max 68.0  67.4 60.6  60.2 63.2 59.4 62.4 53.8 64.6 68.0   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); NDHM = average number of taps achieved with the non-dominant 
hand (males only); TBI = traumatic brain injury, Mild = mTBI; M-S = moderate/severe TBI; NEU = neurological; 
DEP = depression; ANX = anxiety; SMI = severe mental illness (psychosis/Bipolar Disorder); CP/F = chronic pain 
and fibromyalgia; ORT = orthopedic; OTH = other; FET = Fisher’s exact test; Min = minimum FTT-NDHM score in 
the respective group; Max = maximum FTT-NDHM score in the respective group. 
an = 545. bn = 249. cn = 99. dn = 59. en = 24. fn = 8. gn = 12. hn = 9. in = 15. jn = 70. 
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Table 120 
 
Cumulative Percentages of Male Participants Failing Various Finger Tapping Test Non-dominant Hand Cutoffs in 




Valid Samplea  TBI  Diagnostic Groups   
f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≤18.4 2 0.5  0.0 0.0  2.2 6.3 0.0 0.0 0.0 0.0 0.0 - - 
≤27.0 12 3.1  0.6 5.4  4.4 12.5 0.0 0.0 0.0 23.1 0.0 - - 
≤35.2 24 6.2  3.1 8.1  8.9 18.8 14.3 0.0 0.0 30.8 1.8 - - 
≤38.4 42 10.9  5.0 16.2  11.1 37.5 14.3 0.0 40.0 38.5 5.5 - - 
≤41.6 73 18.9  11.8 24.3  24.4 37.5 28.6 0.0 40.0 46.5 16.4 - - 
               
Min 15.0  23.0 19.3  15.0 16.2 34.4 41.8 36.0 19.2 34.2   
Max 68.0  67.4 60.6  60.2 63.2 59.4 62.4 53.8 64.6 68.0   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); NDHM = average number of taps achieved with the non-dominant 
hand (males only); TBI = traumatic brain injury, Mild = mTBI; M-S = moderate/severe TBI; NEU = neurological; 
DEP = depression; ANX = anxiety; SMI = severe mental illness (psychosis/Bipolar Disorder); CP/F = chronic pain 
and fibromyalgia; ORT = orthopedic; OTH = other; FET = Fisher’s exact test; Min = minimum FTT-NDHM score in 
the respective group; Max = maximum FTT-NDHM score in the respective group. 
an = 386. bn = 161. cn = 74. dn = 45. en = 16. fn = 7. gn = 10. hn = 5. in = 13. jn = 55. 
*p < .05.  
 
 
 Tables 121 and 122 characterize FTT-NDHM BRFail as a function of age in the overall 
and valid samples, respectively. Chi-square and Fisher’s exact tests were statistically significant 
at nearly all FTT-NDHM cutoffs in either sample. Age accounted for 3.1% (small to medium 
effect) to 6.4% (medium effect) of the variance in FTT-NDHM BRFail across cutoffs in the 
overall sample, and for 2.1% (small effect) to 6.9% (medium effect) of the variance in FTT-
NDHM BRFail across cutoffs in the valid sample. Visual inspection revealed that BRFail tended to 
increase with older age in both samples. The youngest age group (16-29 years) demonstrated 
slightly higher BRFail at some of the cutoffs than would be expected based on the trend. Notably, 
the oldest group (60-69 years) was small in size in the valid sample (n = 18). 
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Table 121 
 
Cumulative Percentages of Male Participants Failing Various Finger Tapping Test Non-dominant Hand Cutoffs in 
the Overall Sample and across Several Age Groups 
 
 Overall Samplea  Age (years)  
FTT-NDHM f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≤18.4 11 2.0  0.0 1.6 1.3 5.0 3.3 - - 
≤27.0 28 5.0  1.9 2.4 3.8 9.2 16.7 17.55* .032 
≤35.2 54 9.9  7.5 4.0 10.0 13.3 26.7 16.85* .031 
≤38.4 82 15.0  9.4 6.3 16.3 22.5 33.3 23.44* .043 
≤41.6 140 25.7  17.6 15.9 23.1 37.5 56.7 34.29* .064 
          
Min 5.0  19.3 12.8 13.0 5.0 17.8   
Max 68.0  63.2 67.4 64.8 68.0 52.6   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); NDHM = average number of taps achieved with the non-dominant 
hand (males only); Min = minimum FTT-NDHM score in the respective group; Max = maximum FTT-NDHM score 
in the respective group. 
an = 545. bn = 106. cn = 126. dn = 160. en = 120. fn = 30. 




Cumulative Percentages of Male Participants Failing Various Finger Tapping Test Non-dominant Hand Cutoffs in 
the Valid Sample and across Several Age Groups 
 
 Valid Samplea  Age (years)  
FTT-NDHM f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≤18.4 2 0.5  0.0 0.0 0.0 2.4 0.0 - - 
≤27.0 12 3.1  2.5 1.1 1.8 6.1 11.1 FET .021 
≤35.2 24 6.2  2.5 1.1 7.2 9.8 22.2 14.32* .037 
≤38.4 42 10.9  4.9 3.3 12.6 19.5 27.8 20.31* .053 
≤41.6 73 18.9  12.3 7.6 18.9 31.7 44.4 26.52* .069 
          
Min 15.0  19.3 20.6 19.2 15.0 25.6   
Max 68.0  63.2 67.4 64.8 68.0 51.2   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); NDHM = average number of taps achieved with the non-dominant 
hand (males only); FET = Fisher’s exact test; Min = minimum FTT-NDHM score in the respective group; Max = 
maximum FTT-NDHM score in the respective group. 
an = 386. bn = 81. cn = 92. dn = 111. en = 82. fn = 18. 
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Tables 123 and 124 characterize FTT-NDHM BRFail as a function of education level in 
the overall and valid samples, respectively. In the overall sample, education level accounted for 
1.6% (small effect) to 4.9% (small to medium effect) of the variance in FTT-NDHM BRFail 
across cutoffs, and Fisher’s exact tests reached statistical significance at FTT-NDHM ≤38.4 and 
≤41.6. The group with the least education (≤8 years) tended to have the highest BRFail, and BRFail 
generally decreased with higher levels of education. The most educated group (≥17 years) did, 
however, exhibit considerably higher BRFail than would be expected based on the trends at a 
number of FTT-NDHM cutoffs. 
In the valid sample, sample sizes were quite small at many of the cutoffs examined. 
Nonetheless, a pattern similar to that of the overall sample was observed at more liberal cutoffs. 
Chi-square and Fisher’s exact tests reached statistical significance at FTT-NDHM ≤38.4 (p = 
.027, Fisher’s exact test) and ≤41.6, χ2 (5, N = 386) = 17.24, p = .004. Education accounted for 




Cumulative Percentages of Male Participants Failing Finger Tapping Test Non-dominant Hand Cutoffs in the 




Overall Samplea  Education (years)  
f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≤18.4 11 2.0  8.1 0.0 1.7 2.2 4.5 3.4 - - 
≤27.0 28 5.0  10.8 1.8 6.8 3.3 6.8 6.9 FET .016 
≤35.2 54 9.9  18.9 9.6 11.3 5.4 6.8 10.3 FET .012 
≤38.4 82 15.0  27.0 18.1 14.1 6.5 6.8 24.1 FET* .025 
≤41.6 140 25.7  48.6 33.1 19.8 18.5 11.4 34.5 FET* .049 
           
Min 5.0  5.0 22.2 12.8 15.0 13.0 16.2   
Max 68.0  58.4 67.4 64.6 63.2 68.0 64.0   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); NDHM = average number of taps achieved with the non-dominant 
hand (males only); FET = Fisher’s exact test; Min = minimum FTT-NDHM score in the respective group; Max = 
maximum FTT-NDHM score in the respective group. 
an = 545. bn = 37. cn = 166. dn = 177. en = 92. fn = 44. gn = 29. 
*p < .05. 
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Table 124 
 
Cumulative Percentages of Male Participants Failing Finger Tapping Test Non-dominant Hand Cutoffs in the Valid 




Valid Samplea  Education (years)  
f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≤18.4 2 0.5  0.0 0.0 0.0 1.4 0.0 4.5 - - 
≤27.0 12 3.1  0.0 1.0 5.0 2.9 0.0 9.1 - - 
≤35.2 24 6.2  17.6 4.9 8.6 2.9 0.0 9.1 - - 
≤38.4 42 10.9  23.5 12.6 11.5 4.3 2.9 22.7 FET* .031 
≤41.6 73 18.9  29.4 26.2 16.5 12.9 2.9 36.4 17.24* .045 
           
Min 15.0  33.2 26.2 19.2 15.0 38.0 16.2   
Max 68.0  55.2 67.4 64.6 63.2 68.0 64.0   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); NDHM = average number of taps achieved with the non-dominant 
hand (males only); FET = Fisher’s exact test; Min = minimum FTT-NDHM score in the respective group; Max = 
maximum FTT-NDHM score in the respective group. 
an = 386. bn = 17. cn = 103. dn = 139. en = 70. fn = 35. gn = 22. 
*p < .05. 
 
 
 Tables 125 and 126 characterize FTT-NDHM BRFail as a function of English language 
status in the overall and valid samples, respectively. In both samples, NSEs demonstrated lower 
BRFail than ESL patients across most FTT-NDHM cutoffs. All of the chi-square and Fisher’s 
exact tests were statistically significant in the overall sample (LR = 0.27 – 0.65), although they 
did not reach statistical significance in the valid sample, likely due to the small sample sizes 
across cutoffs (LR = 0.40 – 0.74). 
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Table 125 
 
Cumulative Percentages of Male Participants Failing Various Finger Tapping Test Non-dominant Hand Cutoffs in 




Overall Samplea  English   
f %  NSEb ESLc χ2 LR 
        
≤18.4 11 2.0  1.5 5.5 FET* 0.27 
≤27.0 28 5.0  4.1 11.0 FET* 0.37 
≤35.2 54 9.9  8.9 16.4 4.07* 0.54 
≤38.4 82 15.0  13.8 23.3 4.40* 0.59 
≤41.6 140 25.7  24.0 37.0 5.59* 0.65 
       
Min 5.0  13.0 5.0   
Max 68.0  68.0 60.8   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); NDHM = Average number of taps achieved with the non-dominant 
hand (males only); NSE = native speakers of English; ESL = English as a second language; LR = likelihood ratio; 
FET = Fisher’s exact test; Min = minimum FTT-NDHM score in the respective group; Max = maximum FTT-NDHM 
score in the respective group. 
an = 545. bn = 463. cn = 73. 





Cumulative Percentages of Male Participants Failing Various Finger Tapping Test Non-dominant Hand Cutoffs in 




Valid Samplea  English   
f %  NSEb ESLc χ2 LR 
        
≤18.4 2 0.5  0.6 0.0 - - 
≤27.0 12 3.1  2.7 6.8 FET 0.40 
≤35.2 24 6.2  5.6 11.4 FET 0.49 
≤38.4 42 10.9  10.1 18.2 FET 0.55 
≤41.6 73 18.9  18.4 25.0 1.10 0.74 
       
Min 15.0  15.0 19.6   
Max 68.0  68.0 60.8   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); NDHM = Average number of taps achieved with the non-dominant 
hand (males only); NSE = native speakers of English; ESL = English as a second language; LR = likelihood ratio; 
FET = Fisher’s exact test; Min = minimum FTT-NDHM score in the respective group; Max = maximum FTT-NDHM 
score in the respective group. 
an = 386. bn = 337. cn = 44. 
*p < .05. 
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FTT-CM. Table 127 shows FTT-CM BRFail as a function of WMT performance. Chi-
square and Fisher’s exact tests were statistically significant at all FTT-CM cutoffs, suggesting a 
relationship between FTT-CM performance and WMT classification. Those who passed the 
WMT consistently demonstrated lower FTT-CM BRFail than those who failed the WMT. 




Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Combined Cutoffs in the 
Overall Sample and as a Function of Word Memory Test Performance 
 
 Overall Samplea  WMT   
FTT-CM f %  Passb Failc χ2 LR 
        
≤39.4 11 2.0  0.8 5.0 FET* 0.16 
≤54.8 27 5.0  3.1 9.4 9.75* 0.33 
≤72.5 55 10.1  6.0 20.1 24.91* 0.30 
≤79.6 82 15.0  9.1 29.6 37.00* 0.31 
≤87.4 136 25.0  16.8 44.7 46.52* 0.38 
       
Min 9.4  33.6 9.4   
Max 134.4  134.4 121.8   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); CM = sum of the average number of taps achieved with the 
dominant and non-dominant hands (males only); WMT = Word Memory Test (Green, 2003); Pass = participants 
passing the WMT at standard cutoffs; Fail = participants failing the WMT at standard cutoffs; LR = likelihood ratio; 
FET = Fisher’s exact test; Min = minimum FTT-CM score in the respective group; Max = maximum FTT-CM score 
in the respective group. 
an = 545. bn = 386. cn = 159. 
*p < .05. 
 
Tables 128 and 129 characterize FTT-CM BRFail as a function of diagnosis in the overall 
and valid samples, respectively. In the overall sample, a Fisher’s exact test conducted at FTT-
CM ≤87.4 did not reach statistical significance; diagnosis only accounted for 1.9% of the 
variance in BRFail at this cutoff (small effect). In the valid sample, no chi-square tests or Fisher’s 
exact tests were conducted. Due to the small sizes of several clinical groups, no comments are 
made about trends in BRFail. 
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Table 128 
 
Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Combined Cutoffs in the 
Overall Sample and in Specific Clinical Groups 
 
 Overall Samplea  TBI  Diagnostic Groups   
FTT-CM f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≤39.4 11 2.0  2.4 2.0  1.7 4.2 0.0 0.0 0.0 0.0 1.4 - - 
≤54.8 27 5.0  4.0 8.1  5.1 8.3 0.0 0.0 0.0 20.0 1.4 - - 
≤72.5 55 10.1  8.4 15.2  11.9 12.5 0.0 0.0 22.2 26.7 4.3 - - 
≤79.6 82 15.0  11.6 21.2  20.3 20.8 0.0 0.0 33.3 26.7 11.4 - - 
≤87.4 136 25.0  22.1 27.3  28.8 33.3 25.0 8.3 44.4 46.7 21.4 FET .019 
               
Min 9.4  9. 4 35.6  39.4 33.6 83.8 86.0 68.2 51.4 37.0   
Max 134.4  133.2 125.6  121.0 134.4 126.6 117.2 110.0 128.1 129.0   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); CM = sum of average number of taps achieved with the dominant 
and non-dominant hands (males only); TBI = traumatic brain injury, Mild = mTBI; M-S = moderate/severe TBI; 
NEU = neurological; DEP = depression; ANX = anxiety; SMI = severe mental illness (psychosis/Bipolar Disorder); 
CP/F = chronic pain and fibromyalgia; ORT = orthopedic; OTH = other; FET = Fisher’s exact test; Min = minimum 
FTT-CM score in the respective group; Max = maximum FTT-CM score in the respective group. 
an = 545. bn = 249. cn = 99. dn = 59. en = 24. fn = 8. gn = 12. hn = 9. in = 15. jn = 70. 





Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Combined Cutoffs in the Valid 
Sample and in Specific Clinical Groups 
 
 Valid Samplea  TBI  Diagnostic Groups   
FTT-CM f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≤39.4 3 0.8  0.0 1.4  2.2 6.3 0.0 0.0 0.0 0.0 0.0 - - 
≤54.8 12 3.1  1.2 5.4  2.2 12.5 0.0 0.0 0.0 23.1 0.0 - - 
≤72.5 23 6.0  1.9 9.5  8.9 18.8 0.0 0.0 20.0 30.8 1.8 - - 
≤79.6 35 9.1  2.5 14.9  15.6 25.0 0.0 0.0 40.0 30.8 5.5 - - 
≤87.4 65 16.8  8.7 21.6  24.4 31.3 14.3 0.0 40.0 46.2 18.2 - - 
               
Min 33.6  47.8 37.6  39.4 33.6 83.8 89.7 68.2 51.4 71.4   
Max 134.4  133.2 125.6  121.0 134.4 126.6 117.2 110.0 128.1 129.0   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); CM = sum of average number of taps achieved with the dominant 
and non-dominant hands (males only); TBI = traumatic brain injury, Mild = mTBI; M-S = moderate/severe TBI; 
NEU = neurological; DEP = depression; ANX = anxiety; SMI = severe mental illness (psychosis/Bipolar Disorder); 
CP/F = chronic pain and fibromyalgia; ORT = orthopedic; OTH = other; Min = minimum FTT-CM score in the 
respective group; Max = maximum FTT-CM score in the respective group. 
an = 386. bn = 161. cn = 74. dn = 45. en = 16. fn = 7. gn = 10. hn = 5. in = 13. jn = 55. 
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Tables 130 and 131 characterize FTT-CM BRFail as a function of age in the overall and 
valid samples, respectively. In both samples, chi-square and Fisher’s exact tests were statistically 
significant at some cutoffs and non-significant at others. Age accounted for 1.2% (small effect) 
to 5.9% (medium effect) of the variance in FTT-CM BRFail across cutoffs in the overall sample, 
and for 2.1% (small effect) to 6.1% (medium effect) of the variance in FTT-CM BRFail across 
cutoffs in the valid sample. Although sample sizes were small in the oldest group (60-69 years; n 
= 30 in the overall sample, n = 18 in the valid sample) and at more conservative cutoffs in both 
samples, at more liberal cutoffs, the youngest group (16-29 years) tended to have the lowest 




Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Combined Cutoffs in the 
Overall Sample and across Several Age Groups 
 
 Overall Samplea  Age (years)  
FTT-CM f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≤39.4 11 2.0  0.9 2.4 0.6 3.3 6.7 FET .012 
≤54.8 27 5.0  1.9 2.4 3.1 9.2 20.0 23.85* .044 
≤72.5 55 10.1  6.6 6.3 10.0 14.2 20.0 8.90 .016 
≤79.6 82 15.0  9.4 9.5 14.4 20.0 40.0 22.72* .042 
≤87.4 136 25.0  16.0 15.1 26.3 33.3 56.7 31.85* .059 
          
Min 9.4  37.6 26.2 27.6 9.4 35.6   
Max 134.4  127.4 128.8 133.2 134.4 107.4   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); CM = sum of average number of taps achieved with the dominant 
and non-dominant hands (males only); FET = Fisher’s exact test; Min = minimum FTT-CM score in the respective 
group; Max = maximum FTT-CM score in the respective group. 
an = 545. bn = 106. cn = 126. dn = 160. en = 120. fn = 30. 
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Table 131 
 
Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Combined Cutoffs in the Valid 
Sample and across Several Age Groups 
 
 Valid Samplea  Age (years)  
FTT-CM f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≤39.4 3 0.8  1.2 1.1 0.0 1.2 0.0 - - 
≤54.8 12 3.1  2.5 1.1 1.8 6.1 11.1 FET .021 
≤72.5 23 6.0  2.5 3.3 6.3 11.0 11.1 FET .020 
≤79.6 35 9.1  3.7 5.4 10.8 12.2 27.8 13.26* .035 
≤87.4 65 16.8  6.2 8.7 21.6 25.6 38.9 23.41* .061 
          
Min 33.6  37.6 39.4 51.4 33.6 54.8   
Max 134.4  127.4 128.8 133.2 134.4 107.4   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); CM = sum of average number of taps achieved with the dominant 
and non-dominant hands (males only); FET = Fisher’s exact test; Min = minimum FTT-CM score in the respective 
group; Max = maximum FTT-CM score in the respective group. 
an = 386. bn = 81. cn = 92. dn = 111. en = 82. fn = 18. 
*p < .05. 
 
 
Tables 132 and 133 characterize FTT-CM BRFail as a function of education level in the 
overall and valid samples, respectively. In the overall sample, Fisher’s exact tests were 
statistically significant at FTT-CM ≤54.8 and ≤87.4, and education level accounted for only 1.1% 
to 2.8% of the variance in FTT-CM BRFail across cutoffs (small effects). In the valid sample, a 
chi-square test was statistically significant at FTT-CM ≤87.4, and education accounted for 3.4% 
of the variance at this cutoff (small to medium effect). With regard to trends in BRFail, there 
appeared to be a negative relationship between BRFail and education level at more liberal FTT-CM 
cutoffs, but the most educated group (≥17 years) exhibited considerably larger BRFail than would 
be expected based on the trend. Notably, the least and most educated groups were small in size, 
and sample size was also quite small at several of the more conservative cutoffs. 
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Table 132 
 
Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Combined Cutoffs in the 
Overall Sample and across Several Education Levels 
 
 Overall Samplea  Education (years)  
FTT-CM f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≤39.4 11 2.0  5.4 0.0 2.8 2.2 2.3 3.4 - - 
≤54.8 27 5.0  8.1 1.8 7.3 2.2 6.8 10.3 FET* .018 
≤72.5 55 10.1  13.5 9.0 12.4 5.4 6.8 17.2 FET .011 
≤79.6 82 15.0  21.6 17.5 14.1 9.8 6.8 27.6 FET .018 
≤87.4 136 25.0  37.8 30.1 19.8 22.8 11.4 37.9 FET* .028 
           
Min 9.4  9.4 42.2 26.2 36.8 35.6 33.6   
Max 134.4  121.2 128.8 134.4 126.4 129.0 133.2   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); CM = sum of average number of taps achieved with the dominant 
and non-dominant hands (males only); FET = Fisher’s exact test; Min = minimum FTT-CM score in the respective 
group; Max = maximum FTT-CM score in the respective group. 
an = 545. bn = 37. cn = 166. dn = 177. en = 92. fn = 44. gn = 29. 





Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Combined Cutoffs in the Valid 
Sample and across Several Education Levels 
 
 Valid Samplea  Education (years)  
FTT-CM f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≤39.4 3 0.8  0.0 0.0 0.7 1.4 0.0 4.5 - - 
≤54.8 12 3.1  0.0 1.0 5.8 1.4 0.0 9.1 - - 
≤72.5 23 6.0  5.9 3.9 9.4 2.9 0.0 13.6 - - 
≤79.6 35 9.1  11.8 9.7 10.8 2.9 0.0 27.3 - - 
≤87.4 65 16.8  23.5 20.4 15.8 12.9 2.9 36.4 13.24* .034 
           
Min 33.6  68.6 54.2 37.6 39.4 81.1 33.6   
Max 134.4  111.6 128.8 134.4 126.4 129.0 133.2   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); CM = sum of average number of taps achieved with the dominant 
and non-dominant hands (males only); Min = minimum FTT-CM score in the respective group; Max = maximum 
FTT-CM score in the respective group. 
an = 386. bn = 17. cn = 103. dn = 139. en = 70. fn = 35. gn = 22. 
*p < .05. 
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 Tables 134 and 135 characterize FTT-CM BRFail as a function of English language status 
in the overall and valid samples, respectively. Native speakers of English consistently 
demonstrated lower BRFail than ESL patients across FTT-CM cutoffs in both samples. In the 
overall sample, chi-square and Fisher’s exact tests were statistically significant at multiple FTT-
CM scores; likelihood ratios ranged from 0.19 to 0.69. Although chi-square tests and Fisher’s 
exact tests did not reach statistical significance in the valid sample (likely due to the small 
sample sizes across cutoffs), a similar pattern was observed, with NSEs demonstrating lower 




Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Combined Cutoffs in the 
Overall Sample and as a Function of English Language Status 
 
 Overall Samplea  English   
FTT-CM f %  NSEb ESLc χ2 LR 
        
≤39.4 11 2.0  1.3 6.8 FET* 0.19 
≤54.8 27 5.0  3.9 12.3 FET* 0.26 
≤72.5 55 10.1  9.3 15.1 2.33 0.62 
≤79.6 82 15.0  13.6 23.3 4.65* 0.58 
≤87.4 136 25.0  23.5 34.2 3.85 0.69 
       
Min 9.4  27.6 9.4   
Max 134.4  134.4 129.0   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); CM = sum of the average number of taps achieved with the 
dominant and non-dominant hands (males only); NSE = native speakers of English; ESL = English as a second 
language; LR = likelihood ratio; FET = Fisher’s exact test; Min = minimum FTT-CM score in the respective group; 
Max = maximum FTT-CM score in the respective group. 
an = 545. bn = 463. cn = 73. 
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Table 135 
 
Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Combined Cutoffs in the Valid 
Sample and as a Function of English Language Status 
 
 Valid Samplea  English   
FTT-CM f %  NSEb ESLc χ2 LR 
        
≤39.4 3 0.8  0.6 2.3 FET 0.26 
≤54.8 12 3.1  2.7 6.8 FET 0.40 
≤72.5 23 6.0  5.6 6.8 FET 0.82 
≤79.6 35 9.1  8.3 13.6 FET 0.61 
≤87.4 65 16.8  16.6 18.2 0.07 0.91 
       
Min 33.6  33.6 37.6   
Max 134.4  134.4 129.0   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); CM = sum of the average number of taps achieved with the 
dominant and non-dominant hands (males only); NSE = native speakers of English; ESL = English as a second 
language; LR = likelihood ratio; FET = Fisher’s exact test; Min = minimum FTT-CM score in the respective group; 
Max = maximum FTT-CM score in the respective group. 
an = 386. bn = 337. cn = 44. 
*p < .05. 
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FTT-DIFFM. Table 136 shows FTT-DIFFM BRFail, at various cutoffs, as a function of 
WMT performance. Participants who passed the WMT demonstrated somewhat lower BRFail 
than those who failed the WMT across FTT-DIFFM cutoffs. However, chi-square and Fisher’s 
exact tests largely failed to reach statistical significance, likely due to the small sample sizes 




Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Difference Cutoffs in the 




Overall Samplea  WMT   
f %  Passb Failc χ2 LR 
        
≤-12.2 11 2.0  1.3 3.8 FET 0.34 
≤-6.6 27 5.0  3.9 7.5 3.21 0.52 
≤-3.2 55 10.1  8.5 13.8 3.47 0.62 
≤-1.3 81 14.9  13.2 18.9 2.85 0.70 
≤.50 136 25.0  19.7 37.7 19.59* 0.52 
       
Min -27.8  -27.8 -24.2   
Max 32.4  32.4 25.4   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DIFFM = difference between the average number of taps achieved 
with the dominant and non-dominant hands (males only); WMT = Word Memory Test (Green, 2003); Pass = 
participants passing the WMT at standard cutoffs; Fail = participants failing the WMT at standard cutoffs; LR = 
likelihood ratio; FET = Fisher’s exact test; Min = minimum FTT-DIFFM score in the respective group; Max = 
maximum FTT-DIFFM score in the respective group. 
an = 545. bn = 386. cn = 159. 
*p < .05. 
 
Tables 137 and 138 characterize FTT-DIFFM BRFail as a function of diagnosis in the 
overall and valid samples, respectively. In both samples, Fisher’s exact tests failed to reach 
statistical significance at FTT-DIFFM ≤.50. Diagnosis accounted for 1.1% of the variance in 
BRFail at this cutoff in the overall sample, and 2.3% of the variance in BRFail at this cutoff in the 
valid sample (small effects). Trends in BRFail at lower cutoffs were not interpreted due to the 
small sizes of multiple clinical groups. 
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Table 137 
 
Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Difference Cutoffs in the 




Overall Samplea  TBI  Diagnostic Groups   
f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≤-12.2 11 2.0  1.2 2.0  5.1 4.2 0.0 0.0 0.0 0.0 2.9 - - 
≤-6.6 27 5.0  3.2 4.0  6.8 8.3 0.0 25.0 11.1 0.0 7.1 - - 
≤-3.2 55 10.1  7.2 8.1  16.9 12.5 0.0 25.0 22.2 0.0 15.7 - - 
≤-1.3 81 14.9  11.2 13.1  22.0 16.7 0.0 33.3 22.2 0.0 24.3 - - 
≤.50 136 25.0  22.9 24.2  30.5 37.5 12.5 33.3 22.2 13.3 27.1 FET .011 
               
Min -27.8  -21.5 -25.2  -27.8 -15.4 -0.8 -8.4 -9.2 -1.1 -23.0   
Max 32.4  19.6 25.4  32.4 12.4 17.0 10.2 8.4 13.0 13.2   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DIFFM = difference between the average number of taps achieved 
with the dominant and non-dominant hands (males only); TBI = traumatic brain injury, Mild = mTBI; M-S = 
moderate/severe TBI; NEU = neurological; DEP = depression; ANX = anxiety; SMI = severe mental illness 
(psychosis/Bipolar Disorder); CP/F = chronic pain and fibromyalgia; ORT = orthopedic; OTH = other; FET = 
Fisher’s exact test; Min = minimum FTT-DIFFM score in the respective group; Max = maximum FTT-DIFFM score 
in the respective group. 
an = 545. bn = 249. cn = 99. dn = 59. en = 24. fn = 8. gn = 12. hn = 9. in = 15. jn = 70. 





Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Difference Cutoffs in the Valid 




Valid Samplea  TBI  Diagnostic Groups   
f %  Mildb M-Sc  NEUd DEPe ANXf SMIg CP/Fh ORTi OTHj χ2 Φ2 
                
≤-12.2 5 1.3  0.0 1.4  4.4 6.3 0.0 0.0 0.0 0.0 1.8 - - 
≤-6.6 15 3.9  1.2 2.7  6.7 12.5 0.0 20.0 0.0 0.0 7.3 - - 
≤-3.2 33 8.5  5.6 5.4  15.6 12.5 0.0 20.0 20.0 0.0 14.5 - - 
≤-1.3 51 13.2  8.7 10.8  22.2 12.5 0.0 30.0 20.0 0.0 23.6 - - 
≤.50 76 19.7  16.1 16.2  31.1 25.0 14.3 30.0 20.0 7.7 25.5 FET .023 
               
Min -27.8  -9.4 -25.2  -27.8 -15.4 -0.8 -7.6 -3.8 -1.1 -23.0   
Max 32.4  19.6 17.2  32.4 12.4 17.0 10.2 8.4 13.0 11.6   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DIFFM = difference between the average number of taps achieved 
with the dominant and non-dominant hands (males only); TBI = traumatic brain injury, Mild = mTBI; M-S = 
moderate/severe TBI; NEU = neurological; DEP = depression; ANX = anxiety; SMI = severe mental illness 
(psychosis/Bipolar Disorder); CP/F = chronic pain and fibromyalgia; ORT = orthopedic; OTH = other; FET = 
Fisher’s exact test; Min = minimum FTT-DIFFM score in the respective group; Max = maximum FTT-DIFFM score 
in the respective group. 
an = 386. bn = 161. cn = 74. dn = 45. en = 16. fn = 7. gn = 10. hn = 5. in = 13. jn = 55. 
*p < .05. 
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 Tables 139 and 140 characterize FTT-DIFFM BRFail as a function of age in the overall 
and valid samples, respectively. Chi-square tests of independence failed to reach statistical 
significance where conducted in both samples. Age accounted for 0.5% to 1.3% of the variance 
in FTT-DIFFM BRFail in the overall sample (small effects), and for 0.9% to 2.3% of the variance 
in FTT-DIFFM BRFail in the valid sample (small effects). Visual inspection of cumulative 
percentages did not reveal any consistent trends, although sample sizes were small at most 




Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Difference Cutoffs in the 




Overall Samplea  Age (years)  
f 545  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≤-12.2 11 2.0  0.0 0.8 3.8 2.5 3.3 - - 
≤-6.6 27 5.0  2.8 5.6 6.9 4.2 3.3 2.68 .005 
≤-3.2 55 10.1  5.7 9.5 11.3 11.7 16.7 4.31 .008 
≤-1.3 81 14.9  12.3 14.3 13.8 19.2 16.7 2.58 .005 
≤.50 136 25.0  19.8 27.0 21.3 30.0 36.7 6.75 .013 
          
Min -27.8  -7.8 -25.2 -27.8 -21.2 -24.2   
Max 32.4  17.4 18.8 25.4 32.4 18.4   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DIFFM = difference between the average number of taps achieved 
with the dominant and non-dominant hands (males only); Min = minimum FTT-DIFFM score in the respective 
group; Max = maximum FTT-DIFFM score in the respective group. 
an = 545. bn = 106. cn = 126. dn = 160. en = 120. fn = 30. 





BASE RATES OF PVT FAILURE  168
Table 140 
 
Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Difference Cutoffs in the Valid 




Valid Samplea  Age (years)  
f %  16-29b 30-39c 40-49d 50-59e 60-69f χ2 Φ2 
           
≤-12.2 5 1.3  0.0 1.1 3.6 0.0 0.0 - - 
≤-6.6 15 3.9  0.0 5.4 7.2 2.4 0.0 - - 
≤-3.2 33 8.5  3.7 9.8 9.9 11.0 5.6 3.68 .010 
≤-1.3 51 13.2  9.9 14.1 12.6 18.3 5.6 3.64 .009 
≤.50 76 19.7  12.3 23.9 17.1 28.0 11.1 8.69 .023 
          
Min -27.8  -4.4 -25.2 -27.8 -10.8 -3.8   
Max 32.4  17.4 18.8 19.6 32.4 18.4   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DIFFM = difference between the average number of taps achieved 
with the dominant and non-dominant hands (males only); Min = minimum FTT-DIFFM score in the respective 
group; Max = maximum FTT-DIFFM score in the respective group. 
an = 386. bn = 81. cn = 92. dn = 111. en = 82. fn = 18. 
*p < .05.  
  
 
Tables 141 and 142 characterize FTT-DIFFM BRFail as a function of education level in the 
overall and valid samples, respectively. Chi-square and Fisher’s exact tests did not reach 
statistical significance at any FTT-DIFFM cutoffs in either sample, suggesting that FTT-DIFFM 
BRFail did not vary across education levels. Effect sizes indicated that education accounted for 
0.2% to 1.1% of the variance in FTT-DIFFM BRFail in the overall sample (small effects), and 
0.4% to 1.3% of the variance in FTT-DIFFM BRFail in the valid sample (small effects). Visual 
inspection of BRFail did not reveal any consistent trends in either sample, although sample sizes 
were small at most cutoffs. 
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Table 141 
 
Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Difference Cutoffs in the 




Overall Samplea  Education (years)  
f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≤-12.2 11 2.0  2.7 2.4 1.7 1.1 2.3 3.4 FET .002 
≤-6.6 27 5.0  2.7 6.0 3.4 6.5 4.5 6.9 FET .004 
≤-3.2 55 10.1  5.4 13.3 8.5 8.7 9.1 13.8 FET .007 
≤-1.3 81 14.9  8.1 18.7 11.9 16.3 11.4 20.7 FET .011 
≤.50 136 25.0  18.9 30.1 22.0 21.7 22.7 34.5 FET .011 
           
Min -27.8  -27.8 -25.2 -23.0 -21.2 -12.2 -21.5   
Max 32.4  25.4 16.6 17.4 32.4 19.4 13.2   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DIFFM = difference between the average number of taps achieved 
with the dominant and non-dominant hands (males only); FET = Fisher’s exact test; Min = minimum FTT-DIFFM 
score in the respective group; Max = maximum FTT-DIFFM score in the respective group. 
an = 545. bn = 37. cn = 166. dn = 177. en = 92. fn = 44. gn = 29. 






Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Difference Cutoffs in the Valid 




Valid Samplea  Education (years)  
f %  ≤8b 9-11c 12d 13-15e 16f ≥17g χ2 Φ2 
            
≤-12.2 5 1.3  5.9 1.0 2.2 0.0 0.0 0.0 - - 
≤-6.6 15 3.9  5.9 4.9 4.3 2.9 2.9 0.0 - - 
≤-3.2 33 8.5  5.9 10.7 8.6 5.7 8.6 9.1 FET .004 
≤-1.3 51 13.2  5.9 14.6 12.2 15.7 8.6 18.2 FET .007 
≤.50 76 19.7  5.9 22.3 18.0 20.0 17.1 31.8 4.95 .013 
           
Min -27.8  -27.8 -25.2 -23.0 -9.4 -10.8 -4.0   
Max 32.4  21.8 16.6 17.4 32.4 18.8 11.6   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DIFFM = difference between the average number of taps achieved 
with the dominant and non-dominant hands (males only); FET = Fisher’s exact test; Min = minimum FTT-DIFFM 
score in the respective group; Max = maximum FTT-DIFFM score in the respective group. 
an = 386. bn = 17. cn = 103. dn = 139. en = 70. fn = 35. gn = 22. 
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 Tables 143 and 144 characterize FTT-DIFFM BRFail as a function of English language 
status in the overall and valid samples, respectively. Fisher’s exact tests and chi-square tests of 
independence failed to reach statistical significance across cutoffs in either sample. However, 
sample sizes were quite small, particularly at more conservative cutoffs. Likelihood ratios ranged 





Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Difference Cutoffs in the 




Overall Samplea  English   
f %  NSEb ESLc χ2 LR 
        
≤-12.2 11 2.0  1.7 2.7 FET 0.63 
≤-6.6 27 5.0  4.5 6.8 FET 0.66 
≤-3.2 55 10.1  9.9 11.0 0.07 0.90 
≤-1.3 81 14.9  14.0 20.5 2.10 0.68 
≤.50 136 25.0  24.2 30.1 1.19 0.80 
       
Min -27.8  -27.8 -21.5   
Max 32.4  32.4 21.8   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DIFFM = difference between the average number of taps achieved 
with the dominant and non-dominant hands (males only); NSE = native speakers of English; ESL = English as a 
second language; LR = likelihood ratio; FET = Fisher’s exact test; Min = minimum FTT-DIFFM score in the 
respective group; Max = maximum FTT-DIFFM score in the respective group. 
an = 545. bn = 463. cn = 73. 
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Table 144 
 
Cumulative Percentages of Male Participants Failing Various Finger Tapping Test-Difference Cutoffs in the Valid 




Valid Samplea  English   
f %  NSEb ESLc χ2 LR 
        
≤-12.2 5 1.3  1.2 0.0 - - 
≤-6.6 15 3.9  3.9 2.3 FET 1.70 
≤-3.2 33 8.5  8.9 4.5 FET 1.98 
≤-1.3 51 13.2  13.1 13.6 0.01 0.96 
≤.50 76 19.7  19.6 20.5 0.02 0.96 
       
Min -27.8  -27.8 -7.2   
Max 32.4  32.4 21.8   
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DIFFM = difference between the average number of taps achieved 
with the dominant and non-dominant hands (males only); NSE = native speakers of English; ESL = English as a 
second language; LR = likelihood ratio; FET = Fisher’s exact test; Min = minimum FTT-DIFFM score in the 
respective group; Max = maximum FTT-DIFFM score in the respective group. 
an = 386. bn = 337. cn = 44. 
*p < .05. 
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Study 3 
 Classification accuracy statistics are reported below for all PVTs of interest. In all of the 
analyses, the WMT was used as the criterion measure. Although signal detection properties were 
investigated for multiple potential cutoffs on each PVT of interest, data are only presented for 
cutoffs that reached or exceeded the minimum acceptable level of specificity (.84; Larrabee, 
2003). Furthermore, for each cutoff examined on a given PVT, positive and negative predictive 
values are reported at five hypothetical BRFail ranging from 10% to 50%. Given the 30% BRFail 
on the WMT in the overall sample, in the text, PPP and NPP values are interpreted at a 
hypothetical BRFail of 30% for all analyses. Where multiple cutoff scores were investigated on a 
PVT, PPP and NPP are interpreted at the first cutoff that demonstrated at least .90 specificity. As 
in Studies 1 and 2, classification accuracy data are presented for free-standing PVTs first, 
followed by embedded validity indicators. 
 MSVT. Table 145 shows signal detection properties for the MSVT. Standard cutoffs on 
the MSVT (Green, 2004) produced .52 sensitivity and .93 specificity. PPP and NPP values 
indicate that, in a setting with a 30% BRFail, there is a .77 probability that a profile is invalid 
when an examinee fails the MSVT at standard cutoffs, and a .82 probability that a profile is valid 
when the examinee passes the MSVT at standard cutoffs. 
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Table 145 
 
Signal Detection Properties of the Standard Cutoff on the Medical Symptom Validity Test 










MSVT f BRFail  SENS SPEC  10 20 30 40 50 
            
STN 462 21.3  .52 .93 PPP .46 .66 .77 .84 .88 
      NPP .95 .89 .82 .75 .66 
 
Note. MSVT = Medical Symptom Validity Test (Green, 2004); STN = standard cutoffs specified 
in the test manual; BRFail = base rate of failure (percent of the sample that failed the validity 
cutoff); PVT = performance validity test; WMT = Word Memory Test (Green, 2003); SENS = 
sensitivity; SPEC = specificity; Hypothetical BRFail = prevalence of invalid performance in the 
assessment setting (in percent); PPP = positive predictive power; NPP = negative predictive 
power. 
an = 2165 
 
 
 NV-MSVT. Table 146 shows classification accuracy statistics for the NV-MSVT. 
Standard cutoffs on the NV-MSVT (Green, 2008) produced .93 specificity and .45 sensitivity. In 
settings with a 30% BRFail, there is a .72 probability that a profile is invalid when an examinee 
fails the NV-MSVT at standard cutoffs (PPP), and a .80 probability that a profile is valid when 
the examinee passes the NV-MSVT at standard cutoffs (NPP). 
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Table 146 
 
Signal Detection Properties of the Standard Cutoff on the Non-Verbal Medical Symptom Validity 





Overall Samplea  




NV-MSVT f BRFail  SENS SPEC  10 20 30 40 50 
            
STN 308 18.7  .45 .93 PPP .41 .61 .72 .80 .81 
      NPP .94 .87 .80 .72 .72 
 
Note. NV-MSVT = Non-Verbal Medical Symptom Validity Test (Green, 2008); STN = standard 
cutoffs specified in the test manual; BRFail = base rate of failure (percent of the sample that failed 
the validity cutoff); PVT = performance validity test; WMT = Word Memory Test (Green, 
2003); SENS = sensitivity; SPEC = specificity; Hypothetical BRFail = prevalence of invalid 
performance in the assessment setting (in percent); PPP = positive predictive power; NPP = 
negative predictive power. 
an = 1645 
 
 
TOMM Trial 1. Table 147 shows signal detection properties of various cutoffs on 
TOMM Trial 1. Trial 1 cutoffs between ≤33 and ≤44 produced specificity values between .84 
and 1.00. Trial 1 ≤44 achieved .61 sensitivity with .87 specificity. Lowering the cutoff to Trial 1 
≤43 improved specificity (.90) with a negligible loss in sensitivity (.57). Perfect specificity was 
achieved at Trial 1 ≤33, at the expense of sensitivity (.20). 
Although previously published TOMM Trial 1 cutoffs vary widely (i.e., between Trial 1 
≤35 and ≤45), depending on sample characteristics and the criteria used to define invalid 
performance, a cutoff of Trial 1 ≤40 was recommended in a review of Trial 1 findings (Denning, 
2012). In the present sample, Trial 1 ≤40 demonstrated good classification accuracy with .96 
specificity and .42 sensitivity.  
 In a setting with a 30% BRFail, the probability of an invalid profile in an examinee who 
fails Trial 1 ≤43 is .71. The probability of a valid profile in someone who passes Trial 1 ≤43 is 
.83. 
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Table 147 
 
Signal Detection Properties of Various TOMM Trial 1 Cutoffs Achieving Acceptable Specificity 











f BRFail  SENS SPEC  10 20 30 40 50 
            
≤33 125 7.1  .20 1.00 PPP .84 .92 .95 .97 1.00 
      NPP .92 .83 .74 .65 .65 
            
≤34 151 8.6  .24 .99 PPP .78 .89 .93 .95 .94 
      NPP .92 .84 .75 .66 .66 
            
≤35 168 9.6  .27 .99 PPP .78 .89 .93 .95 .95 
      NPP .92 .84 .76 .67 .67 
            
≤36 188 10.7  .29 .99 PPP .70 .84 .90 .93 .95 
      NPP .93 .85 .76 .68 .68 
            
≤37 207 11.8  .32 .98 PPP .68 .83 .89 .93 .91 
      NPP .93 .85 .77 .68 .68 
            
≤38 232 13.2  .35 .98 PPP .64 .80 .87 .91 .92 
      NPP .93 .86 .78 .69 .69 
            
≤39 258 14.7  .38 .97 PPP .58 .75 .84 .89 .89 
      NPP .93 .86 .78 .70 .70 
            
≤40 292 16.6  .42 .96 PPP .55 .74 .83 .88 .88 
      NPP .94 .87 .79 .71 .71 
            
≤41 333 18.9  .46 .95 PPP .49 .68 .79 .85 .86 
      NPP .94 .87 .80 .72 .73 
            
≤42 380 21.6  .51 .93 PPP .45 .65 .76 .83 .83 
      NPP .94 .88 .81 .74 .74 
            
≤43 449 25.5  .57 .90 PPP .39 .59 .71 .79 .79 
      NPP .95 .89 .83 .76 .76 
            
≤44 511 29.1  .61 .87 PPP .34 .54 .67 .76 .76 
      NPP .95 .90 .84 .77 .77 
            
 
Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); BRFail = base rate of failure 
(percent of the sample that failed the validity cutoff); PVT = performance validity test; WMT = 
Word Memory Test (Green, 2003); SENS = sensitivity; SPEC = specificity; Hypothetical BRFail 
= prevalence of invalid performance in the assessment setting (in percent); PPP = positive 
predictive power; NPP = negative predictive power. Boldface font denotes previously published 
cutoffs. 
an = 1759 
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TOMM Trial 2. Table 148 shows signal detection properties for TOMM Trial 2. TOMM 
Trial 2 cutoffs between ≤38 and ≤49 produced specificity values between .84 and 1.00. The 
highest conceivable cutoff (Trial 2 ≤49) achieved .54 sensitivity and .89 specificity. Lowering 
the cutoff to Trial 2 ≤48 improved specificity to .96 but reduced sensitivity to .44. Perfect 
specificity was attained at Trial 2 ≤38, although sensitivity was low (.16). 
With respect to previously identified cutoffs, Trial 2 ≤44, the standard cutoff 
recommended in the TOMM manual (Tombaugh, 1996), was found to be overly conservative 
with .99 specificity and .29 sensitivity. Higher Trial 2 cutoffs were associated with improved 
specificity, while maintaining good specificity. 
In a setting with a 30% BRFail, there is an .83 probability that a failure on Trial 2 ≤48 
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Table 148 
 
Signal Detection Properties of Various TOMM Trial 2 Cutoffs Achieving Acceptable Specificity 











f BRFail  SENS SPEC  10 20 30 40 50 
            
≤38 100 5.7  .16 1.00 PPP .81 .90 .94 .96 1.00 
      NPP .91 .83 .73 .64 .54 
            
≤39 118 6.7  .19 .99 PPP .80 .90 .94 .96 .95 
      NPP .92 .83 .74 .65 .55 
            
≤40 128 7.3  .20 .99 PPP .77 .88 .93 .95 .95 
      NPP .92 .83 .74 .65 .55 
            
≤41 144 8.2  .23 .99 PPP .75 .87 .92 .95 .96 
      NPP .92 .84 .75 .66 .56 
            
≤42 152 8.7  .24 .99 PPP .76 .88 .92 .95 .96 
      NPP .92 .84 .75 .66 .57 
            
≤43 167 9.5  .26 .99 PPP .76 .88 .92 .95 .96 
      NPP .92 .84 .76 .67 .57 
            
≤44 185 10.5  .29 .99 PPP .73 .86 .91 .94 .97 
      NPP .93 .85 .76 .68 .58 
            
≤45 199 11.3  .31 .99 PPP .70 .84 .90 .93 .97 
      NPP .93 .85 .77 .68 .59 
            
≤46 215 12.4  .34 .98 PPP .70 .84 .90 .93 .94 
      NPP .93 .86 .78 .69 .60 
            
≤47 250 14.2  .38 .98 PPP .64 .80 .87 .91 .95 
      NPP .93 .86 .78 .70 .61 
            
≤48 301 17.1  .44 .96 PPP .56 .74 .83 .88 .92 
      NPP .94 .87 .80 .72 .63 
            
≤49 448 25.5  .54 .89 PPP .34 .54 .67 .76 .83 
      NPP .95 .88 .82 .74 .66 
 
Note. TOMM = Test of Memory Malingering (Tombaugh, 1996); BRFail = base rate of failure 
(percent of the sample that failed the validity cutoff); PVT = performance validity test; WMT = 
Word Memory Test (Green, 2003); SENS = sensitivity; SPEC = specificity; Hypothetical BRFail 
= prevalence of invalid performance in the assessment setting (in percent); PPP = positive 
predictive power; NPP = negative predictive power. Boldface font denotes previously published 
cutoffs. 
an = 1759 
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RDS. Table 149 shows signal detection properties for various RDS cutoffs. RDS cutoffs 
between ≤4 and ≤7 produced specificity values between .84 and 1.00. RDS ≤7 achieved .37 
sensitivity and .86 specificity. Lowering the cutoff to RDS ≤6 improved specificity (.96) but 
resulted in a considerable loss in sensitivity (.17). RDS ≤5 resulted in near-perfect specificity 
(.99) and low sensitivity (.07). Perfect specificity was attained at RDS ≤4, although sensitivity 
was very low (.02). In a setting with a 30% BRFail, there is a .66 probability that a fail on RDS ≤6 




Signal Detection Properties of Various Reliable Digit Span Cutoffs Achieving Acceptable 











f BRFail  SENS SPEC  10 20 30 40 50 
            
≤4 12 0.6  .02 1.00 PPP .73 .86 .91 .94 1.00 
      NPP .90 .80 .70 .60 .51 
            
≤5 53 2.6  .07 .99 PPP .52 .71 .81 .87 .88 
      NPP .91 .81 .71 .62 .52 
            
≤6 155 7.7  .17 .96 PPP .34 .54 .66 .75 .81 
      NPP .91 .82 .73 .63 .54 
            
≤7 425 21.2  .37 .86 PPP .22 .39 .53 .63 .73 
      NPP .92 .84 .76 .67 .58 
            
 
Note. RDS = Reliable digit span (Greiffenstein, Baker, & Gola, 1994); BRFail = base rate of 
failure (percent of the sample that failed the validity cutoff); PVT = performance validity test; 
WMT = Word Memory Test (Green, 2003); SENS = sensitivity; SPEC = specificity; 
Hypothetical BRFail = prevalence of invalid performance in the assessment setting (in percent); 
PPP = positive predictive power; NPP = negative predictive power. Boldface font denotes 
previously published cutoffs. 
an = 2003 
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WCST FMS. Table 150 shows signal detection properties for various cutoffs on WCST 
FMS. FMS cutoffs between ≥3 and ≥7 produced specificity values between .84 and 1.00. FMS 
≥3 achieved .29 sensitivity and .86 specificity. Increasing the cutoff to FMS ≥4 improved 
specificity (.94) but produced lower sensitivity (.17). FMS ≥7 achieved perfect specificity with 
nearly zero sensitivity to invalid performance (.01). 
With respect to previously identified cutoffs, FMS ≥3 demonstrated good classification 
accuracy. However, FMS ≥2 (Larrabee, 2003) produced unacceptably low specificity (.73). 
PPP and NPP indicate that, in a setting with a 30% BRFail, there is a .55 probability that a 
failure on FMS ≥4 represents an invalid profile and a .73 probability that a pass on FMS ≥4 
reflects a valid profile. 
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Table 150 
 
Signal Detection Properties of Various Failure to Maintain Set Cutoffs Achieving Acceptable 











f BRFail  SENS SPEC  10 20 30 40 50 
            
≥7 4 0.6  .01 1.00 PPP .22 .39 .52 .63 .72 
      NPP .90 .80 .70 .60 .50 
            
≥6 11 1.7  .02 .98 PPP .14 .27 .38 .49 .50 
      NPP .90 .80 .70 .60 .50 
            
≥5 26 4.1  .08 .98 PPP .28 .46 .60 .70 .80 
      NPP .91 .81 .71 .62 .52 
            
≥4 57 9.0  .17 .94 PPP .24 .41 .55 .65 .74 
      NPP .91 .82 .73 .63 .53 
            
≥3 117 18.5  .29 .86 PPP .18 .34 .47 .58 .67 
      NPP .92 .83 .74 .64 .55 
            
 
Note. WCST = Wisconsin Card Sorting Test (Heaton, Chelune, Talley, Kay, & Curtiss, 1993); 
FMS = Failure to Maintain Set; BRFail = base rate of failure (percent of the sample that failed the 
validity cutoff); PVT = performance validity test; WMT = Word Memory Test (Green, 2003); 
SENS = sensitivity; SPEC = specificity; Hypothetical BRFail = prevalence of invalid performance 
in the assessment setting (in percent); PPP = positive predictive power; NPP = negative 
predictive power. Boldface font denotes previously published cutoffs. 
an = 634 
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 CT-TE. Table 151 shows signal detection properties of various CT-TE cutoffs. CT-TE 
cutoffs between ≥90 and ≥135 produced specificity values between .84 and 1.00. CT-TE ≥90 
achieved .34 sensitivity and .84 specificity. Raising the cutoff to CT-TE ≥100 improved 
specificity to .90 with a loss in sensitivity (.23). Perfect specificity was achieved at CT-TE ≥135, 
although sensitivity was near zero (.01). 
With respect to previously identified cutoffs, CT-TE ≥90 and CT-TE ≥100 produced 
good classification accuracy. However, CT-TE ≥87 (Tenhula & Sweet, 1996; DiCarlo et al., 
2000) was associated with unacceptably low specificity (.83). 
PPP and NPP indicate that, in settings with a 30% BRFail, there is a .51 probability that 
the profile of a patient who fails CT-TE ≥100 is invalid, and a .73 probability that the profile of a 
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Table 151 
 
Signal Detection Properties of Various Category Test Total Errors Cutoffs Achieving Acceptable 











f BRFail  SENS SPEC  10 20 30 40 50 
            
≥135 8 0.4  .01 1.00 PPP .33 .52 .65 .75 .81 
      NPP .90 .80 .70 .60 .50 
            
≥130 16 0.7  .01 .99 PPP .23 .40 .53 .64 .73 
      NPP .90 .80 .70 .60 .50 
            
≥125 35 1.6  .03 .99 PPP .22 .38 .52 .62 .71 
      NPP .90 .80 .70 .60 .50 
            
≥120 62 2.8  .05 .98 PPP .25 .43 .56 .67 .75 
      NPP .90 .81 .71 .61 .51 
            
≥115 94 4.3  .08 .97 PPP .23 .41 .54 .65 .73 
      NPP .90 .81 .71 .61 .51 
            
≥110 143 6.5  .11 .95 PPP .21 .37 .51 .61 .71 
      NPP .91 .81 .71 .62 .52 
            
≥105 217 9.9  .17 .93 PPP .21 .37 .51 .61 .70 
      NPP .91 .82 .72 .63 .53 
            
≥100 294 13.4  .23 .90 PPP .21 .38 .51 .62 .71 
      NPP .91 .82 .73 .64 .54 
            
≥95 366 16.6  .28 .88 PPP .20 .36 .49 .60 .69 
      NPP .92 .83 .74 .65 .55 
            
≥90 459 20.9  .34 .84 PPP .19 .35 .48 .59 .68 
      NPP .92 .84 .75 .66 .56 
            
 
Note. CT-TE = Category Test Total Errors (DeFlippis & McCampbell, 1979, 1991, 1997); BRFail 
= base rate of failure (percent of the sample that failed the validity cutoff); PVT = performance 
validity test; WMT = Word Memory Test (Green, 2003); SENS = sensitivity; SPEC = 
specificity; Hypothetical BRFail = prevalence of invalid performance in the assessment setting (in 
percent); PPP = positive predictive power; NPP = negative predictive power. Boldface font 
denotes previously published cutoffs. 
an = 2199 
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 TMT-A. Table 152 shows signal detection properties for various cutoffs on TMT-A. 
Cutoffs between ≥45 and ≥90 produced specificity values between .84 and 1.00. TMT-A ≥45 
achieved .37 sensitivity and .85 specificity. Raising the cutoff to TMT-A ≥50 improved 
specificity to .91 with a loss in sensitivity (.30). A cutoff of TMT-A ≥90 was associated with 
perfect specificity, although sensitivity was low (.07). 
With respect to previously identified cutoffs, TMT-A ≥63 was somewhat conservative, 
producing high specificity at the cost of low sensitivity (SPEC = .97, SENS = .16). 
 PPP and NPP values indicated that in a setting with a 30% BRFail, there is a .59 
probability that a failure on TMT-A ≥50 represents an invalid profile, and a .75 probability that a 
pass on TMT-A ≥50 reflects a valid profile.  
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Table 152 
 
Signal Detection Properties of Various Trail Making Test Part A Completion Time Cutoffs 











f BRFail  SENS SPEC  10 20 30 40 50 
            
≥90 59 2.4  .07 1.00 PPP .70 .84 .90 .93 .95 
      NPP .91 .81 .71 .62 .52 
            
≥85 71 2.9  .08 .99 PPP .59 .76 .85 .90 .93 
      NPP .91 .81 .72 .62 .52 
            
≥80 91 3.7  .10 .99 PPP .47 .66 .77 .84 .89 
      NPP .91 .81 .72 .62 .52 
            
≥75 111 4.5  .12 .98 PPP .46 .66 .77 .84 .88 
      NPP .91 .82 .72 .63 .53 
            
≥70 136 5.5  .13 .98 PPP .38 .57 .70 .78 .84 
      NPP .91 .82 .72 .63 .53 
            
≥65 165 6.7  .15 .97 PPP .36 .56 .68 .77 .83 
      NPP .91 .82 .73 .63 .53 
            
≥60 209 8.5  .18 .96 PPP .32 .51 .64 .74 .81 
      NPP .91 .82 .73 .64 .54 
            
≥55 271 11.0  .22 .94 PPP .29 .47 .61 .71 .78 
      NPP .92 .83 .74 .64 .55 
            
≥50 372 15.1  .30 .91 PPP .27 .46 .59 .69 .77 
      NPP .92 .84 .75 .66 .57 
            
≥45 527 21.4  .37 .85 PPP .22 .39 .52 .63 .72 
      NPP .92 .85 .76 .67 .58 
            
 
Note. TMT-A = Trail Making Test (Reitan & Wolfson, 1985) Part A completion time in seconds; 
BRFail = base rate of failure (percent of the sample that failed the validity cutoff); PVT = 
performance validity test; WMT = Word Memory Test (Green, 2003); SENS = sensitivity; SPEC 
= specificity; Hypothetical BRFail = prevalence of invalid performance in the assessment setting 
(in percent); PPP = positive predictive power; NPP = negative predictive power. 
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 TMT-B. Table 153 shows signal detection properties of various TMT-B cutoffs. Cutoffs 
between ≥110 and ≥360 produced specificity values between .84 and 1.00. TMT-B ≥110 
achieved .39 sensitivity and.87 specificity. Raising the cutoff to TMT-B ≥120 improved 
specificity to .90 with a minimal loss in sensitivity (.33). Further increases in the cutoff score 
produced steady losses in sensitivity and gradual gains in specificity. Thus, only classification 
accuracy data for cutoffs up to TMT-B ≥230 are shown in Table 149. 
Additional analyses revealed that TMT-B ≥350 was associated with .99 specificity and 
.04 sensitivity (BRFail = 1.6%). Perfect specificity was attained using TMT-B ≥360, although 
sensitivity remained low (.04; BRFail = 1.5%). 
With regard to previously identified cutoffs, TMT-B ≥120 demonstrated good 
classification accuracy in the present sample. TMT-B ≥200 was overly conservative, producing 
high specificity at the cost of low sensitivity (SPEC = .98, SENS = .13). 
In a setting with a 30% BRFail, there is a .58 probability that a failure on TMT-B ≥120 
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Table 153 
 
Signal Detection Properties of Various Trail Making Test Part B Completion Time Cutoffs 











f BRFail  SENS SPEC  10 20 30 40 50 
            
≥230 93 3.8  .10 .99 PPP .45 .65 .76 .83 .88 
      NPP .91 .81 .72 .62 .52 
            
≥220 105 4.3  .11 .98 PPP .42 .62 .74 .81 .87 
      NPP .91 .82 .72 .62 .52 
            
≥210 117 4.8  .12 .98 PPP .43 .63 .75 .82 .87 
      NPP .91 .82 .72 .63 .53 
            
≥200 129 5.3  .13 .98 PPP .38 .58 .70 .79 .85 
      NPP .91 .82 .72 .63 .53 
            
≥190 151 6.2  .14 .97 PPP .36 .56 .68 .77 .84 
      NPP .91 .82 .73 .63 .53 
            
≥180 171 7.0  .16 .97 PPP .35 .55 .67 .76 .83 
      NPP .91 .82 .73 .63 .53 
            
≥170 183 7.5  .17 .96 PPP .34 .54 .66 .75 .82 
      NPP .91 .82 .73 .63 .54 
            
≥160 208 8.5  .19 .96 PPP .33 .53 .66 .75 .82 
      NPP .91 .83 .73 .64 .54 
            
≥150 244 10.0  .22 .95 PPP .32 .52 .65 .74 .81 
      NPP .92 .83 .74 .64 .55 
            
≥140 298 12.2  .25 .93 PPP .29 .48 .61 .71 .79 
      NPP .92 .83 .74 .65 .55 
            
≥130 342 14.0  .28 .92 PPP .27 .45 .59 .69 .77 
      NPP .92 .84 .75 .65 .56 
            
≥120 422 17.3  .33 .90 PPP .26 .44 .58 .68 .76 
      NPP .92 .84 .76 .67 .57 
            
≥110 508 20.8  .39 .87 PPP .25 .43 .56 .66 .75 
      NPP .93 .85 .77 .68 .59 
            
 
Note. TMT-B = Trail Making Test (Reitan & Wolfson, 1985) Part B completion time; BRFail = 
base rate of failure (percent of the sample that failed the validity cutoff); PVT = performance 
validity test; WMT = Word Memory Test (Green, 2003); SENS = sensitivity; SPEC = 
specificity; Hypothetical BRFail = prevalence of invalid performance in the assessment setting (in 
percent); PPP = positive predictive power; NPP = negative predictive power. Boldface font 
denotes previously published cutoffs. 
an = 2442 
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 TMT A+B. Table 154 shows signal detection properties for various cutoffs on TMT 
A+B. Cutoffs between TMT A+B ≥150 and ≥430 produced specificity values between .86 and 
1.00. TMTA+B ≥150 achieved .41 sensitivity and .86 specificity. Raising the cutoff to TMT 
A+B ≥170 improved specificity to .91 but reduced sensitivity to .34. Further increases in cutoff 
scores produced small changes in sensitivity and specificity. Thus, only classification accuracy 
data for cutoffs up to TMT A+B ≥250 are shown in Table 154. 
Additional analyses revealed that TMT A+B ≥300 was associated with .99 specificity and 
.10 sensitivity (BRFail = 4.0%). TMT A+B ≥430 produced perfect specificity and .04 sensitivity 
(BRFail = 1.6%). 
With regard to previously identified cutoffs, TMT A+B ≥170 demonstrated good 
classification accuracy. TMT A+B ≥137 produced good sensitivity (.48) but unacceptably low 
specificity (.81).  
 Examination of PPP and NPP values revealed that in settings with a 30% BRFail, there is 
a .61 probability of an invalid profile in an examinee who fails TMT A+B ≥170 and a .76 
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Table 154 
 
Signal Detection Properties of Various TMT A+B Cutoffs Achieving Acceptable Specificity 











f BRFail  SENS SPEC  10 20 30 40 50 
            
≥250 147 6.0  .14 .97 PPP .36 .56 .69 .77 .84 
      NPP .91 .82 .72 .63 .53 
            
≥240 164 6.7  .15 .97 PPP .36 .55 .68 .77 .83 
      NPP .91 .82 .73 .63 .53 
            
≥230 183 7.5  .17 .97 PPP .37 .56 .69 .78 .84 
      NPP .91 .82 .73 .64 .54 
            
≥220 200 8.2  .18 .96 PPP .34 .54 .66 .75 .82 
      NPP .91 .82 .73 .64 .54 
            
≥210 217 8.9  .20 .96 PPP .34 .54 .67 .76 .82 
      NPP .91 .83 .74 .64 .54 
            
≥200 256 10.5  .23 .95 PPP .34 .53 .66 .75 .82 
      NPP .92 .83 .74 .65 .55 
            
≥190 293 12.0  .26 .94 PPP .33 .52 .65 .74 .81 
      NPP .92 .84 .75 .66 .56 
            
≥180 342 14.0  .30 .93 PPP .31 .51 .64 .73 .81 
      NPP .92 .84 .76 .66 .57 
            
≥170 400 16.4  .34 .91 PPP .29 .48 .61 .71 .79 
      NPP .92 .85 .76 .67 .58 
            
≥160 462 18.9  .37 .89 PPP .27 .45 .59 .69 .77 
      NPP .93 .85 .77 .68 .59 
            
≥150 540 22.1  .41 .86 PPP .25 .43 .56 .66 .75 
      NPP .93 .85 .77 .69 .59 
 
Note. TMT A+B = Sum of completion times (in seconds) on Trail Making Test Part A and Part 
B (Reitan & Wolfson, 1985); BRFail = base rate of failure (percent of the sample that failed the 
validity cutoff); PVT = performance validity test; WMT = Word Memory Test (Green, 2003); 
SENS = sensitivity; SPEC = specificity; Hypothetical BRFail = prevalence of invalid performance 
in the assessment setting (in percent); PPP = positive predictive power; NPP = negative 
predictive power. Boldface font denotes previously published cutoffs. 
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 TMT-B/A. Table 155 shows signal detection properties for various TMT-B/A cutoffs. 
Cutoffs between <1.70 and <1.10 produced specificity values between .86 and 1.00. TMT-B/A 
<1.70 achieved .14 sensitivity and .86 specificity. Lowering the cutoff to TMT-B/A <1.50, which 
was been published previously in the literature, improved specificity to .92 but reduced 
sensitivity to .07. Although perfect specificity was achieved at TMT-B/A <1.10, there was zero 
sensitivity to invalid performance at that cutoff. 
 In a setting with a 30% BRFail, the probability of an invalid profile in an examinee who 
fails TMT-B/A <1.50 is .29. Conversely, the probability of a valid profile in an examinee who 
passes TMT-B/A <1.50 is .70. 
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Table 155 
 
Signal Detection Properties of Various Trail Making Test Ratio Cutoffs Achieving Acceptable 











f BRFail  SENS SPEC  10 20 30 40 50 
            
<1.10 10 0.4  .00 1.00 PPP .10 .20 .30 .40 .50 
      NPP .90 .80 .70 .60 .50 
            
<1.20 29 1.2  .01 .99 PPP .07 .15 .24 .32 .42 
      NPP .90 .80 .70 .60 .50 
            
<1.30 66 2.7  .02 .97 PPP .08 .16 .24 .34 .43 
      NPP .90 .80 .70 .60 .50 
            
<1.40 120 4.9  .05 .95 PPP .09 .18 .28 .37 .47 
      NPP .90 .80 .70 .60 .50 
            
<1.50 183 7.5  .07 .92 PPP .10 .19 .29 .39 .49 
      NPP .90 .80 .70 .60 .50 
            
<1.60 256 10.5  .10 .89 PPP .09 .18 .28 .37 .47 
      NPP .90 .80 .70 .60 .50 
            
<1.70 349 14.3  .14 .86 PPP .10 .19 .29 .39 .49 
      NPP .90 .80 .70 .60 .50 
            
 
Note. TMT-B/A = Trail Making Test ratio (Part B completion time in seconds/Part A completion 
time in seconds; Reitan & Wolfson, 1985); BRFail = base rate of failure (percent of the sample 
that failed the validity cutoff); PVT = performance validity test; WMT = Word Memory Test 
(Green, 2003); SENS = sensitivity; SPEC = specificity; Hypothetical BRFail = prevalence of 
invalid performance in the assessment setting (in percent); PPP = positive predictive power; NPP 
= negative predictive power. Boldface font denotes previously published cutoffs. 
an = 2442 
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FTT-DHM. Table 156 shows signal detection properties for various FTT-DHM cutoffs. 
Cutoffs between FTT-DHM ≤16.0 and ≤44.0 produced specificity values between .84 and 1.00. 
FTT-DHM ≤44.0 achieved .38 sensitivity and .86 specificity. Improved specificity was achieved 
at FTT-DHM ≤42.0 (.91) at the cost of lower sensitivity (.29). Lowering cutoffs further produced 
small increases in specificity and steady decreases in sensitivity. Perfect specificity was attained 
using FTT-DHM ≤16.0; however, sensitivity was low (SENS = .04). 
 With regard to previously identified cutoffs, FTT-DHM ≤35.0 demonstrated acceptable 
classification accuracy, achieving .95 specificity and .19 sensitivity. FTT-DHM ≤37.0 achieved 
.94 specificity and .20 sensitivity. 
 According to PPP and NPP, in settings with a 30% BRFail, there is a .58 probability that a 
failure on FTT-DHM ≤42.0 represents an invalid profile, and a .75 probability that a pass on FTT-
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Table 156 
 
Signal Detection Properties of Various Finger Tapping Test Dominant Hand Cutoffs (in Males) 











f BRFail  SENS SPEC  10 20 30 40 50 
            
≤16.0 7 1.3  .04 1.00 PPP 1.00 1.00 1.00 1.00 1.00 
      NPP .90 .81 .71 .61 .51 
            
≤18.0 11 2.0  .06 .99 PPP .55 .73 .82 .88 .92 
      NPP .90 .81 .71 .61 .51 
            
≤20.0 15 2.7  .07 .99 PPP .42 .62 .74 .82 .87 
      NPP .91 .81 .71 .61 .52 
            
≤22.0 17 3.1  .07 .99 PPP .39 .59 .71 .79 .85 
      NPP .91 .81 .71 .62 .52 
            
≤24.0 19 3.4  .07 .98 PPP .31 .51 .64 .73 .81 
      NPP .91 .81 .71 .61 .51 
            
≤26.0 23 4.2  .08 .97 PPP .26 .44 .57 .68 .76 
      NPP .91 .81 .71 .61 .51 
            
≤28.0 29 5.2  .10 .97 PPP .28 .46 .59 .70 .77 
      NPP .91 .81 .72 .62 .52 
            
≤30.0 32 5.8  .12 .97 PPP .28 .47 .60 .70 .78 
      NPP .91 .81 .72 .62 .52 
            
≤32.0 36 6.5  .14 .97 PPP .32 .52 .65 .74 .81 
      NPP .91 .82 .72 .63 .53 
            
≤34.0 44 8.0  .17 .96 PPP .30 .49 .62 .72 .79 
      NPP .91 .82 .73 .63 .53 
            
≤36.0 55 9.9  .20 .94 PPP .27 .46 .59 .69 .77 
      NPP .91 .82 .73 .64 .54 
            
≤38.0 59 10.7  .21 .94 PPP .27 .45 .58 .69 .77 
      NPP .91 .83 .73 .64 .54 
            
≤40.0 71 12.8  .26 .93 PPP .28 .47 .60 .70 .78 
      NPP .92 .83 .74 .65 .56 
            
≤42.0 82 14.8  .29 .91 PPP .26 .45 .58 .68 .76 
      NPP .92 .84 .75 .66 .56 
            
≤44.0 115 20.8  .38 .86 PPP .23 .41 .54 .65 .73 
      NPP .93 .85 .76 .67 .58 
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DHM = average number of taps achieved with 
the dominant hand (males only); BRFail = base rate of failure (percent of the sample that failed the 
validity cutoff); PVT = performance validity test; WMT = Word Memory Test (Green, 2003); 
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SENS = sensitivity; SPEC = specificity; Hypothetical BRFail = prevalence of invalid performance 
in the assessment setting (in percent); PPP = positive predictive power; NPP = negative 
predictive power. 
an = 553 
 
 
 FTT-DHF. Table 157 shows signal detection properties of various FTT-DHF cutoffs. 
Cutoffs between FTT-DHF ≤12.0 and ≤34.0 produced specificity values between .86 and 1.00. 
FTT-DHF ≤34.0 achieved .41 sensitivity and .86 specificity. FTT-DHF ≤30.0 improved 
specificity to .91 with a reduction in sensitivity (.33). Lowering cutoffs further resulted in steady 
losses in sensitivity and small gains in specificity. Perfect specificity was achieved at FTT-DHF 
≤12.0, although sensitivity was very low (.03). 
 With regard to previously identified cutoffs, FTT-DHF ≤28.0 demonstrated good 
classification accuracy, with .92 specificity and .32 sensitivity. FTT-DHF ≤23.0 produced higher 
specificity (.98) and lower sensitivity (.19). 
 In settings with a 30% BRFail, the probability of an invalid profile given a failure on FTT-
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Table 157 
 
Signal Detection Properties of Various Finger Tapping Test Dominant Hand Cutoffs (in 











f BRFail  SENS SPEC  10 20 30 40 50 
            
≤12.0 2 0.7  .03 1.00 PPP 1.00 1.00 1.00 1.00 1.00 
      NPP .90 .81 .71 .61 .51 
            
≤14.0 4 1.5  .03 .99 PPP .27 .45 .58 .69 .77 
      NPP .90 .80 .70 .61 .51 
            
≤16.0 6 2.2  .06 .99 PPP .42 .62 .74 .81 .87 
      NPP .90 .81 .71 .61 .51 
            
≤18.0 9 3.3  .08 .98 PPP .31 .51 .64 .73 .80 
      NPP .91 .81 .71 .62 .52 
            
≤20.0 11 4.1  .11 .98 PPP .39 .59 .71 .79 .85 
      NPP .91 .82 .72 .62 .52 
            
≤22.0 14 5.2  .14 .98 PPP .40 .60 .72 .80 .85 
      NPP .91 .82 .73 .63 .53 
            
≤24.0 19 7.1  .21 .97 PPP .44 .64 .75 .83 .88 
      NPP .92 .83 .74 .65 .55 
            
≤26.0 26 9.7  .25 .95 PPP .37 .57 .69 .78 .84 
      NPP .92 .84 .75 .66 .56 
            
≤28.0 36 13.4  .32 .92 PPP .31 .51 .64 .73 .80 
      NPP .92 .84 .76 .67 .57 
            
≤30.0 44 16.4  .33 .91 PPP .29 .47 .61 .71 .78 
      NPP .92 .84 .76 .67 .58 
            
≤32.0 51 19.0  .40 .87 PPP .26 .44 .57 .68 .76 
      NPP .93 .85 .77 .68 .59 
            
≤34.0 55 20.4  .41 .86 PPP .25 .42 .56 .66 .75 
      NPP .93 .85 .77 .69 .59 
            
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DHF = average number of taps achieved with 
the dominant hand (females only); BRFail = base rate of failure (percent of the sample that failed 
the validity cutoff); PVT = performance validity test; WMT = Word Memory Test (Green, 
2003); SENS = sensitivity; SPEC = specificity; Hypothetical BRFail = prevalence of invalid 
performance in the assessment setting (in percent); PPP = positive predictive power; NPP = 
negative predictive power. Boldface font denotes previously published cutoffs. 
an = 269 
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 FTT-NDHM. Table 158 shows signal detection properties of various FTT-NDHM cutoffs. 
Cutoffs between ≤16.0 and ≤40.0 produced specificity values between .85 and 1.00. FTT-NDHM 
≤40.0 achieved .33 sensitivity and .85 specificity. FTT-NDHM ≤38.0 improved specificity to .91, 
with a reduction in sensitivity (.25). Lowering cutoffs further produced small gains in specificity 
and steady losses in sensitivity. Zero false positives were observed at FTT-NDHM ≤16.0; 
however, sensitivity to invalid performance was very low (.03). 
 With regard to previously identified cutoffs, Arnold and colleagues’ (2005) cutoff of 
FTT-NDHM ≤30.0 achieved excellent specificity (.96) but low sensitivity (.11) in the present 
sample. 
 In settings with a 30% BRFail, there is a .53 probability that a fail on FTT-NDHM ≤38.0 
represents an invalid profile (PPP), and a .74 probability that a pass on FTT-NDHM ≤38.0 
represents a valid profile (NPP). 
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Table 158 
 
Signal Detection Properties of Various Finger Tapping Test Non-Dominant Hand Cutoffs (in 











f BRFail  SENS SPEC  10 20 30 40 50 
            
≤16.0 6 1.1  .03 1.00 PPP .57 .75 .84 .89 .92 
      NPP .90 .80 .71 .61 .51 
            
≤18.0 10 1.8  .05 .99 PPP .52 .71 .81 .87 .91 
      NPP .90 .81 .71 .61 .51 
            
≤20.0 16 2.9  .06 .98 PPP .31 .50 .63 .73 .80 
      NPP .90 .81 .71 .61 .51 
            
≤22.0 19 3.5  .07 .98 PPP .27 .45 .59 .69 .77 
      NPP .90 .81 .71 .61 .51 
            
≤24.0 22 4.0  .08 .98 PPP .28 .47 .60 .70 .78 
      NPP .91 .81 .71 .61 .52 
            
≤26.0 23 4.2  .08 .97 PPP .26 .44 .57 .68 .76 
      NPP .91 .81 .71 .61 .51 
            
≤28.0 28 5.1  .10 .97 PPP .26 .45 .58 .68 .76 
      NPP .91 .81 .72 .62 .52 
            
≤30.0 33 6.1  .11 .96 PPP .24 .42 .56 .66 .74 
      NPP .91 .81 .72 .62 .52 
            
≤32.0 36 6.6  .13 .96 PPP .25 .43 .57 .67 .75 
      NPP .91 .81 .72 .62 .52 
            
≤34.0 47 8.6  .16 .95 PPP .25 .43 .56 .67 .75 
      NPP .91 .82 .73 .63 .53 
            
≤36.0 64 11.7  .23 .93 PPP .26 .44 .57 .68 .76 
      NPP .92 .83 .74 .64 .55 
            
≤38.0 75 13.8  .25 .91 PPP .23 .40 .53 .64 .72 
      NPP .92 .83 .74 .64 .55 
            
≤40.0 109 20.0  .33 .85 PPP .20 .36 .49 .60 .69 
      NPP .92 .84 .75 .66 .56 
 
Note. FTT = Finger Tapping Test (Reitan, 1969); NDHM = average number of taps achieved with 
the non-dominant hand (males only); BRFail = base rate of failure (percent of the sample that 
failed the validity cutoff); PVT = performance validity test; WMT = Word Memory Test (Green, 
2003); SENS = sensitivity; SPEC = specificity; Hypothetical BRFail = prevalence of invalid 
performance in the assessment setting (in percent); PPP = positive predictive power; NPP = 
negative predictive power. Boldface font denotes previously published cutoffs. 
an = 545 
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FTT-NDHF. Table 159 shows signal detection properties for various FTT-NDHF cutoffs. 
Cutoffs between ≤16.0 and ≤32.0 produced specificity values between .84 and 1.00. FTT-NDHF 
≤32.0 achieved .39 sensitivity and .84 specificity. Lowering the cutoff to FTT-NDHF ≤28.0 
improved specificity to .91 with acceptable sensitivity (.28). Perfect specificity was attained at 
FTT-NDHF ≤16.0, although sensitivity was low (.05). 
With regard to previously identified cutoffs, FTT-NDHF ≤25.0 (Arnold et al., 2005) 
achieved good specificity (.95) and low sensitivity (.11). FTT-NDHF ≤19.0 was overly 
conservative, achieving near-perfect (.99) specificity and low sensitivity (.10). 
In settings with a 30% BRFail, the probability that a failure on FTT-NDHF ≤28.0 
represents an invalid profile is .56. The probability that a pass on FTT-NDHF ≤28.0 represents a 
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Table 159 
 
Signal Detection Properties of Various Finger Tapping Test Non-Dominant Hand Cutoffs (in 











f BRFail  SENS SPEC  10 20 30 40 50 
            
≤16.0 4 1.5  .05 1.00 PPP .53 .72 .81 .87 .91 
      NPP .90 .81 .71 .61 .51 
            
≤18.0 8 3.0  .10 .99 PPP .53 .72 .81 .87 .91 
      NPP .91 .81 .72 .62 .52 
            
≤20.0 13 4.9  .13 .98 PPP .37 .57 .70 .78 .84 
      NPP .91 .82 .72 .63 .53 
            
≤22.0 16 6.0  .16 .97 PPP .38 .58 .71 .79 .85 
      NPP .91 .82 .73 .64 .54 
            
≤24.0 18 6.8  .18 .97 PPP .37 .57 .69 .78 .84 
      NPP .91 .82 .73 .64 .54 
            
≤26.0 25 9.4  .20 .94 PPP .26 .44 .57 .67 .76 
      NPP .91 .82 .73 .64 .54 
            
≤28.0 34 12.8  .26 .91 PPP .25 .43 .56 .67 .75 
      NPP .92 .83 .74 .65 .55 
≤30.0 42 15.8  .31 .89 PPP .24 .41 .54 .65 .74 
      NPP .92 .84 .75 .66 .56 
            
≤32.0 57 21.4  .39 .84 PPP .21 .38 .51 .62 .71 
      NPP .93 .85 .76 .67 .58 
            
 
Note. FTT = Finger Tapping Test (Reitan, 1969); NDHF = average number of taps achieved with 
the non-dominant hand (females only); BRFail = base rate of failure (percent of the sample that 
failed the validity cutoff); PVT = performance validity test; WMT = Word Memory Test (Green, 
2003); SENS = sensitivity; SPEC = specificity; Hypothetical BRFail = prevalence of invalid 
performance in the assessment setting (in percent); PPP = positive predictive power; NPP = 
negative predictive power. 
an = 266 
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 FTT-CM. Table 160 shows signal detection properties for various FTT-CM cutoffs. 
Cutoffs between ≤35.0 and ≤85.0 achieved specificity values between .84 and 1.00. FTT-CM 
≤85.0 produced .37 sensitivity and .87 specificity. FTT-CM ≤80.0 reached .91 specificity with a 
loss in sensitivity (.30). Perfect specificity was achieved at FTT-CM ≤35.0, although sensitivity 
was low (.03). 
 With regard to previously identified cutoffs, FTT-CM ≤66.0 demonstrated excellent 
specificity (.96) and low sensitivity (.13) in the present sample. 
 In a setting with a 30% BRFail, the probability of an invalid profile is .58 in an examinee 
who fails FTT-CM ≤80.0. Conversely, the probability of a valid profile is .75 in someone who 
passes FTT-CM ≤80.0. 
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Table 160 
 
Signal Detection Properties of Various Finger Tapping Test-Combined Cutoffs (in Males) 











f BRFail  SENS SPEC  10 20 30 40 50 
            
≤35.0 6 1.1  .03 1.00 PPP .57 .75 .84 .89 .92 
      NPP .90 .80 .71 .61 .51 
            
≤40.0 11 2.0  .05 .99 PPP .42 .62 .74 .81 .87 
      NPP .90 .81 .71 .61 .51 
            
≤45.0 17 3.1  .08 .99 PPP .47 .66 .77 .84 .89 
      NPP .91 .81 .72 .62 .52 
            
≤50.0 18 3.3  .08 .99 PPP .41 .61 .73 .81 .86 
      NPP .91 .81 .71 .62 .52 
            
≤55.0 27 5.0  .09 .97 PPP .25 .43 .57 .67 .75 
      NPP .91 .81 .71 .62 .52 
            
≤60.0 27 5.0  .09 .97 PPP .25 .43 .57 .67 .75 
      NPP .91 .81 .71 .62 .52 
            
≤65.0 34 6.2  .12 .96 PPP .25 .43 .57 .67 .75 
      NPP .91 .81 .72 .62 .52 
            
≤70.0 47 8.6  .17 .95 PPP .27 .45 .58 .69 .77 
      NPP .91 .82 .73 .63 .53 
            
≤75.0 62 11.4  .22 .93 PPP .26 .44 .57 .68 .76 
      NPP .91 .83 .74 .64 .54 
            
≤80.0 83 15.2  .30 .91 PPP .26 .44 .58 .68 .76 
      NPP .92 .84 .75 .66 .56 
            
≤85.0 111 20.4  .37 .87 PPP .23 .41 .54 .65 .73 
      NPP .93 .85 .76 .67 .58 
            
 
Note. FTT = Finger Tapping Test (Reitan, 1969); CM = sum of average number of taps achieved 
with the dominant and non-dominant hands (males only); BRFail = base rate of failure (percent of 
the sample that failed the validity cutoff); PVT = performance validity test; WMT = Word 
Memory Test (Green, 2003); SENS = sensitivity; SPEC = specificity; Hypothetical BRFail = 
prevalence of invalid performance in the assessment setting (in percent); PPP = positive 
predictive power; NPP = negative predictive power. 
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 FTT-CF. Table 161 shows signal detection properties for various FTT-CF cutoffs. 
Cutoffs between ≤30.0 and ≤65.0 produced specificity values between .84 and 1.00. FTT-CF 
≤65.0 achieved .38 sensitivity and .85 specificity. Excellent specificity (.96) was attained by 
lowering the cutoff to FTT-CF ≤55.0, with a loss in sensitivity (.26). FTT-CF ≤30.0 produced 
perfect specificity with low sensitivity (.03). 
 With regard to previously identified cutoffs, FTT-CF ≤58.0 achieved acceptable 
specificity (.91) and sensitivity (.26). 
 In a setting with a 30% BRFail, there is a .62 probability that a failure on FTT-CF ≤55.0 
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Table 161 
 
Signal Detection Properties of Various Finger Tapping Test-Combined Cutoffs (in Females) 











f BRFail  SENS SPEC  10 20 30 40 50 
            
≤30.0 3 1.1  .03 1.00 PPP .43 .63 .74 .82 .87 
      NPP .90 .80 .71 .61 .51 
            
≤35.0 5 1.9  .05 .99 PPP .36 .56 .68 .77 .83 
      NPP .90 .81 .71 .61 .51 
            
≤40.0 9 3.4  .11 .99 PPP .57 .75 .83 .89 .92 
      NPP .91 .82 .72 .63 .53 
            
≤45.0 13 4.9  .16 .99 PPP .55 .74 .83 .88 .92 
      NPP .91 .83 .73 .64 .54 
            
≤50.0 19 7.1  .21 .97 PPP .45 .65 .76 .83 .88 
      NPP .92 .83 .74 .65 .55 
            
≤55.0 30 11.3  .26 .96 PPP .30 .49 .62 .72 .79 
      NPP .92 .83 .75 .65 .56 
            
≤60.0 42 15.8  .28 .88 PPP .20 .36 .49 .60 .70 
      NPP .92 .83 .74 .65 .55 
            
≤65.0 53 19.9  .38 .85 PPP .22 .39 .52 .63 .72 
      NPP .92 .85 .76 .67 .58 
            
 
Note. FTT = Finger Tapping Test (Reitan, 1969); CM = sum of average number of taps achieved 
with the dominant and non-dominant hands (females only); BRFail = base rate of failure (percent 
of the sample that failed the validity cutoff); PVT = performance validity test; WMT = Word 
Memory Test (Green, 2003); SENS = sensitivity; SPEC = specificity; Hypothetical BRFail = 
prevalence of invalid performance in the assessment setting (in percent); PPP = positive 
predictive power; NPP = negative predictive power. 
an = 266 
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 FTT-DIFFM. Table 162 shows signal detection properties for various FTT-DIFFM 
cutoffs. Cutoffs between FTT-DIFFM ≤-27.0 and ≤-1.0 produced specificity values between .84 
and 1.00. FTT-DIFFM ≤-1.0 achieved .24 sensitivity and .85 specificity. Improved specificity 
(.91) was observed FTT-DIFFM ≤-3.0, with a loss in sensitivity (.14). Lowering the cutoffs 
further produced small gains in specificity and small losses in sensitivity. Thus, only 
classification accuracy data for cutoffs up to FTT-DIFFM ≤-12.0 are shown in Table 158. 
Additional analyses revealed that FTT-DIFFM ≤-27.0 was associated with perfect specificity, 
although there was zero sensitivity to invalid performance at this cutoff (BRFail = 0.2%). 
 With regard to previously identified cutoffs, FTT-DIFFM ≤-2.0 achieved .88 specificity 
and .17 sensitivity in the present sample. 
 PPP and NPP indicate that in a setting with a 30% BRFail, there is a .41 probability of an 
invalid profile given a failure on FTT-DIFFM ≤-3.0, and a .71 probability of a valid profile given 
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Table 162 
 
Signal Detection Properties of Various Finger Tapping Test-Difference cutoffs (in Males) 











f BRFail  SENS SPEC  10 20 30 40 50 
            
≤-12.0 11 2.0  .04 .99 PPP .24 .42 .56 .66 .74 
      NPP .90 .80 .71 .61 .51 
            
≤-11.0 12 2.2  .04 .98 PPP .21 .38 .51 .62 .71 
      NPP .90 .80 .70 .61 .51 
            
≤-10.0 13 2.4  .04 .98 PPP .19 .34 .47 .58 .68 
      NPP .90 .80 .70 .60 .51 
            
≤-9.0 16 2.9  .04 .98 PPP .17 .32 .45 .56 .65 
      NPP .90 .80 .70 .61 .51 
            
≤-8.0 19 3.5  .05 .97 PPP .16 .31 .43 .54 .64 
      NPP .90 .80 .70 .61 .51 
            
≤-7.0 24 4.4  .06 .96 PPP .16 .30 .43 .54 .63 
      NPP .90 .80 .71 .61 .51 
            
≤-6.0 31 5.7  .08 .95 PPP .16 .30 .43 .54 .64 
      NPP .90 .81 .71 .61 .51 
            
≤-5.0 34 6.2  .09 .95 PPP .18 .32 .45 .56 .66 
      NPP .90 .81 .71 .61 .51 
            
≤-4.0 44 8.1  .11 .93 PPP .16 .30 .42 .53 .63 
      NPP .90 .81 .71 .61 .51 
            
≤-3.0 58 10.6  .14 .91 PPP .15 .29 .41 .52 .61 
      NPP .91 .81 .71 .61 .52 
            
≤-2.0 73 13.4  .17 .88 PPP .14 .26 .38 .49 .59 
      NPP .91 .81 .71 .61 .51 
            
≤-1.0 97 17.8  .24 .85 PPP .15 .28 .40 .51 .61 
      NPP .91 .82 .72 .63 .53 
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DIFFM = difference between the average 
number of taps achieved with the dominant and non-dominant hands (males only); BRFail = base 
rate of failure (percent of the sample that failed the validity cutoff); PVT = performance validity 
test; WMT = Word Memory Test (Green, 2003); SENS = sensitivity; SPEC = specificity; 
Hypothetical BRFail = prevalence of invalid performance in the assessment setting (in percent); 
PPP = positive predictive power; NPP = negative predictive power. Boldface font denotes 
previously published cutoffs. 
an = 545 
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 FTT-DIFFF. Table 163 shows signal detection properties for various FTT-DIFFF cutoffs. 
Cutoffs between ≤-21.0 and ≤-1.0 produced specificity values between .85 and 1.00. FTT-DIFFF 
≤-1.0 achieved .28 sensitivity and .85 specificity. Improved specificity (.90) was attained using 
FTT-DIFFF ≤-3.0, with a loss in sensitivity (.20). Lowering cutoffs further resulted in steady 
losses in sensitivity and small gains in specificity. Thus, only classification accuracy data for 
cutoffs up to FTT-DIFFM ≤-11.0 are shown in Table 159. 
Additional analyses revealed that FTT-DIFFM ≤-16.0 produced .99 specificity and .07 
sensitivity (BRFail = 2.6%). Perfect specificity was achieved using FTT-DIFFM ≤-21.0, although 
sensitivity to invalid performance was very low (.03; BRFail = 0.8%). 
 With regard to previously identified cutoffs, FTT-DIFFF ≤-5.0 demonstrated excellent 
specificity (.96) and acceptable sensitivity (.18) in the present sample. 
 In a setting with a 30% BRFail, there is a .48 probability of an invalid profile in an 
examinee who fails FTT-DIFFF ≤-3.0, and a .73 probability of a valid profile in an examinee 
who passes FTT-DIFFF ≤-3.0. 
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Table 163 
 
Signal Detection Properties of Various Finger Tapping Test-Difference Cutoffs (in Females) 











f BRFail  SENS SPEC  10 20 30 40 50 
            
≤-11.0 10 3.8  .08 .98 PPP .27 .46 .59 .69 .77 
      NPP .91 .81 .71 .61 .52 
            
≤-10.0 12 4.5  .10 .97 PPP .27 .46 .59 .69 .77 
      NPP .91 .81 .72 .62 .52 
            
≤-9.0 13 4.9  .11 .97 PPP .30 .49 .63 .72 .80 
      NPP .91 .81 .72 .62 .52 
            
≤-8.0 16 6.0  .16 .97 PPP .38 .58 .71 .79 .85 
      NPP .91 .82 .73 .64 .54 
            
≤-7.0 17 6.4  .16 .97 PPP .35 .55 .67 .76 .83 
      NPP .91 .82 .73 .63 .54 
            
≤-6.0 19 7.1  .16 .96 PPP .29 .48 .62 .71 .79 
      NPP .91 .82 .73 .63 .53 
            
≤-5.0 20 7.5  .18 .96 PPP .31 .51 .64 .73 .80 
      NPP .91 .82 .73 .64 .54 
            
≤-4.0 27 10.2  .21 .93 PPP .26 .44 .57 .68 .76 
      NPP .91 .83 .73 .64 .54 
            
≤-3.0 33 12.4  .20 .90 PPP .20 .35 .48 .59 .69 
      NPP .91 .82 .73 .63 .53 
            
≤-2.0 39 14.7  .25 .88 PPP .19 .34 .47 .58 .68 
      NPP .91 .82 .73 .64 .54 
            
≤-1.0 47 17.7  .28 .85 PPP .17 .32 .45 .56 .66 
      NPP .91 .83 .73 .64 .54 
 
Note. FTT = Finger Tapping Test (Reitan, 1969); DIFFF = difference between the average 
number of taps achieved with the dominant and non-dominant hands (females only); BRFail = 
base rate of failure (percent of the sample that failed the validity cutoff); PVT = performance 
validity test; WMT = Word Memory Test (Green, 2003); SENS = sensitivity; SPEC = 
specificity; Hypothetical BRFail = prevalence of invalid performance in the assessment setting (in 
percent); PPP = positive predictive power; NPP = negative predictive power. Boldface font 
denotes previously published cutoffs. 
an = 266 
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 Relative classification accuracies of PVTs. To determine the relative diagnostic power 
of the PVTs examined in Study 3, the most liberal cutoff achieving at least 90% specificity was 
identified on each PVT, and sensitivity values corresponding to those cutoffs were compared 
between PVTs. Results from these analyses are summarized in Table 164, which shows 
sensitivity rates for all of the PVTs examined, in order from highest to lowest. Specifically, free-
standing PVTs demonstrated the highest sensitivity to invalid performance, although they only 
detected about half of the cases identified as invalid by the WMT (SENS =.44-.57). Embedded 
validity indicators produced lower sensitivity compared to free-standing PVTs; sensitivity rates 
varied considerably, ranging from .35 (using TMT A+B ≥165) to .09 (using TMT-B/A <1.58). 
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Table 164 
 
























Note. PVT = performance validity test; SENS = sensitivity to invalid performance; TOMM = Test of Memory 
Malingering (Tombaugh, 1996); MSVT = Medical Symptom Validity Test (Green, 2004); STN = standard 
cutoffs identified in the test manual; NV-MSVT = Non-Verbal Medical Symptom Validity Test (Green, 2008); 
TMT A+B = Sum of completion times (in seconds) on Trail Making Test Part A and Part B (Reitan & 
Wolfson, 1985); TMT-B = Trail Making Test (Reitan & Wolfson, 1985) Part B completion time; FTT-DHF = 
average number of taps achieved with the dominant hand on the Finger Tapping Test (Reitan, 1969; females 
only); TMT-A = Trail Making Test (Reitan & Wolfson, 1985) Part A completion time in seconds; FTT-CM = 
sum of average number of taps achieved with the dominant and non-dominant hands on the Finger Tapping 
Test (Reitan, 1969; males only); FTT-DHM = average number of taps achieved with the dominant hand on the 
Finger Tapping Test (Reitan, 1969; males only); FTT-NDHF = average number of taps achieved with the non-
dominant hand on the Finger Tapping Test (Reitan, 1969; females only); FTT-CF = sum of average number of 
taps achieved with the dominant and non-dominant hands on the Finger Tapping Test (Reitan, 1969; females 
only); FTT-NDHM = average number of taps achieved with the non-dominant hand on the Finger Tapping Test 
(Reitan, 1969; males only); CT-TE = Total Errors on the Category Test (DeFlippis & McCampbell, 1979, 
1991, 1997); FTT- DIFFF = difference between the average number of taps achieved with the dominant and 
non-dominant hands on the Finger Tapping Test (Reitan, 1969; females only); WCST FMS = Wisconsin Card 
Sorting Test, Failure to Maintain Set (Heaton, Chelune, Talley, Kay, & Curtiss, 1993); RDS = Reliable Digit 
Span (Greiffenstein, Baker, & Gola, 1994); FTT- DIFFM = difference between the average number of taps 
achieved with the dominant and non-dominant hands on the Finger Tapping Test (Reitan, 1969; males only); 
TMT-B/A = Trail Making Test ratio (Part B completion time in seconds/Part A completion time in seconds; 
Reitan & Wolfson, 1985). 
aMost liberal cutoff on the respective PVT that achieved a specificity of at least .90 in the present sample 
 
  
PVT Cutoffa SENS SPEC 
    
TOMM Trial 1 ≤43 .57 .90 
MSVT STN .52 .93 
NV-MSVT STN .45 .93 
TOMM Trial 2 ≤48 .44 .96 
TMT A+B ≥165 .35 .90 
TMT-B ≥120 .33 .90 
FTT-DHF ≤29.6 .33 .90 
FTT-DHM ≤42.8 .33 .90 
TMT-A ≥49 .31 .90 
FTT-CM ≤81.0 .31 .90 
FTT-NDHF ≤29.0 .28 .90 
FTT-CF ≤59.0 .26 .90 
FTT-NDHM ≤38.0 .25 .91 
CT-TE ≥100 .23 .90 
FTT-DIFFF ≤-3.0 .20 .90 
WCST FMS ≥4 .17 .94 
RDS ≤6 .17 .96 
FTT-DIFFM ≤-2.6 .15 .90 
TMT-B/A <1.58 .09 .90 
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CHAPTER 4 
Discussion 
 This dissertation aimed to characterize performance on 14 PVTs of interest (three free-
standing PVTs and 11 embedded validity indicators) in a predominantly medical-legal sample. 
BRFail were reported as a function of various patient variables (i.e., diagnosis, age, education, 
gender, and English language status) in the overall sample (Study 1) and in a subsample of 
patients who passed the WMT (Green, 2003), a well-validated criterion PVT, at standard cutoffs 
(valid sample; Study 2). Classification accuracy statistics were also computed against the WMT 
for various cutoffs on each PVT of interest to determine the range of cutoffs achieving 
acceptable specificity (Study 3). The major findings from this dissertation, concerning (1) the 
criterion PVT, (2) Studies 1 and 2, and (3) Study 3, are discussed below in sequence. 
The Criterion PVT 
 In the present dissertation, the WMT was used as a criterion PVT to demonstrate the 
global effect of invalid performance across PVTs of interest. The overall BRFail on the WMT was 
30.2%, which is consistent with previous estimates for settings with a mixture of clinical and 
forensic referrals (i.e., 30%; Mittenberg et al., 2002) and slightly lower than estimates for 
exclusively medical-legal settings (i.e., 40%; Larrabee, 2003). Examinees who passed the WMT 
had significantly lower BRFail than those who failed the WMT on nearly all PVTs of interest 
including the MSVT, NV-MSVT, TOMM Trials 1 and 2, RDS, WCST FMS, CT-TE, TMT-A, 
TMT-B, TMT A+B, FTT-DHM, FTT-NDHM, and FTT-CM. Although not statistically significant, 
a similar trend was observed on FTT-DIFFM. These results indicate that BRFail on a wide range of 
free-standing PVTs and embedded validity indicators are related to invalid performance as 
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measured by the WMT. In doing so, they provide support for the construct validity of the 
aforementioned PVTs of interest. 
Interestingly, those who passed the WMT and those who failed the WMT demonstrated 
largely comparable BRFail on TMT-B/A. The fact that TMT-B/A BRFail were not related to WMT 
outcome may be due to these measures’ different approaches to performance validity assessment 
(Erdodi, 2017). On the WMT, the decision about performance validity is based on level of 
accuracy and consistency of responses (Green, 2003), while TMT-B/A outcomes are based 
whether examinees demonstrate the expected differences in performance on an easier versus 
more difficult task (Iverson et al., 2002). 
 Predictably, as a whole, the valid sample demonstrated lower BRFail than the overall 
sample across cutoffs on nearly all PVTs of interest, with the exception of TMT-B/A. 
Studies 1 and 2 
 Studies 1 and 2 yield large-scale normative data for a wide range of PVTs in a large 
overall medical-legal sample and in a subsample screened for valid performance using an 
independent criterion. By reporting BRFail as a function of relevant patient variables, these data 
help to provide an empirical basis for the interpretation of individual PVT failures by clinicians. 
For example, using these data, a clinician can compare an examinee’s PVT score to one or more 
reference groups (i.e., overall sample, valid sample, as well as various diagnostic and/or 
demographic groups) in order to better understand how commonly such a score is observed in 
these groups and, ultimately, decide how the examinee’s score should interpreted. 
Specific findings concerning the relationships between patient variables and BRFail on 
PVTs of interest are discussed under the relevant sub-headings below. For each patient variable, 
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findings involving free-standing PVTs are discussed first, followed by those involving embedded 
validity indicators. FTT-based validity indicators are discussed under a separate heading. 
 The effect of diagnosis on PVT failure rates. With regard to free-standing PVTs of 
interest, in the overall sample, diagnosis was related to BRFail on the WMT, MSVT, NV-MSVT, 
and TOMM Trials 1 and 2, although the effects were small in magnitude: patients with mTBI, 
chronic pain/fibromyalgia, and orthopedic injuries tended to demonstrate the highest BRFail, 
while those with moderate-severe TBI had low BRFail. These results indicate that, in the overall 
sample, groups expected to have genuine cognitive impairment secondary to known and/or 
persisting structural brain damage (e.g., those with moderate-severe TBI) demonstrate lower 
BRFail than groups that are not expected to have such impairment (i.e., chronic pain/fibromyalgia, 
mTBI). Although paradoxical, this finding is consistent with the existing literature. In TBI, for 
example, higher BRFail are frequently observed among those with mTBIs as compared to 
moderate-severe TBIs, particularly in medical-legal or forensic settings (Carone, 2008; Erdodi & 
Rai, 2017; Grote et al., 2000; Sweet, Goldman, & Guidotti Breting, 2013). Given that full 
neuropsychological recovery is expected to occur within three months following mTBI 
(Belanger, Curtiss, Demery, Lebowitz, & Vanderploeg, 2005), the higher BRFail among forensic 
mTBI cases have been attributed to various external factors including diagnosis threat (e.g., Suhr 
& Gunstad, 2002) and incentive to appear impaired (e.g., Binder & Rohling, 1996) rather than 
genuine and persisting cognitive impairment. Similarly, patients with chronic pain/fibromyalgia 
and orthopedic injuries frequently complain of cognitive difficulties (Bennett, 1996; Glass & 
Park, 2001; Grace, Neilson, Hopkins, & Berg, 1999; Iverson & McCracken, 1997; Schnurr & 
MacDonald, 1995) and have been found to demonstrate substantial rates of PVT failure in a 
number of studies (Gervais, Rohling, Green, & Ford, 2004; Gervais, Russell, Green, et al., 2001; 
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Greve, Ord, Bianchini, & Curtis, 2009; Meyers & Diep, 2000; Meyers & Volbrecht, 2003; 
Schmand et al., 1998; Suhr, 2003). As in TBI, various emotional and motivational factors (e.g., 
comorbid anxiety or depression, negative expectations/attributions) may contribute to poor 
neuropsychological performance among those with chronic pain or fibromyalgia (Binder, 2012; 
Greve, Bianchini, & Ord, 2012). However, financial incentives appear to be particularly 
influential (e.g., Gervais et al., 2004; Mittenberg et al., 2002). Consistent with this, the rate of 
PVT and SVT failures among pain patients has been found to be associated in a dose-response 
fashion with increasing evidence of malingering and not with injury characteristics (Greve, 
Bianchini et al., 2009; Greve, Etherton et al., 2009; Greve, Ord et al., 2009). 
Results showing higher BRFail among groups expected to have no known and/or 
persisting brain dysfunction (e.g., chronic pain/fibromyalgia, mTBI) relative to groups with 
neurologically-based cognitive impairment (e.g., moderate-severe TBI, neurological conditions) 
are also consistent with the findings of Mittenberg and colleagues’ (2002) survey of 
neuropsychologists. In that study, the highest base rates of malingering/symptom exaggeration 
were reported among litigating or compensation-seeking patients with mTBI, 
fibromyalgia/chronic fatigue, and pain or somatoform disorders, while some of the lowest base 
rates of malingering/symptom exaggeration were reported among those with moderate or severe 
head injury and vascular dementia. Notably, however, survey respondents in the Mittenberg et al. 
(2002) study used multiple sources of evidence to identify malingering/symptom exaggeration 
including: PVT failure; severity or pattern of cognitive impairment that was inconsistent with the 
condition; discrepancies among records, self-report, and observed behaviour; implausible self-
reported symptoms in interview; implausible changes in test scores across repeated 
examinations; validity scales on objective personality tests. 
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Interestingly, in the valid sample, diagnosis was unrelated to BRFail on the MSVT and 
TOMM Trial 1. These findings suggest that, when used with credibly-performing examinees, the 
MSVT and TOMM Trial 1 are not associated with an elevated risk of false positives in any 
particular diagnostic groups relative to others. Unfortunately, the relationship between diagnosis 
and BRFail on TOMM Trial 2 or the NV-MSVT in the valid sample remains unclear as no chi-
square or Fisher’s exact tests were conducted in this sample.   
With regard to embedded validity indicators, BRFail varied significantly as a function of 
diagnosis on CT-TE, TMT-A, TMT-B, and TMT-A+B in both the overall and valid samples, 
although effect sizes were small. Groups expected to have genuine cognitive impairment (i.e., 
those with moderate-severe TBI, neurological conditions, and severe mental illness) were among 
those with the highest BRFail on several of these validity indicators. The fact that BRFail 
continued to vary significantly as a function of diagnosis when cases failing the WMT were 
removed (i.e., in the valid sample) suggests a risk for increased false positives when using these 
indicators to assess performance validity in cognitively impaired groups. Given that the CT and 
TMT were originally designed to detect cognitive dysfunction rather than performance validity 
(Choca & Morris, 1992; DeFlippis & McCampbell, 1979, 1991, 1997; Reitan & Wolfson, 1985), 
these results are not surprising. Consistent with this, the potential sensitivity of embedded 
validity indicators to genuine cognitive impairment (e.g., secondary to neurological and 
neurodevelopmental conditions) has been identified as a risk associated with their use over free-
standing PVTs (Boone, 2007). It has been recommended that such indicators be supplemented 
with one or more free-standing PVTs in practice. 
 On RDS, patients expected to be cognitively impaired generally demonstrated lower 
BRFail compared to groups that are unlikely to have such impairment, suggesting that this 
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indicator may be more resistant to the impact of true cognitive dysfunction than the embedded 
validity indicators discussed above. At RDS ≤6, for example, the highest BRFail were observed 
among the orthopedic injury, chronic pain/fibromyalgia, and mTBI groups in the overall sample, 
and among the orthopedic injury and mTBI groups in the valid sample. Patients with moderate-
severe TBI demonstrated the lowest BRFail in both samples. This pattern of results suggests that 
RDS is largely unaffected by true cognitive dysfunction at a cutoff of ≤6 and therefore likely 
represents an effective validity indicator at that level. Notably, however, elevated BRFail were 
observed among neurological patients at RDS ≤7 in both the overall and valid samples, 
suggesting an increased risk of false positives in this group at this cutoff. The latter finding is 
consistent with past research showing that a cutoff of RDS ≤7 produces unacceptably high false 
positives in several clinical groups including patients with cerebrovascular accidents (Heinly et 
al., 2005). 
BRFail did not vary significantly as a function of diagnosis on WCST FMS or TMT-B/A 
in either the overall or valid samples. These results suggest that WCST FMS and TMT-B/A are 
appropriate for use with a variety of clinical groups and do not carry an increased risk of false-
positive errors in one or more diagnostic groups relative to others. 
The effect of age on PVT failure rates. In the overall sample, BRFail were significantly 
associated with age on all of the free-standing PVTs (i.e., WMT, MSVT, NV-MSVT, TOMM 
Trials 1 and 2), although effects were small in magnitude. On each PVT, BRFail tended to 
increase with older age. Given the prevalence of invalid performance in the overall sample, 
however, it remains unclear whether this finding reflects (a) higher rates of invalid performance 
among older examinees, (b) higher false positive rates among older examinees, or (c) both. 
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In the valid sample, age was unrelated to BRFail on TOMM Trials 1 and 2, with the 
exception of Trial 2 ≤49, where the oldest group demonstrated almost three times the BRFail 
observed among the other age groups.	MSVT and NV-MSVT BRFail also varied significantly as 
a function of age in the valid sample, with comparable BRFail among those aged 16 to 49 years 
and higher BRFail in older examinees. Taken together, these results suggest an elevated risk for 
false positive errors among older examinees when using TOMM Trial 2 ≤49 and the MSVT and 
NV-MSVT (at standard cutoffs). 
The fact that BRFail on the MSVT, NV-MSVT, and TOMM Trial 2 ≤49 were related to 
age in the valid sample is somewhat surprising as free-standing PVTs are often thought to be 
resistant to the effects of older age. BRFail on the MSVT and NV-MSVT were likely related to 
age in the present dissertation because only the standard cutoffs were used to classify patients as 
valid versus invalid on these instruments; the GMIP criteria were not used. As discussed above, 
the GMIPs distinguish severe cognitive impairment from non-credible performance in cases 
where standard cutoffs on the MSVT and NV-MSVT are failed (Green, 2004; Green, 2008) and 
have been shown to reduce false positives among older adults with memory impairment and 
dementia in a number of studies (Henry et al., 2009; Howe et al., 2007; Howe & Loring, 2009; 
Green, 2011; Singhal et al., 2009). Considering this, it is possible that the elevated BRFail among 
older examinees in the valid sample included false positive cases that may have met GMIP 
criteria and ultimately been classified as valid. 
With regard to TOMM Trial 2, previous research found the standard cutoff (Trial 2 ≤44) 
to produce adequate specificity in older adults with mild cognitive impairment (Teichner & 
Wagner, 2004; Walter et al., 2014). The current findings extend past research by showing that, 
although age is not meaningfully related to TOMM Trial 2 BRFail up to a cutoff of Trial 2 ≤48, 
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the most liberal conceivable cutoff (i.e., Trial 2 ≤49) is associated with an increased risk for false 
positive errors among older examinees. 
With regard to embedded validity indicators, age was associated with BRFail on RDS, CT-
TE, TMT-A, TMT-B, and TMT A+B in the overall sample with small to medium effect sizes. 
Similar results were observed in the valid sample, although RDS BRFail only varied significantly 
as a function of age at ≤7. In both samples, and across PVTs, the youngest age group tended to 
have the lowest BRFail, and BRFail increased with age. Although previous research has not 
investigated the effects of age on these scores as indicators of performance validity specifically, 
there is strong evidence for age effects in the tests’ normative samples (Heaton, Miller, Taylor, & 
Grant, 2004; Wechsler, 2008). Consistent with this, the current findings indicate that higher 
BRFail are predictably observed in older examinees compared to younger examinees when these 
tests are co-opted as PVTs. The fact that the relationship between age and BRFail on these validity 
indicators persisted in the valid sample suggests an increased risk for false positive errors when 
using these indicators to assess performance validity among older examinees. Notably, given that 
RDS BRFail were only associated with age at ≤7 in the valid sample, using a more conservative 
cutoff on this indicator (e.g., RDS ≤6) is likely to protect against false positive errors. 
Follow-up analyses suggested that the results observed across the aforementioned PVTs 
with regard to age may have been confounded by education level to some degree. Specifically, 
mean education level was approximately one year lower among the oldest age group (60-69 
years) compared to the other groups. Therefore, the elevated BRFail, which were observed in the 
oldest group across many PVTs of interest, likely reflected a combination of older age and 
slightly lower education level. 
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On WCST FMS and TMT-B/A, BRFail did not vary as a function of age in either sample. 
These findings suggest that these indicators can be used to assess performance validity across 
examinees aged 16 to 69 years, without elevated risks of false positives in some age groups 
relative to others. 
The effect of education level on PVT failure rates. With regard to free-standing PVTs, 
education was associated with BRFail on the WMT, MSVT, NV-MSVT, and TOMM Trial 1 in 
the overall sample, although the effects were small in magnitude. On each PVT, the least 
educated group tended to have the highest BRFail, and BRFail decreased with higher levels of 
education. Again, given the prevalence of invalid performance in the overall sample, it remains 
unclear whether these findings reflect (a) higher rates of invalid performance among less 
educated examinees, (b) higher false positive rates among less educated examinees, or (c) both. 
TOMM Trial 2 BRFail were not related to education level in the overall sample. 
In the valid sample, BRFail were not meaningfully related to education level on any of the 
free-standing PVTs of interest. These results suggest that the MSVT, NV-MSVT, and TOMM 
are appropriate for use with examinees with a wide range of educational levels, and lower levels 
of education are not associated with an increased risk of false positives on these PVTs among 
credibly-performing examinees. 
 With regard to embedded validity indicators, education level was related to BRFail on 
RDS, CT-TE, TMT-A, TMT-B, and TMT A+B in both samples such that the highest BRFail 
tended to be observed in the least educated groups. The fact that BRFail continued to vary as a 
function of education level in the valid sample suggests an increased risk for false positive errors 
when using these indicators to assess performance validity among examinees with low levels of 
education. Notably, given that TMT-A BRFail were only meaningfully associated with education 
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level at the most liberal cutoff examined (≥43) in the valid sample, using more conservative 
TMT-A cutoffs may help protect against false positive errors in examinees with low levels of 
education. 
Consistent with the above findings, examination of demographically-corrected normative 
data for the Category Test (Heaton et al., 2004), Trail Making Test (Heaton et al., 2004), and 
WAIS Digit Span (Pearson, 2009) indicates that more educated examinees perform better on 
these measures than less educated examinees: on each of these tests, the same raw score 
corresponds to lower standardized scores (reflecting worse performance) among examinees with 
more years of education and higher standardized scores (reflecting better performance) among 
examinees with fewer years of education. 
 The relationship between WCST FMS BRFail and education level remains somewhat 
unclear due to the relatively small sample sizes across cutoffs in both samples and, in particular, 
among the least educated group (≤8 years). Nonetheless, the pattern of BRFail across examinees 
with 9 to ≥17 years of education suggests that lower levels of education (i.e., ≤12 years) are 
associated with higher BRFail and an increased risk for false positive errors when using WCST 
FMS as a validity indicator. 
 While the results of Studies 1 and 2 suggest that WCST FMS may vary as a function of 
education level, FMS performance does not appear to be related to education level in the WCST 
normative sample. Based on information reported in the test manual (Heaton et al., 1993), the 
relationship between FMS raw scores and education was not investigated in the normative 
groups. However, age-adjusted FMS scores were not related to education level. Furthermore, due 
to low sample sizes in some age-by-education cells, normative data for FMS were generated 
using only age. Thus, FMS raw scores correspond to the exact same percentile equivalents 
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(standardized scores) for all examinees within a given age bracket, regardless of their education 
levels. It is possible that FMS performance was not related to education level in the WCST 
normative sample because the authors used age-adjusted FMS scores rather than raw scores. 
Given the findings of Studies 1 and 2, however, the relationship between WCST FMS raw scores 
and education level requires further investigation in future studies. 
While BRFail generally decreased with higher levels of education on the aforementioned 
PVTs, unexpectedly high BRFail were observed among one or both of the most highly educated 
groups (16 years and ≥17 years) on a number of PVTs including the MSVT, TOMM Trials 1 and 
2, CT-TE, TMT-A, TMT-B, and TMT A+B. This pattern was observed in both the overall and 
valid samples and, across most PVTs, the elevated BRFail were more pronounced in those with 
≥17 years of education than those with 16 years of education. 
To further investigate these unexpected findings, follow-up analyses were conducted, 
which identified age and diagnosis as potentially significant confounds across education groups. 
Specifically, the average age of examinees with ≤8, 16, and ≥17 years of education was 
approximately five years older than the average age of participants in the remaining groups. 
Additionally, the groups with 16 and ≥17 years of education contained larger proportions of 
patients with neurological conditions compared to other education groups and therefore may 
have been more cognitively impaired. Taken together, these results suggest that the BRFail for the 
least educated group reflected a combination of lower education level and older age, while the 
BRFail for the two most educated groups were likely impacted by older age and more severe 
cognitive impairment. 
 On TMT-B/A, BRFail were positively associated with education level in both samples: the 
lowest BRFail were observed in patients with the lowest levels of education, and BRFail increased 
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with higher levels of education. Although paradoxical, this finding indicates that patients with 
higher levels of education complete TMT-B much more quickly, relative to TMT-A, than those 
with lower levels of education. Thus, a higher education level may confer a greater advantage to 
examinees on TMT-B as compared to TMT-A. Consistent with this hypothesis, a stronger 
negative correlation was reported between education level and TMT-B completion time as 
compared to education level and TMT-A completion time among healthy, community-dwelling 
adults (Tombaugh, 2004). Taken together, these findings indicate that although TMT-B/A is 
appropriate for use with examinees with lower levels of education, there may be an increased 
risk of false positive errors when using this validity indicator with more educated examinees. 
The effect of gender on PVT failure rates. In the overall sample, BRFail on the WMT, 
MSVT, and NV-MSVT were related to gender, with males demonstrating slightly higher BRFail 
than females, while BRFail on TOMM Trials 1 and 2 were not. Among credibly-performing 
examinees (i.e., in the valid sample), there was no relationship between gender and BRFail on any 
of the free-standing PVTs of interest. 
With regard to embedded validity indicators, there was some evidence for a gender effect 
on WCST FMS in the overall sample: although BRFail were not associated with gender at WCST 
FMS ≥2, males were more likely than females to fail WCST FMS ≥3. Gender was not related to 
WCST FMS BRFail at either cutoff in the valid sample. Additionally, there were no significant 
relationships between gender and BRFail on RDS, CT-TE, TMT-A, TMT-B, TMT A+B, or TMT-
B/A in either sample. 
Taken together, the results indicate that, among credibly-performing examinees, there are 
no meaningful relationships between gender and BRFail across any of the PVTs of interest 
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examined. As such, the free-standing PVTs and embedded validity indicators examined in this 
dissertation are appropriate for assessing performance validity among both males and females.  
The effect of English language status on PVT failure rates. In the overall sample, 
NSEs demonstrated significantly lower BRFail than ESL patients on all free-standing PVTs, 
including the WMT. As suggested above, this finding may reflect higher rates of invalid 
performance among ESL examinees and/or higher rates of false positives among ESL 
examinees. 
When cases failing the WMT were removed (i.e., in the valid sample), MSVT BRFail did 
not differ meaningfully as a function of English language status: NSEs and ESL patients 
demonstrated generally comparable BRFail. The fact that BRFail on a verbal task like the MSVT 
were not related to English language status is unexpected. However, this finding may be due to 
the use of the WMT as the criterion to establish the valid sample. Both the WMT and MSVT 
require a grade 3 reading level (Green, 2003; Green, 2004). Considering this, ESL examinees 
who were included in the valid sample possessed, at the very least, this level of reading ability 
and therefore were able to pass the MSVT at comparable rates to their NSE counterparts. 
Interestingly, NSEs did demonstrate significantly lower BRFail as compared to ESL 
patients on non-verbal free-standing PVTs (i.e., the NV-MSVT and TOMM Trials 1 and 2) in 
the valid sample. These results suggest a risk for false-positive errors when using these 
instruments to assess performance validity among ESL patients. 
With regard to embedded validity indicators, NSEs demonstrated significantly lower 
BRFail than ESL patients on RDS, CT-TE, TMT-A, TMT-B, and TMT A+B, in both the overall 
and valid samples. The fact that BRFail continued to vary as a function of English language status 
when cases failing the WMT were excluded (i.e., in the valid sample) suggests a risk for false 
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positive errors when using these indicators to assess performance validity among ESL patients. 
The finding involving higher RDS BRFail among ESL examinees is consistent with previous 
research in which various RDS cutoffs achieved lower levels of specificity among ESL 
examinees as compared to Caucasians (Salazar et al., 2007). It is also consistent with past studies 
showing that ESL status affects performance on various neuropsychological tasks involving high 
verbal mediation (e.g., Boone et al., 2007). 
 Although ESL patients are often expected to perform more poorly than NSEs on verbal 
tasks specifically, the results of Studies 1 and 2 indicate that (1) ESL examinees also fail PVTs 
involving non-verbal or visuospatial stimuli at higher rates than NSEs (i.e., NV-MSVT, TOMM, 
CT-TE, TMT), and (2) these differences in BRFail continue to be observed after examinees 
demonstrating non-credible performance on an external criterion PVT are excluded from the 
analyses. The elevated BRFail observed among ESL patients on visuospatial and non-verbal 
PVTs, particularly in the valid sample, may be the result of cultural differences. Although 
neuropsychologists have long believed that the use of visuospatial and non-verbal tests 
ameliorates the impact of culture on testing, it has been argued that such instruments are not 
“culture free” (Rosselli & Ardila, 2003). Indeed, skills that are considered to be universal among 
neurotypical adults (e.g., those involving writing or drawing, or remembering abstract 
information, for example) may be less emphasized or entirely absent in some cultures (Ardila & 
Moreno, 2001; Berry, Poortinga, & Segall, 1992; Irvine & Berry, 1988). Furthermore, other 
cultures may not value “fast performance” in the same way that the North American culture 
does, which would affect performance on tests such as TMT (e.g., Leon-Carrion, 1989). In 
addition to cultural differences, factors such as educational experience, educational level, level of 
acculturation, and socioeconomic status may contribute to the lower neuropsychological test 
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scores (and higher PVT BRFail) observed among ESL patients relative to NSEs (Manly, Byrd, 
Touradji, & Stern, 2004; Mehta et al., 2004; Perez-Arce & Puente, 1996).  
BRFail on WCST FMS and TMT-B/A were unrelated to English language status in either 
sample, suggesting that these indicators are equally appropriate for use with NSEs and ESL 
patients. 
FTT-based validity indicators. BRFail on FTT-based validity indicators among males 
were reported as part of Studies 1 and 2. Because the FTT was not as widely administered in the 
current data set as other measures used in this dissertation, sample sizes were small at most 
cutoffs in the overall sample and all cutoffs in the valid sample. Not surprisingly, further 
stratification of the data as a function of various patient variables (e.g., diagnosis, age, education) 
resulted in several small cell sizes across analyses. In light of this, some estimates of BRFail 
reported for FTT-based validity indicators in Studies 1 and 2 may be unreliable. Additionally, the 
relationships between BRFail and patient variables remain somewhat unclear as null-hypothesis 
significance tests were not conducted at many of the cutoffs examined and, where such tests 
were conducted, they were likely underpowered. Considering these issues, further investigation 
of the relationships between FTT-based validity indicators and patient variables is warranted 
with larger samples. Nonetheless, the findings from Studies 1 and 2 are discussed below. 
 The relationship between BRFail on FTT-based validity indicators and diagnosis remains 
unclear due to the small sizes of several clinical groups, although effect sizes suggested small 
effects where computed (i.e., at one cutoff each on FTT-DHM and FTT-CM). 
 BRFail on FTT-DHM, FTT-NDHM, and FTT-CM appeared to be related to age in both 
samples, with small to medium effect sizes. The youngest group tended to have the lowest BRFail, 
and BRFail increased with older age. The fact that FTT-DHM and FTT-NDHM scores decline with 
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older age is supported by normative data for the FTT. In the widely used Heaton et al. (2004) 
normative data, for example, the same raw score on FTT-DH or FTT-NDH corresponds to a 
higher standardized score (indicating better performance) among older men and to a low 
standardized score (indicating worse performance) among younger men, suggesting that older 
examinees are expected to obtain lower raw scores on FTT, while younger examinees are 
expected to obtain higher raw scores. FTT-DIFFM BRFail did not appear to be associated with age 
in either sample and, therefore, this indicator is likely equally appropriate for use with examinees 
between the ages of 16 and 69 years. 
 BRFail on FTT-DHM, FTT-NDHM, and FTT-CM appeared to be related to education level 
in both samples, although effect sizes were small. On each of these validity indicators, BRFail 
tended to decrease with higher levels of education. This finding is consistent with normative data 
for FTT (Heaton et al., 2004), in which the same raw score on FTT-DH or FTT-NDH 
corresponds to a higher standardized score in men with low levels of education and to a lower 
standardized score in men with high levels of education. However, in the present dissertation, the 
most educated group (≥17 years of education) demonstrated unexpectedly high BRFail relative to 
other education groups in both the overall and valid samples. As noted above, follow-up analyses 
suggested that age and diagnosis may represent confounds in the most educated group. While it 
is possible that the older age of examinees in this group may have accounted for their higher 
BRFail on FTT-DHM, FTT-NDHM, and FTT-CM, normative data for the FTT (Heaton et al., 2004) 
suggest that older age alone is unlikely to fully account for this finding: although older age 
would be expected to result in higher BRFail, the high level of education among the most educated 
group would likely buffer the effects of age, at least to some degree. Considering this, the 
unexpectedly high BRFail observed among the most educated group is likely driven by a larger 
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proportion of patients with motor impairment secondary to neurological conditions. BRFail on 
FTT-DIFFM did not appear to be related to education level in either sample, suggesting that this 
indicator may be equally appropriate for use with individuals of varying education levels. 
 With respect to English language status, ESL patients tended to demonstrate higher BRFail 
on FTT-DHM, FTT-NDHM, and FTT-CM relative to NSEs in both the overall and valid samples. 
Given that BRFail continued to vary as a function of English language status when examinees who 
failed the WMT were excluded from the analyses, the higher BRFail among ESL patients, 
particularly in the valid sample, may reflect cultural differences, where motor speed may not be 
valued and/or emphasized in the ESL patients’ cultures to the same degree as it is in the North 
American culture, for example (Rosselli & Ardila, 2003). BRFail on FTT-DIFFM were largely 
comparable among ESL patients and NSEs, suggesting that this validity indicator may not be 
affected by English language status. 
 Taken together, results for FTT-based validity indicators suggest that there may be an 
increased risk for false positive errors on FTT-DHM, FTT-NDHM, and FTT-CM among older, less 
educated, and ESL examinees. FTT-DIFFM BRFail, however, appear to be unrelated to the patient 
variables examined. 
Study 3 
 Classification accuracy of individual PVTs and validity indicators. The results of 
Study 3 are largely consistent with past research in that many of the previously published cutoffs 
on PVTs of interest achieved acceptable (.84-1.00) specificity in the current sample. These 
include previously published cutoffs for the MSVT and NV-MSVT (Armistead-Jehle & Gervais, 
2012; Green, 2007; Green, 2011), TOMM Trials 1 and Trial 2 (Bauer et al., 2007; Denning, 
2012; Erdodi & Rai, 2017; Fazio, 2016; Greve et al., 2006a; Greve et al., 2006b; Greve, Etherton 
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et al., 2009; Horner et al., 2006; Jones, 2013; Schroeder et al., 2013; Tombaugh, 1996; Wisdom 
et al., 2012), RDS (Babikian et al., 2006; Duncan & Ausborn, 2005; Greiffenstein et al., 1994; 
Heinly et al., 2005; Larrabee, 2003; Mathias et al., 2002; Meyers & Volbrecht, 1998), WCST 
FMS (Greve, Heinly et al., 2009), CT-TE (Greve et al., 2007), TMT-based indicators (Busse & 
Whiteside, 2012; Iverson et al., 2002), and FTT-based indicators (Arnold et al., 2005; Axelrod et 
al., 2014; Shura et al., 2016; Smith et al., 2014).  
Notably, there were a few cutoffs that demonstrated acceptable classification accuracy in 
previous studies but were associated with unacceptably low specificity in the current sample. For 
example, in a study by Larrabee (2003), WCST FMS ≥2 achieved acceptable specificity in 
moderate-to-severe closed head injury patients and good sensitivity in cases demonstrating 
worse-than-chance performance on a free-standing PVT (PDRT; Binder, 1993). However, the 
same cutoff produced a 27% false positive rate in Study 3 of the present dissertation. Similarly, 
TMT A+B ≥137”, which was associated with .90 specificity and .21 sensitivity in a sample of 
post-deployment veterans (Shura et al., 2016), resulted in a 19% false positive error rate in Study 
3.  
These discrepancies in classification accuracy results for WCST FMS ≥2 and TMT A+B 
≥137” are likely due to different sample characteristics. The valid group in Larrabee’s (2003) 
study consisted of patients with moderate-to-severe closed head injury, while Study 3 involved a 
more heterogeneous sample containing patients with neurological, psychiatric, and 
medical/orthopedic diagnoses. Base rate data reported in Studies 1 and 2 indicate that, in addition 
to patients with TBI, those with neurological conditions, severe mental illness, orthopedic 
injuries, and other diagnosis demonstrate elevated BRFail on WCST FMS ≥2. Considering this, 
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the unacceptably high false-positive rate associated with WCST FMS ≥2 in the present 
dissertation is not surprising. 
In the case of TMT A+B ≥137”, although more than half of the post-deployment veterans 
included in the Shura et al. (2016) study met criteria for a psychiatric disorder at the time of the 
assessment and approximately 60% had a lifetime history of mTBI, individuals with moderate or 
severe TBI were excluded. In contrast, the current sample contained patients with a variety of 
conditions that would be expected to produce genuine and significant cognitive impairment (e.g., 
moderate to severe TBI, neurological conditions, severe mental illness). Thus, the mixed clinical 
sample in the present study was likely more cognitively impaired than the sample of post-
deployment veterans used in the Shura et al. (2016) study and, therefore, required a more 
conservative cutoff to maintain an acceptable level of specificity. 
In addition to WCST FMS ≥2 and TMT A+B ≥137”, CT-TE ≥87 produced an 
unacceptably high false positive rate (17%) in the present dissertation. The latter finding is likely 
due to the fact that this cutoff originated from studies using analogue-simulation designs 
(Tenhula & Sweet, DiCarlo et al., 2000). As discussed earlier, analogue-simulation designs tend 
to overestimate classification accuracy (Babikian & Boone, 2007; Sollman & Berry, 2011). 
While the majority of previously published cutoffs produced acceptable classification 
accuracy in Study 3, some previously published cutoffs were found to be overly conservative, 
producing high specificity at the cost of low sensitivity. This was particularly true for lower (i.e., 
more conservative) cutoffs on TOMM Trials 1 and 2, TMT-A ≥63, TMT-B ≥200, and cutoffs on 
several FTT-based indicators. Study 3 results indicate that more liberal cutoffs on these 
indicators can be used to assess performance validity in medical-legal samples, while 
maintaining good (≥.90) specificity. 
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Relative classification accuracy of PVTs of interest. Comparison of classification 
accuracy statistics across PVTs of interest revealed that free-standing PVTs achieved higher 
levels of sensitivity than did embedded validity indicators. Although these findings are consistent 
with previous literature showing that free-standing PVTs achieve greater sensitivity to invalid 
performance than embedded validity indicators when used alone (Iverson & Binder, 2000; Miele 
et al., 2012; Sweet & Nelson, 2007), it is possible that instrumentation artifacts influenced these 
findings to some degree (Erdodi, 2017). Specifically, all of the free-standing PVTs of interest in 
the present dissertation matched the criterion PVT in terms of testing paradigm and cognitive 
domain (i.e., the WMT and all free-standing PVTs were forced-choice recognition memory 
tests). On the other hand, none of the embedded validity indicators were derived from memory 
tests and only one of them (i.e., CT-TE) employed a forced-choice recognition paradigm. As a 
result of these differences, sensitivity and specificity may have been overestimated for the free-
standing PVTs and underestimated for the embedded validity indicators. 
General Discussion 
 Free-standing PVTs versus embedded validity indicators. Taken together, the results 
of this dissertation suggest that free-standing PVTs are not only more sensitive to invalid 
performance than embedded validity indicators, but they also tend to be more resistant to the 
effects of some patient variables (e.g., diagnosis, education). The stronger association between 
diagnosis and BRFail on embedded validity indicators (as compared to free-standing PVTs) is 
likely due to the fact that these indicators are derived from standard tests of neuropsychological 
ability. Given that neuropsychological tests are designed to detect true cognitive (or in the case 
of FTT, motor) impairment, the “after-market” validity cutoffs are less effective than free-
standing PVTs at separating genuine impairment from non-credible responding. 
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 The fact that BRFail on embedded validity indicators tended to be more strongly related to 
age and education level than BRFail on free-standing PVTs is likely due in large part to the fact 
that nearly all of the embedded validity indicators examined (with the exception of RDS) 
represented raw rather than standardized scores, either alone in combination. It is well 
established that age and education affect raw scores on neuropsychological tests (Strauss et al., 
2006). As a result, these variables are routinely accounted for in the normative data used to 
interpret patients’ neuropsychological test scores (e.g., Heaton et al., 2004; Pearson, 2009; 
Strauss et al., 2006). Considering this, the practice of co-opting raw scores as validity indicators 
is particularly problematic as it carries the risk for increased false positives in older and less 
educated examinees. 
To reduce the impact of patient variables such as age and education on PVT scores, more 
recent studies have examined the utility of age- and demographically-corrected test scores as 
validity indicators. Examples of such indicators include the age-corrected scaled score on the 
Digit Span subtest of the WAIS (DS-ACSS; Jasinski et al., 2011), age-corrected scores on TMT-
A and TMT-B (Ashendorf, Clark, & Sugarman, 2017), and demographically-corrected T scores 
on the Controlled Oral Word Association Test (Sugarman & Axelrod, 2015). The existing 
literature suggests that these indicators not only account for confounding demographic factors 
but they also demonstrate good classification accuracy. Thus, standardized scores may represent 
more effective embedded validity indicators than raw scores and should continue to be 
investigated further in future research. 
 Subtypes of embedded validity indicators. Compared to the other embedded validity 
indicators examined in this dissertation, WCST FMS, TMT-B/A and FTT-DIFF differed in that 
they were largely unrelated to the patient variables examined in Studies 1 and 2, and they also 
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demonstrated among the lowest sensitivity to invalid performance (as defined by the WMT) in 
Study 3. These findings may be due to the fact that WCST FMS, TMT-B/A and FTT-DIFF 
assess performance validity in different ways than do many of the other PVTs of interest (Erdodi, 
2017). 
Most of the PVTs of interest examined in this dissertation evaluate performance validity 
based on the examinee’s absolute level of performance on the task: better performance on the 
task is classified as valid and worse performance is classified as invalid. WCST FMS, however, 
captures an atypical aspect of performance rather than poor performance on the task more 
globally (Larrabee, 2003). An FMS error is recorded when an examinee matches a card 
incorrectly after matching five or more consecutive cards correctly but before successfully 
completing the category. Data presented in the WCST manual (Heaton et al., 1993) indicate that 
multiple FMS errors are observed infrequently across examinees, irrespective of age, diagnosis, 
or level of impairment. Given the rarity of such errors, when used as an embedded validity 
indicator, WCST FMS provides qualitatively different information from most other performance 
validity assessment tools and, therefore, may be conceptualized as a unique subtype of embedded 
validity indicator. 
 TMT-B/A and FTT-DIFF also differ from most other embedded validity indicators in 
their approach to performance validity assessment. Specifically, rather than considering the 
absolute performance on a single task, these indicators evaluate examinees’ relative 
performances on two tasks of varying difficulty levels (i.e., TMT-A and TMT-B, FTT-DH and 
FTT-NDH) and flag as invalid those examinees who perform comparably or better on the more 
difficult task as compared to the easier task (Arnold et al., 2005; Iverson et al., 2002). The inner 
logic behind the use of TMT-B/A and FTT-DIFF as validity indicators may explain why these 
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indicators were found to be unrelated to patient variables in Studies 1 and 2. Specifically, 
although performance on each task is affected by diagnosis and demographic variables, the act of 
comparing an examinee’s performance on one task to their own performance on another task 
offsets the effects of these variables. Thus, the resulting difference- or ratio-score is not 
associated with diagnosis and demographic variables in the same way as the scores on each 
individual task. Taken together, the findings from this dissertation suggest that, like WCST FMS, 
TMT-B/A and FTT-DIFF may also constitute a unique subtype of embedded validity indicators. 
 When compared to free-standing PVTs and other embedded validity indicators, WCST 
FMS, TMT-B/A and FTT-DIFF were among the least sensitive to invalid performance as defined 
by the WMT. While these findings can be interpreted as suggesting that these indicators are less 
effective as PVTs, their low sensitivities may simply reflect a mismatch in assessment 
modality/detection mechanism between the predictor PVTs and the criterion PVT (Erdodi, 
2017): indeed, an examinee who fails the WMT may not necessarily violate the normative 
difficulty gradients on tasks like the TMT and FTT or make multiple atypical FMS errors on the 
WCST. Consistent with this hypothesis, recent studies have found that the match between 
criterion and predictor variables (i.e., in terms of sensory modality, cognitive domain, and testing 
paradigm) influences the outcome of signal detection analyses and may represent a significant 
confound in performance validity research more broadly (Erdodi, 2017; Erdodi, Abeare, et al., 
2017; Erdodi, Tyson, et al., 2017). Given the major research and clinical implications of these 
findings, further investigation of Erdodi’s (2017) domain specificity hypothesis is required to 
better understand how various characteristics of predictor and criteria PVTs, and the match or 
mismatch between them, impact classification accuracy. 
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 Implications for clinical and medical-legal practice. Based on research indicating that 
a large proportion of invalid cases go undetected when using a single PVT, experts in the field 
have repeatedly recommended using multiple, non-redundant PVTs, interspersed throughout the 
test battery, to monitor test-taking effort continuously during neuropsychological assessments 
(Bush et al., 2005; Heilbronner et al., 2009; Larrabee, 2012c; Orey et al., 2000; Sweet & Nelson, 
2007; Vickery et al., 2004). Despite the fact that such recommendations were first made nearly 
two decades ago, however, there is currently little consensus on which PVTs and/or embedded 
validity indicators should be used in different assessment settings, the order in which they should 
be administered, and whether liberal or conservative cutoffs should be applied. Additionally, 
although there is reasonable agreement among experts that evidence of invalid performance on 
two independent measures renders the overall neuropsychological profile invalid (Bilder, Sugar, 
& Hellemann, 2014; Boone, 2013; Davis & Millis, 2014; Larrabee, 2003), the question about 
how many PVTs to administer continues to be hotly debated (Davis & Millis, 2014; Larrabee, 
2014a; Silk-Eglit, Stenclik, Miele, Lynch, & McCaffrey, 2015). Larrabee (2014a), for example, 
demonstrated that administering multiple PVTs, each with .90 specificity (i.e., a 10% per-test 
false-positive rate), results in a small increase in the overall false-positive rate as the number of 
PVTs increases. In such cases, he recommended reducing false positives by adjusting cutoffs in 
light of patient characteristics and/or increasing the number of PVT “failures” required before a 
neuropsychological profile is deemed invalid (Larrabee, 2014b). 
 Results from this dissertation can help to address some of the challenges identified with 
the use of PVTs in practice, particularly with respect to the selection of PVTs and cutoff scores. 
By reporting classification accuracy for multiple cutoffs on a wide range of PVTs, the results of 
Study 3 allow clinicians to compare sensitivity and specificity both between and within PVTs 
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(i.e., how the classification accuracy of one PVT compares to another, how different cutoffs on a 
given PVT compare to eachother) and select PVTs and cutoff scores according to the needs of 
their practices. Once the PVTs and cutoff scores are selected, the base rate data reported as part 
of Study 2 can be used as an empirical basis to adjust cutoffs for particular patient groups. If, for 
example, credibly-performing older examinees demonstrated an elevated BRFail at a particular 
cutoff on a given PVT, clinicians using that PVT with older patients may wish to use a more 
conservative cutoff to protect against false-positive errors. 
Limitations. The results of this dissertation should be interpreted in light of its 
limitations. First, the data used for this dissertation were collected in a primarily medical-legal 
setting and in a relatively restricted geographical region (i.e., a midwestern Canadian city). 
Therefore, these findings may not generalize to other assessment settings (e.g., where 
neuropsychological assessments are conducted purely for clinical purposes) or geographical 
regions. Second, participants were assigned to diagnostic groups based on their primary 
diagnoses and no information was available about comorbid conditions. Given that patients 
assessed in clinical/medical-legal practice often have multiple diagnoses, the diagnostic groups 
included in the present dissertation were not mutually exclusive. Third, there was large 
variability in the sizes of various diagnostic and demographic groups, and some patient variables 
were confounded with others. For example, the oldest age group was slightly less educated than 
the younger groups; the least educated group and the two most educated groups were older in age 
than the remaining education groups; and the two most educated groups contained a larger 
proportion of patients with neurological conditions than the other education groups. Considering 
these findings, in many cases, the reported BRFail likely reflect the interaction of multiple patient 
variables as opposed to any single variable. Fourth, due to the retrospective nature of this 
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dissertation and a flexible-battery approach to test selection at the practices from which the data 
were obtained, there were many tests that were not administered to all participants and some tests 
(e.g., FTT) were not administered widely enough to draw meaningful conclusions about trends in 
BRFail across diagnostic/demographic groups in Studies 1 and 2. Fifth, the WMT (Green, 2003) 
was used as the criterion PVT, in part because it was the most widely administered PVT. It is 
possible that the results of the present dissertation would have been different if another criterion 
(e.g., MND criteria, a criterion based on a different free-standing PVT or multiple PVTs) had 
been used. Finally, while very interesting findings related to English language status emerged in 
Studies 1 and 2, unfortunately, the ESL group in the present dissertation was poorly defined and 
quite heterogeneous. Participants were included in the ESL group if they identified as non-native 
speakers of English during the clinical interview, regardless of their country of origin (i.e., 
Canada or elsewhere in the world). Considering this, the ESL group likely contained examinees 
who varied widely in their true levels of English proficiency. Unfortunately, however, additional 
information that would have been important for quantifying the participants’ levels of English 
proficiency (e.g., age at which conversational English was learned, years of education completed 
in Canada or in the English language, number of years spent living in Canada) was not available.  
Future Directions. The results of the present dissertation suggest a number of important 
directions for future research. First and foremost, further research is needed on individual PVTs 
(both free-standing and embedded) to better understand how they operate in different clinical and 
demographic groups, including and especially among ESL populations, and in different settings 
(e.g., medical-legal versus clinical). Ideally, future research would lead to the development of 
population-specific cutoffs (i.e., cutoffs unique to different clinical and/or demographic groups) 
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on each PVT so that cutoffs established with one clinical group (e.g., mTBI) do not have to be 
extended to new groups in the absence of any evidence to support this practice. 
The results of the present dissertation also provide some evidence for differentiating 
embedded validity indicators into subtypes based on assessment modality/detection mechanism. 
However, further research is required to better understand the classification accuracy and clinical 
utility of validity indicators that differ in their detection mechanisms (e.g., whether certain 
detection mechanisms are better suited for particular patient groups and/or specific assessment 
contexts than other detection mechanisms). Importantly, given recent studies suggesting that the 
classification accuracy of predictor PVTs may vary depending on the extent to which they match 
criteria PVT (i.e., in terms of sensory modality, cognitive domain, or testing paradigm; Erdodi, 
2017; Erdodi, Abeare, et al., 2017; Erdodi, Tyson, et al., 2017), PVTs of interest should be 
evaluated against a variety of criteria (e.g., MND criteria, different free-standing PVTs, and/or 
aggregrate measures based on multiple PVTs) in order to obtain more accurate estimates of their 
true classification accuracies.  
Finally, where possible, multiple PVTs should be evaluated in the same samples so as to 
facilitate direct comparisons between individual PVTs. Such data would help to determine 
whether and to what extent different PVTs provide non-redundant information with respect to 
performance validity and, ultimately, inform the selection of PVTs for multivariate models of 
performance validity assessment. 
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CHAPTER 5 
Conclusions 
 The results of this dissertation converge in three major conclusions. First, the assessment 
of performance validity using psychometric instruments is necessary in order to establish the 
veracity of neuropsychological test data, particularly in medical-legal settings where patients 
often have substantial external incentives to appear impaired. Second, given the relationships 
between patient characteristics and BRFail, particularly on embedded validity indicators, future 
research investigating population-specific cutoffs would greatly enhance the clinical utility of 
PVTs. In the meantime, individual PVT scores should be interpreted in the context of patient 
variables, in an empirically-informed manner, rather than by rigid adherence to published 
cutoffs. Finally, although free-standing PVTs tend to be more sensitive to invalid performance 
than embedded validity indicators when used individually, no PVT has perfect classification 
accuracy. Therefore, rather than using a single PVT to assess performance validity, practitioners 
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